TWI690541B - Copolymer - Google Patents
Copolymer Download PDFInfo
- Publication number
- TWI690541B TWI690541B TW105114662A TW105114662A TWI690541B TW I690541 B TWI690541 B TW I690541B TW 105114662 A TW105114662 A TW 105114662A TW 105114662 A TW105114662 A TW 105114662A TW I690541 B TWI690541 B TW I690541B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- general formula
- acid
- present
- copolymer
- Prior art date
Links
- 229920001577 copolymer Polymers 0.000 title claims abstract description 290
- 239000000178 monomer Substances 0.000 claims abstract description 302
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 86
- 125000004432 carbon atom Chemical group C* 0.000 claims description 95
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 87
- 125000002252 acyl group Chemical group 0.000 claims description 63
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 55
- 229910052799 carbon Inorganic materials 0.000 claims description 52
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 51
- 125000000217 alkyl group Chemical group 0.000 claims description 48
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 48
- 239000000470 constituent Substances 0.000 claims description 44
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 43
- 235000011187 glycerol Nutrition 0.000 claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 19
- 125000001931 aliphatic group Chemical group 0.000 claims description 18
- 125000002947 alkylene group Chemical group 0.000 claims description 12
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 claims description 11
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 claims description 10
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 9
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims description 8
- 150000001721 carbon Chemical group 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 125000003892 C18 acyl group Chemical group 0.000 claims description 2
- -1 acetyl taurate type Chemical class 0.000 description 975
- 239000000203 mixture Substances 0.000 description 102
- 235000014113 dietary fatty acids Nutrition 0.000 description 96
- 239000000194 fatty acid Substances 0.000 description 96
- 229930195729 fatty acid Natural products 0.000 description 96
- 239000003921 oil Substances 0.000 description 95
- 235000019198 oils Nutrition 0.000 description 94
- 229920001223 polyethylene glycol Polymers 0.000 description 73
- 239000002202 Polyethylene glycol Substances 0.000 description 72
- 239000012071 phase Substances 0.000 description 64
- 150000003839 salts Chemical class 0.000 description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 61
- 229920005862 polyol Polymers 0.000 description 54
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 53
- 150000003077 polyols Chemical class 0.000 description 53
- 150000004665 fatty acids Chemical class 0.000 description 51
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 50
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 48
- 239000011248 coating agent Substances 0.000 description 47
- 238000000576 coating method Methods 0.000 description 47
- 239000002537 cosmetic Substances 0.000 description 47
- 229920001296 polysiloxane Polymers 0.000 description 45
- 239000002253 acid Substances 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 239000002245 particle Substances 0.000 description 43
- 229940048053 acrylate Drugs 0.000 description 42
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 40
- 239000003795 chemical substances by application Substances 0.000 description 40
- 239000000047 product Substances 0.000 description 40
- 239000004166 Lanolin Substances 0.000 description 36
- 235000019388 lanolin Nutrition 0.000 description 36
- 229940039717 lanolin Drugs 0.000 description 36
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 35
- 239000006096 absorbing agent Substances 0.000 description 33
- 238000006116 polymerization reaction Methods 0.000 description 32
- 238000000034 method Methods 0.000 description 30
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 29
- 239000002736 nonionic surfactant Substances 0.000 description 29
- 229920003169 water-soluble polymer Polymers 0.000 description 29
- 239000001993 wax Substances 0.000 description 29
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 28
- 230000000475 sunscreen effect Effects 0.000 description 28
- 239000000516 sunscreening agent Substances 0.000 description 28
- 229920000642 polymer Polymers 0.000 description 27
- 239000003995 emulsifying agent Substances 0.000 description 26
- 150000002430 hydrocarbons Chemical group 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- 239000004359 castor oil Substances 0.000 description 25
- 235000019438 castor oil Nutrition 0.000 description 25
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 25
- 239000007864 aqueous solution Substances 0.000 description 24
- 230000002829 reductive effect Effects 0.000 description 24
- 239000004094 surface-active agent Substances 0.000 description 24
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 23
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 23
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 21
- 229920001451 polypropylene glycol Polymers 0.000 description 21
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 20
- 235000013985 cinnamic acid Nutrition 0.000 description 20
- 229930016911 cinnamic acid Natural products 0.000 description 20
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 20
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 20
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 19
- 238000004945 emulsification Methods 0.000 description 19
- 239000000499 gel Substances 0.000 description 19
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000005191 phase separation Methods 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 17
- 239000003599 detergent Substances 0.000 description 17
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 17
- 239000007788 liquid Substances 0.000 description 17
- 239000000344 soap Substances 0.000 description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 16
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 16
- 150000001298 alcohols Chemical class 0.000 description 16
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 16
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 16
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- 235000000346 sugar Nutrition 0.000 description 16
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 15
- 150000001412 amines Chemical class 0.000 description 15
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 15
- 238000005187 foaming Methods 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 239000011734 sodium Substances 0.000 description 15
- 239000003945 anionic surfactant Substances 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 14
- 150000002148 esters Chemical class 0.000 description 14
- 229910052708 sodium Inorganic materials 0.000 description 14
- PIGFYZPCRLYGLF-UHFFFAOYSA-N Aluminum nitride Chemical compound [Al]#N PIGFYZPCRLYGLF-UHFFFAOYSA-N 0.000 description 13
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 13
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 13
- 230000014759 maintenance of location Effects 0.000 description 13
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 12
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 12
- 229920000768 polyamine Polymers 0.000 description 12
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 12
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 11
- 150000001408 amides Chemical class 0.000 description 11
- 235000019864 coconut oil Nutrition 0.000 description 11
- 239000003240 coconut oil Substances 0.000 description 11
- 239000001257 hydrogen Substances 0.000 description 11
- 229910052739 hydrogen Inorganic materials 0.000 description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 11
- 229930182490 saponin Natural products 0.000 description 11
- 235000017709 saponins Nutrition 0.000 description 11
- 239000000600 sorbitol Substances 0.000 description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 10
- 125000003562 2,2-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])* 0.000 description 10
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 229960001231 choline Drugs 0.000 description 10
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 10
- 229920000591 gum Polymers 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 10
- 229930195733 hydrocarbon Natural products 0.000 description 10
- 239000002563 ionic surfactant Substances 0.000 description 10
- 229940119170 jojoba wax Drugs 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 239000012188 paraffin wax Substances 0.000 description 10
- 229920000223 polyglycerol Polymers 0.000 description 10
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 10
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 10
- 229920002545 silicone oil Polymers 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 10
- 125000003944 tolyl group Chemical group 0.000 description 10
- 229960000401 tranexamic acid Drugs 0.000 description 10
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 10
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 9
- 239000004386 Erythritol Substances 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 235000021314 Palmitic acid Nutrition 0.000 description 9
- 239000004721 Polyphenylene oxide Substances 0.000 description 9
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 9
- 235000019414 erythritol Nutrition 0.000 description 9
- 229940009714 erythritol Drugs 0.000 description 9
- 239000010696 ester oil Substances 0.000 description 9
- 238000005886 esterification reaction Methods 0.000 description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 9
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 9
- 229920000570 polyether Polymers 0.000 description 9
- 235000010356 sorbitol Nutrition 0.000 description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 8
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 8
- RJWUMFHQJJBBOD-UHFFFAOYSA-N 2-methylheptadecane Chemical compound CCCCCCCCCCCCCCCC(C)C RJWUMFHQJJBBOD-UHFFFAOYSA-N 0.000 description 8
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 8
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 8
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 8
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 8
- 229910019142 PO4 Inorganic materials 0.000 description 8
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 8
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 150000004985 diamines Chemical class 0.000 description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 8
- 239000003925 fat Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 239000006260 foam Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229930182830 galactose Natural products 0.000 description 8
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000007794 irritation Effects 0.000 description 8
- 239000008101 lactose Substances 0.000 description 8
- DIDDVZFHORVZMG-UHFFFAOYSA-N methyl 2-methylprop-2-eneperoxoate Chemical compound COOC(=O)C(C)=C DIDDVZFHORVZMG-UHFFFAOYSA-N 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 239000010452 phosphate Substances 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 8
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- KUQRLZZWFINMDP-BGNLRFAXSA-N 2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KUQRLZZWFINMDP-BGNLRFAXSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- 229930003316 Vitamin D Natural products 0.000 description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 7
- 125000000539 amino acid group Chemical group 0.000 description 7
- 239000002280 amphoteric surfactant Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 150000007949 saponins Chemical class 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000019166 vitamin D Nutrition 0.000 description 7
- 239000011710 vitamin D Substances 0.000 description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 description 7
- 229940046008 vitamin d Drugs 0.000 description 7
- 239000002023 wood Substances 0.000 description 7
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 6
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 6
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 6
- 239000005639 Lauric acid Substances 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 6
- 229920001214 Polysorbate 60 Polymers 0.000 description 6
- 230000006750 UV protection Effects 0.000 description 6
- 229930003779 Vitamin B12 Natural products 0.000 description 6
- 150000001414 amino alcohols Chemical group 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 235000013871 bee wax Nutrition 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 239000010495 camellia oil Substances 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 6
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 6
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 6
- 239000000845 maltitol Substances 0.000 description 6
- 235000010449 maltitol Nutrition 0.000 description 6
- 229940035436 maltitol Drugs 0.000 description 6
- 235000019271 petrolatum Nutrition 0.000 description 6
- 159000000001 potassium salts Chemical class 0.000 description 6
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 6
- 229960004063 propylene glycol Drugs 0.000 description 6
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 229960002920 sorbitol Drugs 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- 238000001308 synthesis method Methods 0.000 description 6
- 239000003760 tallow Substances 0.000 description 6
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 6
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 235000019163 vitamin B12 Nutrition 0.000 description 6
- 239000011715 vitamin B12 Substances 0.000 description 6
- 239000011787 zinc oxide Substances 0.000 description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 5
- TXHZNLCKXHJYNX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C(C)=C TXHZNLCKXHJYNX-UHFFFAOYSA-N 0.000 description 5
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- 241000238631 Hexapoda Species 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- 235000019482 Palm oil Nutrition 0.000 description 5
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 5
- 239000004264 Petrolatum Substances 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 235000019484 Rapeseed oil Nutrition 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- 229930003471 Vitamin B2 Natural products 0.000 description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 5
- 150000005215 alkyl ethers Chemical class 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 229940087168 alpha tocopherol Drugs 0.000 description 5
- 150000003863 ammonium salts Chemical class 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 235000021302 avocado oil Nutrition 0.000 description 5
- 239000008163 avocado oil Substances 0.000 description 5
- 239000012166 beeswax Substances 0.000 description 5
- 229940066595 beta tocopherol Drugs 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 5
- 239000004204 candelilla wax Substances 0.000 description 5
- 235000013868 candelilla wax Nutrition 0.000 description 5
- 229940073532 candelilla wax Drugs 0.000 description 5
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 5
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 5
- 239000004203 carnauba wax Substances 0.000 description 5
- 235000013869 carnauba wax Nutrition 0.000 description 5
- 229940081733 cetearyl alcohol Drugs 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 235000005687 corn oil Nutrition 0.000 description 5
- 239000002285 corn oil Substances 0.000 description 5
- 235000012343 cottonseed oil Nutrition 0.000 description 5
- 239000002385 cottonseed oil Substances 0.000 description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000010382 gamma-tocopherol Nutrition 0.000 description 5
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 5
- 239000004200 microcrystalline wax Substances 0.000 description 5
- 235000019808 microcrystalline wax Nutrition 0.000 description 5
- 239000012184 mineral wax Substances 0.000 description 5
- 229940043348 myristyl alcohol Drugs 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 239000002540 palm oil Substances 0.000 description 5
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 5
- 235000008975 pantethine Nutrition 0.000 description 5
- 239000011581 pantethine Substances 0.000 description 5
- 229960000903 pantethine Drugs 0.000 description 5
- 235000019161 pantothenic acid Nutrition 0.000 description 5
- 239000011713 pantothenic acid Substances 0.000 description 5
- 229940055726 pantothenic acid Drugs 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 5
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 5
- 229940066842 petrolatum Drugs 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 5
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 5
- 229960002477 riboflavin Drugs 0.000 description 5
- 239000003813 safflower oil Substances 0.000 description 5
- 229960004889 salicylic acid Drugs 0.000 description 5
- 235000011803 sesame oil Nutrition 0.000 description 5
- 239000008159 sesame oil Substances 0.000 description 5
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 229960000984 tocofersolan Drugs 0.000 description 5
- 229940042585 tocopherol acetate Drugs 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 235000019164 vitamin B2 Nutrition 0.000 description 5
- 239000011716 vitamin B2 Substances 0.000 description 5
- 235000019158 vitamin B6 Nutrition 0.000 description 5
- 239000011726 vitamin B6 Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 229940011671 vitamin b6 Drugs 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- 239000002076 α-tocopherol Substances 0.000 description 5
- 235000004835 α-tocopherol Nutrition 0.000 description 5
- 235000007680 β-tocopherol Nutrition 0.000 description 5
- 239000011590 β-tocopherol Substances 0.000 description 5
- 239000002478 γ-tocopherol Substances 0.000 description 5
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 4
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 4
- PJGSXAZUFMCQKA-UHFFFAOYSA-N 1-bromo-2-dichlorophosphorylethane Chemical compound ClP(Cl)(=O)CCBr PJGSXAZUFMCQKA-UHFFFAOYSA-N 0.000 description 4
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 4
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 4
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 4
- SEILKFZTLVMHRR-UHFFFAOYSA-N 2-phosphonooxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOP(O)(O)=O SEILKFZTLVMHRR-UHFFFAOYSA-N 0.000 description 4
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 4
- 239000005995 Aluminium silicate Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 235000002147 Australian walnut Nutrition 0.000 description 4
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical compound COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
- 244000301850 Cupressus sempervirens Species 0.000 description 4
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 4
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- UNXHWFMMPAWVPI-IMJSIDKUSA-N L-threitol Chemical compound OC[C@H](O)[C@@H](O)CO UNXHWFMMPAWVPI-IMJSIDKUSA-N 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 4
- 229930003756 Vitamin B7 Natural products 0.000 description 4
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 4
- 235000012211 aluminium silicate Nutrition 0.000 description 4
- 238000007112 amidation reaction Methods 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 4
- 239000012964 benzotriazole Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 4
- 150000007942 carboxylates Chemical class 0.000 description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 150000002016 disaccharides Chemical class 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 229960000735 docosanol Drugs 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 239000001530 fumaric acid Substances 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 229940100463 hexyl laurate Drugs 0.000 description 4
- 229920001477 hydrophilic polymer Polymers 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- JJOJFIHJIRWASH-UHFFFAOYSA-N icosanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 4
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 4
- 229910044991 metal oxide Inorganic materials 0.000 description 4
- 150000004706 metal oxides Chemical class 0.000 description 4
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 4
- 229940049964 oleate Drugs 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 4
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 4
- 108700024047 pangamic acid Proteins 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 4
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- 239000001540 sodium lactate Substances 0.000 description 4
- 235000011088 sodium lactate Nutrition 0.000 description 4
- 229940005581 sodium lactate Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 229940033134 talc Drugs 0.000 description 4
- HQHCYKULIHKCEB-UHFFFAOYSA-N tetradecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCC(O)=O HQHCYKULIHKCEB-UHFFFAOYSA-N 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 4
- GZBUMTPCIKCWFW-UHFFFAOYSA-N triethylcholine Chemical compound CC[N+](CC)(CC)CCO GZBUMTPCIKCWFW-UHFFFAOYSA-N 0.000 description 4
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 4
- 150000004043 trisaccharides Chemical class 0.000 description 4
- 229960002703 undecylenic acid Drugs 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 235000011912 vitamin B7 Nutrition 0.000 description 4
- 239000011735 vitamin B7 Substances 0.000 description 4
- 239000008170 walnut oil Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 4
- 229940031723 1,2-octanediol Drugs 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 3
- UDXXYUDJOHIIDZ-UHFFFAOYSA-N 2-phosphonooxyethyl prop-2-enoate Chemical compound OP(O)(=O)OCCOC(=O)C=C UDXXYUDJOHIIDZ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229920002567 Chondroitin Polymers 0.000 description 3
- 235000017788 Cydonia oblonga Nutrition 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 229920000288 Keratan sulfate Polymers 0.000 description 3
- 244000280244 Luffa acutangula Species 0.000 description 3
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 description 3
- 240000002657 Thymus vulgaris Species 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- GKXVJHDEWHKBFH-UHFFFAOYSA-N [2-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC=C1CN GKXVJHDEWHKBFH-UHFFFAOYSA-N 0.000 description 3
- 125000005037 alkyl phenyl group Chemical group 0.000 description 3
- 150000008051 alkyl sulfates Chemical class 0.000 description 3
- 229960004050 aminobenzoic acid Drugs 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 3
- 239000012965 benzophenone Substances 0.000 description 3
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 3
- CFAFEJHONLMPQY-UHFFFAOYSA-N beta-Dimethylamino-aethan-alpha-sulfonsaeure Natural products CN(C)CCS(O)(=O)=O CFAFEJHONLMPQY-UHFFFAOYSA-N 0.000 description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 229940105990 diglycerin Drugs 0.000 description 3
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 229940113120 dipropylene glycol Drugs 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- FBQVFXLUGAFMIO-UHFFFAOYSA-N hexadecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FBQVFXLUGAFMIO-UHFFFAOYSA-N 0.000 description 3
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 3
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 3
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000001023 inorganic pigment Substances 0.000 description 3
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 3
- 229960000448 lactic acid Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229960004665 menthyl salicylate Drugs 0.000 description 3
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 3
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
- 239000012860 organic pigment Substances 0.000 description 3
- 238000010587 phase diagram Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 3
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 3
- 229940012831 stearyl alcohol Drugs 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000003784 tall oil Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000001585 thymus vulgaris Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 2
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 2
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- REHQLKUNRPCYEW-UHFFFAOYSA-N 1-methylcyclohexane-1-carboxylic acid Chemical compound OC(=O)C1(C)CCCCC1 REHQLKUNRPCYEW-UHFFFAOYSA-N 0.000 description 2
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 2
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 2
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 2
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 2
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 2
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 2
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 2
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 2
- 240000000073 Achillea millefolium Species 0.000 description 2
- 235000007754 Achillea millefolium Nutrition 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000157282 Aesculus Species 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 2
- 235000002657 Artemisia tridentata Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 2
- 244000266618 Atriplex confertifolia Species 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 241000219475 Bougainvillea Species 0.000 description 2
- 241000202726 Bupleurum Species 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000003301 Ceiba pentandra Nutrition 0.000 description 2
- 244000146553 Ceiba pentandra Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 240000000982 Malva neglecta Species 0.000 description 2
- 235000000060 Malva neglecta Nutrition 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 241000246044 Sophora flavescens Species 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 239000004163 Spermaceti wax Substances 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 2
- 241001506047 Tremella Species 0.000 description 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 2
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 2
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229920006243 acrylic copolymer Polymers 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229940072049 amyl acetate Drugs 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 2
- 239000012179 bayberry wax Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 229960000106 biosimilars Drugs 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000010410 calcium alginate Nutrition 0.000 description 2
- 239000000648 calcium alginate Substances 0.000 description 2
- 229960002681 calcium alginate Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 229910000428 cobalt oxide Inorganic materials 0.000 description 2
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
- 229940051593 dermatan sulfate Drugs 0.000 description 2
- VUWPIBNKJSEYIN-UHFFFAOYSA-N diethyl 2-benzylidenepropanedioate Chemical compound CCOC(=O)C(C(=O)OCC)=CC1=CC=CC=C1 VUWPIBNKJSEYIN-UHFFFAOYSA-N 0.000 description 2
- 229940031769 diisobutyl adipate Drugs 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 2
- GWTCIAGIKURVBJ-UHFFFAOYSA-L dipotassium;dodecyl phosphate Chemical compound [K+].[K+].CCCCCCCCCCCCOP([O-])([O-])=O GWTCIAGIKURVBJ-UHFFFAOYSA-L 0.000 description 2
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 2
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 2
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 2
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 2
- AGDANEVFLMAYGL-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCC(O)=O AGDANEVFLMAYGL-UHFFFAOYSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 229960002568 ethinylestradiol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 229960005219 gentisic acid Drugs 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- KMZHZAAOEWVPSE-UHFFFAOYSA-N glycerol monoacetate Natural products CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 2
- SLKWROUNLHVIIQ-UHFFFAOYSA-N hexachlorocyclohexa-2,5-dien-1-one Chemical compound ClC1=C(Cl)C(Cl)(Cl)C(Cl)=C(Cl)C1=O SLKWROUNLHVIIQ-UHFFFAOYSA-N 0.000 description 2
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 235000010181 horse chestnut Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229940078545 isocetyl stearate Drugs 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 229940114937 microcrystalline wax Drugs 0.000 description 2
- 239000012170 montan wax Substances 0.000 description 2
- 150000002780 morpholines Chemical class 0.000 description 2
- JFCLRCMKDGTKPI-UHFFFAOYSA-N n,1-dimethylcyclohexane-1-carboxamide Chemical compound CNC(=O)C1(C)CCCCC1 JFCLRCMKDGTKPI-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-butyl carbinol Natural products CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000155 polyglutamine Polymers 0.000 description 2
- 108010040003 polyglutamine Proteins 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229940033623 potassium lauryl phosphate Drugs 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940093625 propylene glycol monostearate Drugs 0.000 description 2
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 239000012176 shellac wax Substances 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 229940082004 sodium laurate Drugs 0.000 description 2
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940045870 sodium palmitate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 2
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 2
- 235000002316 solid fats Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000019385 spermaceti wax Nutrition 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 2
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000001069 triethyl citrate Substances 0.000 description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 2
- 235000013769 triethyl citrate Nutrition 0.000 description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 2
- 239000002383 tung oil Substances 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- TWNIBLMWSKIRAT-FPRJBGLDSA-N (1r,2r,3s,4r,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@H](O)[C@H](O)[C@H]2O TWNIBLMWSKIRAT-FPRJBGLDSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- JGQWKLHHTRIVSL-UHFFFAOYSA-N 10-octan-3-yloxy-10-oxodecanoic acid Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCC(O)=O JGQWKLHHTRIVSL-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SVUARJADWOEMTC-UHFFFAOYSA-N 2-(2,3-dihydroxypropoxycarbonylamino)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCNC(=O)OCC(O)CO SVUARJADWOEMTC-UHFFFAOYSA-N 0.000 description 1
- KHICUSAUSRBPJT-UHFFFAOYSA-N 2-(2-octadecanoyloxypropanoyloxy)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C(O)=O KHICUSAUSRBPJT-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- SVXPSKKRNACRPB-UHFFFAOYSA-N 2-[acetyl(methyl)amino]acetic acid Chemical compound CC(=O)N(C)CC(O)=O SVXPSKKRNACRPB-UHFFFAOYSA-N 0.000 description 1
- BIHQJMSIEXRWPS-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;dodecyl dihydrogen phosphate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOP(O)(O)=O BIHQJMSIEXRWPS-UHFFFAOYSA-N 0.000 description 1
- BQJLEQAXRYBKPQ-UHFFFAOYSA-N 2-amino-2-methylpropane-1,1-diol Chemical compound CC(C)(N)C(O)O BQJLEQAXRYBKPQ-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- ICFRVXBXPFMEST-UHFFFAOYSA-N 2-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(CCCC)C(=O)C1=CC=CC=C1 ICFRVXBXPFMEST-UHFFFAOYSA-N 0.000 description 1
- VSXIZXFGQGKZQG-UHFFFAOYSA-N 2-cyano-3,3-diphenylprop-2-enoic acid Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)O)C1=CC=CC=C1 VSXIZXFGQGKZQG-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- TXUFSOZBHYGQBO-UHFFFAOYSA-N 2-ethylhexyl 3-imidazolidin-1-ylpropanoate Chemical compound C(C)C(COC(CCN1CNCC1)=O)CCCC TXUFSOZBHYGQBO-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- QSTURKXDYNIRGT-UHFFFAOYSA-N 2-hydroxydec-2-enoic acid Chemical compound CCCCCCCC=C(O)C(O)=O QSTURKXDYNIRGT-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- RKOOOVKGLHCLTP-UHFFFAOYSA-N 2-methylprop-2-enoic acid;propane-1,2,3-triol Chemical compound CC(=C)C(O)=O.OCC(O)CO RKOOOVKGLHCLTP-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- AXKLSEHRUHRCIJ-UHFFFAOYSA-N 3,3-bis(hydroxymethyl)butane-1,1,1,4-tetrol Chemical group OCC(CO)(CO)CC(O)(O)O AXKLSEHRUHRCIJ-UHFFFAOYSA-N 0.000 description 1
- VBOZFTYRQDFTKX-UHFFFAOYSA-N 3-methylbutane-1,1-diol Chemical compound CC(C)CC(O)O VBOZFTYRQDFTKX-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- JPFTUUXPCFNLIX-UHFFFAOYSA-N 5-methyl-2-phenyl-1h-indole Chemical compound C=1C2=CC(C)=CC=C2NC=1C1=CC=CC=C1 JPFTUUXPCFNLIX-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000220487 Bauhinia Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- HTLOQTJMVHLFOV-UHFFFAOYSA-N C(C(O)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)[Na] Chemical compound C(C(O)C)(=O)O.C(CCCCCCCCCCCCCCC(C)C)[Na] HTLOQTJMVHLFOV-UHFFFAOYSA-N 0.000 description 1
- PNGXUJXDFJQYAF-UHFFFAOYSA-L C(CC(O)(C(=O)[O-])CC(=O)O)(=O)O.[K+].C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)O)(=O)O.[K+].C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+] PNGXUJXDFJQYAF-UHFFFAOYSA-L 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- DGHQAROSQYHYAE-UHFFFAOYSA-N CC(C)(C(C)(C)O)C(C=C)(C1=CC=CC2=NNN=C21)C3=CC=CC4=NNN=C43 Chemical compound CC(C)(C(C)(C)O)C(C=C)(C1=CC=CC2=NNN=C21)C3=CC=CC4=NNN=C43 DGHQAROSQYHYAE-UHFFFAOYSA-N 0.000 description 1
- CCHKXNBMAMZNJG-UHFFFAOYSA-N CC=COCCOP(=O)(O)O Chemical compound CC=COCCOP(=O)(O)O CCHKXNBMAMZNJG-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000219138 Luffa Species 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- XNGBKOMJBLWVJW-UHFFFAOYSA-N OC(CC1=C(C=CC=C1)N1N=C2C(=N1)C=CC=C2)CCC(CCC)C(C)(C)C Chemical compound OC(CC1=C(C=CC=C1)N1N=C2C(=N1)C=CC=C2)CCC(CCC)C(C)(C)C XNGBKOMJBLWVJW-UHFFFAOYSA-N 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000018907 Tylosema fassoglense Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- RNVYQYLELCKWAN-YFKPBYRVSA-N [(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol Chemical compound CC1(C)OC[C@H](CO)O1 RNVYQYLELCKWAN-YFKPBYRVSA-N 0.000 description 1
- DWNRBPAUINAYFD-UHFFFAOYSA-N [2-(16-methylheptadecanoyloxy)-3-(2-methylprop-2-enoyloxy)propyl] 16-methylheptadecanoate Chemical compound C(C(=C)C)(=O)OCC(COC(CCCCCCCCCCCCCCC(C)C)=O)OC(CCCCCCCCCCCCCCC(C)C)=O DWNRBPAUINAYFD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- HXEQAVFXRNYRDT-UHFFFAOYSA-N diheptan-2-yl hexanedioate Chemical compound CCCCCC(C)OC(=O)CCCCC(=O)OC(C)CCCCC HXEQAVFXRNYRDT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- MOLMQFZOMKFKPO-UHFFFAOYSA-N dihydroxy-methyl-propylsilane Chemical compound CCC[Si](C)(O)O MOLMQFZOMKFKPO-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- HDFXRQJQZBPDLF-UHFFFAOYSA-L disodium hydrogen carbonate Chemical compound [Na+].[Na+].OC([O-])=O.OC([O-])=O HDFXRQJQZBPDLF-UHFFFAOYSA-L 0.000 description 1
- IBWFTYGYHIGFQS-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)C(C)O IBWFTYGYHIGFQS-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- JNNNAJIAXISWGB-UHFFFAOYSA-N icosane-1,1-diol Chemical compound CCCCCCCCCCCCCCCCCCCC(O)O JNNNAJIAXISWGB-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 229960000829 kaolin Drugs 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- DKJCSMHIPYRALV-UHFFFAOYSA-N methoxymethyl propanoate Chemical compound CCC(=O)OCOC DKJCSMHIPYRALV-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- PQRHBEQNPCVBSM-UHFFFAOYSA-M potassium;2-carboxybenzoate;hydrochloride Chemical compound Cl.[K+].OC(=O)C1=CC=CC=C1C([O-])=O PQRHBEQNPCVBSM-UHFFFAOYSA-M 0.000 description 1
- KVMLCRQYXDYXDX-UHFFFAOYSA-M potassium;chloride;hydrochloride Chemical compound Cl.[Cl-].[K+] KVMLCRQYXDYXDX-UHFFFAOYSA-M 0.000 description 1
- AFDCXHSYKIVOOQ-UHFFFAOYSA-K potassium;disodium;phosphate Chemical compound [Na+].[Na+].[K+].[O-]P([O-])([O-])=O AFDCXHSYKIVOOQ-UHFFFAOYSA-K 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/285—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety
- C08F220/286—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety and containing polyethylene oxide in the alcohol moiety, e.g. methoxy polyethylene glycol (meth)acrylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本發明的課題在於提供一種具有彈力感之新穎的共聚物。 The object of the present invention is to provide a novel copolymer having elasticity.
一種共聚物,其係將自具有特定結構之疏水性單體衍生的一種或兩種以上之構成單元(a)與自下述通式(2)所示之親水性單體衍生的一種或兩種以上之構成單元(b)作為必要構成單元具有,且重量平均分子量為20000~110000。 A copolymer which is one or two structural units (a) derived from a hydrophobic monomer having a specific structure and one or two derived from a hydrophilic monomer represented by the following general formula (2) More than one type of structural unit (b) is provided as an essential structural unit, and the weight average molecular weight is 20,000 to 110,000.
Description
本發明係關於一種為疏水性單體與親水性單體的共聚物之新穎的共聚物。 The invention relates to a novel copolymer which is a copolymer of a hydrophobic monomer and a hydrophilic monomer.
又,本發明係關於一種利用水溶性共聚物乳化的乳化組成物。 In addition, the present invention relates to an emulsified composition emulsified by a water-soluble copolymer.
又,本發明係關於一種包含水溶性共聚物的皮膚清潔劑。 In addition, the present invention relates to a skin cleanser containing a water-soluble copolymer.
又,本發明係關於一種包含水溶性共聚物的防曬化妝品。 In addition, the present invention relates to a sunscreen cosmetic containing a water-soluble copolymer.
又,本發明係關於一種具有在水性凝膠的海分散有兩親媒性共聚物的島粒子之海島結構的被膜及形成其之組成物。 In addition, the present invention relates to a film having a sea-island structure in which island particles in which an amphiphilic copolymer is dispersed in the sea of an aqueous gel and a composition forming the same.
一般而言,油劑之彈力感或濕潤感的使用感均佳,且自古以來作為化妝品的材料使用。但是,油劑發揮上述優異的使用感之另一方面,高摻合時,有時產生黏膩感且帶來使用感之惡化。 Generally speaking, the oil has a good sense of elasticity or moistness, and has been used as a cosmetic material since ancient times. However, on the other hand, the oil agent exerts the above-mentioned excellent use feeling, and when it is highly blended, a sticky feeling may occur and the use feeling may deteriorate.
如此狀況下,已嘗試藉由設計化妝品之組成或結構等而減輕起因於油劑之黏膩感。例如,專利文獻1中,提出在乳化組成物之化妝品中,藉由使乳化粒徑減小而抑制黏膩感的技術。
Under such circumstances, attempts have been made to reduce the stickiness caused by oils by designing the composition or structure of cosmetics. For example,
但是,如專利文獻1所記載之藉由化妝品之組成或結構等之設計而減輕黏膩感的技術,有限定於可應用的劑型之問題。
However, as described in
另一方面,提出兼具濕潤感與無黏膩感之使用感之新穎的素材。例如,專利文獻2中,揭露兼具優異的觸感與保濕性之包含環氧烷衍生物之化妝品用基礎劑。
On the other hand, we propose novel materials that have both a moist feel and a non-sticky feel. For example,
又,油相成分與水相成分藉由乳化劑混合的乳化組成物,係作為化妝品的劑型廣泛使用。但是,一般的低分子之乳化劑,有產生對肌膚之刺激性或黏膩感等之問題。 In addition, the emulsified composition in which the oil phase component and the water phase component are mixed with an emulsifier is widely used as a dosage form of cosmetics. However, general low-molecular emulsifiers have problems such as irritation or stickiness to the skin.
為了解決如此問題,近年來提出種種使用高分子之乳化劑的乳化技術。 In order to solve such problems, various emulsification technologies using polymer emulsifiers have been proposed in recent years.
專利文獻3中,揭露將羥乙基纖維素作為乳化劑的乳化組成物。
又,專利文獻4中,揭露將烷基改性聚羧乙烯作為乳化劑的乳化組成物。
In addition,
再者,以往在洗面乳等之皮膚清潔劑中,從起泡性之良度、清潔力之良度、沖洗後之清爽感等均優異之觀點,大多使用高級脂肪酸之鉀鹽。然而,將高級脂肪酸之鉀鹽作為主成分的皮膚清潔劑,具有如此優異的性質之另一方面,也有不易得到綿密的泡沫品質、因為清洗而使肌膚容易過度地脫脂,而且因皂垢(渣滓)殘留於肌膚而使肌膚容易在使用後緊繃的問題點。 In addition, in the past, skin cleansers such as facial cleansers have mostly used potassium salts of higher fatty acids from the viewpoint of excellent foaming properties, cleansing power, and refreshing feeling after rinsing. However, skin cleansers that use potassium salts of higher fatty acids as the main component have such excellent properties. On the other hand, they also have difficulty in obtaining dense foam quality. They can easily degrease the skin due to washing, and due to soap scale (scum) ) The problem of remaining on the skin and making the skin easy to tighten after use.
作為改善如此問題點之方法,係提出高級脂肪酸與醯基牛磺酸鹽型、醯基羥乙磺酸型、磷酸酯型、醯基胺基酸型等之界面活性劑之併用(例如專利文獻5)、界面活性劑以外的添加劑(例如,矽酮化合物或特定的糖脂質、棉子糖、植物種子黏質物、種種的高分子化合物等)之摻合(例如專利文獻6~12)等。
As a method for improving such problems, a combination of higher fatty acids and surfactants such as acetyl taurate type, acetyl isethionate type, phosphate type, and amide amino acid type has been proposed (for example, Patent Literature 5). Blending of additives other than surfactants (for example, silicone compounds or specific glycolipids, raffinose, plant seed slime, various polymer compounds, etc.) (for example,
而且也嘗試未將高級脂肪酸之鉀鹽作為主成分,藉由組合醯基甘胺酸型界面活性劑與特定的高分子化合物而改良上述問題點(參照專利文獻13)。 In addition, attempts have been made to improve the above-mentioned problems by combining a glycylglycine type surfactant and a specific polymer compound without using the potassium salt of a higher fatty acid as a main component (refer to Patent Document 13).
而且,水中油型乳化型的防曬化妝品,有清爽的使用感,容易連續使用。為了提高紫外線防禦效果,水中油型乳化化妝品中,係使用紫外線吸收劑、氧化鋅或氧化鈦等之金屬氧化物粉末的紫外線散射劑。但是,大量摻合紫外線吸收劑時,有產生變色、延伸差、黏膩等之使用感變差的問題。又,大量摻合金屬氧化物粉末時,不僅隨時間產生粉末之凝聚、沉澱等,且有黏度下降、乳化分離、析出等之經時安定性下降的問題。併用該等時,有變得更容易產生上述問題的傾向。 In addition, the oil-in-water emulsified sunscreen cosmetics have a refreshing feel and are easy to use continuously. In order to improve the UV protection effect, in the oil-in-water emulsified cosmetics, UV absorbers using metal oxide powders such as UV absorbers, zinc oxide or titanium oxide are used. However, when a large amount of ultraviolet absorber is blended, there is a problem that the sense of use such as discoloration, poor elongation, and stickiness is deteriorated. In addition, when a large amount of metal oxide powder is blended, not only does the powder agglomerate and precipitate, etc., with time, but also there is a problem that the viscosity stability, emulsification separation, precipitation, etc. decrease in stability over time. When these are used together, there is a tendency to cause the above-mentioned problems more easily.
為了改善該等之問題,係提出併用二苯甲醯基甲烷衍生物等之紫外線吸收劑與利用矽烷及/或矽酮處理之氧化鈦(參照專利文獻14)。 In order to improve these problems, it has been proposed to use ultraviolet absorbers such as dibenzoylmethane derivatives and titanium oxide treated with silane and/or silicone (refer to Patent Document 14).
又,提出使用聚丙烯酸醯胺、三仙膠、(丙烯酸鈉/丙烯醯基二甲基牛磺酸)共聚物等之水溶性高分子的水中油型乳化化妝品(參照專利文獻15、16)。
Furthermore, water-in-oil emulsified cosmetics using water-soluble polymers such as polyacrylamide, three gums, (sodium acrylate/acryl dimethyl taurine) copolymer, etc. have been proposed (see
又,海島結構係指相互不相溶的2種高分子引起相分離,且在包含一方的高分子之連續相(海相)散布有包含另一方的高分子之分散相(島相)的結構。如前述,因為海島結構具有相分離之不均勻的結構,所以具有與具有均勻的結構之組成物不同的性質。欲利用如此性質,對於海島結構,積極進行關於塑膠或橡膠、調色劑、接著劑等之技術領域的研究開發。 The island-in-sea structure refers to a structure in which two types of polymers that are incompatible with each other cause phase separation, and a continuous phase (sea phase) containing one polymer is dispersed with a dispersed phase (island phase) containing the other polymer. . As described above, since the sea island structure has a non-uniform structure with phase separation, it has different properties from the composition having a uniform structure. To take advantage of such properties, research and development in the technical field of plastics or rubber, toners, adhesives, etc. are actively carried out for the island structure.
例如,專利文獻17中,揭露一種輪胎,其係以具有包含熱塑性樹脂的海相與包含聚胺酯系熱塑性彈性體的島相之海島結構的被覆用混合物被覆。
For example,
但是,在化妝品領域中,欲利用海島結構的嘗試並沒有進行至此。 However, in the field of cosmetics, attempts to utilize the sea island structure have not been carried out so far.
然後,專利文獻18中,係揭露一種含有具有自特定的疏水性之丙烯酸酯系單體衍生的構成單元與自特定的親水性之丙烯酸系單體衍生的構成單元之兩親媒性共聚物的皮膚外用劑。 Then, Patent Document 18 discloses an amphiphilic copolymer containing a structural unit derived from a specific hydrophobic acrylic monomer and a structural unit derived from a specific hydrophilic acrylic monomer External preparation for skin.
專利文獻1 日本特開2012-116783號公報
專利文獻2 日本再表2006/038724號公報
專利文獻3 日本特開2011-231049號公報
專利文獻4 日本特開平09-019631號公報
專利文獻5 日本特開平6-248298號公報 Patent Literature 5 Japanese Patent Laid-Open No. 6-248298
專利文獻6 日本特開平10-77206號公報
專利文獻7 日本特開2001-72574號公報 Patent Document 7 Japanese Patent Laid-Open No. 2001-72574
專利文獻8 日本特開2000-178172號公報 Patent Document 8 Japanese Patent Laid-Open No. 2000-178172
專利文獻9 日本特開平11-209799號公報 Patent Document 9 Japanese Patent Laid-Open No. 11-209799
專利文獻10 日本特開2003-73257號公報
專利文獻11 日本特開2007-277140號公報
專利文獻12 日本特開平10-183193號公報
專利文獻13 日本特開平9-78082號公報
專利文獻14 日本特開平9-2929號公報
專利文獻15 日本特開2003-104859號公報
專利文獻16 日本特開2010-215602號公報
專利文獻17 日本特開2013-180652號公報
專利文獻18 日本特開2014-9189號公報 Patent Literature 18 Japanese Patent Application Publication No. 2014-9189
如上述,油劑具有彈力感之較佳的使用感之另一方面,也具有黏膩感等之問題。如此狀況下,需要如油劑的具有彈力感之新穎的素材。 As mentioned above, the oil has a better sense of elasticity on the other hand, it also has problems such as stickiness. Under such circumstances, new materials with elasticity like oils are needed.
本發明的課題在於提供一種具有彈力感之新穎的共聚物。又,本發明之較佳的形態中,更將提供一種不易產生黏膩感,有濕潤感的共聚物作為第1課題。 The object of the present invention is to provide a novel copolymer having elasticity. Furthermore, in a preferred embodiment of the present invention, it is the first problem to provide a copolymer which does not easily produce a sticky feeling and has a moist feeling.
又,如上述的高分子乳化劑,對肌膚之刺激少,雖然有以低濃度含有時,黏膩感少等之優點,但與以往的低分子之乳化劑比較時,乳化力差。因此,為了確保乳化狀態之安定性,需要高摻合乳化組成物之高分子乳化劑,而成為高黏度,其結果有黏膩感之課題。 Furthermore, the above-mentioned polymer emulsifier has less irritation to the skin and has the advantages of less stickiness when contained in a low concentration, but when compared with the conventional low-molecular emulsifier, the emulsifying power is poor. Therefore, in order to ensure the stability of the emulsified state, a high-molecular emulsifier blended with an emulsified composition is required, which becomes a high viscosity, and as a result, has a problem of stickiness.
鑑於如此情況,本發明將提供一種對肌膚之刺激少,黏膩感少,同時乳化安定性佳的乳化組成物作為第2課題。 In view of such circumstances, the present invention will provide an emulsified composition with less irritation to the skin, less stickiness, and good emulsification stability as the second subject.
由於近年來消費者需求高漲,特別是關於泡沫品質或清洗後的觸感,該等之方法已不能充分滿足,且需要進一步之改良。 Due to the surge in consumer demand in recent years, especially with regard to foam quality or touch after cleaning, these methods have not been fully satisfied and further improvements are needed.
鑑於如此情況,本發明所欲解決的第3課題,係提供一種可減低皮膚清潔劑之使用後的肌膚之緊繃感的新穎技術。 In view of such circumstances, the third problem to be solved by the present invention is to provide a novel technology that can reduce the tightness of the skin after the use of the skin cleanser.
又,將提供一種不損及清潔力、起泡性的良度、良好的泡沫品質、使用後之無黏滑感、對肌膚之延展易度等之原本皮膚清潔劑具有之有利的效果,且可減低使用後的肌膚之緊繃感的技術作為第4課題。 In addition, it will provide a beneficial effect of the original skin cleanser that does not impair cleansing power, good foaming quality, good foam quality, non-sticky and slippery feeling after use, and ease of extension to the skin, etc., and The technology that can reduce the tightness of the skin after use is the fourth issue.
而且,在水中油型之防曬化妝品的技術之領域中,兼具紫外線防禦機能與使用感或乳化安定性係為課題。以往為了解決該課題而提出種種的技術,但不足夠。 Furthermore, in the technical field of oil-in-water sunscreen cosmetics, it is a problem to have both ultraviolet protection function and sense of use or emulsion stability. In the past, various technologies have been proposed to solve this problem, but this is not enough.
鑑於如此情事,本發明所欲解決的第5課題,在於提供一種具有良好的紫外線防禦機能,同時無黏膩感或保濕感等之使用感佳,且有乳化安定性之水中油型的防曬化妝品。 In view of such circumstances, the fifth problem to be solved by the present invention is to provide an oil-in-water sunscreen cosmetic that has good ultraviolet protection function, has no sticky feeling or moisturizing feeling, and has good emulsification stability. .
又,本發明所欲解決的課題,在於提供一種具有將水溶性成分作為主體之海島結構的被膜及形成該被膜的技術。又,將提供一種在將水溶性成分作為主體之被膜,賦予如包含油劑之牛奶的觸感之技術作為課 題。較佳為將提供一種兼具保濕性與柔軟性之被膜及形成該被膜之技術作為本發明的第6課題。 In addition, the problem to be solved by the present invention is to provide a film having a sea-island structure mainly composed of a water-soluble component and a technique for forming the film. In addition, we will provide a lesson in the film that uses water-soluble ingredients as the main body to give a touch to milk such as oil. question. Preferably, it is the sixth subject of the present invention to provide a coating having both moisture retention and flexibility and a technique for forming the coating.
鑑於成為第一課題之背景的狀態,本案發明人等追求彈力感共聚物而仔細研究的結果發現:使具有疏水性、聚合性之羧基及2個具有特定分支結構之醯基的丙烯酸酯系單體與具有特定結構的親水性丙烯酸系單體聚合的共聚物,其溶解性佳,特別是對水之溶解性佳,且具有有如油劑之彈力性的觸感,進而完成本發明。亦即,本發明係如下述。 In view of the state of being the background of the first subject, the inventors of the present application have pursued a stretch-sensitive copolymer and conducted careful research. As a result, they have found that: a hydrophobic, polymerizable carboxyl group and two acrylate groups with a specific branched structure are mono- The copolymer of the polymer and the hydrophilic acrylic monomer having a specific structure has good solubility, especially good solubility in water, and has an elastic feel like an oil agent, thereby completing the present invention. That is, the present invention is as follows.
一種共聚物,其係將自下述通式(1)所示之疏水性單體衍生的一種或兩種以上之構成單元(a)與自下述通式(2)所示之親水性單體衍生的一種或兩種以上之構成單元(b)作為必要構成單元而具有,且重量平均分子量為20000~110000。 A copolymer comprising one or two or more structural units (a) derived from a hydrophobic monomer represented by the following general formula (1) and a hydrophilic monomer represented by the following general formula (2) One or two or more types of structural units (b) derived from the body are required as structural units, and the weight average molecular weight is 20,000 to 110,000.
(通式(1)中,R1表示氫原子或碳數1~3的烷基,R2、R3可相同亦可不同,且表示未含有環結構之具有分支的碳數6~22之醯基。X表示自三元醇脫附OH基的基)。 (In general formula (1), R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 2 and R 3 may be the same or different, and represents a branched carbon number having 6 to 22 that does not contain a ring structure. Acyl group. X represents a group desorbing an OH group from a triol).
(通式(2)中,R4表示氫原子或碳數1~3的烷基,R5表示可具有羥基之碳數2~4的伸烷基,R6表示氫原子、碳數6~10的芳香族烴基、碳數1~14的脂肪族烴基或碳數1~12的醯基。n表示6~40的整數)。 (In the general formula (2), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents a hydrogen atom and a carbon atom having 6 to 6 carbon atoms. 10 aromatic hydrocarbon groups, aliphatic hydrocarbon groups having 1 to 14 carbon atoms or acyl groups having 1 to 12 carbon atoms. n represents an integer of 6 to 40).
如此共聚物,在塗布於肌膚時有彈力感,而且具有不黏膩感或濕潤感。 Such a copolymer has an elastic feeling when applied to the skin, and has a non-sticky or moist feeling.
本發明之較佳的形態中,前述構成單元(a)與前述構成單元(b)的質量比為25:75~35:65。 In a preferred embodiment of the present invention, the mass ratio of the structural unit (a) to the structural unit (b) is 25:75 to 35:65.
構成單元(a)與構成單元(b)的質量比為前述範圍的共聚物,彈力感與無黏膩感的使用感佳。 The copolymer having a mass ratio of the structural unit (a) to the structural unit (b) within the aforementioned range has good elasticity and non-sticky feel.
本發明之較佳的形態中,前述構成單元(a)與前述構成單元(b)的莫耳比為35:65~46:54。 In a preferred embodiment of the present invention, the molar ratio of the structural unit (a) to the structural unit (b) is 35:65 to 46:54.
構成單元(a)與構成單元(b)的莫耳比為前述範圍的共聚物,彈力感與無黏膩感的使用感佳。 The molar ratio of the structural unit (a) and the structural unit (b) is a copolymer in the aforementioned range, and the elasticity feeling and the stickiness-free feeling are excellent.
本發明之較佳的形態中,前述疏水性單體為下述通式(3)所示的疏水性單體。 In a preferred embodiment of the present invention, the hydrophobic monomer is a hydrophobic monomer represented by the following general formula (3).
通式(3)
(通式(3)中,R7表示氫原子或碳數1~3的烷基,R8、R9可相同亦可不同,且表示未含有環結構的具有分支之碳數10~22的醯基、或未含有環結構的具有2個以上之分支的碳數6~9之醯基。Y表示自三元醇脫附OH基的基)。 (In general formula (3), R 7 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 8 and R 9 may be the same or different, and represents a branched carbon number having 10 to 22 carbon atoms that does not contain a ring structure. An acyl group, or an acyl group having 6 or more carbon atoms that does not contain a ring structure and has 2 or more branches. Y represents a group that desorbs an OH group from a triol).
作為疏水性單體,藉由使用前述單體,可成為具有更優異的觸感之共聚物。 As the hydrophobic monomer, by using the aforementioned monomer, it can become a copolymer having more excellent touch.
又,本發明之較佳的形態中,前述親水性單體為下述通式(4)所示的親水性單體。 Furthermore, in a preferred embodiment of the present invention, the hydrophilic monomer is a hydrophilic monomer represented by the following general formula (4).
(通式(4)中,R10表示氫原子或碳數1~3的烷基,R11表示氫原子、碳數6~10的芳香族烴基、碳數1~14的脂肪族烴基或碳數1~12的醯基。m表示6~40的整數)。 (In general formula (4), R 10 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 11 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms or carbon The number is 1~12 of acetyl group. m represents an integer of 6~40).
作為親水性單體,藉由使用前述單體,可成為具有更優異的觸感之共聚物。 As the hydrophilic monomer, by using the aforementioned monomer, it can become a copolymer having a more excellent touch.
本發明之較佳的形態中,前述三元醇為丙三醇、三羥甲基丙烷、三羥甲基乙烷。 In a preferred embodiment of the present invention, the triol is glycerin, trimethylolpropane, and trimethylolethane.
藉由成為如此形態,可提升彈力感。 By becoming such a form, the sense of elasticity can be improved.
前述疏水性單體為下述通式(5)所示的化合物。 The aforementioned hydrophobic monomer is a compound represented by the following general formula (5).
(通式(5)中,R12、R13可相同亦可不同,且表示未含有環結構之具有分支的碳數18之醯基)。 (In the general formula (5), R 12 and R 13 may be the same or different, and represent a branched C 18 acyl group that does not contain a ring structure).
藉由使用如此疏水性單體,可提升彈力感。 By using such a hydrophobic monomer, the elasticity can be improved.
本發明之較佳的形態中,前述親水性單體為下述通式(6)所示的親水性單體。 In a preferred embodiment of the present invention, the hydrophilic monomer is a hydrophilic monomer represented by the following general formula (6).
(通式(6)中,l表示6~40的整數)。 (In the general formula (6), l represents an integer of 6 to 40).
藉由使用如此親水性單體,可提升彈力感。 By using such a hydrophilic monomer, the elasticity can be improved.
又,本發明也關於一種含有上述本發明的共聚物之皮膚外用劑。該皮膚外用劑,在塗布於肌膚後有彈力感。又,無黏膩感或濕潤感佳。 In addition, the present invention also relates to an external preparation for skin containing the copolymer of the present invention. This external preparation for skin has an elastic feeling after being applied to the skin. Also, there is no sticky or moist feeling.
解決第二課題的本發明為一種乳化組成物,其係包含將自前述通式(1)、下述(7)或(8)所示之疏水性單體衍生的1種或2種以上之構成單元(c)與自親水性單體衍生的1種或2種以上之構成單元(d)作為必要構成單元具有之水溶性共聚物,且實質上未含有該水溶性共聚物以外的乳化劑。 The present invention for solving the second problem is an emulsified composition containing one or more types derived from a hydrophobic monomer represented by the aforementioned general formula (1), (7) or (8) below The structural unit (c) and one or more structural units (d) derived from a hydrophilic monomer are water-soluble copolymers that are essential structural units and do not substantially contain emulsifiers other than the water-soluble copolymer .
(通式(7)中,R14表示氫原子或碳數1~3的烷基,R15表示碳數13~30的未含有環結構之分支狀烴基、或未含有環結構的具有2個以上之分支的碳數6~12之烴基)。 (In the general formula (7), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 represents a branched hydrocarbon group having 13 to 30 carbon atoms which does not contain a ring structure, or 2 which does not contain a ring structure. (The above branches have 6 to 12 hydrocarbon groups).
通式(8)
(通式(8)中,R16表示氫原子或碳數1~3的烷基,R17、R18、R19可相同亦可不同,且表示未含有環結構之具有分支的碳數6~22之醯基。Y表示自四元醇脫附OH基的基)。
(In the general formula (8), R 16 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 17 , R 18 , and R 19 may be the same or different, and represents a branched
本發明之乳化組成物,藉由包含前述水溶性共聚物,在使用時之黏膩感少。 The emulsified composition of the present invention contains the above-mentioned water-soluble copolymer, and has less stickiness during use.
本發明之較佳的形態中,前述親水性單體為選自於包含聚合性羧酸、上述通式(2)所示之親水性單體、下述通式(9)所示之親水性單體、下述通式(10)所示之親水性單體及下述通式(11)所示之親水性單體的群組之1種或2種以上的親水性單體。 In a preferred embodiment of the present invention, the hydrophilic monomer is selected from the group consisting of a polymerizable carboxylic acid, a hydrophilic monomer represented by the above general formula (2), and a hydrophilic property represented by the following general formula (9) One type, or two or more types of hydrophilic monomers of a monomer, a hydrophilic monomer represented by the following general formula (10), and a hydrophilic monomer represented by the following general formula (11).
(通式(9)中,R20表示氫原子或甲基)。 (In the general formula (9), R 20 represents a hydrogen atom or a methyl group).
通式(10)
(通式(10)中,R21表示氫原子或甲基,G-O-表示自還原糖之1位的羥基除去氫的基。m表示2或3的整數,l表示1~5的整數)。 (In the general formula (10), R 21 represents a hydrogen atom or a methyl group, GO- represents a group in which hydrogen is removed from the hydroxyl group at the 1-position of the reducing sugar. m represents an integer of 2 or 3, and l represents an integer of 1 to 5).
(通式(11)中,R22表示氫原子或甲基,R23表示胺基酸殘基、多胺殘基或胺醇殘基。Q表示氧原子或NH所示的基)。 (In the general formula (11), R 22 represents a hydrogen atom or a methyl group, and R 23 represents an amino acid residue, a polyamine residue, or an amino alcohol residue. Q represents an oxygen atom or a group represented by NH).
藉由包含含有自如此親水性單體衍生之構成單元(d)的水溶性共聚物,可進一步減低本發明的乳化組成物之使用時的黏膩感。 By including the water-soluble copolymer containing the structural unit (d) derived from such a hydrophilic monomer, the sticky feeling during use of the emulsified composition of the present invention can be further reduced.
本發明之較佳的形態中,前述疏水性單體為前述通式(1)所示的疏水性單體,前述水溶性單體為前述通式(2)所示的親水性單體。 In a preferred embodiment of the present invention, the hydrophobic monomer is a hydrophobic monomer represented by the general formula (1), and the water-soluble monomer is a hydrophilic monomer represented by the general formula (2).
包含具有自如此疏水性單體與親水性單體衍生之構成單元的水溶性共聚物,其乳化力佳,且減低本發明的乳化組成物之使用時的黏膩感之效果佳。 The water-soluble copolymer containing structural units derived from such a hydrophobic monomer and a hydrophilic monomer has a good emulsifying power, and has a good effect of reducing the sticky feeling when using the emulsified composition of the present invention.
本發明之較佳的形態中,前述水溶性共聚物之含量為0.5~30質量%。 In a preferred embodiment of the present invention, the content of the water-soluble copolymer is 0.5 to 30% by mass.
藉由使前述水溶性共聚物之含量成為前述範圍,可提升乳化組成物之安定性。 By setting the content of the water-soluble copolymer to the aforementioned range, the stability of the emulsified composition can be improved.
本發明之較佳的形態中,油相成分之含量為0.1~70質量%。 In a preferred form of the present invention, the content of the oil phase component is 0.1 to 70% by mass.
油相成分之含量為前述範圍的本發明之乳化組成物,安定性優異。 The emulsified composition of the present invention in which the content of the oil phase component is in the aforementioned range is excellent in stability.
本發明之乳化組成物,黏膩感少,因此作為化妝品較佳。 The emulsified composition of the present invention has less stickiness and is therefore suitable as a cosmetic.
又,本發明也關於一種包含將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的1種或2種以上之構成單元(c)與自親水性單體衍生的1種或2種以上之構成單元(d)作為必要構成單元具有之水溶性共聚物的乳化劑。 In addition, the present invention also relates to a structural unit (c) including one or more structural units derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) and a self-hydrophilic monomer One type or two or more types of structural units (d) derived from the polymer are used as an emulsifier of the water-soluble copolymer that the necessary structural units have.
該乳化劑為低刺激且同時具有優異的乳化力。 The emulsifier is low in irritation and at the same time has excellent emulsifying power.
又,本發明也關於一種製造方法,其係為包含使用前述乳化劑進行乳化之步驟的乳化組成物之製造方法,特徵為實質上未使用該乳化劑以外的乳化劑。 In addition, the present invention also relates to a manufacturing method, which is a manufacturing method of an emulsified composition including the step of emulsification using the emulsifier, and is characterized in that substantially no emulsifier other than the emulsifier is used.
根據該方法,未使用會產生黏膩感之以往的乳化劑,而且,即使未高摻合乳化劑,也可輕易地製造乳化組成物。 According to this method, a conventional emulsifier that gives a sticky feeling is not used, and an emulsified composition can be easily produced even if the emulsifier is not highly blended.
解決第3、第4課題的本發明為包含將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的1種或2種以上之構成單元(e)與自親水性單體衍生的1種或2種以上之構成單元(f)作為必要構成單元具有之水溶性共聚物的皮膚清潔劑。 The present invention for solving the third and fourth problems is to include one or more structural units (e) derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) and One or two or more structural units (f) derived from a hydrophilic monomer are used as a skin cleansing agent of a water-soluble copolymer having essential structural units.
本發明的皮膚清潔劑,藉由包含前述水溶性共聚物,具備良質的起泡性與綿密的泡沫品質,同時可實現使用後的緊繃感之減低。 The skin cleansing agent of the present invention, by containing the water-soluble copolymer, has good foaming properties and dense foam quality, and at the same time can reduce the tightness after use.
本發明之較佳的形態中,前述親水性單體為選自於包含聚合性羧酸、前述通式(2)所示之親水性單體、前述通式(9)所示之親水性單體、前述通式(10)所示之親水性單體及前述通式(11)所示之親水性單體的群組之1種或2種以上的親水性單體。 In a preferred embodiment of the present invention, the hydrophilic monomer is selected from the group consisting of a polymerizable carboxylic acid, a hydrophilic monomer represented by the general formula (2), and a hydrophilic monomer represented by the general formula (9). 1 type, or 2 or more types of hydrophilic monomers of the group, the hydrophilic monomer represented by the general formula (10), and the hydrophilic monomer represented by the general formula (11).
藉由包含含有自如此親水性單體衍生之構成單元(e)的水溶性共聚物,可進一步減低本發明的皮膚清潔劑之使用後的緊繃感。 By including the water-soluble copolymer containing the structural unit (e) derived from such a hydrophilic monomer, the tightness of the skin cleansing agent of the present invention after use can be further reduced.
本發明之較佳的形態中,前述疏水性單體為前述通式(1)所示的疏水性單體,前述水溶性單體為前述通式(2)所示的親水性單體。 In a preferred embodiment of the present invention, the hydrophobic monomer is a hydrophobic monomer represented by the general formula (1), and the water-soluble monomer is a hydrophilic monomer represented by the general formula (2).
藉由包含具有自如此疏水性單體與親水性單體衍生之構成單元的水溶性共聚物,可進一步減低本發明的皮膚清潔劑之使用後的緊繃感。 By including a water-soluble copolymer having structural units derived from such a hydrophobic monomer and a hydrophilic monomer, the tightness of the skin cleansing agent of the present invention after use can be further reduced.
本發明之實施形態中,前述水溶性共聚物之含量為0.1~20質量%。 In an embodiment of the present invention, the content of the water-soluble copolymer is 0.1 to 20% by mass.
藉由使水溶性共聚物之含量成為前述範圍,可減低本發明的皮膚清潔劑之使用時的黏滑感。 By setting the content of the water-soluble copolymer to the aforementioned range, the stickiness of the skin cleanser of the present invention when used can be reduced.
本發明應用於起泡性清潔劑較佳。 The invention is preferably applied to foaming detergents.
根據本發明,不會阻礙起泡清潔劑之起泡性或泡沫品質,且可減低使用後的肌膚之緊繃感。 According to the present invention, it does not hinder the foamability or foam quality of the foaming cleanser, and can reduce the tightness of the skin after use.
本發明應用於凝膠狀的皮膚清潔劑較佳。 The invention is preferably applied to gel-like skin cleansers.
根據本發明,可提升凝膠狀的皮膚清潔劑對肌膚的延展易度,同時可減低使用後的肌膚之緊繃感。 According to the present invention, the ease of extension of the gel-like skin cleanser on the skin can be improved, and at the same time, the tightness of the skin after use can be reduced.
因為包含界面活性劑的皮膚清潔劑之清潔力較強,所以使用後的緊繃感也強。因此,本發明應用於包含界面活性劑之形態的皮膚清潔劑較佳。根據本發明,不會損及界面活性劑之優異的清潔力,或者可一邊提升清潔力一邊減低皮膚清潔劑之使用後的肌膚之緊繃感。 Because skin cleansers containing surfactants have a higher cleaning power, the tightness after use is also stronger. Therefore, the present invention is preferably applied to skin cleansers containing surfactants. According to the present invention, the excellent cleansing power of the surfactant is not compromised, or the cleansing power of the skin cleanser after use can be reduced while improving the cleansing power.
包含脂肪酸皂的皮膚清潔劑,其起泡性佳,具有綿密的泡沫品質,清潔力佳,但在使用後感到很強的緊繃感。因此,本發明應用於包含脂肪酸皂之形態的皮膚清潔劑較佳。根據本發明,不損及包含脂肪酸皂的皮膚清潔劑具有之有利的效果,可減低使用後的肌膚之緊繃感。 Skin cleansers containing fatty acid soaps have good foaming properties, dense foam quality, and good cleansing power, but they feel a strong sense of tightness after use. Therefore, the present invention is preferably applied to a skin cleanser containing fatty acid soap. According to the present invention, the beneficial effects of skin cleansers containing fatty acid soaps are not compromised, and the tightness of the skin after use can be reduced.
本發明之較佳的形態中,前述水溶性共聚物與前述脂肪酸皂之含有質量的比為1:500~1:2,較佳為1:200~1:3,更佳為1:100~1:5。 In a preferred embodiment of the present invention, the content ratio of the water-soluble copolymer to the fatty acid soap is 1:500~1:2, preferably 1:200~1:3, more preferably 1:100~ 1:5.
藉由使前述水溶性共聚物之含量成為前述範圍,可更有效地減低包含脂肪酸皂的皮膚清潔劑之使用後的緊繃感。 By setting the content of the water-soluble copolymer to the aforementioned range, it is possible to more effectively reduce the tightness of the skin cleanser containing fatty acid soap after use.
本發明應用於包含非離子性界面活性劑的皮膚清潔劑也較佳。 The present invention is also preferably applied to skin cleansers containing nonionic surfactants.
根據本發明,提升包含非離子性界面活性劑的皮膚清潔劑之清潔力,同時可減低使用後的肌膚之緊繃感。 According to the present invention, the cleansing power of a skin cleanser containing a nonionic surfactant is improved, and at the same time, the tightness of the skin after use can be reduced.
本發明之較佳的形態中,前述水溶性共聚物與前述非離子性界面活性劑之含有質量的比為1:20~1:0.5,較佳為1:15~1:0.7,更佳為1:10~1:1。 In a preferred embodiment of the present invention, the content ratio of the water-soluble copolymer to the nonionic surfactant is 1:20~1:0.5, preferably 1:15~1:0.7, more preferably 1:10~1:1.
藉由使水溶性共聚物與非離子性界面活性劑之含量的比成為前述範圍,可更有效地減低使用後的緊繃感。 By setting the content ratio of the water-soluble copolymer to the nonionic surfactant to the aforementioned range, the tightness after use can be more effectively reduced.
解決第5課題的本發明為包含成分(A)~(D)之水中油型的防曬化妝品。 The present invention that solves the fifth problem is an oil-in-water sunscreen cosmetic containing components (A) to (D).
(A)將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的1種或2種以上之構成單元(g)與自親水性單體衍生的1種或2種以上之構成單元(h)作為必要構成單元具有之水溶性共聚物 (A) One or more structural units (g) derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) and one derived from the hydrophilic monomer Or a water-soluble copolymer having two or more kinds of structural units (h) as essential structural units
(B)聚合度為10之聚丙三醇1分子與碳數16以上之脂肪酸2~5分子酯縮合而成之聚丙三醇脂肪酸酯 (B) Polyglycerol fatty acid ester formed by condensation of 1 molecule of polyglycerol with a polymerization degree of 10 and 2 to 5 molecules of fatty acid with carbon number of 16 or more
(C)離子性界面活性劑 (C) Ionic surfactant
(D)紫外線散射劑及/或紫外線吸收劑 (D) UV scattering agent and/or UV absorber
本發明的防曬化妝品,具有紫外線防禦機能,同時黏膩感少且保濕性佳。又,本發明的防曬化妝品,有乳化安定性。 The sunscreen cosmetics of the present invention have ultraviolet protection function, meanwhile, they have less sticky feeling and good moisturizing properties. In addition, the sunscreen cosmetic of the present invention has emulsification stability.
本發明之較佳的形態中,前述親水性單體為選自於包含聚合性羧酸、上述通式(2)所示之親水性單體、上述通式(9)所示之親水性單體、上述通式(10)所示 之親水性單體及上述通式(11)所示之親水性單體的群組之1種或2種以上的親水性單體。 In a preferred embodiment of the present invention, the hydrophilic monomer is selected from the group consisting of a polymerizable carboxylic acid, a hydrophilic monomer represented by the general formula (2), and a hydrophilic monomer represented by the general formula (9). Body, represented by the above general formula (10) One or more hydrophilic monomers of the group of the hydrophilic monomer and the hydrophilic monomer represented by the general formula (11).
藉由使用含有自如此親水性單體衍生之構成單元(h)的水溶性共聚物,可提升少黏膩感或保濕感等之使用感。 By using the water-soluble copolymer containing the structural unit (h) derived from such a hydrophilic monomer, the sense of use such as less sticky feeling or moisturizing feeling can be improved.
本發明之較佳的形態中,前述疏水性單體為前述通式(1)所示的疏水性單體,前述水溶性單體為前述通式(2)所示的親水性單體。 In a preferred embodiment of the present invention, the hydrophobic monomer is a hydrophobic monomer represented by the general formula (1), and the water-soluble monomer is a hydrophilic monomer represented by the general formula (2).
包含具有自如此疏水性單體與親水性單體衍生之構成單元的水溶性共聚物之防曬化妝品,具有更優異的使用感。 Sunscreen cosmetics containing water-soluble copolymers having structural units derived from such hydrophobic monomers and hydrophilic monomers have a more excellent sense of use.
本發明之較佳的形態中,前述成分(C)為陰離子性界面活性劑。 In a preferred embodiment of the present invention, the aforementioned component (C) is an anionic surfactant.
作為離子性界面活性劑,藉由使用陰離子性界面活性劑,可進一步提升乳化安定性。又,使用陰離子性界面活性劑之本發明的防曬化妝品,使用感也佳。 As an ionic surfactant, by using an anionic surfactant, emulsification stability can be further improved. In addition, the sunscreen cosmetics of the present invention using an anionic surfactant also have a good feeling of use.
本發明之較佳的形態中,前述陰離子性界面活性劑為醯基乳酸鈉。 In a preferred embodiment of the present invention, the anionic surfactant is sodium acyl lactylate.
作為陰離子性界面活性劑,藉由使用醯基乳酸鈉,可進一步提升乳化安定性。又,使用醯基乳酸鈉之本發明的防曬化妝品,使用感也佳。 As an anionic surfactant, by using sodium acylate lactate, the stability of emulsification can be further improved. In addition, the sunscreen cosmetics of the present invention using sodium acyl lactylate have a good feeling of use.
本發明之較佳的形態中,前述成分(B)為五硬脂酸聚甘油酯-10。 In a preferred embodiment of the present invention, the aforementioned component (B) is polyglyceryl pentastearate-10.
包含五硬脂酸聚丙三醇酯-10之本發明的防曬化妝品,乳化安定性與使用感均優異。 The sunscreen cosmetic of the present invention containing polyglycerol pentastearate-10 has excellent emulsification stability and feeling of use.
本發明之較佳的形態中,前述成分(D)為水分散性的紫外線散射劑。 In a preferred embodiment of the present invention, the aforementioned component (D) is a water-dispersible ultraviolet scattering agent.
因為水分散性之紫外線散射劑均勻地分散於水相,所以如此形態的本發明之防曬化妝品,其紫外線防禦機能佳。 Because the water-dispersible ultraviolet scattering agent is uniformly dispersed in the water phase, the sunscreen cosmetic of the present invention in such a form has a good ultraviolet defense function.
本發明之較佳的形態中,前述水分散性的紫外線散射劑為利用聚丙烯酸鈉進行表面處理的紫外線散射劑。 In a preferred embodiment of the present invention, the water-dispersible ultraviolet scattering agent is an ultraviolet scattering agent surface-treated with sodium polyacrylate.
如前述形態的防曬化妝品,紫外線散射劑更均勻地分散,且紫外線防禦機能佳。 As in the sunscreen cosmetics of the aforementioned form, the ultraviolet scattering agent is more evenly dispersed, and the ultraviolet protection function is good.
解決第6課題的本發明為包含將自疏水性單體衍生的1種或2種以上之構成單元(i)與自親水性單體衍生的1種或2種以上之構成單元(j)作為必要構成單元具有的兩親媒性共聚物、水溶性高分子及/或其鹽、以及水,藉由前述水之蒸發,在前述水溶性高分子及/或其鹽形成的水性凝膠中,形成具有包含前述兩親媒性共聚物的島粒子分散之海島結構的被膜之組成物。 The present invention that solves the sixth problem is to include one or more structural units (i) derived from a hydrophobic monomer and one or more structural units (j) derived from a hydrophilic monomer as The amphiphilic copolymer, water-soluble polymer and/or salt thereof, and water necessary in the constituent unit are evaporated in the water to form an aqueous gel formed by the water-soluble polymer and/or salt thereof. A composition having a film having a sea-island structure in which island particles containing the amphiphilic copolymer are dispersed is formed.
前述被膜具有將水溶性成分作為主體的海島結構,且具有如包含油劑之牛奶的觸感。根據本發明的組成物,可將具有如此海島結構之被膜形成於肌膚上。 The aforementioned film has a sea-island structure mainly composed of water-soluble components, and has a tactile feel like milk containing oil. According to the composition of the present invention, a film having such a sea-island structure can be formed on the skin.
本發明之較佳的形態中,前述島粒子之平均長軸短軸比為0.8以上,平均粒徑為1~5μm的前述島粒子之個數粒度分布為80%以上。 In a preferred embodiment of the present invention, the island particles have an average long axis to short axis ratio of 0.8 or more, and the particle size distribution of the island particles having an average particle size of 1 to 5 μm is 80% or more.
具有如此結構特徵之前述被膜,保濕性與柔軟性均佳。 The aforementioned coating film having such structural characteristics has excellent moisture retention and flexibility.
然後,本發明的組成物,藉由塗布於肌膚,可輕易地形成具有如此優異的性質之被膜。 Then, by applying the composition of the present invention to the skin, a film having such excellent properties can be easily formed.
本發明之較佳的形態中,前述水溶性高分子為選自於包含丙烯酸系水溶性聚合物、水溶性多胜肽及水溶性多糖的群組之1種或2種以上的水溶性高分子及/或其鹽。 In a preferred embodiment of the present invention, the water-soluble polymer is one or more water-soluble polymers selected from the group consisting of acrylic water-soluble polymer, water-soluble polypeptide and water-soluble polysaccharide. And/or its salts.
藉由成為如此包含水溶性高分子的形態,可提升組成物的成分之水溶性,而且,藉由抑制沉澱之產生,可提升組成物之安定性。 By adopting such a form containing a water-soluble polymer, the water solubility of the components of the composition can be improved, and by suppressing the occurrence of precipitation, the stability of the composition can be improved.
本發明之較佳的形態中,前述水溶性高分子為選自於包含聚丙烯酸鈉、(丙烯酸酯/丙烯酸烷酯(C10-30))交聯聚合物、聚麩胺酸鈉、三仙膠及銀耳多糖體的群組之1種或2種以上的水溶性高分子。 In a preferred embodiment of the present invention, the water-soluble polymer is selected from the group consisting of sodium polyacrylate, (acrylate/alkyl acrylate (C10-30)) cross-linked polymer, sodium polyglutamine, and sanxian gum One or more water-soluble polymers in the group of Tremella polysaccharides.
藉由成為如此包含水溶性高分子的形態,可進一步提升組成物之安定性。 By adopting such a form containing a water-soluble polymer, the stability of the composition can be further improved.
本發明之較佳的形態中,前述組成物係包含促進前述水性凝膠與前述兩親媒性共聚物之相分離的多元醇及/或抑制前述水性凝膠與前述兩親媒性共聚物之相分離的多元醇。 In a preferred embodiment of the present invention, the composition includes a polyol that promotes phase separation of the aqueous gel and the amphiphilic copolymer and/or an inhibitor that inhibits the aqueous gel and the amphiphilic copolymer Phase separated polyol.
藉由包含如此多元醇,可提升前述被膜之均一性。 By including such a polyol, the uniformity of the aforementioned coating can be improved.
本發明之較佳的形態中,前述促進相分離的多元醇為藉由與在親水性部分具有聚醚鏈之非離子性界面活性劑的水溶液混合,使該水溶液之濁點提升的多 元醇;前述抑制相分離的多元醇為藉由與在親水性部分具有聚醚鏈之非離子性界面活性劑的水溶液混合,使該水溶液之濁點下降的多元醇。 In a preferred embodiment of the present invention, the aforementioned phase separation-promoting polyol is mixed with an aqueous solution of a nonionic surfactant having a polyether chain in the hydrophilic part, so that the cloud point of the aqueous solution is much increased. Monohydric alcohol; the aforementioned polyol that inhibits phase separation is a polyol that reduces the cloud point of the aqueous solution by mixing with an aqueous solution of a nonionic surfactant having a polyether chain in the hydrophilic portion.
藉由包含如此多元醇,可提升前述被膜之均一性。 By including such a polyol, the uniformity of the aforementioned coating can be improved.
本發明之較佳的形態中,前述促進相分離的多元醇為選自於包含1,3-丁二醇、聚乙二醇的群組之1種或2種以上的多元醇。 In a preferred embodiment of the present invention, the polyol for promoting phase separation is one or more polyols selected from the group consisting of 1,3-butanediol and polyethylene glycol.
藉由使用如此多元醇,可有效地促進水性凝膠與兩親媒性共聚物之相分離,且可提升前述被膜之均一性。 By using such a polyol, the phase separation of the aqueous gel and the amphiphilic copolymer can be effectively promoted, and the uniformity of the aforementioned coating can be improved.
本發明之較佳的形態中,前述抑制相分離的多元醇為選自於包含丙三醇、二丙三醇、山梨糖醇、麥芽糖醇的群組之1種或2種以上的多元醇。 In a preferred embodiment of the present invention, the polyhydric alcohol that inhibits phase separation is one or more polyhydric alcohols selected from the group consisting of glycerin, diglycerin, sorbitol, and maltitol.
藉由使用如此多元醇,可有效地促進水性凝膠與兩親媒性共聚物之相分離,且可提升前述被膜之均一性。 By using such a polyol, the phase separation of the aqueous gel and the amphiphilic copolymer can be effectively promoted, and the uniformity of the aforementioned coating can be improved.
本發明之較佳的形態中,前述促進相分離的多元醇及前述抑制相分離的多元醇之總量與前述兩親媒性共聚物及前述水溶性高分子之總量的質量比為5:1~20:1。 In a preferred embodiment of the present invention, the mass ratio of the total amount of the phase separation promoting polyol and the phase separation suppression polyol to the total amount of the amphiphilic copolymer and the water soluble polymer is 5: 1~20:1.
藉由成為如此形態,可提升前述被膜之均一性。 By adopting such a shape, the uniformity of the aforementioned coating can be improved.
本發明之較佳的形態中,前述促進相分離的多元醇及前述抑制相分離的多元醇之質量比為3.5:1~1:2.5。 In a preferred embodiment of the present invention, the mass ratio of the phase separation promoting polyol and the phase separation inhibiting polyol is 3.5:1 to 1:2.5.
藉由成為如此形態,可提升前述被膜之均一性。 By adopting such a shape, the uniformity of the aforementioned coating can be improved.
本發明之較佳的形態中,前述兩親媒性共聚物之含量為0.1~5質量%。 In a preferred embodiment of the present invention, the content of the amphiphilic copolymer is 0.1 to 5% by mass.
藉由使兩親媒性共聚物之含量成為前述範圍,可進一步成為可形成有柔軟性之觸感佳的前述被膜之組成物。 By making the content of the amphiphilic copolymer into the aforementioned range, it can be further formed into a composition capable of forming the aforementioned coating film having excellent soft touch.
本發明之較佳的形態中,油劑之含量為1質量%以下。 In a preferred embodiment of the present invention, the content of the oil agent is 1% by mass or less.
藉由成為如此形態,可成為可形成黏膩感少之前述被膜的組成物。 By adopting such a form, it becomes a composition capable of forming the aforementioned coating film with little stickiness.
本發明之較佳的形態中,作為前述兩親媒性共聚物,係包含選自於下述E群之1種或2種以上的共聚物。 In a preferred embodiment of the present invention, the amphiphilic copolymer includes one or more copolymers selected from Group E below.
E群:聚季銨鹽-51、聚季銨鹽-61、(甲基丙烯酸甘油基醯胺乙酯/甲基丙烯酸硬脂酯)共聚物、及包含自選自於通式(1)、(7)、(8)的疏水性單體衍生之構成單元(i)的丙烯酸系兩親媒性共聚物 Group E: polyquaternium-51, polyquaternium-61, (glyceryl methacrylate ethyl ester/stearyl methacrylate) copolymer, and selected from general formula (1), ( 7) Acrylic amphiphilic copolymer of structural unit (i) derived from hydrophobic monomer of (8)
包含如此兩親媒性共聚物之本發明的組成物,如牛奶的觸感更強,而且,可形成柔軟性更佳的前述被膜。 The composition of the present invention containing such an amphiphilic copolymer, such as milk, has a stronger touch and can form the aforementioned coating film having better flexibility.
本發明之較佳的形態中,前述丙烯酸系兩親媒性共聚物,係包含自選自於下述F群之1種或2種以上的親水性單體衍生的構成單元(j)。 In a preferred embodiment of the present invention, the acrylic amphiphilic copolymer includes a structural unit (j) derived from one or more hydrophilic monomers selected from Group F below.
F群:聚合性羧酸、上述通式(2)所示的共聚物、上述通式(9)所示的共聚物、上述通式(10)所示的共聚物及上述通式(11)所示的共聚物 Group F: polymerizable carboxylic acid, copolymer represented by the general formula (2), copolymer represented by the general formula (9), copolymer represented by the general formula (10), and the general formula (11) Copolymer shown
包含具有自如此親水性單體衍生之構成單元(j)的兩親媒性共聚物之本發明的組成物,如牛奶的觸感更強,而且,可形成柔軟性更佳的前述被膜。 The composition of the present invention containing an amphiphilic copolymer having a structural unit (j) derived from such a hydrophilic monomer has a stronger tactile feel, and can form the aforementioned coating film having better flexibility.
本發明之較佳的形態中,前述丙烯酸系兩親媒性共聚物係包含自前述通式(1)所示之疏水性單體衍生的構成單元(i)與自前述通式(2)所示之親水性單體衍生的構成單元(j)。 In a preferred embodiment of the present invention, the acrylic amphiphilic copolymer includes a structural unit (i) derived from the hydrophobic monomer represented by the general formula (1) and a component derived from the general formula (2) The structural unit (j) derived from the hydrophilic monomer shown.
根據包含如此丙烯酸系兩親媒性共聚物之本發明的組成物,可進一步形成保濕性與柔軟性均佳的前述被膜。 According to the composition of the present invention containing such an acrylic amphiphilic copolymer, the aforementioned coating film having excellent moisture retention and flexibility can be further formed.
又,本發明也關於一種被膜,其係在水溶性高分子形成的水性凝膠中,具有包含兩親媒性共聚物的島粒子分散之海島結構的被膜,前述兩親媒性共聚物將自疏水性單體衍生的1種或2種以上之構成單元(i)與自親水性單體衍生的1種或2種以上之構成單元(j)作為必要構成單元含有。 In addition, the present invention also relates to a film having a sea-island structure in which island particles containing an amphiphilic copolymer are dispersed in an aqueous gel formed of a water-soluble polymer. The amphiphilic copolymer will be One or more structural units (i) derived from a hydrophobic monomer and one or more structural units (j) derived from a hydrophilic monomer are contained as necessary structural units.
本發明的被膜,具有將水溶性成分作為主體的海島結構。然後,不論是否將水溶性成分作為主體,均具有如包含油劑之牛奶的觸感。 The coating of the present invention has a sea-island structure mainly composed of water-soluble components. Then, regardless of whether the water-soluble component is the main component, it has a touch like milk containing oil.
本發明之較佳的形態中,前述島粒子之平均長軸短軸比為0.8以上,平均粒徑為1~5μm的前述島粒子之個數粒度分布為80%以上。 In a preferred embodiment of the present invention, the island particles have an average long axis to short axis ratio of 0.8 or more, and the particle size distribution of the island particles having an average particle size of 1 to 5 μm is 80% or more.
具有如此結構特徵之前述被膜,如包含油劑之牛奶的觸感佳。 The aforementioned coating film having such structural characteristics, such as milk containing oil, has a good touch.
又,本發明也關於一種方法,其係形成上述本發明的被膜之方法,將包含自疏水性單體衍生的1種或2種以上之構成單元(i)與自親水性單體衍生的1種或2種以上之構成單元(j)作為必要構成單元具有的兩親媒性共聚物、水溶性高分子及/或其鹽、以及水的組成物塗布於肌膚。 In addition, the present invention also relates to a method of forming the above-mentioned coating film of the present invention, comprising one or more structural units derived from a hydrophobic monomer (i) and 1 derived from a hydrophilic monomer One or two or more types of structural units (j) are applied to the skin as a composition of the amphiphilic copolymer, water-soluble polymer and/or its salt, and water as essential structural units.
根據本發明的方法,可輕易地形成前述被膜。 According to the method of the present invention, the aforementioned coating can be easily formed.
又,本發明之較佳的形態中,前述組成物係包含促進前述兩親媒性共聚物與前述水性凝膠之相分離的多元醇及/或抑制前述水性凝膠與前述兩親媒性共聚物之相分離的多元醇。 Furthermore, in a preferred embodiment of the present invention, the composition includes a polyol that promotes phase separation of the amphiphilic copolymer and the aqueous gel and/or inhibits the copolymerization of the aqueous gel and the amphiphilic copolymer The phase separated polyol.
藉由使用包含如此多元醇的水溶液,可形成均一性佳的前述被膜。 By using an aqueous solution containing such a polyhydric alcohol, the aforementioned coating film with good uniformity can be formed.
根據本發明,可提供具有彈力感的共聚物及皮膚外用劑。 According to the present invention, a copolymer having elasticity and an external preparation for skin can be provided.
又,根據本發明,可提供一種對肌膚之刺激少,黏膩感少,同時乳化安定性佳的乳化組成物。 In addition, according to the present invention, it is possible to provide an emulsified composition which has less irritation to the skin, less stickiness, and excellent emulsification stability.
又,根據本發明,可提供使用後之緊繃感減低的皮膚清潔劑。 Furthermore, according to the present invention, it is possible to provide a skin cleanser with reduced tightness after use.
又,將本發明應用於包含脂肪酸皂的皮膚清潔劑時,不會阻礙良質的起泡性或綿密的泡沫品質,且可減低使用後的緊繃感。 In addition, when the present invention is applied to a skin cleanser containing fatty acid soaps, it does not hinder good foaming properties or dense foam quality, and can reduce tightness after use.
又,將本發明應用於凝膠狀的皮膚清潔劑時,也可得到減低使用後的緊繃感之效果。 In addition, when the present invention is applied to a gel-like skin cleanser, an effect of reducing tightness after use can also be obtained.
又,根據本發明,可提供一種具有良好的紫外線防禦機能,同時無黏膩感或保濕感等之使用感佳,且有乳化安定性之水中油型的防曬化妝品。 In addition, according to the present invention, it is possible to provide an oil-in-water sunscreen cosmetic which has a good ultraviolet protection function, has no sticky feeling or moisturizing feeling, and has emulsification stability.
又,根據本發明,可提供一種具有將水溶性成分作為主體之海島結構的被膜及形成該被膜的技術。前述被膜,不論是否將水溶性成分作為主體,均具有如包含油劑之牛奶的觸感。 Furthermore, according to the present invention, it is possible to provide a film having a sea-island structure mainly composed of a water-soluble component and a technique for forming the film. The aforementioned coating, regardless of whether or not the water-soluble component is the main component, has a touch like milk containing oil.
又,本發明之較佳的形態中,可提供一種無黏膩感之前述被膜及形成該被膜的技術。 In addition, in a preferred embodiment of the present invention, the aforementioned coating film without stickiness and a technique for forming the coating film can be provided.
1‧‧‧實施例103 1‧‧‧Example 103
2‧‧‧實施例104 2‧‧‧Example 104
3‧‧‧實施例105 3‧‧‧Example 105
4‧‧‧實施例106 4‧‧‧Example 106
5‧‧‧實施例107 5‧‧‧Example 107
6‧‧‧實施例108 6‧‧‧Example 108
7‧‧‧實施例109 7‧‧‧Example 109
8‧‧‧實施例110 8‧‧‧Example 110
9‧‧‧實施例111 9‧‧‧Example 111
10‧‧‧實施例112 10‧‧‧Example 112
11‧‧‧實施例113 11‧‧‧Example 113
12‧‧‧實施例114 12‧‧‧Example 114
13‧‧‧實施例115 13‧‧‧Example 115
14‧‧‧實施例116 14‧‧‧Example 116
15‧‧‧實施例117 15‧‧‧Example 117
16‧‧‧實施例118 16‧‧‧Example 118
17‧‧‧實施例119 17‧‧‧Example 119
18‧‧‧實施例120 18‧‧‧Example 120
19‧‧‧實施例121 19‧‧‧Example 121
20‧‧‧實施例122 20‧‧‧Example 122
21‧‧‧實施例123 21‧‧‧Example 123
第1圖為表示包含實施例1與比較例1之共聚物的凝膠狀化妝品之評價結果的長條圖。 FIG. 1 is a bar graph showing the evaluation results of gel-like cosmetics including the copolymers of Example 1 and Comparative Example 1. FIG.
第2圖表示將實施例9~31之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙酸甲氧酯PEG-23)共聚物與鯊烷及水之摻合比率製圖的3成分系相圖。 Figure 2 shows the blending ratio of the glycerin diisostearate methacrylate/methacrylic acid PEG-23 copolymer of Examples 9 to 31, squalane and water. Composition diagram.
第3圖表示將實施例32~62之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙酸甲氧酯PEG-23)共聚物與三(辛酸/癸酸)甘油酯及水之摻合比率製圖的3成分系相圖。 Figure 3 shows the copolymers of Examples 32-62 (glyceryl diisostearate methacrylate/methacrylic acid PEG-23) and tris(octanoic acid/capric acid) glyceride and water The three components of the blend ratio mapping are phase diagrams.
第4圖表示將實施例63~89之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙酸甲氧酯PEG-23)共聚物與矽靈(dimethicone)及水之摻合比率製圖的3成分系相圖。 Fig. 4 shows the blending ratio of the copolymers of (glyceryl diisostearate methacrylate/methoxymethyl propionate PEG-23) of Examples 63 to 89, dimethicone and water The 3-component phase diagram of cartography.
第5圖表示實施例104~124所含之1,3-丁二醇、丙三醇、三仙膠與(甲基丙酸甲氧酯PEG-23/二異硬脂酸酯甲基丙烯酸甘油酯)共聚物之總量的3成分系相圖。 Figure 5 shows the 1,3-butanediol, glycerin, tannin gum and (methacrylic acid methyl ester PEG-23/diisostearate glycerol methacrylate contained in Examples 104-124) The three-component phase diagram of the total amount of ester) copolymer.
第6圖表示實施例105、106、108、111、113、114、115、119、120、122、123之組成物的顯微鏡照片。 Fig. 6 shows micrographs of the compositions of Examples 105, 106, 108, 111, 113, 114, 115, 119, 120, 122, and 123.
第7圖表示顯示試驗例7之實施例104的組成物之觸感評價的結果之圓餅圖。 FIG. 7 shows a pie chart showing the results of tactile evaluation of the composition of Example 104 of Test Example 7. FIG.
解決第1課題之本發明的共聚物,係將自前述通式(1)所示之疏水性單體衍生的一種或兩種以上之構成單元(a)與自下述通式(2)所示之親水性單體衍生的一種或兩種以上之構成單元(b)作為必要構成單元具有。 The copolymer of the present invention for solving the first problem is composed of one or two or more structural units (a) derived from the hydrophobic monomer represented by the aforementioned general formula (1) and the following general formula (2) One or two or more structural units (b) derived from the hydrophilic monomers shown are included as essential structural units.
再者,在本發明中,「自單體衍生的構成單元」,係指對應的單體具有之碳-碳不飽和鍵藉由聚合反應裂解而形成的構成單元。 Furthermore, in the present invention, "constituent unit derived from a monomer" refers to a constituent unit formed by cleaving a carbon-carbon unsaturated bond possessed by the corresponding monomer by a polymerization reaction.
以下對於通式(1)所示之疏水性單體及通式(2)所示之親水性單體進行說明。 Hereinafter, the hydrophobic monomer represented by the general formula (1) and the hydrophilic monomer represented by the general formula (2) will be described.
本發明的共聚物含有自前述通式(1)所示的疏水性單體衍生之構成單元(以下有時也簡稱為「構成單元(1)」)的一種或二種以上作為必要構成單元。 The copolymer of the present invention contains one or two or more structural units derived from the hydrophobic monomer represented by the general formula (1) (hereinafter sometimes simply referred to as "constituent unit (1)") as essential structural units.
在此,作為R1所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R1為氫或甲基較佳。 Here, examples of the alkyl group represented by R 1 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 1 is preferably hydrogen or methyl.
又,作為R2、R3所示之未含有環結構的具有分支之碳數6~22的醯基,可例示2-甲基戊醯基、3-甲基戊醯基、4-甲基戊醯基、2-乙基丁醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、2-甲基己醯基、4-甲基己醯基、5-甲基己醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2-甲基庚醯基、2-乙基己基、2-丙基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、2-甲基辛醯基、3,3,5-三甲基己醯基、2-甲基壬醯基、4-甲基壬醯基、8-甲基壬 醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 In addition, examples of R 2 and R 3 that do not contain a ring structure and have branched C 6-22 acyl groups include 2-methylpentyl group, 3-methylpentyl group, and 4-methyl group. Pentamyl, 2-ethylbutyryl, 2,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2-methylhexyl, 4-methylhexyl, 5-methylhexyl Group, 2,2-dimethylpentyl group, 4,4-dimethylpentyl group, 2-methylheptyl group, 2-ethylhexyl group, 2-propylpentyl group, 2,2- Dimethylhexyl, 2,2,3-trimethylpentyl, 2-methyloctyl, 3,3,5-trimethylhexyl, 2-methylnonyl, 4-methyl Ylnonyl, 8-methylnonyl, 4-ethyloctyl, 2-ethyloctyl, 2-butylhexyl, 2-third butylhexyl, 2,2-diethyl Hexamyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl, 2-methyl Undecylenyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2-butyloctyl, diethyloctyl, 2-third butyl -2,2,4-trimethylpentanyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyldodecyl, 11-methyldodecyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl-2-ethyloctyl, 12-methyltetradecyl , 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-dimethylhexyl, 2-butyl Hexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nonadecyl, 3,7,11,15-tetra-methyl deca Hexaacetyl, 19-methyl eicosyl, etc.
本發明之更佳的實施形態中,前述通式(1)所示的疏水性單體為前述通式(3)所示的疏水性單體。 In a more preferred embodiment of the present invention, the hydrophobic monomer represented by the general formula (1) is the hydrophobic monomer represented by the general formula (3).
作為如此較佳的實施形態之R8、R9所示之未含有環結構的具有分支之碳數10~22的醯基,可例示2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二 醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As such a preferred embodiment, R 8 and R 9 which do not contain a ring structure and have a branched carbon number of 10 to 22 acyl group, can be exemplified by 2-methylnonyl group, 4-methylnonyl group , 8-methylnonanoyl, 4-ethyloctyl, 2-ethyloctyl, 2-butylhexyl, 2-third butylhexyl, 2,2-diethylhexyl, 2,2-Dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl, 2-methylundecyl , 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2-butyloctyl, diethyloctyl, 2-third-butyl-2,2 ,4-trimethylpentyl acetyl, 10-methyl dodecyl, 3-methyl dodecyl, 4-methyl dodecyl, 11-methyl dodecyl, 10-ethyl Undecylenyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl-2-ethyloctyl, 12-methyltetradecyl, 14-methyl Ethyl pentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-dimethylhexyl, 2-butylhexadecyl , 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nonadecyl, 3,7,11,15-tetra-methylhexadecyl, 19-methyl eicosyl, etc.
又,作為較佳的實施形態之R8、R9所示之未含有環結構的具有2個以上之分支的碳數6~9之醯基,可例示2,2-二甲基丁醯基、3,3-二甲基丁醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、3,5,5-三甲基己醯基等。 In addition, as a preferred embodiment, R 8 and R 9 which do not contain a ring structure and have 2 or more branches of C 6-9 acryloyl groups can be exemplified by 2,2-dimethylbutyroyl, 3 ,3-dimethylbutyryl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethyl Pentyl, 3,5,5-trimethylhexyl, etc.
通式(3)之R8、R9之醯基的碳數,較佳為12~22,更佳為14~20,特佳為16~20。 The carbon number of the acyl group of R 8 and R 9 in the general formula (3) is preferably 12-22, more preferably 14-20, and particularly preferably 16-20.
又,通式(3)之R8、R9之醯基的主鏈之碳數,較佳為9~21,更佳為12~20,特佳為16~18。 In addition, the carbon number of the main chain of the acyl group of R 8 and R 9 in the general formula (3) is preferably 9 to 21, more preferably 12 to 20, and particularly preferably 16 to 18.
又,通式(3)之R8、R9之醯基的分支數,較佳為1~3,更佳為1或2,特佳為1。 In addition, the number of branching of the acyl group of R 8 and R 9 in the general formula (3) is preferably 1 to 3, more preferably 1 or 2, and particularly preferably 1.
而且,在通式(3)之R8、R9之醯基中,分支鏈鍵結的主鏈之碳的位置編號越大越佳。具體而言,分支鏈較佳係以與自主鏈端部的第1~3個碳鍵結為較佳,更佳為第1或2個碳,特佳為第1個碳。 In addition, in the acyl group of R 8 and R 9 in the general formula (3), the larger the position number of the carbon of the main chain of the branch chain bonding, the better. Specifically, the branched chain is preferably bonded to the first to third carbons at the end of the autonomous chain, more preferably the first or second carbon, and particularly preferably the first carbon.
作為R8、R9,具體而言,可適當例示10-甲基十一醯基、10-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、12-甲基十四醯基、 14-甲基十五醯基、16-甲基十七醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As R 8 and R 9 , specifically, 10-methyl undecyl group, 10-methyl dodecyl group, 11-methyl dodecyl group, 10-ethyl undecyl group, 12-Methyltridecyl, 12-methyltetradecyl, 14-methylpentadecyl, 16-methylheptadecyl, 2,4,10,14-tetramethylpentyl , 18-methyl nineteen amide, 3,7,11,15-tetra-methyl hexadecyl, 19-methyl eicosyl, etc.
在前述通式(1)、(3)中,X或Y所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the aforementioned general formulas (1) and (3), the group derived from triol represented by X or Y is not particularly limited as long as it is a group from which the OH group is desorbed from the triol, and can be appropriately exemplified from The OH group is desorbed from the triol including glycerin, trimethylolpropane, and trimethylolethane.
本發明之較佳的形態中,作為疏水性單體,使用前述通式(5)所示的單體較佳。 In a preferred embodiment of the present invention, it is preferable to use the monomer represented by the general formula (5) as the hydrophobic monomer.
作為通式(5)所示的疏水性單體,可例示下述式(12)~(14)所示的化合物。宜使用分支鏈加成於醯基的末端之下述式(12)所示的化合物。 As the hydrophobic monomer represented by the general formula (5), compounds represented by the following formulas (12) to (14) can be exemplified. It is preferable to use a compound represented by the following formula (12) in which a branched chain is added to the terminal of the acyl group.
構成本發明的共聚物之通式(1)所示的疏水性單體,例如,可以下述的方法進行合成。 The hydrophobic monomer represented by the general formula (1) constituting the copolymer of the present invention can be synthesized, for example, by the following method.
a)將三元醇縮酮化。作為具體的合成方法,例如,可例示日本特開2009-136749號公報之製造例1記載的方法。 a) Ketalize the triol. As a specific synthesis method, for example, the method described in Production Example 1 of Japanese Patent Laid-Open No. 2009-136749 can be exemplified.
b)a所合成之縮酮化的三元醇與(甲基)丙烯酸烷酯之酯交換,合成縮酮的(甲基)丙烯酸酯,進行得到的縮酮之(甲基)丙烯酸酯的去酮反應,合成三元醇之單(甲基)丙烯酸酯。作為具體的合成方法,例如,可例示日本特開2004-18389號公報之實施例1記載的方法。 b) Transesterification of the ketalized triol synthesized in a with alkyl (meth)acrylate to synthesize the (meth)acrylate of the ketal and remove the (meth)acrylate of the obtained ketal Ketone reaction to synthesize mono(meth)acrylate of triol. As a specific synthesis method, for example, the method described in Example 1 of Japanese Patent Laid-Open No. 2004-18389 can be exemplified.
c)使b所得到之三元醇的單(甲基)丙烯酸酯與具有所定分支結構的羧酸或其酐或是其氯化物反應,得到通式(1)所示的疏水性單體。 c) The mono(meth)acrylate of the triol obtained in b is reacted with a carboxylic acid having a predetermined branch structure or its anhydride or its chloride to obtain a hydrophobic monomer represented by the general formula (1).
再者,因為縮酮化的三元醇中也存在市售品,所以也可利用該市售品,且利用上述步驟b)及c)得到本發明的三元醇之酯。作為如此市售品,可例示(S)-(+)-2,2-二甲基-1,3-二氧雜環戊烷-4-甲醇、(R)-(+)-2,2-二甲基-1,3-二氧雜環戊烷-4-甲醇(均為東京 化成工業(股)製)。而且,因為三元醇的單(甲基)丙烯酸酯中也存在市售品,所以也可利用該市售品,且利用上述步驟c)得到本發明的三元醇之酯。作為如此市售品,可例示「Blenmer GLM」(丙三醇單甲基丙烯酸酯日本油脂(股)製)。 In addition, since a commercial product is also present in the ketalized triol, the commercial product can also be used, and the ester of the triol of the present invention can be obtained by the above steps b) and c). As such a commercially available product, (S)-(+)-2,2-dimethyl-1,3-dioxolane-4-methanol, (R)-(+)-2,2 can be exemplified -Dimethyl-1,3-dioxolane-4-methanol (both Tokyo Chemical industry (stock) system). In addition, since a commercially available product also exists in the mono(meth)acrylate of the triol, the commercially available product can also be used, and the ester of the triol of the present invention can be obtained by the above step c). As such a commercially available product, "Blenmer GLM" (made by glycerin monomethacrylate Nippon Oil & Fats Co., Ltd.) can be exemplified.
本發明的共聚物之構成單元(a)在全構成單元所佔之比例,較佳為1~40質量%,更佳為5~35質量%。 The proportion of the structural unit (a) of the copolymer of the present invention in all the structural units is preferably 1 to 40% by mass, more preferably 5 to 35% by mass.
藉由使構成單元(a)所佔之比例成為前述範圍,可提升本發明的共聚物之彈力性。 By making the ratio of the structural unit (a) within the aforementioned range, the elasticity of the copolymer of the present invention can be improved.
本發明的共聚物含有自前述通式(2)所示的親水性單體衍生之構成單元的一種或二種以上作為必要構成單元。 The copolymer of the present invention contains one or more structural units derived from the hydrophilic monomer represented by the aforementioned general formula (2) as essential structural units.
作為在前述通式(2)中R4所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基。在本發明中,R4為氫原子或甲基較佳。 Examples of the alkyl group represented by R 4 in the general formula (2) include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 4 is preferably a hydrogen atom or a methyl group.
又,作為R5所示的伸烷基,可例示伸乙基、伸丙基、異伸丙基、2-羥基伸丙基、1-羥基-2-甲基伸乙基、2-羥基-1-甲基伸乙基等,但該等之中,較佳為伸乙基或伸丙基,更佳為伸乙基。 In addition, examples of the alkylene group represented by R 5 include ethyl group, ethyl group, isopropyl group, 2-hydroxypropyl group, 1-hydroxy-2-methyl ethyl group, and 2-hydroxy- 1-methylethylidene, etc., but among these, ethylidene or propylidene are preferred, and ethylidene is more preferred.
又,R6所示的基中,作為碳數6~10的芳香族基,可例示苯基、苯甲基、甲苯基、乙苯基等;作為碳數1~14的脂肪族烴基,可適當例示甲基、乙基、丁基、第三丁基、己基、環己基、辛基、2-乙基己基、月桂基等;作為碳數1~12的醯基,可適當例示甲醯基、乙 醯基、丙醯基、丁醯基、異丁醯基、戊醯基、月桂醯基等。該等之中,作為R5所示的基,較佳為碳數1~14的脂肪族烴基,更佳為碳數1~12的烷基。 In addition, among the groups represented by R 6 , examples of the aromatic groups having 6 to 10 carbon atoms include phenyl, benzyl, tolyl, and ethylphenyl groups. As the aliphatic hydrocarbon groups having 1 to 14 carbon atoms, Appropriate examples include methyl, ethyl, butyl, tertiary butyl, hexyl, cyclohexyl, octyl, 2-ethylhexyl, lauryl, etc.; as a C 1-12 acyl group, a methyl acyl group can be appropriately exemplified. , Acetyl, propyl, butyl, isobutyl, pentyl, lauryl, etc. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
而且,通式(2)之n為6~40的數值範圍。 Furthermore, n in the general formula (2) is in the range of 6 to 40.
前述通式(2)所示的單體中,作為R5為伸丙基之單體,具體而言,可舉出聚丙二醇(9)單丙烯酸酯、聚丙二醇(13)單丙烯酸酯、聚丙二醇(9)單甲基丙烯酸酯、聚丙二醇(13)單甲基丙烯酸酯等。再者,括弧內的數字表示N。該等之聚合物大多可作為市售品取得。作為該等市售品,具體而言,可例示商品名「Blenmer」AP-400、AP-550、AP-800、PP-500、PP-800(均為日本油脂(股)製)等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is propylene, specifically, polypropylene glycol (9) monoacrylate, polypropylene glycol (13) monoacrylate, poly Propylene glycol (9) monomethacrylate, polypropylene glycol (13) monomethacrylate, etc. Furthermore, the number in parentheses indicates N. Most of these polymers are available as commercial products. Specific examples of these commercially available products include trade names "Blenmer" AP-400, AP-550, AP-800, PP-500, and PP-800 (all manufactured by Nippon Oil & Fats Co., Ltd.).
前述通式(2)所示的單體中,作為R5為伸乙基之單體,具體而言,可舉出聚乙二醇(10)單丙烯酸酯、聚乙二醇(8)單甲基丙烯酸酯、聚乙二醇(23)單丙烯酸酯、聚乙二醇(23)單甲基丙烯酸酯、甲氧基聚乙二醇(9)丙烯酸酯、甲氧基聚乙二醇(9)甲基丙烯酸酯、甲氧基聚乙二醇(23)甲基丙烯酸酯、油氧基聚乙二醇(18)甲基丙烯酸酯、月桂氧基聚乙二醇(18)丙烯酸酯、月桂醯氧基聚乙二醇(10)甲基丙烯酸酯、硬脂氧基聚乙二醇(30)單甲基丙烯酸酯等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is an ethylidene group, specifically, polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomer Methacrylate, polyethylene glycol (23) monoacrylate, polyethylene glycol (23) monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol ( 9) Methacrylate, methoxypolyethylene glycol (23) methacrylate, oleyloxy polyethylene glycol (18) methacrylate, lauryloxy polyethylene glycol (18) acrylate, Lauryloxy polyethylene glycol (10) methacrylate, stearyl polyethylene glycol (30) monomethacrylate, etc.
本發明之較佳的實施形態中,作為親水性單體,係使用前述通式(6)所示的單體。 In a preferred embodiment of the present invention, as the hydrophilic monomer, the monomer represented by the general formula (6) is used.
前述通式(6)中的1,較佳為6~30,更佳為8~30。 1 in the aforementioned general formula (6) is preferably 6-30, and more preferably 8-30.
上述親水性單體,可藉由對應的聚乙二醇、聚乙二醇單醚、聚乙二醇單酯與丙烯酸或甲基丙烯酸之氯化物或酐之酯化反應而以高產率得到。又,因為已存在很多市售品,所以也可利用該市售品。作為如此市售品,具體而言,可例示商品名Blenmer、AE-400、PE-350、AME-400、PME-400、PME-1000、ALE-800、PSE-1300(均為日本油脂(股)製)等。 The above-mentioned hydrophilic monomers can be obtained in a high yield by esterification reaction of corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester with acrylic acid or methacrylic acid chloride or anhydride. In addition, since many commercial products already exist, the commercial products can also be used. As such a commercially available product, specifically, the trade names of Blenmer, AE-400, PE-350, AME-400, PME-400, PME-1000, ALE-800, and PSE-1300 (all of which are Japanese oil ) System) etc.
本發明的共聚物所含之自親水性的單體衍生之構成單元可僅為1種,但只要滿足前述條件者,亦可組合2種以上的構成單元而含有。 The structural unit derived from the hydrophilic monomer contained in the copolymer of the present invention may be only one type, but as long as the aforementioned conditions are satisfied, two or more types of structural units may be combined and contained.
本發明的共聚物之自親水性的單體衍生之構成單元(b)在全構成單元所佔之比例為30~95質量%、較佳為40~90質量%。 The proportion of the structural unit (b) derived from the hydrophilic monomer of the copolymer of the present invention in all the structural units is 30 to 95% by mass, preferably 40 to 90% by mass.
藉由使構成單元(b)所佔之比例成為前述範圍,可提升本發明的共聚物之彈力感。 By making the ratio of the structural unit (b) within the aforementioned range, the elasticity of the copolymer of the present invention can be improved.
本發明的共聚物,除了上述構成單元1及構成單元2以外,可將通常共聚物所使用之自單體衍生的單元,在不損及發明的效果之範圍作為任意的構成單元含有。作為該任意的構成單元,可例示自丙烯酸醯胺、甲基丙烯酸醯胺、丙烯酸單烷醯胺、甲基丙烯酸單烷醯胺等之(甲基)丙烯酸醯胺、(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸異丁酯、(甲基)丙烯酸第三丁酯、(甲基)丙烯酸正辛酯、(甲基)丙烯酸-2-乙基己酯、甲基丙烯酸正十二酯、(甲基)丙烯酸
硬脂酯、(甲基)丙烯酸異硬脂酯等之(甲基)丙烯酸烷酯、(甲基)丙烯酸環己酯等之(甲基)丙烯酸的環狀烷酯、(甲基)丙烯酸2-羥乙酯、(甲基)丙烯酸2-羥丙酯、(甲基)丙烯酸4-羥丁酯等之(甲基)丙烯酸羥烷酯、(甲基)丙烯酸苯甲酯等之(甲基)丙烯酸芳酯、(甲基)丙烯酸甲氧甲酯、(甲基)丙烯酸甲氧乙酯等之(甲基)丙烯酸烷氧烷酯、乙酸乙烯酯、乙烯吡咯啶酮、苯乙烯、α-甲基苯乙烯、丙烯腈等之單體衍生的構成單元。該等之單體幾乎可作為市售品取得。
The copolymer of the present invention may contain, as well as the above-mentioned
本發明的共聚物為在其骨架中含有構成單元(a)及構成單元(b)的共聚物。又,本發明的共聚物通常為其構成單元無規地鍵結的無規共聚物,亦可為嵌段共聚物或接枝共聚物。 The copolymer of the present invention is a copolymer containing the structural unit (a) and the structural unit (b) in its skeleton. In addition, the copolymer of the present invention is generally a random copolymer in which constituent units are randomly bonded, and may also be a block copolymer or a graft copolymer.
本發明的共聚物,其特徵為重量平均分子量為20000~110000。藉由使重量平均分子量成為前述範圍,本發明的共聚物係成為有彈力感者。 The copolymer of the present invention is characterized by a weight average molecular weight of 20,000 to 110,000. By setting the weight-average molecular weight to the aforementioned range, the copolymer of the present invention becomes elastic.
本發明的共聚物之重量平均分子量,較佳為20000~80000,進一步較佳為30000~80000,更佳為40000~70000,進一步更佳為50000~70000,特佳為57000~66000。 The weight average molecular weight of the copolymer of the present invention is preferably from 20,000 to 80,000, further preferably from 30,000 to 80,000, more preferably from 40,000 to 70,000, even more preferably from 50,000 to 70,000, and particularly preferably from 57,000 to 66000.
再者,在此,重量平均分子量係指利用GPC測定之聚苯乙烯換算的重量平均分子量。 Here, the weight average molecular weight refers to the weight average molecular weight in terms of polystyrene measured by GPC.
本發明的共聚物之製造方法,並沒有特別限定,例如,可利用將衍生各構成單元的單體於溶媒中 混合,且依據在丙烯酸系單體之聚合通常使用之方法進行聚合反應的方法得到。 The method for producing the copolymer of the present invention is not particularly limited. For example, a monomer derived from each constituent unit may be used in a solvent It is mixed and obtained by a method of conducting a polymerization reaction according to a method generally used in the polymerization of acrylic monomers.
在此藉由變更聚合反應之反應時間或反應溫度,可調整共聚物之重量平均分子量。具體而言,藉由縮短反應時間,可減小重量平均分子量。 Here, by changing the reaction time or reaction temperature of the polymerization reaction, the weight average molecular weight of the copolymer can be adjusted. Specifically, by shortening the reaction time, the weight average molecular weight can be reduced.
又,本發明的共聚物,在活用時,從處理容易之觀點,水溶性較佳。在此之共聚物係定義為在25℃中,共聚物之20質量%水溶液的透過率在90%以上的共聚物。為了得到如此聚合物,在上述聚合方法中,將前述單體混合物,在水溶液與於25℃以任何比例與水混合的水性溶媒之混合溶媒中進行自由基聚合的聚合方法特佳。又,從聚合反應後之殘留單體的量少之觀點,使用緩衝溶液代替水的聚合法特佳。作為該方法所使用之具有緩衝作用的水溶液,只要為通常使用之緩衝溶液,則沒有特別限定,具體而言,可例示氯化鉀-鹽酸溶液、苯二甲酸氫鉀-鹽酸溶液、磷酸二氫鉀-磷酸氫二鈉溶液、檸檬酸氫鉀-檸檬酸溶液、碳酸鈉-碳酸氫鈉等。又,亦可使用如與起始劑的離子形成緩衝溶液的鹽類、酸或鹼類之水溶液,在添加起始劑的時間點,製成緩衝溶液。而且,作為該方法所使用之在25℃以任何比例與水混合的水性溶媒,具體而言,可例示甲醇、乙醇、正丙醇、異丙醇等之碳數1~3的醇、丙酮、甲基乙酮等之酮、乙二醇、聚乙二醇、丙二醇、1,3-丁二醇等之二醇、乙二醇單甲醚、乙二醇單乙醚等之乙二醇單烷醚、四氫呋喃等。該等之水性溶媒中,從容易進行聚合反應之觀點,甲醇、乙醇、正丙醇、異丙醇等之碳數1~3的醇特佳。 In addition, when the copolymer of the present invention is used, water solubility is preferable from the viewpoint of ease of handling. The copolymer here is defined as a copolymer whose transmittance of a 20% by mass aqueous solution of the copolymer is at least 90% at 25°C. In order to obtain such a polymer, in the above-mentioned polymerization method, a polymerization method in which the aforementioned monomer mixture is subjected to radical polymerization in a mixed solvent of an aqueous solution and an aqueous solvent mixed with water at any ratio at 25° C. is particularly preferred. In addition, from the viewpoint that the amount of residual monomer after the polymerization reaction is small, the polymerization method using a buffer solution instead of water is particularly preferable. The buffering aqueous solution used in this method is not particularly limited as long as it is a commonly used buffer solution. Specifically, potassium chloride-hydrochloric acid solution, potassium hydrogen phthalate-hydrochloric acid solution, and dihydrogen phosphate can be exemplified. Potassium-disodium hydrogen phosphate solution, potassium hydrogen citrate-citric acid solution, sodium carbonate-sodium bicarbonate, etc. Alternatively, an aqueous solution of salts, acids, or alkalis that form a buffer solution with the ions of the initiator may be used to prepare a buffer solution at the time when the initiator is added. In addition, as the aqueous solvent used in this method, which is mixed with water at any ratio at 25°C, specifically, methanol, ethanol, n-propanol, isopropanol and the like having 1 to 3 carbon atoms, acetone, Ketones such as methyl ethyl ketone, glycols such as ethylene glycol, polyethylene glycol, propylene glycol, 1,3-butanediol, ethylene glycol monomethyl ether and ethylene glycol monoethyl ether Ether, tetrahydrofuran, etc. Among these aqueous solvents, from the viewpoint of easy polymerization reaction, alcohols having 1 to 3 carbon atoms such as methanol, ethanol, n-propanol, and isopropanol are particularly preferred.
在本發明中,構成共聚物之構成單元(a)與構成單元(b)的質量比,較佳為5:95~50:50,進一步較佳為10:90~45:55,更佳為20:80~40:60,特佳為25:75~35:65。 In the present invention, the mass ratio of the structural unit (a) to the structural unit (b) constituting the copolymer is preferably 5:95-50:50, further preferably 10:90-45:55, and more preferably 20:80~40:60, especially good is 25:75~35:65.
又,構成共聚物之構成單元(a)與構成單元(b)的莫耳比,較佳為8:92~62:38,進一步較佳為15:85~57:43,更佳為29:71~52:48,特佳為35:65~46:54。 Moreover, the molar ratio of the structural unit (a) and the structural unit (b) constituting the copolymer is preferably 8:92 to 62:38, further preferably 15:85 to 57:43, and more preferably 29: 71~52:48, especially good is 35:65~46:54.
藉由使共聚物的構成單元(a)及構成單元(b)之質量比及莫耳比成為前述範圍,可進一步提升彈力感。 By setting the mass ratio and the molar ratio of the structural unit (a) and the structural unit (b) of the copolymer to the aforementioned range, the elasticity can be further improved.
含有本發明的共聚物之皮膚外用劑,具有彈力感,同時不易產生黏膩感。 The skin external preparation containing the copolymer of the present invention has an elastic feeling and is not liable to be sticky at the same time.
在皮膚外用劑中,本發明的共聚物之含量,較佳為0.5~30質量%,更佳為1~25質量%。 In the external preparation for skin, the content of the copolymer of the present invention is preferably 0.5 to 30% by mass, and more preferably 1 to 25% by mass.
作為本發明的皮膚外用劑,可適當例示軟膏等之外用醫藥品、化妝品等。而且,作為化妝品,可例示乳霜、乳液、化妝水、美容液、防曬化妝品等之保養品、底妝、粉底、眼線、睫毛膏等之美妝、洗面乳等之皮膚清潔劑、養髮液、整髮液、定型噴霧等之毛髮化妝品等。 As the external preparation for skin of the present invention, medicines, cosmetics, etc. other than ointment can be appropriately exemplified. Furthermore, as cosmetics, skin care products such as creams, lotions, lotions, beauty lotions, sunscreen cosmetics, foundations, foundations, eyeliners, mascaras, skin cleansers such as facial cleansers, hair tonics, etc. can be exemplified. Hair cosmetics such as hair styling lotion, styling spray, etc.
本發明的皮膚外用劑,在不損及發明之效果的範圍,通常可含有在皮膚外用劑使用之成分作為任意成分。作為該任意成分,具體而言,
尤可例示澳洲胡桃油(macadamia nut oil)、酪梨油、玉米油、橄欖油、油菜籽油、芝麻油、蓖麻油、紅花籽油、棉籽油、荷荷芭油、椰子油、棕櫚油、液狀羊毛脂、硬化椰子油、硬化油、木蠟、硬化蓖麻油、蜂蠟、小燭樹蠟、巴西棕櫚蠟、蟲蠟、羊毛脂、還原羊毛脂、硬質羊毛脂、荷荷芭蠟等之油、蠟類、流動石蠟、鯊烷、異十八烷、地蠟、石蠟、礦蠟、凡士林、微晶蠟等之烴類、油酸、異硬脂酸、月桂酸、肉荳蔻酸、棕櫚酸、硬脂酸、二十二酸、十一烯酸等之高級脂肪酸類、鯨臘醇、硬脂醇、異硬脂醇、二十二醇、辛基十二醇、肉豆蔻醇、鯨蠟硬脂醇等之高級醇類、異辛酸鯨蠟酯、肉荳蔻酸異丙酯、異硬脂酸十六酯、己二酸二異丙酯、癸二酸二-2-乙基己酯、乳酸鯨蠟酯、蘋果酸二異硬脂酯、二-2-乙基己酸乙二醇、二癸酸新戊二醇、二-2-庚基十一酸丙三醇、三-2-乙基己酸丙三醇酯、三-2-乙基己酸、三羥甲基丙烷三異硬脂酸酯、四-2-乙基己酸季戊四醇酯等之合成酯油類、二甲基聚矽氧烷、甲基苯基聚矽氧烷、二苯基聚矽氧烷等之鏈狀聚矽氧烷、八甲基環四矽氧烷、十甲基環五矽氧烷、十二甲基環己烷矽氧烷等之環狀聚矽氧烷、胺基改性聚矽氧烷、聚醚改性聚矽氧烷、烷基改性聚矽氧烷、氟改性聚矽氧烷等之改性聚矽氧烷等之矽酮油等之油劑類、脂肪酸皂(月桂酸鈉、棕櫚酸鈉等)、月桂基硫酸鉀、烷基硫酸三乙醇胺醚等之陰離子界面活性劑類、硬脂基三甲基氯化銨、氯化苯二甲烴銨、月桂基氧化胺等之陽離子界面活性劑類、咪唑啉系兩性界面活性
劑(2-椰油基-2-氫氧化咪唑嗡-1-羧基乙氧基2鈉鹽等)、甜菜鹼系界面活性劑(烷基甜菜鹼、醯胺基甜菜鹼、硫代甜菜鹼等)、醯基甲基牛磺酸等之兩性界面活性劑類、山梨糖醇酐脂肪酸酯類(山梨糖醇酐單硬脂酸酯、山梨糖醇酐倍半油酸酯等)、丙三醇脂肪酸類(單硬脂酸丙三醇等)、丙二醇脂肪酸酯類(單硬脂酸丙二醇等)、硬化蓖麻油衍生物、POE山梨糖醇酐脂肪酸酯類(POE山梨糖醇酐單油酸酯、單硬脂酸聚氧乙烯山梨糖醇酐等)、POE山梨糖醇脂肪酸酯類(POE-山梨糖醇單月桂酸酯等)、POE丙三醇脂肪酸酯類(POE-丙三醇單異硬脂酸酯等)、POE脂肪酸酯類(聚乙二醇單油酸酯、POE二硬脂酸酯等)、POE烷醚類(POE2-辛基十二醚等)、POE烷基苯醚類(POE壬基苯醚等)、普朗尼克(Pluronic)型類、POE‧POP烷醚類(POE‧POP2-癸基十四醚等)、特窗(Tetronic)類、POE蓖麻油‧硬化蓖麻油衍生物(POE蓖麻油、POE硬化蓖麻油等)、蔗糖脂肪酸酯、烷基葡萄糖苷等之非離子界面活性劑類、聚乙二醇、丙三醇、1,3-丁二醇、赤藻糖醇、山梨糖醇、木糖醇、麥芽糖醇、丙二醇、二丙二醇、二丙三醇、異戊二醇、1,2-戊二醇、2,4-己二醇、1,2-己二醇、1,2-辛二醇等之多元醇類、吡咯啶酮羧酸鈉、乳酸、乳酸鈉等之保濕成分類、關華豆膠、榅桲種子、卡拉膠、半乳聚糖、阿拉伯膠、果膠、甘露聚糖、澱粉、三仙膠、卡德蘭膠、甲基纖維素、羥乙基纖維素、羧甲基纖維素、甲基羥丙基纖維素、硫酸軟骨素、硫酸皮膚素、肝醣、硫酸乙醯肝素、玻尿酸、玻尿酸鈉、黃蓍膠、硫酸角質
素、軟骨素、硫酸黏多糖、羥乙基關華豆膠、羧甲基關華豆膠、葡聚糖、硫酸角質素、刺槐豆膠、琥珀醯聚糖、栝樓酸、甲殼素、殼聚糖、羧甲基甲殼素、洋菜、聚乙烯醇、聚乙烯吡咯啶酮、聚羧乙烯、聚丙烯酸鈉、聚乙二醇、膨潤土等之增黏劑、乙醇、異丙醇等之低級醇類、二乙基胺基羥基苯甲醯基苯甲酸己酯、及第三丁基甲氧基苯甲醯基甲烷、對胺基苯甲酸系紫外線吸收劑、鄰胺苯甲酸系紫外線吸收劑、水楊酸系紫外線吸收劑、肉桂酸系紫外線吸收劑等之紫外線吸收劑、維他命A或其衍生物、維他命B6鹽酸鹽、維他命B6三棕櫚酸酯、維他命B6二辛酸酯、維他命B2或其衍生物、維他命B12、維他命B15或其衍生物等之維他命B類、α-生育酚、β-生育酚、γ-生育酚、維他命E乙酸酯等之維他命E類、維他命D類、維他命H、泛酸、泛硫乙胺、吡咯并喹啉醌等之維他命類等。
The external preparation for skin of the present invention can generally contain, as an optional component, a component used in the external preparation for skin, as long as the effect of the invention is not impaired. As this arbitrary component, specifically,
Especially exemplified macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower seed oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid Lanolin, hardened coconut oil, hardened oil, wood wax, hardened castor oil, beeswax, candelilla wax, carnauba wax, insect wax, lanolin, reduced lanolin, hard lanolin, jojoba wax, etc. , Waxes, flowing paraffin, squalane, isooctadecane, ozokerite, paraffin, mineral wax, petrolatum, microcrystalline wax and other hydrocarbons, oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid , Higher fatty acids such as stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, spermaceti Higher alcohols such as stearyl alcohol, cetyl isooctanoate, isopropyl myristate, cetyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, Cetyl lactate, diisostearyl malate, ethylene glycol di-2-ethylhexanoate, neopentyl glycol dicaprate, glycerol di-2-heptyl undecanoate, tri-2- Synthetic ester oils such as glycerol ethylhexanoate, tri-2-ethylhexanoic acid, trimethylolpropane triisostearate, pentaerythritol tetra-2-ethylhexanoate, etc. Chain polysiloxane such as polysiloxane, methylphenyl polysiloxane, diphenyl polysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, twelve Cyclopolysiloxane such as methylcyclohexane silicone, amine-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane Anionic surfactants such as silicone oils such as modified polysiloxanes, fatty acid soaps (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, alkyl sulfate triethanolamine ether, etc. Cationic surfactants such as stearyl trimethylammonium chloride, xylylenediamine hydrochloride, lauryl amine oxide, and amphoteric interfacial activity of imidazoline series
Agents (2-cocoyl-2-imidazolium hydroxide-1-
本發明的皮膚外用劑,藉由將上述必要成分與任意成分利用常法進行處理而可製備。 The external preparation for skin of the present invention can be prepared by treating the above-mentioned essential components and optional components by an ordinary method.
又,解決第二課題的本發明之乳化組成物的特徵為包含具有自疏水性單體衍生的構成單元(c)與自親水性單體衍生的構成單元(d)之水溶性共聚物。以下在<1>之項目中,對於疏水性單體、親水性單體及該等之共聚物的水溶性共聚物進行說明。 Moreover, the emulsified composition of the present invention that solves the second problem is characterized by including a water-soluble copolymer having a structural unit (c) derived from a hydrophobic monomer and a structural unit (d) derived from a hydrophilic monomer. In the following item <1>, water-soluble copolymers of hydrophobic monomers, hydrophilic monomers and copolymers of these will be described.
在本發明中,使用將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的構成單元(以下有時也單純稱為「構成單元(7)」等)之一種或兩種以上作為必要構成單元含有的水溶性共聚物。 In the present invention, a structural unit derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) (hereinafter sometimes simply referred to as "constituent unit (7)" etc.) is used One or two or more of them are water-soluble copolymers contained as essential structural units.
再者,在本發明中,「自單體衍生的構成單元」係指對應的單體具有之碳-碳不飽和鍵藉由聚合反應裂解而形成的構成單元。 Furthermore, in the present invention, "constituent unit derived from a monomer" refers to a structural unit formed by cleaving a carbon-carbon unsaturated bond possessed by a corresponding monomer by a polymerization reaction.
以下對於通式(1)、(7)或(8)所示之疏水性單體進行說明。 Hereinafter, the hydrophobic monomer represented by the general formula (1), (7) or (8) will be described.
在前述通式(7)中,R14表示氫原子或碳數1~3的烷基,R15表示碳數13~30的未含有環結構之分支狀烴基、或未含有環結構的具有2個以上之分支的碳數6~12之烴基。 In the aforementioned general formula (7), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 represents a branched hydrocarbon group having 13 to 30 carbon atoms that does not contain a ring structure, or 2 that does not contain a ring structure. More than 6 branched hydrocarbon groups with 6 to 12 carbon atoms.
在此,作為R14所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R14為氫原子或甲基較佳。 Here, examples of the alkyl group represented by R 14 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 14 is preferably a hydrogen atom or a methyl group.
又,作為R15所示之碳數13~30的未含有環結構之分支狀烴基,可例示1-甲基十二基、11-甲基十二基、3-乙基十一基、3-乙基-4,5,6-三甲基辛基、1-甲基十三基、1-己基辛基、2-丁基癸基、2-己基辛基、4-乙基-1-異丁基辛基、1-甲基十五基、2-己基癸基、2-辛基癸基、2-己基十二基、16-甲基十七基、9-甲基十七基、7-甲基-2-(3-甲基己基)癸基、3,7,11,15-四-甲基十六基、2-辛基十二基、2-癸基十四基、2-十二基十六基等。 In addition, as a branched hydrocarbon group having a ring structure of 13 to 30 carbon atoms represented by R 15 , 1-methyldodecyl, 11-methyldodecyl, 3-ethylundecyl, 3 -Ethyl-4,5,6-trimethyloctyl, 1-methyltridecyl, 1-hexyloctyl, 2-butyldecyl, 2-hexyloctyl, 4-ethyl-1- Isobutyloctyl, 1-methylpentadecyl, 2-hexyldecyl, 2-octyldecyl, 2-hexyldodecyl, 16-methylheptadecyl, 9-methylheptadecyl, 7-methyl-2-(3-methylhexyl)decyl, 3,7,11,15-tetra-methylhexadecyl, 2-octyldodecyl, 2-decyltetradecyl, 2 -Twelve bases and sixteen bases.
又,作為R15所示之未含有環結構的具有2個以上之分支的碳數6~12之烴基,可例示2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1,3-二甲基丁基、1,2,2-三甲基丙基、1,1-二甲基戊基、1-異丙基丁基、1-異丙基-2-甲基丙基、1,1-二乙基丙基、1-乙基-1-異丙基丙基、2-乙基-4-甲基戊基、1-丙基-2,2-二甲基丙基、1,1,2-三甲基-戊基、1-異丙基-3-甲基丁基、1,2-二甲基-1-乙基丁基、1,3-二甲基-1-乙基丁基、1-乙基-1-異丙基-丙基、1,1-二甲基己基、1-甲基-1-乙基戊基、1-甲基-1-丙基丁基、1,4-二甲基己基、1-乙基-3-甲基戊基、1,5-二甲基己基、1-乙基-6-甲基庚基、1,1,3,3-四甲基丁基、1,2-二甲基-1-異丙基丙基、3-甲基-1-(2,2-二甲基乙基)丁基、1-異丙基己基、3,5,5-三甲基己基、2-異丙基-5-甲基己基、1,5-二甲基-1-乙基己基、3,7-二甲基辛基、2,4,5-三甲基庚基、2,4,6-三甲基庚基、3,5-二甲基-1-(2,2-二甲基乙基)己基等。 In addition, examples of the hydrocarbon group having 6 or more carbon atoms and having 2 or more branches not containing a ring structure represented by R 15 include 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,3-dimethylbutyl, 1,2,2-trimethylpropyl, 1,1-dimethylpentyl, 1-isopropylbutyl, 1-isopropyl-2-methylpropyl, 1,1-diethylpropyl, 1-ethyl-1-isopropylpropyl, 2-ethyl-4-methylpentyl, 1- Propyl-2,2-dimethylpropyl, 1,1,2-trimethyl-pentyl, 1-isopropyl-3-methylbutyl, 1,2-dimethyl-1-ethyl Butyl, 1,3-dimethyl-1-ethylbutyl, 1-ethyl-1-isopropyl-propyl, 1,1-dimethylhexyl, 1-methyl-1-ethyl Amylpentyl, 1-methyl-1-propylbutyl, 1,4-dimethylhexyl, 1-ethyl-3-methylpentyl, 1,5-dimethylhexyl, 1-ethyl -6-methylheptyl, 1,1,3,3-tetramethylbutyl, 1,2-dimethyl-1-isopropylpropyl, 3-methyl-1-(2,2- Dimethylethyl)butyl, 1-isopropylhexyl, 3,5,5-trimethylhexyl, 2-isopropyl-5-methylhexyl, 1,5-dimethyl-1-ethyl Hexyl, 3,7-dimethyloctyl, 2,4,5-trimethylheptyl, 2,4,6-trimethylheptyl, 3,5-dimethyl-1-(2, 2-dimethylethyl)hexyl and so on.
在前述通式(1)及(8)中,R1、R16表示氫原子或碳數1~3的烷基,R2、R3、R17、R18、R19可相同亦可不同,且表示未含有環結構之具有分支的碳數6~22之醯基。X表示自三元醇脫附OH基的基。 In the aforementioned general formulas (1) and (8), R 1 and R 16 represent a hydrogen atom or a C 1-3 alkyl group, and R 2 , R 3 , R 17 , R 18 and R 19 may be the same or different , And represents a branched C 6-22 acyl group that does not contain a ring structure. X represents a group that desorbs the OH group from the triol.
在此,作為R1、R16所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R1為氫或甲基較佳。 Here, examples of the alkyl group represented by R 1 and R 16 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 1 is preferably hydrogen or methyl.
又,作為R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數6~22的醯基,可例示2-甲基戊醯基、3-甲基戊醯基、4-甲基戊醯基、2-乙基丁醯基、2-乙基丁醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、2-甲基己醯基、4-甲基己醯基、5-甲基己醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2-甲基庚醯基、2-乙基己基、2-丙基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、2-甲基辛醯基、3,3,5-三甲基己醯基、2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 In addition, examples of R 2 , R 3 , R 17 , R 18 , and R 19 that do not contain a ring structure and have branched C 6-22 acyl groups include 2-methylpentyl acyl and 3-methyl Pentylpentyl, 4-methylpentyl, 2-ethylbutyryl, 2-ethylbutyryl, 2,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2-methylhexyl , 4-methylhexyl, 5-methylhexyl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2-methylheptyl, 2-ethyl Hexyl, 2-propylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentyl, 2-methyloctyl, 3,3,5-trimethyl Hexamyl, 2-methylnonyl, 4-methylnonyl, 8-methylnonyl, 4-ethyloctyl, 2-ethyloctyl, 2-butylhexyl, 2- Tert-butylhexyl, 2,2-diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl, 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2- Butyloctyl, diethyloctyl, 2-third butyl-2,2,4-trimethylpentyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyl Yldodecyl, 11-methyldodecyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl -2-ethyloctyl, 12-methyltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-Dimethylhexyl, 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nineteen amide Base, 3,7,11,15-tetra-methylhexadecyl, 19-methyleicosyl, etc.
又,本發明之較佳的實施形態中,在通式(1)及(8)中,R2、R3、R17、R18、R19可相同亦可不同,且為未含有環結構的具有分支之碳數10~22的醯基、或未含有環結構的具有2個以上之分支的碳數6~9之醯基。 Moreover, in a preferred embodiment of the present invention, in the general formulas (1) and (8), R 2 , R 3 , R 17 , R 18 , and R 19 may be the same or different, and have no ring structure A branched carbon group with a carbon number of 10 to 22, or a ring group with no more than 2 branches and a carbon group with a carbon number of 6 to 9.
作為如此較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數10~22的醯基,可例示2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As such a preferred embodiment, R 2 , R 3 , R 17 , R 18 , and R 19 which do not contain a ring structure and have a branched C 10-22 acyl group may include 2-methylnonyl Group, 4-methylnonylyl group, 8-methylnonylyl group, 4-ethyloctylyl group, 2-ethyloctylyl group, 2-butylhexylyl group, 2-butylhexylyl group, 2-third butylhexylyl group, 2, 2-Diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl , 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2-butyloctyl, diethyloctyl, 2 -Third-butyl-2,2,4-trimethylpentylyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyldodecyl, 11-methyl Dodecanoyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl-2-ethyloctyl, 12-methyl Yltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-dimethylhexyl , 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nonadecyl, 3,7,11,15- Tetramethyl hexadecyl, 19-methyl eicosyl, etc.
又,作為較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有2個以上之分支的碳數6~9之醯基,可例示2,2-二甲基丁醯基、3,3-二甲基丁醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、3,5,5-三甲基己醯基等。 In addition, as a preferred embodiment, an acyl group having 6 to 9 carbon atoms having 2 or more branches and not containing a ring structure represented by R 2 , R 3 , R 17 , R 18 , and R 19 can be exemplified by 2 ,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentanyl, 3,5,5-trimethylhexyl, etc.
在通式(1)中,X所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可 適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (1), the group derived from triol represented by X is not particularly limited as long as it is a group from which the OH group is desorbed from the triol. A group exemplified by a trihydric alcohol selected from the group consisting of glycerin, trimethylolpropane, and trimethylolethane desorbs the OH group is suitably exemplified.
又,在通式(8)中,Y所示之自四元醇衍生的基,只要是自四元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含二丙三醇、季戊四醇、赤藻糖醇、D-蘇糖醇、L-蘇糖醇的群組之四元醇脫附OH基的基。 In addition, in the general formula (8), the group derived from a tetrahydric alcohol represented by Y is not particularly limited as long as it desorbs the OH group from the tetrahydric alcohol, and can be appropriately exemplified by The tetrahydric alcohol of the group of alcohol, pentaerythritol, erythritol, D-threitol, and L-threitol desorbs the OH group.
在本發明中,使用包含構成單元(1)的水溶性共聚物特佳。 In the present invention, it is particularly preferable to use a water-soluble copolymer containing the structural unit (1).
又,本發明之更佳的實施形態中,通式(1)所示的疏水性單體為下述通式(15)所示的疏水性單體。 Furthermore, in a more preferred embodiment of the present invention, the hydrophobic monomer represented by the general formula (1) is a hydrophobic monomer represented by the following general formula (15).
(通式(15)中,R24、R25,可相同亦可不同,且表示未含有環結構之具有分支的碳數16~22之醯基。Z表示自三元醇脫附OH基的基)。 (In the general formula (15), R 24 and R 25 may be the same or different, and represent a branched carbon group having 16 to 22 carbon atoms that does not contain a ring structure. Z represents a OH group desorbed from a triol base).
通式(15)之R24、R25之醯基的碳數為12~22,更佳為14~20,特佳為16~20。 The carbon number of the acyl group of R 24 and R 25 in the general formula (15) is 12-22, more preferably 14-20, and particularly preferably 16-20.
又,通式(15)之R24、R25之醯基的主鏈之碳數,較佳為9~21,更佳為12~20,特佳為16~18。 In addition, the carbon number of the main chain of the acyl group of R 24 and R 25 in the general formula (15) is preferably 9 to 21, more preferably 12 to 20, and particularly preferably 16 to 18.
又,通式(15)之R24、R25之醯基的分支數,較佳為1~3,更佳為1或2,特佳為1。 In addition, the branch number of the acyl group of R 24 and R 25 in the general formula (15) is preferably 1 to 3, more preferably 1 or 2, and particularly preferably 1.
而且,在通式(15)之R24、R25之醯基中,分支鏈鍵結的主鏈之碳的位置編號越大越佳。具體而言,分支鏈較佳係以與自主鏈端部的第1~3個碳鍵結為較佳,更佳為第1或2個碳,特佳為第1個碳。 In addition, in the acyl group of R 24 and R 25 in the general formula (15), the larger the position number of the carbon of the main chain of the branch chain bonding, the better. Specifically, the branched chain is preferably bonded to the first to third carbons at the end of the autonomous chain, more preferably the first or second carbon, and particularly preferably the first carbon.
作為R24、R25,具體而言,可適當例示10-甲基十一醯基、10-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、12-甲基十四醯基、14-甲基十五醯基、16-甲基十七醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As R 24 and R 25 , specifically, 10-methyl undecyl group, 10-methyl dodecyl group, 11-methyl dodecyl group, 10-ethyl undecyl group, 12-Methyltridecyl, 12-methyltetradecyl, 14-methylpentadecyl, 16-methylheptadecyl, 2,4,10,14-tetramethylpentyl , 18-methyl nineteen amide, 3,7,11,15-tetra-methyl hexadecyl, 19-methyl eicosyl, etc.
在通式(15)中,Z所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (15), the group derived from triol represented by Z is not particularly limited as long as it desorbs the OH group from the triol, and can be appropriately exemplified by a group selected from the group consisting of glycerol and triol. The trihydric alcohol of the group of methylolpropane and trimethylolethane desorbs the OH group.
作為本發明的親水性單體,可使用聚合性羧酸、以及前述通式(2)、前述通式(9)、(10)及(11)所示的化合物。 As the hydrophilic monomer of the present invention, a polymerizable carboxylic acid and compounds represented by the general formula (2), the general formulas (9), (10), and (11) can be used.
在本發明中,作為聚合性羧酸或其鹽,具體而言,可例示丙烯酸、甲基丙烯酸、巴豆酸、伊康酸、富馬酸及其鈉鹽、鉀鹽、銨鹽、胺鹽等。該等之中,從聚合性高之觀點,丙烯酸、甲基丙烯酸及其鹽特佳。在 本發明的水溶性共聚物導入自聚合性的羧酸鹽衍生之構成單元時,可將聚合性羧酸預先製成鹽以進行聚合反應,亦可利用聚合反應,將自聚合性羧酸衍生之構成單元衍生為水溶性共聚物後,利用鹼中和而製成鹽。 In the present invention, specific examples of the polymerizable carboxylic acid or its salt include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, fumaric acid and its sodium, potassium, ammonium, and amine salts. . Among these, acrylic acid, methacrylic acid, and their salts are particularly preferred from the viewpoint of high polymerizability. in When the water-soluble copolymer of the present invention is introduced into a structural unit derived from a polymerizable carboxylic acid salt, the polymerizable carboxylic acid may be prepared as a salt in advance to perform a polymerization reaction, or the polymerization reaction may be used to derive After derivation of the structural unit into a water-soluble copolymer, it is neutralized with an alkali to make a salt.
前述通式(2)中、R4表示氫原子或碳數1~3的烷基,R5表示可具有羥基之碳數2~4的伸烷基,R6表示氫原子、碳數6~10的芳香族烴基、碳數1~14的脂肪族烴基或碳數1~12的醯基。n表示6~40的整數。 In the aforementioned general formula (2), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents a hydrogen atom and a carbon atom having 6 to 6 carbon atoms The aromatic hydrocarbon group of 10, the aliphatic hydrocarbon group of 1 to 14 carbon atoms, or the acyl group of 1 to 12 carbon atoms. n represents an integer of 6~40.
作為在前述通式(2)中R4所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基。在本發明中,R4為氫原子或甲基較佳。 Examples of the alkyl group represented by R 4 in the general formula (2) include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 4 is preferably a hydrogen atom or a methyl group.
又,作為R5所示的伸烷基,可例示伸乙基、伸丙基、異伸丙基、2-羥基伸丙基、2-羥基-2-甲基伸乙基、2-羥基-1-甲基伸乙基等,但該等之中,較佳為伸乙基或伸丙基,更佳為伸乙基。 In addition, as the alkylene group represented by R 5 , ethyl group, ethyl group, isopropyl group, 2-hydroxypropyl group, 2-hydroxy-2-methyl ethyl group, 2-hydroxy- 1-methylethylidene, etc., but among these, ethylidene or propylidene are preferred, and ethylidene is more preferred.
又,R6所示的基中,作為碳數6~10的芳香族基,可例示苯基、苯甲基、甲苯基、乙苯基等;作為碳數1~14的脂肪族烴基,可適當例示甲基、乙基、丁基、第三丁基、己基、環己基、辛基、2-乙基己基、月桂基等;作為碳數1~12的醯基,可適當例示甲醯基、乙醯基、丙醯基、丁醯基、異丁醯基、戊醯基、月桂醯基等。該等之中,作為R5所示的基,較佳為碳數1~14的脂肪族烴基,更佳為碳數1~12的烷基。 In addition, among the groups represented by R 6 , examples of the aromatic groups having 6 to 10 carbon atoms include phenyl, benzyl, tolyl, and ethylphenyl groups. As the aliphatic hydrocarbon groups having 1 to 14 carbon atoms, Appropriate examples include methyl, ethyl, butyl, tertiary butyl, hexyl, cyclohexyl, octyl, 2-ethylhexyl, lauryl, etc.; as a C 1-12 acyl group, a methyl acyl group can be appropriately exemplified. , Acetyl, propyl, butyl, isobutyl, pentyl, lauryl, etc. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
而且,通式(2)之n為6~40的數值範圍。 Furthermore, n in the general formula (2) is in the range of 6 to 40.
前述通式(2)所示的單體中,作為R5為伸丙基之單體,具體而言,可舉出聚丙二醇(9)單丙烯酸酯、聚丙二醇(13)單丙烯酸酯、聚丙二醇(9)單甲基丙烯酸酯、聚丙二醇(13)單甲基丙烯酸酯等。再者,括弧內的數字表示N。該等之聚合物大多可作為市售品取得。作為該等市售品,具體而言,可例示商品名「Blenmer」AP-400、AP-550、AP-800、PP-500、PP-800(均為日本油脂(股)製)等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is propylene, specifically, polypropylene glycol (9) monoacrylate, polypropylene glycol (13) monoacrylate, poly Propylene glycol (9) monomethacrylate, polypropylene glycol (13) monomethacrylate, etc. Furthermore, the number in parentheses indicates N. Most of these polymers are available as commercial products. Specific examples of these commercially available products include trade names "Blenmer" AP-400, AP-550, AP-800, PP-500, and PP-800 (all manufactured by Nippon Oil & Fats Co., Ltd.).
前述通式(2)所示的單體中,作為R5為伸乙基之單體,具體而言,可舉出聚乙二醇(10)單丙烯酸酯、聚乙二醇(8)單甲基丙烯酸酯、聚乙二醇(23)單丙烯酸酯、聚乙二醇(23)單甲基丙烯酸酯、甲氧基聚乙二醇(9)丙烯酸酯、甲氧基聚乙二醇(9)甲基丙烯酸酯、甲氧基聚乙二醇(23)甲基丙烯酸酯、油氧基聚乙二醇(18)甲基丙烯酸酯、月桂氧基聚乙二醇(18)丙烯酸酯、月桂醯氧基聚乙二醇(10)甲基丙烯酸酯、硬脂氧基聚乙二醇(30)單甲基丙烯酸酯等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is an ethylidene group, specifically, polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomer Methacrylate, polyethylene glycol (23) monoacrylate, polyethylene glycol (23) monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol ( 9) Methacrylate, methoxypolyethylene glycol (23) methacrylate, oleyloxy polyethylene glycol (18) methacrylate, lauryloxy polyethylene glycol (18) acrylate, Lauryloxy polyethylene glycol (10) methacrylate, stearyl polyethylene glycol (30) monomethacrylate, etc.
上述親水性單體,可藉由對應的聚乙二醇、聚乙二醇單醚、聚乙二醇單酯與丙烯酸或甲基丙烯酸之氯化物或酐之酯化反應而以高產率得到。又,因為已存在很多市售品,所以也可利用該市售品。作為如此市售品,具體而言,可例示商品名Blenmer、AE-400、PE-350、AME-400、PME-400、PME-1000、ALE-800、PSE-1300(均為日本油脂(股)製)等。 The above-mentioned hydrophilic monomers can be obtained in a high yield by esterification reaction of corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester with acrylic acid or methacrylic acid chloride or anhydride. In addition, since many commercial products already exist, the commercial products can also be used. As such a commercially available product, specifically, the trade names of Blenmer, AE-400, PE-350, AME-400, PME-400, PME-1000, ALE-800, and PSE-1300 (all of which are Japanese oil ) System) etc.
作為本發明的親水性單體,亦可使用前述通式(9)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the aforementioned general formula (9) can also be used.
作為前述通式(9)所示的親水性單體,具體而言,可舉出2-丙烯醯氧基乙基磷酸膽鹼(APC)、2-甲基丙烯醯氧乙基磷酸膽鹼(MPC)。該等之單體,例如,可利用Polymer Journal,Vol22,No.5記載之以下的方法合成。 Specific examples of the hydrophilic monomer represented by the general formula (9) include 2-acryloyloxyethyl phosphate choline (APC) and 2-methacryloyloxyethyl phosphate choline ( MPC). Such monomers can be synthesized by the following method described in Polymer Journal, Vol22, No. 5, for example.
使二氯化2-溴乙基磷醯與甲基丙烯酸2-羥乙酯或丙烯酸2-羥乙酯反應,得到2-甲基丙烯醯氧乙基-2‘-溴乙基磷酸或2-丙烯醯氧乙基-2‘-溴乙基磷酸後,將該等化合物與三乙胺於甲醇中進行反應。 Reacting 2-bromoethylphosphoryl dichloride with 2-hydroxyethyl methacrylate or 2-hydroxyethyl acrylate to obtain 2-methacryloxyethyl-2'-bromoethyl phosphoric acid or 2- After acryloyloxyethyl-2'-bromoethyl phosphoric acid, these compounds are reacted with triethylamine in methanol.
作為本發明的親水性單體,亦可使用前述通式(10)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the general formula (10) can also be used.
在通式(10)所示的親水性單體中,作為G-O-所示的自還原糖之1位的羥基除去氫的基之還原糖,具體而言,可例示選自於包含葡萄糖、甘露糖、半乳糖、阿拉伯糖、木糖、核糖等之單糖、麥芽糖、乳糖、纖維雙糖等之雙糖、麥芽三糖等之三糖、麥芽寡糖等之寡糖的群組之一種或兩種以上,其中尤以選自於包含葡萄糖、半乳糖、阿拉伯糖、木糖、核糖、麥芽糖、乳糖、纖維雙糖的群組之一種或兩種以上較佳,葡萄糖特佳。又,作為通式(10)所示的單體,甲基丙烯酸葡萄糖基氧 乙酯(以下省略為GEMA)或丙烯酸葡萄糖基氧乙酯(以下省略為GEA)較佳。 Among the hydrophilic monomers represented by the general formula (10), the reducing sugar that is a group that removes hydrogen from the hydroxyl group at the 1-position of the reducing sugar represented by GO- can be specifically selected from the group consisting of glucose and mannose. Groups of monosaccharides such as sugar, galactose, arabinose, xylose, ribose, disaccharides such as maltose, lactose, cellobiose, trisaccharides such as maltotriose, and oligosaccharides such as maltooligosaccharide One or two or more, among which one or two or more selected from the group consisting of glucose, galactose, arabinose, xylose, ribose, maltose, lactose, and cellobiose is preferred, and glucose is particularly preferred. In addition, as the monomer represented by the general formula (10), methacrylic acid glucosyloxy Ethyl ester (hereinafter abbreviated as GEMA) or glucosyloxyethyl acrylate (hereinafter abbreviated as GEA) is preferred.
作為本發明的親水性單體,亦可使用前述通式(11)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the aforementioned general formula (11) can also be used.
在通式(11)的單體中,作為R23所示之胺基酸殘基的胺基酸,只要是通常已知的胺基酸,則沒有特別限定,具體而言,可例示甘胺酸、丙胺酸、麩胺酸、離胺酸、精胺酸等。該等之中,因為得到的水溶性共聚物之皮膚屏障的恢復效果佳,所以以離胺酸殘基為特佳。 In the monomer of the general formula (11), the amino acid as the amino acid residue represented by R 23 is not particularly limited as long as it is a generally known amino acid, and specifically, glycine can be exemplified. Acid, alanine, glutamic acid, lysine, arginine, etc. Among these, since the skin barrier effect of the water-soluble copolymer obtained is good, ionic acid residues are particularly preferable.
又,R23所示的多胺殘基之多胺,意指在同一分子內具有可以烷基取代之胺基2個以上的胺,具體而言,可例示二胺、三胺、四胺或該等之胺基的氫原子被烷基取代的胺。該等之中,從含有得到的水溶性共聚物之皮膚外用劑的使用感特佳之觀點,二胺較佳,作為特佳的具體例,從合成之際的原料取得之容易度的觀點,可舉出乙二胺、1,4-二胺基-正丁烷、1,6-二胺基-正己烷等。 In addition, the polyamine of the polyamine residue represented by R 23 means an amine having two or more amine groups that can be substituted with an alkyl group in the same molecule. Specifically, a diamine, triamine, tetraamine or An amine in which the hydrogen atom of the amine group is substituted with an alkyl group. Among these, from the viewpoint of excellent use of skin external preparations containing the obtained water-soluble copolymer, diamine is preferable, and as a particularly preferable specific example, from the viewpoint of ease of obtaining raw materials at the time of synthesis, Examples include ethylenediamine, 1,4-diamino-n-butane, 1,6-diamino-n-hexane, and the like.
而且,作為R23所示之胺醇殘基的胺醇,意指在同一分子內具有可以烷基取代之胺基及醇式羥基的化合物。作為胺醇,只要是通常已知者,則沒有特別限定,作為具體例,可例示乙醇胺、三乙胺基乙醇等。 The amine alcohol as the amine alcohol residue represented by R 23 means a compound having an alkyl-substituted amine group and an alcoholic hydroxyl group in the same molecule. The amino alcohol is not particularly limited as long as it is generally known, and specific examples include ethanolamine, triethylaminoethanol, and the like.
作為通式(11)所示之單體的鹽,沒有特別限定,具體而言,可例示將酸部分以鹼中和的鈉鹽、鉀鹽、銨鹽、胺鹽等,或者,將胺基部分以酸中和的鹽酸 鹽、硫酸鹽、硝酸鹽、磷酸鹽、檸檬酸鹽、草酸鹽、碳酸鹽等。在本發明的水溶性共聚物導入自通式(11)所示的單體鹽衍生之構成單元時,可將通式(11)所示的單體預先製成鹽,進行聚合反應,亦可利用聚合反應,將自通式(11)所示的單體衍生之構成單元衍生為水溶性共聚物後,中和而製成鹽。 The salt of the monomer represented by the general formula (11) is not particularly limited, and specifically, there can be exemplified sodium salts, potassium salts, ammonium salts, amine salts and the like neutralized with an acid moiety, or Hydrochloric acid partially neutralized with acid Salt, sulfate, nitrate, phosphate, citrate, oxalate, carbonate, etc. When the water-soluble copolymer of the present invention is introduced into the structural unit derived from the monomer salt represented by the general formula (11), the monomer represented by the general formula (11) may be prepared as a salt in advance to perform a polymerization reaction, or Using a polymerization reaction, the structural unit derived from the monomer represented by the general formula (11) is derived as a water-soluble copolymer, and then neutralized to form a salt.
作為通式(11)所示的單體、其鹽的具體例,可適當例示具有以下結構的化合物1~11及其鹽。 As specific examples of the monomer represented by the general formula (11) and salts thereof, compounds 1 to 11 having the following structure and salts thereof can be appropriately exemplified.
化合物3
化合物6
化合物9
通式(11)所示的親水性單體,例如,如下述反應式(1)及(2)所示,可藉由使用(甲基)丙烯酸、(甲基)丙烯醯氯的酯化反應、醯胺化反應而合成。 The hydrophilic monomer represented by the general formula (11), for example, as shown in the following reaction formulas (1) and (2), can be obtained by an esterification reaction using (meth)acrylic acid or (meth)acryloyl chloride , Amidation reaction synthesis.
(反應式中,R22表示氫原子或甲基,R23表示胺基酸殘基、多胺殘基或胺醇殘基。Q表示氧原子或NH所示的基)。 (In the reaction formula, R 22 represents a hydrogen atom or a methyl group, and R 23 represents an amino acid residue, a polyamine residue, or an amino alcohol residue. Q represents an oxygen atom or a group represented by NH).
如上述,在本發明中作為親水性聚合物,可使用前述通式(2)、前述通式(9)、前述通式(10)、前述通式(11)。 As described above, in the present invention, as the hydrophilic polymer, the aforementioned general formula (2), the aforementioned general formula (9), the aforementioned general formula (10), and the aforementioned general formula (11) can be used.
本發明之較佳的實施形態中,水溶性共聚物係包含自前述通式(2)衍生的構成單元(2)。 In a preferred embodiment of the present invention, the water-soluble copolymer contains the structural unit (2) derived from the aforementioned general formula (2).
在本發明中,尤能適用具有構成單元(1)與構成單元(2)的水溶性共聚物。又,更佳可使用具有構成單元(15)與構成單元(2)的水溶性共聚物。 In the present invention, a water-soluble copolymer having a structural unit (1) and a structural unit (2) is particularly applicable. Furthermore, it is more preferable to use a water-soluble copolymer having a structural unit (15) and a structural unit (2).
如此水溶性共聚物中,特佳可使用(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物。 Among such water-soluble copolymers, (methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer can be particularly preferably used.
藉由含有如此水溶性共聚物,可成為低刺激且黏膩感少,乳化安定性佳的乳化組成物。 By containing such a water-soluble copolymer, it can be an emulsified composition with low irritation, less stickiness, and excellent emulsification stability.
(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物,作為構成單元(c),主要包含自前述通式(15)所示的疏水性單體中,R24、R25為16-甲基十七醯基之疏水性單體衍生的構成單元(c)。 (Methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer, as the structural unit (c), is mainly contained from the hydrophobic monomer represented by the general formula (15), R 24 and R 25 are structural units (c) derived from a hydrophobic monomer of 16-methylheptadecyl group.
又,作為構成單元(d),主要包含自前述通式(2)所示的親水性單體中,R4為甲基,R5為伸乙基,R6為甲基,n為23之親水性單體衍生的構成單元(d)。 Moreover, as a structural unit (d), it is mainly comprised from the hydrophilic monomer represented by the said general formula (2), R 4 is a methyl group, R 5 is an ethyl group, R 6 is a methyl group, and n is 23 Structural unit (d) derived from a hydrophilic monomer.
一般而言,疏水性高的界面活性劑適於油中水型的乳化組成物之形成,反之,親水性高的界面活性劑適於水中油型的乳化組成物之形成。關於本發明的水溶性共聚物也同樣,疏水性的構成單元(c)所佔之比例高時,適於形成油中水型的乳化組成物,而且,親水性的構成單元(d)所佔之比例高時,適於形成水中油型的乳化組成物。 Generally speaking, surfactants with high hydrophobicity are suitable for the formation of water-based emulsified compositions in oil, and conversely, surfactants with high hydrophilicity are suitable for the formation of oil-based emulsified compositions in water. The same applies to the water-soluble copolymer of the present invention. When the proportion of the hydrophobic constituent unit (c) is high, it is suitable for forming a water-based emulsified composition in oil, and the hydrophilic constituent unit (d) When the ratio is high, it is suitable for forming an oil-in-water emulsified composition.
如前述,藉由適當調整構成單元(c)及構成單元(d)所佔之比例與比率,可調整形成的乳化組成物之乳化形態。 As described above, the emulsified form of the formed emulsified composition can be adjusted by appropriately adjusting the ratio and ratio of the structural unit (c) and the structural unit (d).
在本發明中水溶性共聚物之構成單元(c)在全構成單元所佔之比例,較佳為1~50質量%,更佳為20~50質量%、30~40質量%。 In the present invention, the proportion of the constituent units (c) of the water-soluble copolymer in all constituent units is preferably 1 to 50% by mass, more preferably 20 to 50% by mass, and 30 to 40% by mass.
藉由使水溶性共聚物之構成單元(c)所佔之比例成為前述範圍,可提供黏膩感進一步減低之水中油型的乳化組成物。 By setting the proportion of the structural unit (c) of the water-soluble copolymer within the aforementioned range, an oil-in-water emulsified composition with a further reduced stickiness can be provided.
在本發明中,水溶性共聚物之構成單元(d)在全構成單元所佔之比例,較佳為50~99質量%,更佳為50~80質量%、60~70質量%。 In the present invention, the proportion of the constituent units (d) of the water-soluble copolymer in all constituent units is preferably 50 to 99% by mass, more preferably 50 to 80% by mass, and 60 to 70% by mass.
藉由使水溶性共聚物之構成單元(d)所佔之比例成為前述範圍,可提供黏膩感進一步減低之水中油型的乳化組成物。 By setting the ratio of the structural unit (d) of the water-soluble copolymer to the aforementioned range, it is possible to provide an oil-in-water emulsified composition in which the stickiness is further reduced.
在本發明中,構成水溶性共聚物之構成單元(c)與構成單元(d)的質量比,較佳為10:90~50:50,更佳為20:80~50:50,特佳為30:70~40:60。 In the present invention, the mass ratio of the structural unit (c) and the structural unit (d) constituting the water-soluble copolymer is preferably 10:90-50:50, more preferably 20:80-50:50, and particularly preferably It is 30:70~40:60.
又,構成水溶性共聚物之構成單元(c)與構成單元(d)的莫耳比,較佳為15:85~62:38,更佳為29:71~62:38,特佳為41:59~52:48。 In addition, the molar ratio of the structural unit (c) and the structural unit (d) constituting the water-soluble copolymer is preferably 15:85 to 62:38, more preferably 29:71 to 62:38, and particularly preferably 41 : 59~52: 48.
藉由使水溶性共聚物的構成單元(c)及構成單元(d)之質量比及莫耳比成為前述範圍,可成為適於形成水中油型的乳化組成物之乳化力佳的水溶性共聚物。 By setting the mass ratio and the molar ratio of the structural unit (c) and structural unit (d) of the water-soluble copolymer to the aforementioned range, it can be a water-soluble copolymer with good emulsifying power suitable for forming an oil-in-water emulsion composition Thing.
在本發明中,水溶性共聚物之平均分子量,較佳為20000~110000,進一步較佳為20000~80000,更佳為30000~80000,進一步更佳為40000~70000,特佳為50000~70000,進一步特佳為57000~66000。 In the present invention, the average molecular weight of the water-soluble copolymer is preferably from 20,000 to 110,000, further preferably from 20,000 to 80,000, more preferably from 30,000 to 80,000, even more preferably from 40,000 to 70,000, and particularly preferably from 50,000 to 70,000. Further particularly preferred is 57000~66000.
再者,在此,平均分子量係指利用GPC測定之聚苯乙烯換算的重量平均分子量。 Here, the average molecular weight refers to the weight average molecular weight in terms of polystyrene measured by GPC.
本發明之乳化組成物,其特徵為實質上未包含上述水溶性共聚物以外的乳化劑。 The emulsified composition of the present invention is characterized in that it does not substantially contain an emulsifier other than the water-soluble copolymer.
在此,「實質上未包含上述水溶性共聚物以外的乳化劑」,係指上述水溶性共聚物以外的乳化劑之含量為0.3質量%以下,較佳為0.1質量%以下,特佳為0.01質量%以下,特佳為0.001質量%以下。又,未包含上述水溶性共聚物以外的乳化劑特佳。 Here, "substantially does not contain an emulsifier other than the above water-soluble copolymer" means that the content of the emulsifier other than the above water-soluble copolymer is 0.3% by mass or less, preferably 0.1% by mass or less, particularly preferably 0.01 Mass% or less, particularly preferably 0.001 mass% or less. In addition, emulsifiers other than the above water-soluble copolymer are particularly preferred.
乳化組成物之上述水溶性共聚物的含量,較佳為0.1~50質量%,更佳為0.5~30質量%。 The content of the water-soluble copolymer of the emulsified composition is preferably 0.1 to 50% by mass, and more preferably 0.5 to 30% by mass.
藉由使上述水溶性共聚物之含量成為前述範圍,可進一步提升乳化組成物之乳化安定性。 By setting the content of the water-soluble copolymer to the aforementioned range, the emulsification stability of the emulsified composition can be further improved.
本發明的乳化組成物之水相及油相的含量,可藉由變更水溶性共聚物的構成單元(c)及構成單元(d)之比率而適當調整。 The content of the water phase and the oil phase of the emulsified composition of the present invention can be appropriately adjusted by changing the ratio of the structural unit (c) and the structural unit (d) of the water-soluble copolymer.
以下對於使用以適於形成上述水中油型的乳化組成物之比例包含構成單元(c)與構成單元(d)的水溶性共聚物時之油相及水相的含量進行說明。 The content of the oil phase and the water phase when using the water-soluble copolymer containing the structural unit (c) and the structural unit (d) in a ratio suitable for forming the above-mentioned oil-in-water emulsion composition will be described below.
再者,在本說明書中,是作為油相與油相成分、以及水相與水相成分中未包含本發明的水溶性共聚物者進行說明。 In addition, in this specification, description is made as a case where the water-soluble copolymer of the present invention is not included in the oil phase and oil phase components, and the water phase and water phase components.
本發明的乳化組成物之油相成分的含量,較佳為0.01~80質量%,更佳為0.1~70質量%。 The content of the oil phase component of the emulsified composition of the present invention is preferably 0.01 to 80% by mass, more preferably 0.1 to 70% by mass.
藉由使油相成分的含量成為前述範圍,可提升乳化組成物之乳化安定性。 By setting the content of the oil phase component to the aforementioned range, the emulsification stability of the emulsified composition can be improved.
再者,油相成分為油劑及親油性的成分,且指在乳化組成物中油相所含的成分。 In addition, the oil phase component is an oil agent and a lipophilic component, and refers to the component contained in the oil phase in the emulsified composition.
在本發明之乳化組成物中,上述水溶性共聚物與油相成分之質量比,較佳為1:100~1:0.2,更佳為1:70~1:0.3。 In the emulsified composition of the present invention, the mass ratio of the water-soluble copolymer to the oil phase component is preferably 1:100 to 1:0.2, and more preferably 1:70 to 1:0.3.
藉由使水溶性共聚物與油相成分之質量比成為前述範圍,可提升乳化組成物之乳化安定性。 By setting the mass ratio of the water-soluble copolymer to the oil phase component to the aforementioned range, the emulsification stability of the emulsified composition can be improved.
在本發明之乳化組成物中,油相與水相之質量比,較佳為0.1:99.9~80:20,更佳為1:99~65:35。 In the emulsified composition of the present invention, the mass ratio of the oil phase to the water phase is preferably 0.1:99.9~80:20, more preferably 1:99~65:35.
藉由使油相與水相之質量比成為前述範圍,可形成安定的水中油型之乳化組成物。 By setting the mass ratio of the oil phase to the water phase to the aforementioned range, a stable oil-in-water emulsified composition can be formed.
油相與水相所含的成分沒有特別限定。 The components contained in the oil phase and the water phase are not particularly limited.
作為構成油相的油劑,可舉出例如,液體油脂、固體油脂、蠟、烴油、高級脂肪酸、高級醇、合成酯油、矽酮油等。 Examples of the oil agent constituting the oil phase include liquid fats and oils, solid fats and oils, waxes, hydrocarbon oils, higher fatty acids, higher alcohols, synthetic ester oils, and silicone oils.
作為液體油脂,可舉出例如,酪梨油、山茶油、海龜油、澳洲胡桃油、玉米油、貂油、橄欖油、油菜籽油、蛋黃油、芝麻油、杏核油、小麥胚芽油、山茶花油、蓖麻油、亞麻仁油、紅花籽油、棉籽油、紫蘇油、白芒花籽油、大豆油、花生油、苦茶油、日本榧樹籽油、米糠油、九重桐油、日本桐油、荷荷芭油、胚芽油、三丙三醇、三辛酸丙三醇、三異棕櫚酸丙三醇等。 Examples of the liquid fats and oils include avocado oil, camellia oil, turtle oil, Australian walnut oil, corn oil, mink oil, olive oil, rapeseed oil, egg butter, sesame oil, apricot kernel oil, wheat germ oil, and camellia Oil, castor oil, linseed oil, safflower seed oil, cottonseed oil, perilla oil, white awn flower seed oil, soybean oil, peanut oil, bitter tea oil, Japanese cypress seed oil, rice bran oil, bougainvillea oil, Japanese tung oil, Dutch Jojoba oil, germ oil, triglycerin, trioctanoic acid glycerin, triisopalmitic acid glycerin, etc.
作為固體油脂,可舉出可可脂、椰子油、馬脂、硬化椰子油、棕櫚油、牛脂、羊脂、硬化牛脂、棕櫚仁油、豬脂、牛骨脂、木蠟仁油、硬化油、牛腳油、木蠟、硬化蓖麻油等。 Examples of solid oils and fats include cocoa butter, coconut oil, horse fat, hardened coconut oil, palm oil, tallow, sheep fat, hardened tallow, palm kernel oil, lard, beef bone fat, wood wax kernel oil, hardened oil, Shea butter, wood wax, hardened castor oil, etc.
作為蠟類,可舉出蜂蠟、小燭樹蠟、棉蠟、巴西棕櫚蠟、楊梅蠟、蟲蠟、鯨蠟、褐煤蠟、糠蠟、羊毛脂、木棉蠟、羊毛脂乙酸酯、液狀羊毛脂、甘蔗蠟、羊毛脂脂肪酸異丙酯、月桂酸己酯、還原羊毛脂、荷荷芭蠟、硬質羊毛脂、蟲膠蠟、POE羊毛脂醇醯、POE羊 毛脂醇乙酸酯、POE膽固醇醚、羊毛脂脂肪酸聚乙二醇、POE氫化羊毛脂醇醚等。 Examples of waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, insect wax, spermaceti wax, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, and liquid Lanolin, sugarcane wax, isopropyl lanolin fatty acid, hexyl laurate, reduced lanolin, jojoba wax, rigid lanolin, shellac wax, POE lanolin alcohol, POE sheep Lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, etc.
作為烴油,可舉出流動石蠟、地蠟、異十八烷、石蠟、礦蠟、鯊烯、凡士林、微晶蠟等。 Examples of the hydrocarbon oil include fluid paraffin, ozokerite, isooctadecane, paraffin, mineral wax, squalene, petrolatum, and microcrystalline wax.
作為高級脂肪酸,可舉出例如,月桂酸、肉荳蔻酸、棕櫚酸、硬脂酸、二十二酸(俞樹酸)、12-羥基硬脂酸、十一烯酸、妥爾油酸(tall oil acid)等。 Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid (behenic acid), 12-hydroxystearic acid, undecylenic acid, and tall oil acid ( tall oil acid) etc.
作為高級醇,可舉出例如,鯨臘醇、硬脂醇、二十二醇、鯊肝醇、肉豆蔻醇、鯨蠟硬脂醇等。 Examples of higher alcohols include cetyl alcohol, stearyl alcohol, behenyl alcohol, squalanol, myristyl alcohol, and cetearyl alcohol.
作為合成酯油,可舉出肉荳蔻酸異丙酯、辛酸鯨蠟酯、肉荳蔻酸辛基十二酯、棕櫚酸異丙酯、硬脂酸丁酯、月桂酸己酯、肉荳蔻酸肉荳蔻酯、油酸癸酯、二甲基辛酸己基癸酯、乳酸鯨蠟酯、乳酸肉荳蔻酯、羊毛脂乙酸酯、硬脂酸異鯨蠟酯、異硬脂酸異鯨蠟酯、蔗糖硬脂酸酯、蔗糖油酸酯、12-羥基硬脂酸膽固醇酯、二-2-乙基己酸乙二醇酯、二季戊四醇脂肪酸酯、單異硬脂酸N-烷二醇、二癸酸新戊二醇、蘋果酸二異硬脂酯、二-2-庚基十一酸丙三醇酯、三羥甲基丙烷三-2-乙基己酸酯、三羥甲基丙烷三異硬脂酸酯、四-2-乙基己酸季戊四醇酯、三-2-乙基己酸丙三醇酯、三羥甲基丙烷三異硬脂酸酯、己酸鯨蠟基2-乙酯、棕櫚酸2-乙基己酯、三肉荳蔻酸丙三醇酯、三-2-庚基十一酸甘油酯、蓖麻油脂肪酸甲酯、油酸油酯、鯨蠟硬脂醇、乙酸甘油酯、棕櫚酸2-庚基十一酯、棕櫚酸鯨蠟酯、己二酸二異丁酯、N-月桂醯基-L-麩胺酸-2-辛基十二酯、己二酸二-2-庚基十一 酯、月桂酸乙酯、癸二酸二-2-乙基己酯、肉荳蔻酸2-己基癸酯、棕櫚酸2-己基癸酯、己二酸2-己基癸酯、癸二酸二異丙酯、琥珀酸2-乙基己酯、乙酸乙酯、乙酸丁酯、乙酸戊酯、檸檬酸三乙酯等。 Examples of synthetic ester oils include isopropyl myristate, cetyl caprylate, octyl dodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, and myristate myristate. Ester, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, sucrose hard Fatty acid ester, sucrose oleate, cholesterol 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkanediol monoisostearate, didecane Neopentyl glycol acid, diisostearyl malate, glycerol di-2-heptyl undecanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triiso Stearate, pentaerythritol tetra-2-ethylhexanoate, glycerol tri-2-ethylhexanoate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate , 2-ethylhexyl palmitate, glycerol trimyristate, tri-2-heptyl undecyl glyceride, castor oil fatty acid methyl ester, oleic oleate, cetearyl alcohol, glycerol acetate Ester, 2-heptyl undecyl palmitate, cetyl palmitate, diisobutyl adipate, N-lauryl-L-glutamic acid-2-octyl dodecyl ester, diadipate -2-heptyl eleven Ester, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisosebacate Propyl ester, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, etc.
作為矽酮油,可舉出二甲基聚矽氧烷、甲基苯基聚矽氧烷、甲基氫聚矽氧烷等之鏈狀聚矽氧烷、或十甲基聚矽氧烷、十二甲基聚矽氧烷、四甲基四氫聚矽氧烷等之環狀聚矽氧烷等。 Examples of the silicone oil include chain polysiloxanes such as dimethyl polysiloxane, methyl phenyl polysiloxane, methyl hydrogen polysiloxane, and decamethyl polysiloxane. Cyclic polysiloxane such as dodecyl polysiloxane, tetramethyl tetrahydropolysiloxane, etc.
油劑可使用1種或2種以上。 One oil or two or more oils can be used.
本發明之乳化組成物中,在不損及本發明之效果的範圍,亦可摻合在通常化妝品摻合之任意添加成分。作為如此添加成分,可舉出例如,聚乙二醇、丙三醇、1,3-丁二醇、赤藻糖醇、山梨糖醇、木糖醇、麥芽糖醇等之保濕劑;乙醇等之低級醇;丁基羥基甲苯、生育酚、植酸等之抗氧化劑;苯甲酸、水楊酸、山梨酸、對羥基苯甲酸烷酯、六氯酚等之抗菌劑;對胺基苯甲酸(以下簡記為「PABA」)、PABA單甘油酯、N,N-二丙氧基PABA乙酯、N,N-二乙氧基PABA乙酯、N,N-二甲基PABA甲酯、N,N-二甲基PABA乙酯、N,N-二甲基PABA丁酯、N,N-二甲基PABA2-乙基己酯等之苯甲酸系紫外線吸收劑;高薄荷基-N-乙醯基鄰胺苯甲酸酯等之鄰胺苯甲酸系紫外線吸收劑;水楊酸戊酯、水楊酸薄荷酯、水楊酸高薄荷酯、水楊酸辛酯、水楊酸苯酯、水楊酸苯甲酯、p-異丙醇水楊酸苯酯等之水楊酸系紫外線吸收劑;肉桂酸辛酯、肉桂酸乙基-4-異丙酯、肉桂酸甲基-2,5-二異丙 酯、肉桂酸乙基-2,4-二異丙酯、肉桂酸甲基-2,4-二異丙酯、肉桂酸丙基-p-甲氧酯、肉桂酸異丙基-p-甲氧酯、肉桂酸異戊基-p-甲氧酯、肉桂酸辛基-p-甲氧酯(肉桂酸2-乙基己基-p-甲氧酯)、肉桂酸2-乙氧乙基-p-甲氧酯、肉桂酸環己基-p-甲氧酯、肉桂酸乙基-α-氰基-β-苯酯、肉桂酸2-乙基己基-α-氰基-β-苯酯、肉桂酸甘油基單-2-乙基己醯基-二對甲氧酯等之肉桂酸系紫外線吸收劑;肉桂酸〔3-雙(三甲基矽氧基)甲基矽基-1-甲基丙基〕-3,4,5-三甲氧酯、肉桂酸〔3-雙(三甲基矽氧基)甲基矽基-3-甲基丙基〕-3,4,5-三甲氧酯、肉桂酸〔3-雙(三甲基矽氧基)甲基矽基丙基〕-3,4,5-三甲氧酯、肉桂酸〔3-雙(三甲基矽氧基)甲基矽基丁基〕-3,4,5-三甲氧酯、肉桂酸〔3-參(三甲基矽氧基)矽基丁基〕-3,4,5-三甲氧酯、肉桂酸〔3-參(三甲基矽氧基)矽基丁基〕-3,4,5-三甲氧酯、肉桂酸〔3-參(三甲基矽氧基)矽基-1-甲基丙基〕-3,4-二甲氧酯等之矽酮系肉桂酸紫外線吸收劑;2,4-二羥基二苯甲酮、2,2’-二羥基-4-甲氧基二苯甲酮、2,2’-二羥基-4,4’-二甲氧基二苯甲酮、2,2’,4,4’-四羥基二苯甲酮、2-羥基-4-甲氧基二苯甲酮、2-羥基-4-甲氧基-4’-甲基二苯甲酮、2-羥基-4-甲氧基二苯甲酮-5-磺酸鹽、4-苯基二苯甲酮、2-乙基己基-4’-苯基-二苯甲酮-2-羧酸酯、2-羥基-4-正辛氧基二苯甲酮、4-羥基-3-羧基二苯甲酮等之二苯甲酮系紫外線吸收劑;3-(4’-甲基苯亞甲基)-d,l-樟腦、3-苯亞甲基-d,l-樟腦、4-咪唑丙烯酸乙酯、2-苯基-5-甲基苯并唑、2,2’-羥基-5-甲苯基苯并三唑、2-(2’-羥基-5’-第三丁基辛苯基) 苯并三唑、2-(2’-羥基-5’-甲苯基)苯并三唑、二苄肼、二對甲氧苯甲醯基甲烷、4-甲氧基-4’-第三丁基二苯甲醯基甲烷、5-(3,3’二甲基-2-亞降冰片基)-3-戊-2-酮等之紫外線吸收劑;醯基肌胺酸(例如,月桂醯基肌胺酸鈉)、麩胱甘肽、檸檬酸、蘋果酸、酒石酸、乳酸等之有機酸;維他命A及其衍生物、維他命B6鹽酸鹽、維他命B6三棕櫚酸酯、維他命B6二辛酸酯、維他命B2及其衍生物、維他命B12、維他命B15及其衍生物等之維他命B類、α-生育酚、β-生育酚、γ-生育酚、維他命E乙酸酯等之維他命E類、維他命D類、維他命H、泛酸、泛硫乙胺、菸鹼酸醯胺、菸鹼酸苯甲酯等之維他命類;γ-榖維素、尿囊素、甘草酸(鹽)、甘草次酸及其衍生物、傳明酸及其衍生物〔作為傳明酸衍生物,傳明酸的二聚體(例如,鹽酸反式-4-(反式-胺甲基環己烷羰基)胺甲基環己烷羧酸等)、傳明酸與氫醌之酯(例如,反式-4-胺甲基環己烷羧酸4’-羥苯酯等)、傳明酸與龍膽酸之酯(例如,2-(反式-4-胺甲基環己基羰氧基)-5-羥基苯甲酸及其鹽等)、傳明酸的醯胺(例如,反式-4-胺甲基環己烷羧酸甲基醯胺及其鹽、反式-4-(P-甲氧基苯甲醯基)胺甲基環己烷羧酸及其鹽、反式-4-胍甲基環己烷羧酸及其鹽)〕、檜木醇、沒藥醇、大果桉醛、百里酚、肌醇、柴胡皂素、人參皂素、絲瓜皂素、無患子皂素等之皂素類、泛酸醇基乙醚、乙炔雌二醇、傳明酸、熊果素、千金藤素、胎盤素等之各種藥劑;羊蹄、苦參、日本萍蓬草、橙、鼠尾草、蓍、錦葵、當藥、麝香草、東當歸、雲杉、樺木、問荊、絲 瓜、七葉樹、虎耳草、兔菊、百合、魁蒿、芍藥、蘆薈、梔子、日本花柏等之植物的萃取物;色素;多孔質及/或吸水性的粉末(例如,由玉米或馬鈴薯等得到的澱粉類、矽酸酐、滑石、高嶺土、矽酸鋁鎂、海藻酸鈣等之粉末);中和劑;防腐劑;香料;顏料等。 The emulsified composition of the present invention may be blended with any additional components that are usually blended in cosmetics as long as the effects of the present invention are not impaired. As such added components, for example, moisturizing agents such as polyethylene glycol, glycerin, 1,3-butanediol, erythritol, sorbitol, xylitol, and maltitol; ethanol, etc. Lower alcohols; antioxidants such as butylhydroxytoluene, tocopherol, phytic acid, etc.; antibacterial agents such as benzoic acid, salicylic acid, sorbic acid, alkyl p-hydroxybenzoate, hexachlorophenol; p-aminobenzoic acid (below (Abbreviated as "PABA"), PABA monoglyceride, N,N-dipropoxy PABA ethyl ester, N,N-diethoxy PABA ethyl ester, N,N-dimethyl PABA methyl ester, N,N -Dimethyl PABA ethyl ester, N,N-dimethyl PABA butyl ester, N,N-dimethyl PABA2-ethylhexyl ester and other benzoic acid type ultraviolet absorbers; high mintyl-N-acetyl acetyl group Ortho-aminobenzoic acid and other anthranilic acid-based ultraviolet absorbers; amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, salicylic acid Salicylic acid ultraviolet absorber such as benzyl methyl ester, p-isopropyl alcohol phenyl salicylate; octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisocinnamate Propyl ester, cinnamic acid ethyl-2,4-diisopropyl ester, cinnamic acid methyl-2,4-diisopropyl ester, cinnamic acid propyl-p-methoxy ester, cinnamic acid isopropyl-p- Methoxyester, isoamyl-p-methoxycinnamate, octyl-p-methoxycinnamate (2-ethylhexyl-cinnamate-p-methoxyester), 2-ethoxyethyl cinnamate- p-methoxy ester, cinnamic acid cyclohexyl-p-methoxy ester, cinnamic acid ethyl-α-cyano-β-phenyl ester, cinnamic acid 2-ethylhexyl-α-cyano-β-phenyl ester, Cinnamic acid glyceryl mono-2-ethylhexyl-di-p-methoxy ester and other cinnamic acid ultraviolet absorbers; cinnamic acid [3-bis (trimethylsiloxy) methylsilyl-1-methyl Propylpropyl]-3,4,5-trimethoxyester, cinnamic acid [3-bis(trimethylsiloxy)methylsilyl-3-methylpropyl]-3,4,5-trimethoxy Ester, cinnamic acid [3-bis(trimethylsiloxy)methylsilylpropyl]-3,4,5-trimethoxyester, cinnamic acid [3-bis(trimethylsiloxy)methyl Silylbutyl]-3,4,5-trimethoxyester, cinnamic acid [3-ginseng (trimethylsiloxy)silylbutyl]-3,4,5-trimethoxyester, cinnamic acid [3 -Ginseng(trimethylsiloxy)silylbutyl]-3,4,5-trimethoxyester, cinnamic acid[3-ginseng(trimethylsiloxy)silyl-1-methylpropyl] Silicone-based cinnamic acid ultraviolet absorbers such as -3,4-dimethoxyester; 2,4-dihydroxybenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, 2 ,2'-Dihydroxy-4,4'-dimethoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone Ketone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone , 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octyloxy Benzophenone-based ultraviolet absorbers such as benzophenone and 4-hydroxy-3-carboxybenzophenone; 3-(4'-methylbenzylidene)-d,l-camphor, 3-benzene Methylene-d,l-camphor, ethyl 4-imidazole acrylate, 2-phenyl-5-methylbenzo Azole, 2,2'-hydroxy-5-tolylbenzotriazole, 2-(2'-hydroxy-5'-third butyloctylphenyl) benzotriazole, 2-(2'-hydroxy- 5'-tolyl) benzotriazole, dibenzhydrazine, di-p-methoxybenzyl methane, 4-methoxy-4'-third butyl dibenzoyl methane, 5-(3, 3'dimethyl-2-norbornyl)-3-pentan-2-one and other ultraviolet absorbers; acetylsarcosinate (for example, sodium lauryl sarcosinate), glutathione, lemon Organic acids such as acids, malic acid, tartaric acid, and lactic acid; vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B12, Vitamin B15 and its derivatives such as vitamin B, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, etc. Vitamin E, vitamin D, vitamin H, pantothenic acid, pantethine Vitamins such as amine, niacinamide, benzyl nicotinate, etc.; γ-duoweisu, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, tranexamic acid and its derivatives [As a tranexamic acid derivative, a dimer of tranexamic acid (for example, trans-4-hydrochloride (trans-aminomethylcyclohexanecarbonyl)aminemethylcyclohexanecarboxylic acid, etc.), tranexamic acid Esters with hydroquinone (for example, trans-4-aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester, etc.), esters of tranexamic acid and gentisic acid (for example, 2-(trans-4- (Aminomethylcyclohexylcarbonyloxy)-5-hydroxybenzoic acid and its salts, etc.), tranexamic acid amide (for example, trans-4-amine methylcyclohexane carboxylic acid methyl amide and its salts) , Trans-4-(P-methoxybenzyl)aminomethylcyclohexanecarboxylic acid and its salts, trans-4-guanidinemethylcyclohexanecarboxylic acid and its salts)], cypressol , Myrrhol, eucalyptol, thymol, inositol, Bupleurum saponin, ginseng saponin, loofah saponin, saponin saponin, pantothenol alcohol ether, ethinyl estradiol Various medicaments such as methic acid, arbutin, erythrophyllin, placenta, etc.; sheep's hoof, Sophora flavescens, Japanese wing grass, orange, sage, yarrow, mallow, Chinese medicine, thyme, angelica, spruce, birch , Hydrangea, loofah, horse chestnut, saxifrage, rabbit chrysanthemum, lily, sagebrush, peony, aloe, gardenia, Japanese cypress and other plant extracts; pigment; porous and/or water-absorbing powder (For example, powders of starches, silicic anhydride, talc, kaolin, magnesium aluminum silicate, calcium alginate, etc. obtained from corn or potatoes, etc.; neutralizers; preservatives; spices; pigments, etc.
本發明之乳化組成物,可藉由各別製備包含上述水溶性共聚物的水相成分與油相成分,並將該等利用常法攪拌混合而製造。 The emulsified composition of the present invention can be produced by separately preparing an aqueous phase component and an oil phase component including the above-mentioned water-soluble copolymer, and stirring and mixing these by a conventional method.
本發明之乳化組成物為低刺激,從黏膩感少之觀點,作為乳液、乳霜、美容液、防曬、粉底液等之化妝品、皮膚外用劑、類醫藥產品或醫藥品使用較佳。 The emulsified composition of the present invention is low in irritation and is preferably used as cosmetics, skin external preparations, quasi-medicinal products, or pharmaceutical products such as emulsions, creams, cosmetic liquids, sunscreens, liquid foundations, etc. from the viewpoint of less stickiness.
本發明也關於一種包含上述水溶性共聚物的乳化劑。與上述水溶性共聚物及乳化組成物相關的記載事項,可應用於本發明的乳化劑。 The present invention also relates to an emulsifier containing the above water-soluble copolymer. The descriptions related to the above water-soluble copolymer and emulsified composition can be applied to the emulsifier of the present invention.
本發明也關於一種使用上述本發明之乳化劑製造乳化組成物的方法。本發明的方法,其特徵為未使用本發明之乳化劑以外的乳化劑。與上述水溶性共聚物及乳化組成物相關的記載事項,可應用於本發明的製造方法。 The present invention also relates to a method for producing an emulsified composition using the emulsifier of the present invention described above. The method of the present invention is characterized in that an emulsifier other than the emulsifier of the present invention is not used. The descriptions related to the above water-soluble copolymer and emulsified composition can be applied to the production method of the present invention.
解決第3、第4課題的本發明之皮膚清潔劑的特徵為包含具有自疏水性單體衍生的構成單元(e)與自親水性單體衍生之構成單元(f)的水溶性共聚物。以下在<1>之項目中,對於疏水性單體、親水性單體及該等之共聚物的水溶性共聚物進行說明。 The skin cleansing agent of the present invention that solves the third and fourth problems is characterized by including a water-soluble copolymer having a structural unit (e) derived from a hydrophobic monomer and a structural unit (f) derived from a hydrophilic monomer. In the following item <1>, water-soluble copolymers of hydrophobic monomers, hydrophilic monomers and copolymers of these will be described.
在本發明中,使用將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的構成單元(以下有時也單純稱為「構成單元(7)」等)之一種或兩種以上作為必要構成單元含有的水溶性共聚物。 In the present invention, a structural unit derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) (hereinafter sometimes simply referred to as "constituent unit (7)" etc.) is used One or two or more of them are water-soluble copolymers contained as essential structural units.
再者,在本發明中,「自單體衍生的構成單元」,係指對應的單體具有之碳-碳不飽和鍵藉由聚合反應裂解而形成的構成單元。 Furthermore, in the present invention, "constituent unit derived from a monomer" refers to a constituent unit formed by cleaving a carbon-carbon unsaturated bond possessed by the corresponding monomer by a polymerization reaction.
以下對於通式(1)、(7)或(8)所示之疏水性單體進行說明。 Hereinafter, the hydrophobic monomer represented by the general formula (1), (7) or (8) will be described.
在前述通式(7)中,R14表示氫原子或碳數1~3的烷基,R15表示碳數13~30的未含有環結構之分支狀烴基、或未含有環結構的具有2個以上之分支的碳數6~12之烴基。 In the aforementioned general formula (7), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 represents a branched hydrocarbon group having 13 to 30 carbon atoms that does not contain a ring structure, or 2 that does not contain a ring structure. More than 6 branched hydrocarbon groups with 6 to 12 carbon atoms.
在此,作為R14所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R14為氫原子或甲基較佳。 Here, examples of the alkyl group represented by R 14 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 14 is preferably a hydrogen atom or a methyl group.
又,作為R15所示之碳數13~30的未含有環結構之分支狀烴基,可例示1-甲基十二基、11-甲基十二基、3-乙基十一基、3-乙基-4,5,6-三甲基辛基、1-甲基十三基、1-己基辛基、2-丁基癸基、2-己基辛基、4-乙基-1-異丁基辛基、1-甲基十五基、2-己基癸基、2-辛基癸基、2-己基十二基、16-甲基十七基、9-甲基十七基、7- 甲基-2-(3-甲基己基)癸基、3,7,11,15-四-甲基十六基、2-辛基十二基、2-癸基十四基、2-十二基十六基等。 In addition, as a branched hydrocarbon group having a ring structure of 13 to 30 carbon atoms represented by R 15 , 1-methyldodecyl, 11-methyldodecyl, 3-ethylundecyl, 3 -Ethyl-4,5,6-trimethyloctyl, 1-methyltridecyl, 1-hexyloctyl, 2-butyldecyl, 2-hexyloctyl, 4-ethyl-1- Isobutyloctyl, 1-methylpentadecyl, 2-hexyldecyl, 2-octyldecyl, 2-hexyldodecyl, 16-methylheptadecyl, 9-methylheptadecyl, 7-methyl-2-(3-methylhexyl)decyl, 3,7,11,15-tetra-methylhexadecyl, 2-octyldodecyl, 2-decyltetradecyl, 2 -Twelve bases and sixteen bases.
又,作為R15所示之未含有環結構的具有2個以上之分支的碳數6~12之烴基,可例示2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1,3-二甲基丁基、1,2,2-三甲基丙基、1,1-二甲基戊基、1-異丙基丁基、1-異丙基-2-甲基丙基、1,1-二乙基丙基、1-乙基-1-異丙基丙基、2-乙基-4-甲基戊基、1-丙基-2,2-二甲基丙基、1,1,2-三甲基-戊基、1-異丙基-3-甲基丁基、1,2-二甲基-1-乙基丁基、1,3-二甲基-1-乙基丁基、1-乙基-1-異丙基-丙基、1,1-二甲基己基、1-甲基-1-乙基戊基、1-甲基-1-丙基丁基、1,4-二甲基己基、1-乙基-3-甲基戊基、1,5-二甲基己基、1-乙基-6-甲基庚基、1,1,3,3-四甲基丁基、1,2-二甲基-1-異丙基丙基、3-甲基-1-(2,2-二甲基乙基)丁基、1-異丙基己基、3,5,5-三甲基己基、2-異丙基-5-甲基己基、1,5-二甲基-1-乙基己基、3,7-二甲基辛基、2,4,5-三甲基庚基、2,4,6-三甲基庚基、3,5-二甲基-1-(2,2-二甲基乙基)己基等。 In addition, examples of the hydrocarbon group having 6 or more carbon atoms and having 2 or more branches not containing a ring structure represented by R 15 include 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,3-dimethylbutyl, 1,2,2-trimethylpropyl, 1,1-dimethylpentyl, 1-isopropylbutyl, 1-isopropyl-2-methylpropyl, 1,1-diethylpropyl, 1-ethyl-1-isopropylpropyl, 2-ethyl-4-methylpentyl, 1- Propyl-2,2-dimethylpropyl, 1,1,2-trimethyl-pentyl, 1-isopropyl-3-methylbutyl, 1,2-dimethyl-1-ethyl Butyl, 1,3-dimethyl-1-ethylbutyl, 1-ethyl-1-isopropyl-propyl, 1,1-dimethylhexyl, 1-methyl-1-ethyl Amylpentyl, 1-methyl-1-propylbutyl, 1,4-dimethylhexyl, 1-ethyl-3-methylpentyl, 1,5-dimethylhexyl, 1-ethyl -6-methylheptyl, 1,1,3,3-tetramethylbutyl, 1,2-dimethyl-1-isopropylpropyl, 3-methyl-1-(2,2- Dimethylethyl)butyl, 1-isopropylhexyl, 3,5,5-trimethylhexyl, 2-isopropyl-5-methylhexyl, 1,5-dimethyl-1-ethyl Hexyl, 3,7-dimethyloctyl, 2,4,5-trimethylheptyl, 2,4,6-trimethylheptyl, 3,5-dimethyl-1-(2, 2-dimethylethyl)hexyl and so on.
在前述通式(1)及(8)中,R1、R16表示氫原子或碳數1~3的烷基,R2、R3、R17、R18、R19可相同亦可不同,且表示未含有環結構之具有分支的碳數6~22之醯基。X表示自三元醇脫附OH基的基。 In the aforementioned general formulas (1) and (8), R 1 and R 16 represent a hydrogen atom or a C 1-3 alkyl group, and R 2 , R 3 , R 17 , R 18 and R 19 may be the same or different , And represents a branched C 6-22 acyl group that does not contain a ring structure. X represents a group that desorbs the OH group from the triol.
在此,作為R1、R16所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R1為氫或甲基較佳。 Here, examples of the alkyl group represented by R 1 and R 16 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 1 is preferably hydrogen or methyl.
又,作為R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數6~22的醯基,可例示2-甲基戊醯基、3-甲基戊醯基、4-甲基戊醯基、2-乙基丁醯基、2-乙基丁醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、2-甲基己醯基、4-甲基己醯基、5-甲基己醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2-甲基庚醯基、2-乙基己基、2-丙基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、2-甲基辛醯基、3,3,5-三甲基己醯基、2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 In addition, examples of R 2 , R 3 , R 17 , R 18 , and R 19 that do not contain a ring structure and have branched C 6-22 acyl groups include 2-methylpentyl acyl and 3-methyl Pentylpentyl, 4-methylpentyl, 2-ethylbutyryl, 2-ethylbutyryl, 2,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2-methylhexyl , 4-methylhexyl, 5-methylhexyl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2-methylheptyl, 2-ethyl Hexyl, 2-propylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentyl, 2-methyloctyl, 3,3,5-trimethyl Hexamyl, 2-methylnonyl, 4-methylnonyl, 8-methylnonyl, 4-ethyloctyl, 2-ethyloctyl, 2-butylhexyl, 2- Tert-butylhexyl, 2,2-diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl, 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2- Butyloctyl, diethyloctyl, 2-third butyl-2,2,4-trimethylpentyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyl Yldodecyl, 11-methyldodecyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl -2-ethyloctyl, 12-methyltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-Dimethylhexyl, 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nineteen amide Base, 3,7,11,15-tetra-methylhexadecyl, 19-methyleicosyl, etc.
又,本發明之較佳的實施形態中,在通式(1)及(8)中,R2、R3、R17、R18、R19可相同亦可不同,且為未含有環結構的具有分支之碳數10~22的醯基、或未含有環結構的具有2個以上之分支的碳數6~9之醯基。 Moreover, in a preferred embodiment of the present invention, in the general formulas (1) and (8), R 2 , R 3 , R 17 , R 18 , and R 19 may be the same or different, and have no ring structure A branched carbon group with a carbon number of 10 to 22, or a ring group with no more than 2 branches and a carbon group with a carbon number of 6 to 9.
作為如此較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數10~22的醯基,可例示2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As such a preferred embodiment, R 2 , R 3 , R 17 , R 18 , and R 19 which do not contain a ring structure and have a branched C 10-22 acyl group may include 2-methylnonyl Group, 4-methylnonylyl group, 8-methylnonylyl group, 4-ethyloctylyl group, 2-ethyloctylyl group, 2-butylhexylyl group, 2-butylhexylyl group, 2-third butylhexylyl group, 2, 2-Diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl , 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2-butyloctyl, diethyloctyl, 2 -Third-butyl-2,2,4-trimethylpentylyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyldodecyl, 11-methyl Dodecanoyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl-2-ethyloctyl, 12-methyl Yltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-dimethylhexyl , 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nonadecyl, 3,7,11,15- Tetramethyl hexadecyl, 19-methyl eicosyl, etc.
又,作為較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有2個以上之分支的碳數6~9之醯基,可例示2,2-二甲基丁醯基、3,3-二甲基丁醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、3,5,5-三甲基己醯基等。 In addition, as a preferred embodiment, an acyl group having 6 to 9 carbon atoms having 2 or more branches and not containing a ring structure represented by R 2 , R 3 , R 17 , R 18 , and R 19 can be exemplified by 2 ,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentanyl, 3,5,5-trimethylhexyl, etc.
在通式(1)中,X所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可 適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (1), the group derived from triol represented by X is not particularly limited as long as it is a group from which the OH group is desorbed from the triol. A group exemplified by a trihydric alcohol selected from the group consisting of glycerin, trimethylolpropane, and trimethylolethane desorbs the OH group is suitably exemplified.
又,在通式(8)中,Y所示之自四元醇衍生的基,只要是自四元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含二丙三醇、季戊四醇、赤藻糖醇、D-蘇糖醇、L-蘇糖醇的群組之四元醇脫附OH基的基。 In addition, in the general formula (8), the group derived from a tetrahydric alcohol represented by Y is not particularly limited as long as it desorbs the OH group from the tetrahydric alcohol, and can be appropriately exemplified by The tetrahydric alcohol of the group of alcohol, pentaerythritol, erythritol, D-threitol, and L-threitol desorbs the OH group.
在本發明中,使用包含構成單元(1)的水溶性共聚物特佳。 In the present invention, it is particularly preferable to use a water-soluble copolymer containing the structural unit (1).
又,本發明之更佳的實施形態中,通式(1)所示的疏水性單體為前述通式(15)所示的疏水性單體。 In a more preferred embodiment of the present invention, the hydrophobic monomer represented by the general formula (1) is the hydrophobic monomer represented by the general formula (15).
通式(15)之R24、R25之醯基的碳數為12~22,更佳為14~20,特佳為16~20。 The carbon number of the acyl group of R 24 and R 25 in the general formula (15) is 12-22, more preferably 14-20, and particularly preferably 16-20.
又,通式(15)之R24、R25之醯基的主鏈之碳數,較佳為9~21,更佳為12~20,特佳為16~18。 In addition, the carbon number of the main chain of the acyl group of R 24 and R 25 in the general formula (15) is preferably 9 to 21, more preferably 12 to 20, and particularly preferably 16 to 18.
又,通式(15)之R24、R25之醯基的分支數,較佳為1~3,更佳為1或2,特佳為1。 In addition, the branch number of the acyl group of R 24 and R 25 in the general formula (15) is preferably 1 to 3, more preferably 1 or 2, and particularly preferably 1.
而且,在通式(15)之R24、R25之醯基中,分支鏈鍵結的主鏈之碳的位置編號越大越佳。具體而言,分支鏈較佳係以與自主鏈端部的第1~3個碳鍵結為較佳,更佳為第1或2個碳,特佳為第1個碳。 In addition, in the acyl group of R 24 and R 25 in the general formula (15), the larger the position number of the carbon of the main chain of the branch chain bonding, the better. Specifically, the branched chain is preferably bonded to the first to third carbons at the end of the autonomous chain, more preferably the first or second carbon, and particularly preferably the first carbon.
作為R24、R25,具體而言,可適當例示10-甲基十一醯基、10-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、12-甲基十四醯基、14-甲基十五醯基、16-甲基十七醯基、2,4,10,14-四甲基 戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As R 24 and R 25 , specifically, 10-methyl undecyl group, 10-methyl dodecyl group, 11-methyl dodecyl group, 10-ethyl undecyl group, 12-Methyltridecyl, 12-methyltetradecyl, 14-methylpentadecyl, 16-methylheptadecyl, 2,4,10,14-tetramethylpentyl , 18-methyl nineteen amide, 3,7,11,15-tetra-methyl hexadecyl, 19-methyl eicosyl, etc.
在通式(15)中,Z所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (15), the group derived from triol represented by Z is not particularly limited as long as it desorbs the OH group from the triol, and can be appropriately exemplified by a group selected from the group consisting of glycerol and triol. The trihydric alcohol of the group of methylolpropane and trimethylolethane desorbs the OH group.
作為本發明的親水性單體,可使用聚合性羧酸、以及前述通式(2)、(9)、(10)及(11)所示的化合物。 As the hydrophilic monomer of the present invention, a polymerizable carboxylic acid and compounds represented by the aforementioned general formulas (2), (9), (10), and (11) can be used.
在本發明中,作為聚合性羧酸或其鹽,具體而言,可例示丙烯酸、甲基丙烯酸、巴豆酸、伊康酸、富馬酸及其鈉鹽、鉀鹽、銨鹽、胺鹽等。該等之中,從聚合性高之觀點,丙烯酸、甲基丙烯酸及其鹽特佳。在本發明的水溶性共聚物導入自聚合性的羧酸鹽衍生之構成單元時,可將聚合性羧酸預先製成鹽,進行聚合反應,亦可利用聚合反應,將自聚合性羧酸衍生之構成單元衍生為水溶性共聚物後,利用鹼中和而製成鹽。 In the present invention, specific examples of the polymerizable carboxylic acid or its salt include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, fumaric acid and its sodium, potassium, ammonium, and amine salts. . Among these, acrylic acid, methacrylic acid, and their salts are particularly preferred from the viewpoint of high polymerizability. When the water-soluble copolymer of the present invention is introduced into a structural unit derived from a polymerizable carboxylate, the polymerizable carboxylic acid may be prepared as a salt in advance to perform a polymerization reaction, or the polymerization reaction may be used to derive the self-polymerizable carboxylic acid After the constituent units are derived into water-soluble copolymers, they are made into salts by neutralization with alkali.
前述通式(2)中、R4表示氫原子或碳數1~3的烷基,R5表示可具有羥基之碳數2~4的伸烷基,R6表示氫原子、碳數6~10的芳香族烴基、碳數1~14的脂肪族烴基或碳數1~12的醯基。n表示6~40的整數。 In the aforementioned general formula (2), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents a hydrogen atom and a carbon atom having 6 to 6 carbon atoms The aromatic hydrocarbon group of 10, the aliphatic hydrocarbon group of 1 to 14 carbon atoms, or the acyl group of 1 to 12 carbon atoms. n represents an integer of 6~40.
作為在前述通式(2)中R4所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基。在本發明中,R4為氫原子或甲基較佳。 Examples of the alkyl group represented by R 4 in the general formula (2) include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 4 is preferably a hydrogen atom or a methyl group.
又,作為R5所示的伸烷基,可例示伸乙基、伸丙基、異伸丙基、2-羥基伸丙基、2-羥基-2-甲基伸乙基、2-羥基-1-甲基伸乙基等,但該等之中,較佳為伸乙基或伸丙基,更佳為伸乙基。 In addition, as the alkylene group represented by R 5 , ethyl group, ethyl group, isopropyl group, 2-hydroxypropyl group, 2-hydroxy-2-methyl ethyl group, 2-hydroxy- 1-methylethylidene, etc., but among these, ethylidene or propylidene are preferred, and ethylidene is more preferred.
又,R6所示的基中,作為碳數6~10的芳香族基,可例示苯基、苯甲基、甲苯基、乙苯基等;作為碳數1~14的脂肪族烴基,可適當例示甲基、乙基、丁基、第三丁基、己基、環己基、辛基、2-乙基己基、月桂基等;作為碳數1~12的醯基,可適當例示甲醯基、乙醯基、丙醯基、丁醯基、異丁醯基、戊醯基、月桂醯基等。該等之中,作為R5所示的基,較佳為碳數1~14的脂肪族烴基,更佳為碳數1~12的烷基。 In addition, among the groups represented by R 6 , examples of the aromatic groups having 6 to 10 carbon atoms include phenyl, benzyl, tolyl, and ethylphenyl groups. As the aliphatic hydrocarbon groups having 1 to 14 carbon atoms, Appropriate examples include methyl, ethyl, butyl, tertiary butyl, hexyl, cyclohexyl, octyl, 2-ethylhexyl, lauryl, etc.; as a C 1-12 acyl group, a methyl acyl group can be appropriately exemplified. , Acetyl, propyl, butyl, isobutyl, pentyl, lauryl, etc. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
而且,通式(2)之n為6~40的數值範圍。 Furthermore, n in the general formula (2) is in the range of 6 to 40.
前述通式(2)所示的單體中,作為R5為伸丙基之單體,具體而言,可舉出聚丙二醇(9)單丙烯酸酯、聚丙二醇(13)單丙烯酸酯、聚丙二醇(9)單甲基丙烯酸酯、聚丙二醇(13)單甲基丙烯酸酯等。再者,括弧內的數字表示N。該等之聚合物大多可作為市售品取得。作為該等市售品,具體而言,可例示商品名「Blenmer」AP-400、AP-550、AP-800、PP-500、PP-800(均為日本油脂(股)製)等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is propylene, specifically, polypropylene glycol (9) monoacrylate, polypropylene glycol (13) monoacrylate, poly Propylene glycol (9) monomethacrylate, polypropylene glycol (13) monomethacrylate, etc. Furthermore, the number in parentheses indicates N. Most of these polymers are available as commercial products. Specific examples of these commercially available products include trade names "Blenmer" AP-400, AP-550, AP-800, PP-500, and PP-800 (all manufactured by Nippon Oil & Fats Co., Ltd.).
前述通式(2)所示的單體中,作為R5為伸乙基之單體,具體而言,可舉出聚乙二醇(10)單丙烯酸酯、聚乙二醇(8)單甲基丙烯酸酯、聚乙二醇(23)單丙烯酸酯、聚乙二醇(23)單甲基丙烯酸酯、甲氧基聚乙二醇(9) 丙烯酸酯、甲氧基聚乙二醇(9)甲基丙烯酸酯、甲氧基聚乙二醇(23)甲基丙烯酸酯、油氧基聚乙二醇(18)甲基丙烯酸酯、月桂氧基聚乙二醇(18)丙烯酸酯、月桂醯氧基聚乙二醇(10)甲基丙烯酸酯、硬脂氧基聚乙二醇(30)單甲基丙烯酸酯等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is an ethylidene group, specifically, polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomer Methacrylate, polyethylene glycol (23) monoacrylate, polyethylene glycol (23) monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol ( 9) Methacrylate, methoxy polyethylene glycol (23) methacrylate, oleyloxy polyethylene glycol (18) methacrylate, lauryloxy polyethylene glycol (18) acrylate, Lauryloxy polyethylene glycol (10) methacrylate, stearyl polyethylene glycol (30) monomethacrylate, etc.
上述親水性單體,可藉由對應的聚乙二醇、聚乙二醇單醚、聚乙二醇單酯與丙烯酸或甲基丙烯酸之氯化物或酐之酯化反應而以高產率得到。又,因為已存在很多市售品,所以也可利用該市售品。作為如此市售品,具體而言,可例示商品名Blenmer、AE-400、PE-350、AME-400、PME-400、PME-1000、ALE-800、PSE-1300(均為日本油脂(股)製)等。 The above-mentioned hydrophilic monomers can be obtained in a high yield by esterification reaction of corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester with acrylic acid or methacrylic acid chloride or anhydride. In addition, since many commercial products already exist, the commercial products can also be used. As such a commercially available product, specifically, the trade names of Blenmer, AE-400, PE-350, AME-400, PME-400, PME-1000, ALE-800, and PSE-1300 (all of which are Japanese oil ) System) etc.
作為本發明的親水性單體,亦可使用前述通式(9)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the aforementioned general formula (9) can also be used.
作為前述通式(9)所示的親水性單體,具體而言,可舉出2-丙烯醯氧基乙基磷酸膽鹼(APC)、2-甲基丙烯醯氧乙基磷酸膽鹼(MPC)。該等之單體,例如,可利用Polymer Journal,Vol22,No.5記載之以下的方法合成。 Specific examples of the hydrophilic monomer represented by the general formula (9) include 2-acryloyloxyethyl phosphate choline (APC) and 2-methacryloyloxyethyl phosphate choline ( MPC). Such monomers can be synthesized by the following method described in Polymer Journal, Vol22, No. 5, for example.
使二氯化2-溴乙基磷醯與甲基丙烯酸2-羥乙酯或丙烯酸2-羥乙酯反應,得到2-甲基丙烯醯氧乙基-2’-溴乙基磷酸或2-丙烯醯氧乙基-2’-溴乙基磷酸後,將該等化合物與三乙胺於甲醇中進行反應。 Reacting 2-bromoethylphosphoryl dichloride with 2-hydroxyethyl methacrylate or 2-hydroxyethyl acrylate to obtain 2-methacryloxyethyl-2'-bromoethyl phosphoric acid or 2- After acryloyloxyethyl-2'-bromoethyl phosphoric acid, these compounds are reacted with triethylamine in methanol.
作為本發明的親水性單體,亦可使用前述通式(10)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the general formula (10) can also be used.
在通式(10)所示的親水性單體中,作為G-O-所示的自還原糖之1位的羥基除去氫的基之還原糖,具體而言,可例示選自於包含葡萄糖、甘露糖、半乳糖、阿拉伯糖、木糖、核糖等之單糖、麥芽糖、乳糖、纖維雙糖等之雙糖、麥芽三糖等之三糖、麥芽寡糖等之寡糖的群組之一種或兩種以上,其中尤以選自於包含葡萄糖、半乳糖、阿拉伯糖、木糖、核糖、麥芽糖、乳糖、纖維雙糖的群組之一種或兩種以上較佳,葡萄糖特佳。又,作為通式(10)所示的單體,甲基丙烯酸葡萄糖基氧乙酯(以下省略為GEMA)或丙烯酸葡萄糖基氧乙酯(以下省略為GEA)較佳。 Among the hydrophilic monomers represented by the general formula (10), the reducing sugar that is a group that removes hydrogen from the hydroxyl group at the 1-position of the reducing sugar represented by GO- can be specifically selected from the group consisting of glucose and mannose. Groups of monosaccharides such as sugar, galactose, arabinose, xylose, ribose, disaccharides such as maltose, lactose, cellobiose, trisaccharides such as maltotriose, and oligosaccharides such as maltooligosaccharide One or two or more, among which one or two or more selected from the group consisting of glucose, galactose, arabinose, xylose, ribose, maltose, lactose, and cellobiose is preferred, and glucose is particularly preferred. Further, as the monomer represented by the general formula (10), glucosyloxyethyl methacrylate (hereinafter abbreviated as GEMA) or glucosyloxyethyl acrylate (hereinafter abbreviated as GEA) is preferred.
在通式(11)的單體中,作為R23所示之胺基酸殘基的胺基酸,只要是通常已知的胺基酸,則沒有特別限定,具體而言,可例示甘胺酸、丙胺酸、麩胺酸、離胺酸、精胺酸等。該等之中,因為得到的水溶性共聚物之皮膚屏障的恢復效果佳,所以以離胺酸殘基為特佳。 In the monomer of the general formula (11), the amino acid as the amino acid residue represented by R 23 is not particularly limited as long as it is a generally known amino acid, and specifically, glycine can be exemplified. Acid, alanine, glutamic acid, lysine, arginine, etc. Among these, since the skin barrier effect of the water-soluble copolymer obtained is good, ionic acid residues are particularly preferable.
又,R23所示的多胺殘基之多胺,意指在同一分子內具有可以烷基取代之胺基2個以上的胺,具體而言,可例示二胺、三胺、四胺或該等之胺基的氫原子被烷基取代的胺。該等之中,從含有得到的水溶性共聚物之皮膚外用劑的使用感特佳之觀點,二胺較佳,作為特佳的具體例,從合成之際的原料取得之容易度的觀 點,可舉出乙二胺、1,4-二胺基-正丁烷、1,6-二胺基-正己烷等。 In addition, the polyamine of the polyamine residue represented by R 23 means an amine having two or more amine groups that can be substituted with an alkyl group in the same molecule. Specifically, a diamine, triamine, tetraamine or An amine in which the hydrogen atom of the amine group is substituted with an alkyl group. Among these, from the viewpoint of excellent use of skin external preparations containing the obtained water-soluble copolymer, diamine is preferable, and as a particularly preferable specific example, from the viewpoint of ease of obtaining raw materials at the time of synthesis, Examples include ethylenediamine, 1,4-diamino-n-butane, 1,6-diamino-n-hexane, and the like.
而且,作為R23所示之胺醇殘基的胺醇,意指在同一分子內具有可以烷基取代之胺基及醇式羥基的化合物。作為胺醇,只要是通常已知者,則沒有特別限定,作為具體例,可例示乙醇胺、三乙胺基乙醇等。 The amine alcohol as the amine alcohol residue represented by R 23 means a compound having an alkyl-substituted amine group and an alcoholic hydroxyl group in the same molecule. The amino alcohol is not particularly limited as long as it is generally known, and specific examples include ethanolamine, triethylaminoethanol, and the like.
作為通式(11)所示之單體的鹽,沒有特別限定,具體而言,可例示將酸部分以鹼中和的鈉鹽、鉀鹽、銨鹽、胺鹽等,或者,將胺基部分以酸中和的鹽酸鹽、硫酸鹽、硝酸鹽、磷酸鹽、檸檬酸鹽、草酸鹽、碳酸鹽等。在本發明的水溶性共聚物導入自通式(11)所示的單體鹽衍生之構成單元時,可將通式(11)所示的單體預先製成鹽,進行聚合反應,亦可利用聚合反應,將自通式(11)所示的單體衍生之構成單元衍生為水溶性共聚物後,中和而製成鹽。 The salt of the monomer represented by the general formula (11) is not particularly limited, and specifically, there can be exemplified sodium salts, potassium salts, ammonium salts, amine salts and the like neutralized with an acid moiety, or Partially acid neutralized hydrochloride, sulfate, nitrate, phosphate, citrate, oxalate, carbonate, etc. When the water-soluble copolymer of the present invention is introduced into the structural unit derived from the monomer salt represented by the general formula (11), the monomer represented by the general formula (11) may be prepared as a salt in advance to perform a polymerization reaction, or Using a polymerization reaction, the structural unit derived from the monomer represented by the general formula (11) is derived as a water-soluble copolymer, and then neutralized to form a salt.
作為通式(11)所示的單體、其鹽的具體例,可適當例示上述的化合物1~11及其鹽。
As specific examples of the monomer represented by the general formula (11) and salts thereof, the above-mentioned
通式(11)所示的親水性單體,例如,如前述反應式(1)及(2)所示,可藉由使用(甲基)丙烯酸、(甲基)丙烯醯氯的酯化反應、醯胺化反應而合成。 The hydrophilic monomer represented by the general formula (11), for example, as shown in the aforementioned reaction formulas (1) and (2), can be obtained by an esterification reaction using (meth)acrylic acid or (meth)acryloyl chloride , Amidation reaction synthesis.
如上述,在本發明中作為親水性聚合物,可使用前述通式(2)、前述通式(9)、前述通式(10)、前述通式(11)。 As described above, in the present invention, as the hydrophilic polymer, the aforementioned general formula (2), the aforementioned general formula (9), the aforementioned general formula (10), and the aforementioned general formula (11) can be used.
本發明之較佳的實施形態中,水溶性共聚物係包含自前述通式(2)衍生的構成單元(2)。 In a preferred embodiment of the present invention, the water-soluble copolymer contains the structural unit (2) derived from the aforementioned general formula (2).
在本發明中,尤能適用具有構成單元(1)與構成單元(2)的水溶性共聚物。又,更佳可使用具有構成單元(15)與構成單元(2)的水溶性共聚物。 In the present invention, a water-soluble copolymer having a structural unit (1) and a structural unit (2) is particularly applicable. Furthermore, it is more preferable to use a water-soluble copolymer having a structural unit (15) and a structural unit (2).
如此水溶性共聚物中,特佳可使用(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物。 Among such water-soluble copolymers, (methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer can be particularly preferably used.
藉由含有如此水溶性共聚物,可提供使用後之緊繃感更少的皮膚清潔劑。 By containing such a water-soluble copolymer, it is possible to provide a skin cleanser with less tightness after use.
(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物,作為構成單元(e),主要包含自前述通式(15)所示的疏水性單體中,R24、R25為16-甲基十七醯基之疏水性單體衍生的構成單元(e)。 (Methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer, as the structural unit (e), is mainly contained in the hydrophobic monomer represented by the general formula (15), R 24 and R 25 are structural units (e) derived from a hydrophobic monomer of 16-methylheptadecyl group.
又,作為構成單元(f),主要包含自前述通式(2)所示的親水性單體中,R4為甲基,R5為伸乙基,R6為甲基,n為23之親水性單體衍生的構成單元(f)。 Moreover, as a structural unit (f), it is mainly comprised from the hydrophilic monomer represented by the said general formula (2), R 4 is a methyl group, R 5 is an ethyl group, R 6 is a methyl group, and n is 23 Structural unit (f) derived from a hydrophilic monomer.
在本發明中,水溶性共聚物之構成單元(e)在全構成單元所佔之比例,較佳為1~60質量%,更佳為10~50質量%、20~40質量%。 In the present invention, the proportion of the structural units (e) of the water-soluble copolymer in all the structural units is preferably 1 to 60% by mass, more preferably 10 to 50% by mass, and 20 to 40% by mass.
藉由使水溶性共聚物之構成單元(e)所佔之比例成為前述範圍,可提供使用後之緊繃感進一步減低的皮膚清潔劑。 By setting the proportion of the structural unit (e) of the water-soluble copolymer within the aforementioned range, it is possible to provide a skin cleanser with a further reduced feeling of tightness after use.
在本發明中,水溶性共聚物之構成單元(f)在全構成單元所佔之比例,較佳為40~99質量%,更佳為50~90質量%、60~80質量%。 In the present invention, the proportion of the constituent units (f) of the water-soluble copolymer in all constituent units is preferably 40 to 99% by mass, more preferably 50 to 90% by mass, and 60 to 80% by mass.
藉由使水溶性共聚物之構成單元(f)所佔之比例成為前述範圍,可提供使用後之緊繃感進一步減低的皮膚清潔劑。 By setting the proportion of the structural unit (f) of the water-soluble copolymer within the aforementioned range, it is possible to provide a skin cleanser with a further reduced feeling of tightness after use.
在本發明中,構成水溶性共聚物之構成單元(e)與構成單元(f)的質量比,較佳為1:99~60:40,更佳為10:90~50:50,特佳為20:80~40:60。 In the present invention, the mass ratio of the constituent unit (e) and the constituent unit (f) constituting the water-soluble copolymer is preferably 1:99-60:40, more preferably 10:90-50:50, and particularly preferably It is 20:80~40:60.
又,構成水溶性共聚物之構成單元(e)與構成單元(f)的莫耳比,較佳為1:99~71:29,進一步較佳為15:85~62:38,更佳為29:71~52:48,特佳為35:65~45:55。 In addition, the molar ratio of the structural unit (e) and the structural unit (f) constituting the water-soluble copolymer is preferably 1:99 to 71:29, further preferably 15:85 to 62:38, and more preferably 29:71~52:48, especially good is 35:65~45:55.
藉由使水溶性共聚物的構成單元(e)及構成單元(f)之質量比及莫耳比成為前述範圍,可成為緊繃感之減低效果更佳的水溶性共聚物。 By setting the mass ratio and the molar ratio of the structural unit (e) and the structural unit (f) of the water-soluble copolymer to the aforementioned range, it is possible to obtain a water-soluble copolymer having a better effect of reducing tightness.
在本發明中,水溶性共聚物之平均分子量,較佳為20000~110000,進一步較佳為20000~80000,更佳為30000~80000,進一步更佳為40000~70000,特佳為50000~70000,進一步特佳為57000~66000。 In the present invention, the average molecular weight of the water-soluble copolymer is preferably from 20,000 to 110,000, further preferably from 20,000 to 80,000, more preferably from 30,000 to 80,000, even more preferably from 40,000 to 70,000, and particularly preferably from 50,000 to 70,000. Further particularly preferred is 57000~66000.
再者,在此,平均分子量係指利用GPC測定之聚苯乙烯換算的重量平均分子量。 Here, the average molecular weight refers to the weight average molecular weight in terms of polystyrene measured by GPC.
皮膚清潔劑係指包含清潔成分的組成物,以洗掉皮脂等之皮膚的污垢為目的而使用。如前述,皮膚清潔劑有洗掉存在於皮膚的皮脂之作用,因此具有在使用後於肌膚產生緊繃感的問題。 A skin cleanser refers to a composition containing cleansing ingredients, and is used for the purpose of washing away skin dirt such as sebum. As mentioned above, the skin cleanser has the effect of washing away the sebum present in the skin, and therefore has the problem of producing a tight feeling on the skin after use.
本發明的皮膚清潔劑,其特徵為包含上述水溶性共聚物。根據本發明,不會阻礙皮膚清潔劑原本具有的清潔力,或者可一邊提升清潔力一邊減低使用後的肌膚之緊繃感。 The skin cleanser of the present invention is characterized by containing the above water-soluble copolymer. According to the present invention, the cleansing power originally possessed by the skin cleanser is not hindered, or the cleansing power of the skin after use can be reduced while enhancing the cleansing power.
作為本發明的皮膚清潔劑之劑型,只要為通常使用於皮膚清潔劑的劑型,則沒有特別限定而可應用。通常的皮膚清潔劑中,存在有固體狀、粉末狀、乳霜狀、液狀、凝膠狀的皮膚清潔劑等,本發明可應用任一種之劑型。 The dosage form of the skin cleansing agent of the present invention is not particularly limited as long as it is a dosage form generally used for skin cleansing agents, and can be applied. Common skin cleansers include solid, powder, cream, liquid, and gel skin cleansers, etc., and any of the dosage forms can be applied in the present invention.
劑型為乳霜狀、液狀、凝膠狀等之液體的皮膚清潔劑之上述水溶性共聚物的含量,較佳為0.1~20質量%,更佳為0.5~10質量%,特佳為1~3質量%。 The content of the above-mentioned water-soluble copolymer of the skin cleansing agent whose liquid form is cream, liquid, gel, etc. is preferably 0.1 to 20% by mass, more preferably 0.5 to 10% by mass, and particularly preferably 1 ~3% by mass.
藉由使上述水溶性共聚物之含量成為前述範圍,不會阻礙皮膚清潔劑原本具有的清潔力,可進一步減低使用後的肌膚之緊繃感。 By setting the content of the above-mentioned water-soluble copolymer to the aforementioned range, the cleansing power originally possessed by the skin cleanser will not be hindered, and the tightness of the skin after use can be further reduced.
皮膚清潔劑可分為起泡而使用型與不起泡而使用型。本發明即使應用於任一型的皮膚清潔劑,也不會阻礙皮膚清潔劑原本具有的清潔力,且可減低使用後的肌膚之緊繃感。 Skin cleansers can be divided into a foaming type and a non-foaming type. Even if the invention is applied to any type of skin cleanser, it will not hinder the original cleansing power of the skin cleanser, and can reduce the tightness of the skin after use.
在起泡而使用型的皮膚清潔劑中,從可提升起泡性的良度之觀點,上述水溶性共聚物的含量為0.1質量%以上,較佳為0.5質量%以上,更佳為0.8質量%以上,特佳為1質量%以上。 In the foaming and use type skin cleansing agent, from the viewpoint of improving the foamability, the content of the water-soluble copolymer is 0.1% by mass or more, preferably 0.5% by mass or more, and more preferably 0.8% by mass % Or more, especially good is more than 1% by mass.
又,從減低使用後之肌膚的黏滑感之觀點,上述水溶性共聚物的含量,較佳為20質量%以下,進一步佳為 10質量%以下,更佳為3質量%以下,特佳為1質量%以下。 In addition, from the viewpoint of reducing the stickiness of the skin after use, the content of the water-soluble copolymer is preferably 20% by mass or less, and more preferably 10% by mass or less, more preferably 3% by mass or less, and particularly preferably 1% by mass or less.
作為起泡而使用型的皮膚清潔劑,尤可舉出乳霜狀的皮膚清潔劑。 As a foaming skin cleanser, a cream-like skin cleanser is particularly mentioned.
在不起泡而使用型的皮膚清潔劑中,上述水溶性共聚物的含量,從可提升對肌膚的延展易度之觀點,較佳為0.1~10質量%,進一步較佳為0.5~5質量%,更佳為0.6~3質量%,特佳為0.7~2質量%。 In the non-foaming type skin cleansing agent, the content of the water-soluble copolymer is preferably 0.1 to 10% by mass, and more preferably 0.5 to 5 from the viewpoint of improving the ease of extension to the skin %, more preferably 0.6 to 3% by mass, and particularly preferably 0.7 to 2% by mass.
作為不起泡而使用型的皮膚清潔劑,尤可舉出凝膠狀的皮膚清潔劑。 As a non-foaming type skin cleanser, a gel-like skin cleanser is particularly exemplified.
包含界面活性劑作為清潔成分的皮膚清潔劑,具有很強的清潔力之另一方面,有使用後之肌膚的緊繃感強之問題。因此,在包含界面活性劑的皮膚清潔劑應用本發明較佳。 A skin cleanser containing a surfactant as a cleaning ingredient has a strong cleaning power. On the other hand, it has a problem of a strong feeling of tightness of the skin after use. Therefore, it is preferable to apply the present invention to skin cleansers containing surfactants.
作為可在本發明的皮膚清潔劑含有之界面活性劑,只要為通常使用於皮膚清潔劑者,則沒有特別限定,可使用離子性界面活性劑、非離子性界面活性劑之任一者。 The surfactant that can be contained in the skin cleansing agent of the present invention is not particularly limited as long as it is generally used in skin cleansing agents, and any of ionic surfactants and nonionic surfactants can be used.
作為離子性界面活性劑,可使用陰離子性界面活性劑、陽離子性界面活性劑、兩性界面活性劑及非離子性界面活性劑之任一者。 As the ionic surfactant, any of anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants can be used.
作為陰離子性界面活性劑,尤能例示例如,脂肪酸鈉、脂肪酸鉀、脂肪酸三乙醇胺等之脂肪酸皂、可具有聚氧乙烯基之月桂基硫酸鈉、月桂基硫酸鉀、月 桂基硫酸三乙醇胺等之可具有聚氧乙烯基之烷基硫酸酯鹽、可具有聚氧乙烯基之月桂基磷酸鈉、月桂基磷酸鉀、月桂基磷酸三乙醇胺等之可具有聚氧乙烯基之烷基磷酸酯鹽、磺琥珀酸烷酯鹽等。 As anionic surfactants, specific examples include fatty acid soaps such as sodium fatty acid, potassium fatty acid, and fatty acid triethanolamine, sodium lauryl sulfate, potassium lauryl sulfate, which may have polyoxyethylene Triethanolamine such as lauryl sulfate can have polyoxyethylene alkyl sulfate salt, sodium lauryl phosphate can have polyoxyethylene, potassium lauryl phosphate, triethanolamine lauryl etc. can have polyoxyethylene Alkyl phosphate ester salts, alkyl sulfosuccinate salts, etc.
作為陰離子性界面活性劑,尤可例示例如,烷基三甲基銨鹽、烷基吡啶鹽、氯化二硬脂基二甲基銨二烷基二甲基銨鹽、氯化聚(N,N’-二甲基-3,5-亞甲基哌啶)、烷基四級銨鹽、烷基二甲基苯甲基銨鹽、烷基異喹啉鹽、二烷基嗎啉鹽、POE-烷胺、烷基胺鹽、多胺脂肪酸衍生物、戊醇脂肪酸衍生物、氯化苯二甲烴銨、苄索氯銨等。 As anionic surfactants, particularly exemplified examples include alkyl trimethyl ammonium salt, alkyl pyridine salt, distearyl dimethyl ammonium chloride, dialkyl dimethyl ammonium salt, and poly(N, N'-dimethyl-3,5-methylenepiperidine), alkyl quaternary ammonium salt, alkyl dimethyl benzyl ammonium salt, alkyl isoquinoline salt, dialkyl morpholine salt, POE-alkylamine, alkylamine salt, polyamine fatty acid derivative, pentanol fatty acid derivative, xylylenediamine chloride, benzethonium chloride, etc.
作為兩性界面活性劑,可舉出咪唑啉系兩性界面活性劑、甜菜鹼系界面活性劑等。 Examples of amphoteric surfactants include imidazoline-based amphoteric surfactants and betaine-based surfactants.
作為非離子性界面活性劑,尤可例示丙三醇脂肪酸酯、聚丙三醇脂肪酸酯、聚氧乙烯丙三醇脂肪酸酯、山梨糖醇酐脂肪酸酯、聚氧乙烯山梨糖醇酐脂肪酸酯、聚氧乙烯山梨糖醇脂肪酸酯、聚氧乙烯烷基苯醚、聚氧乙烯羊毛脂.羊毛脂醇.蜂蠟衍生物、聚氧乙烯蓖麻油.硬化蓖麻油、聚氧乙烯固醇.氫化固醇、聚氧乙烯烷醚、聚氧乙烯聚氧丙烯烷醚、聚氧乙烯脂肪酸酯、聚氧乙烯烷醚脂肪酸酯、聚氧乙烯硬化蓖麻油脂肪酸酯、聚氧乙烯三羥甲基丙烷脂肪酸酯、聚乙二醇脂肪酸酯、蔗糖脂肪酸酯、聚氧乙烯聚氧丙烯嵌段共聚物、有機改性矽酮等。 As the nonionic surfactant, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan Fatty acid ester, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene alkyl phenyl ether, polyoxyethylene lanolin. Lanolin alcohol. Beeswax derivatives, polyoxyethylene castor oil. Hardened castor oil, polyoxyethylene sterol. Hydrogenated sterol, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene ether, polyoxyethylene fatty acid ester, polyoxyethylene alkyl ether fatty acid ester, polyoxyethylene hardened castor oil fatty acid ester, polyoxyethylene trihydroxy Methyl propane fatty acid ester, polyethylene glycol fatty acid ester, sucrose fatty acid ester, polyoxyethylene polyoxypropylene block copolymer, organically modified silicone, etc.
該等界面活性劑之含量沒有特別限定,可根據界面活性劑的種類適當設定。 The content of these surfactants is not particularly limited, and can be appropriately set according to the type of surfactant.
以下對於包含脂肪酸皂的形態、包含非離子性界面活性劑的形態及凝膠狀之形態的皮膚清潔劑,更具體地進行說明。 Hereinafter, the skin cleansing agent containing the form of fatty acid soap, the form containing the nonionic surfactant, and the gel-like form will be described more specifically.
本發明藉由應用於包含脂肪酸皂的皮膚清潔劑,不損及該皮膚清潔劑具有之良質的起泡性、綿密的泡沫品質,而可減低使用後的肌膚之緊繃感。 The invention is applied to a skin cleanser containing fatty acid soaps, without compromising the good foaming and dense foam quality of the skin cleanser, and can reduce the tightness of the skin after use.
包含脂肪酸皂的皮膚清潔劑之形態,亦可為固體狀、液狀、乳霜狀之任一種,但成為液狀或乳霜狀之形態較佳。特別是成為起泡而使用的乳霜狀之皮膚清潔劑的形態較佳。 The form of the skin cleanser containing fatty acid soap may be any of solid, liquid, and cream, but the liquid or cream is preferred. In particular, the form of cream-like skin cleansers used for foaming is preferred.
作為構成脂肪酸皂的脂肪酸,只要為可應用於皮膚清潔劑者,則沒有特別限定,可為飽和或不飽和中之任一種,碳數8~24,特別是10~22者較佳。作為較佳者的具體例,可舉出月桂酸、肉荳蔻酸、棕櫚酸、硬脂酸、異硬脂酸、油酸、羥基硬脂酸、羥基癸烯酸、椰子油脂肪酸、還原椰子油脂肪酸、牛脂脂肪酸、還原牛脂脂肪酸、棕櫚仁脂肪酸等。該等之脂肪酸中,從起泡性、安全性、安定性之觀點,含有選自於肉荳蔻酸、棕櫚酸、硬脂酸之1種或2種以上較佳,特別是使用肉荳蔻酸與棕櫚酸及硬脂酸之3種較佳。作為形成該等之高級脂肪酸與鹽的鹼劑,可舉出鈉、鉀等之鹼金屬鹽、銨鹽、單乙醇胺鹽、二乙醇胺鹽、三乙醇胺鹽、2-胺基 -2-甲基丙醇、2-胺基-2-甲基丙二醇等之烷醇胺鹽、離胺酸、精胺酸等之鹼性胺基酸鹽等。 The fatty acid constituting the fatty acid soap is not particularly limited as long as it can be applied to skin cleansers, and it may be either saturated or unsaturated. The carbon number is 8 to 24, and particularly 10 to 22 is preferred. Specific examples of preferred ones include lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, oleic acid, hydroxystearic acid, hydroxydecenoic acid, coconut oil fatty acid, reduced coconut oil Fatty acids, tallow fatty acids, reduced tallow fatty acids, palm kernel fatty acids, etc. Among these fatty acids, one or more selected from the group consisting of myristic acid, palmitic acid, and stearic acid is preferred from the standpoint of foamability, safety, and stability. In particular, myristic acid and Three types of palmitic acid and stearic acid are preferred. Examples of the alkaline agent for forming such higher fatty acids and salts include alkali metal salts such as sodium and potassium, ammonium salts, monoethanolamine salts, diethanolamine salts, triethanolamine salts, and 2-amino groups. Alkanolamine salts such as 2-methylpropanol and 2-amino-2-methylpropanediol, and basic amino acid salts such as lysine and arginine.
皮膚清潔劑所含的脂肪酸之含量,並沒有特別限制。作成乳霜狀之皮膚清潔劑的情況中,脂肪酸之含量較佳為10~70質量%,更佳為20~60質量%,特佳可設為30~50質量%。 The content of fatty acids contained in skin cleansers is not particularly limited. In the case of a cream-like skin cleanser, the content of fatty acid is preferably 10 to 70% by mass, more preferably 20 to 60% by mass, and particularly preferably 30 to 50% by mass.
從可減低皮膚清潔劑之使用後的緊繃感之觀點,上述水溶性共聚物與脂肪酸的含有質量之比,較佳為1:500~1:2,更佳為1:200~1:3,特佳為1:100~1:5。 From the viewpoint of reducing the tightness of the skin cleanser after use, the content ratio of the water-soluble copolymer to the fatty acid is preferably 1:500~1:2, more preferably 1:200~1:3 , The best is 1:100~1:5.
又,從可提升起泡性的良度之觀點,上述水溶性共聚物與脂肪酸的含有質量之比,較佳為1:200~1:2,更佳為1:100~1:5,特佳為成為1:50~1:10,又,從減低使用後之肌膚的黏滑感之觀點,上述水溶性共聚物與脂肪酸的含有質量之比,較佳為1:500~1:10,更佳為1:200~1:20,特佳為成為1:100~1:50。 In addition, from the viewpoint of improving the goodness of foamability, the content ratio of the water-soluble copolymer and the fatty acid is preferably 1:200~1:2, more preferably 1:100~1:5, especially It is preferably 1:50 to 1:10, and from the viewpoint of reducing the stickiness of the skin after use, the content ratio of the above-mentioned water-soluble copolymer to fatty acid is preferably 1:500 to 1:10. More preferably, it is 1:200~1:20, and especially good is 1:100~1:50.
本發明應用於包含非離子性界面活性劑的皮膚清潔劑時,也可更有效地減低使用後的肌膚之緊繃感。作為非離子性界面活性劑,可無限制地使用上述者。 When the present invention is applied to a skin cleanser containing a nonionic surfactant, it can also more effectively reduce the tightness of the skin after use. As the nonionic surfactant, the above can be used without limitation.
在包含非離子性界面活性劑的形態中,從可減低使用後的緊繃感之觀點,上述水溶性共聚物的含量,較佳為0.1質量%以上,更佳為0.5質量%以上,特佳為1質量%以上。
In the form containing a nonionic surfactant, the content of the water-soluble copolymer is preferably 0.1% by mass or more, more preferably 0.5% by mass or more, particularly preferably from the viewpoint of reducing the tight feeling after
又,從可提升清潔力之觀點,上述水溶性共聚物的含量,較佳為0.5質量%以上,進一步較佳為1質量%以上,更佳為2質量%以上,特佳為3質量%以上。 Also, from the viewpoint of improving the cleaning power, the content of the water-soluble copolymer is preferably 0.5% by mass or more, more preferably 1% by mass or more, more preferably 2% by mass or more, and particularly preferably 3% by mass or more .
從可減低皮膚清潔劑之使用後的緊繃感之觀點,上述水溶性共聚物與非離子性界面活性劑之含有質量的比,較佳為1:20~1:0.5,更佳為1:10~1:0.7,特佳為成為1:5~1:1。 From the viewpoint of reducing the feeling of tightness after use of the skin cleanser, the content ratio of the water-soluble copolymer and the nonionic surfactant is preferably 1:20 to 1:0.5, and more preferably 1: 10~1: 0.7, especially good to become 1:5~1:1.
又,從可提升清潔力之觀點,上述水溶性共聚物與非離子性界面活性劑之含有質量的比,較佳為1:10~1:0.5,進一步較佳為1:5~1:0.5,更佳為1:3~1:0.6,特佳為成為1:1.5~1:0.7。 In addition, from the viewpoint of improving the cleaning power, the content ratio of the water-soluble copolymer and the nonionic surfactant is preferably 1:10~1:0.5, more preferably 1:5~1:0.5 , Better is 1:3~1:0.6, especially good is 1:1.5~1:0.7.
又,作成包含非離子性界面活性劑的凝膠狀之皮膚清潔劑的情況中,從可提升使用時之對肌膚的延展易度之觀點,上述水溶性共聚物與非離子性界面活性劑之含有質量的比,較佳為1:15~1:0.7,更佳為1:10~1:1,特佳為成為1:7~1:3。 In addition, in the case of making a gel-like skin cleansing agent containing a nonionic surfactant, the water-soluble copolymer and the nonionic surfactant have The content ratio is preferably 1:15 to 1:0.7, more preferably 1:10 to 1:1, and particularly preferably 1:7 to 1:3.
在本發明的皮膚清潔劑中,除了上述成分以外,可含有通常皮膚外用劑所使用的任意成分。作為如此任意成分,尤可例示例如,澳洲胡桃油、酪梨油、玉米油、橄欖油、油菜籽油、芝麻油、蓖麻油、紅花籽油、棉籽油、荷荷芭油、椰子油、棕櫚油、液狀羊毛脂、硬化椰子油、硬化油、木蠟、硬化蓖麻油、蜂蠟、小燭樹蠟、巴西棕櫚蠟、蟲蠟、羊毛脂、還原羊毛脂、硬質羊毛脂、荷荷芭蠟等之油、蠟類;流動石蠟、鯊烷、異 十八烷、地蠟、石蠟、礦蠟、凡士林、微晶蠟等之烴類;油酸、異硬脂酸、月桂酸、肉荳蔻酸、棕櫚酸、硬脂酸、二十二酸、十一烯酸等之高級脂肪酸類;鯨臘醇、硬脂醇、異硬脂醇、二十二醇、辛基十二醇、肉豆蔻醇、鯨蠟硬脂醇等之高級醇類;異辛酸鯨蠟酯、肉荳蔻酸異丙酯、異硬脂酸十六酯、乳酸鯨蠟酯、蘋果酸二異硬脂酯、二-2-乙基己酸乙二醇、二癸酸新戊二醇、二-2-庚基十一酸丙三醇酯、三-2-乙基己酸丙三醇酯、三羥甲基丙烷三-2-乙基己酸酯、三羥甲基丙烷三異硬脂酸酯、四-2-乙基己酸季戊四醇酯等之合成酯油類、二甲基聚矽氧烷、甲基苯基聚矽氧烷、二苯基聚矽氧烷等之鏈狀聚矽氧烷;八甲基環四矽氧烷、十甲基環五矽氧烷、十二甲基環己烷矽氧烷等之環狀聚矽氧烷;胺基改性聚矽氧烷、聚醚改性聚矽氧烷、烷基改性聚矽氧烷、氟改性聚矽氧烷等之改性聚矽氧烷等之矽酮油等之油劑類;聚乙二醇、丙三醇、1,3-丁二醇、赤藻糖醇、山梨糖醇、木糖醇、麥芽糖醇、丙二醇、二丙二醇、二丙三醇、異戊二醇、1,2-戊二醇、2,4-己二醇、1,2-己二醇、1,2-辛二醇等之多元醇類;吡咯啶酮羧酸鈉、乳酸、乳酸鈉等之保濕成分類;可將表面進行處理之雲母、滑石、高嶺土、合成雲母、碳酸鈣、碳酸鎂、矽酸酐(二氧化矽)、氧化鋁、硫酸鋇等之粉體類、可將表面進行處理之鐵丹、黃色氧化鐵、黑色氧化鐵、氧化鈷、群青、紺青、氧化鈦、氧化鋅之無機顏料類;可將表面進行處理之雲母鈦、魚燐箔、氧氯化鉍等之珠光劑類;可色澱化之紅色202號、紅色228 號、紅色226號、黃色4號、藍色404號、黃色5號、紅色505號、紅色230號、紅色223號、橙色201號、紅色213號、黃色204號、黃色203號、藍色1號、綠色201號、紫色201號、紅色204號等之有機色素類;聚甲基丙烯酸甲酯、耐綸粉末、有機聚矽氧烷彈性體等之有機粉體類;對胺基苯甲酸系紫外線吸收劑;鄰胺苯甲酸系紫外線吸收劑;水楊酸系紫外線吸收劑、肉桂酸系紫外線吸收劑、二苯甲酮系紫外線吸收劑;糖系紫外線吸收劑、2-(2’-羥基-5’-第三丁基辛苯基)苯并三唑、4-甲氧基-4’-第三丁基二苯甲醯基甲烷等之紫外線吸收劑類;乙醇、異丙醇等之低級醇類;維他命A或其衍生物、維他命B6鹽酸鹽、維他命B6三棕櫚酸酯、維他命B6二辛酸酯、維他命B2或其衍生物、維他命B12、維他命B15或其衍生物等之維他命B類;α-生育酚、β-生育酚、γ-生育酚、維他命E乙酸酯等之維他命E類、維他命D類、維他命H、泛酸、泛硫乙胺、吡咯并喹啉醌等之維他命類等;苯氧基乙醇等之抗菌劑等。 The skin cleansing agent of the present invention may contain, in addition to the above-mentioned components, any components generally used in external skin preparations. As such arbitrary ingredients, particularly exemplified examples include Australian walnut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower seed oil, cottonseed oil, jojoba oil, coconut oil, palm oil , Liquid lanolin, hardened coconut oil, hardened oil, wood wax, hardened castor oil, beeswax, candelilla wax, carnauba wax, insect wax, lanolin, reduced lanolin, hard lanolin, jojoba wax, etc. Oils, waxes; flowing paraffin, squalane, iso Hydrocarbons such as octadecane, ceresin, paraffin, mineral wax, petrolatum, microcrystalline wax, etc.; oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, ten Higher fatty acids such as monoenoic acid; higher alcohols such as cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetearyl alcohol, etc.; isooctanoic acid Cetyl ester, isopropyl myristate, cetyl isostearate, cetyl lactate, diisostearyl malate, ethylene glycol di-2-ethylhexanoate, neopentyl didecanoate Alcohol, glycerol di-2-heptyl undecanoate, glycerol tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triol Chains of synthetic ester oils such as isostearate, pentaerythritol tetra-2-ethylhexanoate, dimethyl polysiloxane, methylphenyl polysiloxane, diphenyl polysiloxane, etc. Polysiloxanes; cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecylcyclohexanesiloxane, etc.; amine-modified polysiloxane Alkanes, polyether modified polysiloxanes, alkyl modified polysiloxanes, fluorine modified polysiloxanes, modified polysiloxanes and other silicone oils; polyethylene glycol , Glycerin, 1,3-butanediol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerol, isopentanediol, 1,2-pentanediol Polyols such as alcohol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol, etc.; moisturizing components of sodium pyrrolidone carboxylate, lactic acid, sodium lactate, etc.; the surface can be classified Powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (silicon dioxide), aluminum oxide, barium sulfate, etc. that can be treated on the surface are iron red, yellow iron oxide, Inorganic pigments of black iron oxide, cobalt oxide, ultramarine, cyanine, titanium oxide, zinc oxide; pearlescent agents such as titanium mica, fish foil, bismuth oxychloride that can be treated on the surface; red color that can be laked No. 202, red 228 No., Red No. 226, Yellow No. 4, Blue No. 404, Yellow No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue 1 Organic pigments such as No., green No. 201, purple No. 201, red No. 204, etc.; organic powders such as polymethyl methacrylate, nylon powder, organic polysiloxane elastomer, etc.; p-aminobenzoic acid series UV absorbers; o-aminobenzoic acid-based UV absorbers; salicylic acid-based UV absorbers, cinnamic acid-based UV absorbers, benzophenone-based UV absorbers; sugar-based UV absorbers, 2-(2'-hydroxyl) -5'-tert-butyloctylphenyl)benzotriazole, 4-methoxy-4'-tert-butyldibenzoylmethane and other ultraviolet absorbers; ethanol, isopropanol, etc. Lower alcohols; vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, vitamin B15 or its derivatives, etc. Class B; Vitamin E of α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, etc., vitamin D, vitamin H, pantothenic acid, pantethine, pyrroloquinoline quinone, etc. Vitamins, etc.; antibacterial agents such as phenoxyethanol.
本發明的皮膚清潔劑,可藉由將上述各成分依據常法進行處理而製造。 The skin cleansing agent of the present invention can be manufactured by processing the above-mentioned components according to a conventional method.
本發明應用於洗面乳較佳。根據本發明,可提供一種在洗臉後不易感到肌膚之緊繃感的洗面乳。 The invention is preferably applied to facial cleanser. According to the present invention, it is possible to provide a facial cleanser that does not easily make the skin feel tight after washing the face.
解決第5課題的本發明之防曬化妝品的特徵為含有上述[1]~[4]的4種成分作為必要成分。以下對於[1]~[4]的成分詳述。 The sunscreen cosmetic of the present invention that solves the fifth problem is characterized by containing the above four components [1] to [4] as essential components. The components of [1] to [4] are detailed below.
成分(A)為將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的構成單元(以下有時也單純稱為「構成單元(7)」等)之一種或兩種以上作為必要構成單元含有的水溶性共聚物。 The component (A) is a structural unit derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) (hereinafter sometimes simply referred to as "constituent unit (7)", etc.) One or two or more water-soluble copolymers contained as essential constituent units.
再者,在本發明中,「自單體衍生的構成單元」,係指對應的單體具有之碳-碳不飽和鍵藉由聚合反應裂解而形成的構成單元。 Furthermore, in the present invention, "constituent unit derived from a monomer" refers to a constituent unit formed by cleaving a carbon-carbon unsaturated bond possessed by the corresponding monomer by a polymerization reaction.
以下對於通式(1)、(7)或(8)所示之疏水性單體進行說明。 Hereinafter, the hydrophobic monomer represented by the general formula (1), (7) or (8) will be described.
在前述通式(7)中,R14表示氫原子或碳數1~3的烷基,R15表示碳數13~30的未含有環結構之分支狀烴基、或未含有環結構的具有2個以上之分支的碳數6~12之烴基。 In the aforementioned general formula (7), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 represents a branched hydrocarbon group having 13 to 30 carbon atoms that does not contain a ring structure, or 2 that does not contain a ring structure. More than 6 branched hydrocarbon groups with 6 to 12 carbon atoms.
在此,作為R14所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R14為氫原子或甲基較佳。 Here, examples of the alkyl group represented by R 14 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 14 is preferably a hydrogen atom or a methyl group.
又,作為R15所示之碳數13~30的未含有環結構之分支狀烴基,可例示1-甲基十二基、11-甲基十二基、3-乙基十一基、3-乙基-4,5,6-三甲基辛基、1-甲基十三基、1-己基辛基、2-丁基癸基、2-己基辛基、4-乙基-1-異丁基辛基、1-甲基十五基、2-己基癸基、2-辛基癸基、2-己基十二基、16-甲基十七基、9-甲基十七基、7- 甲基-2-(3-甲基己基)癸基、3,7,11,15-四-甲基十六基、2-辛基十二基、2-癸基十四基、2-十二基十六基等。 In addition, as a branched hydrocarbon group having a ring structure of 13 to 30 carbon atoms represented by R 15 , 1-methyldodecyl, 11-methyldodecyl, 3-ethylundecyl, 3 -Ethyl-4,5,6-trimethyloctyl, 1-methyltridecyl, 1-hexyloctyl, 2-butyldecyl, 2-hexyloctyl, 4-ethyl-1- Isobutyloctyl, 1-methylpentadecyl, 2-hexyldecyl, 2-octyldecyl, 2-hexyldodecyl, 16-methylheptadecyl, 9-methylheptadecyl, 7-methyl-2-(3-methylhexyl)decyl, 3,7,11,15-tetra-methylhexadecyl, 2-octyldodecyl, 2-decyltetradecyl, 2 -Twelve bases and sixteen bases.
又,作為R15所示之未含有環結構的具有2個以上之分支的碳數6~12之烴基,可例示2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1,3-二甲基丁基、1,2,2-三甲基丙基、1,1-二甲基戊基、1-異丙基丁基、1-異丙基-2-甲基丙基、1,1-二乙基丙基、1-乙基-1-異丙基丙基、2-乙基-4-甲基戊基、1-丙基-2,2-二甲基丙基、1,1,2-三甲基-戊基、1-異丙基-3-甲基丁基、1,2-二甲基-1-乙基丁基、1,3-二甲基-1-乙基丁基、1-乙基-1-異丙基-丙基、1,1-二甲基己基、1-甲基-1-乙基戊基、1-甲基-1-丙基丁基、1,4-二甲基己基、1-乙基-3-甲基戊基、1,5-二甲基己基、1-乙基-6-甲基庚基、1,1,3,3-四甲基丁基、1,2-二甲基-1-異丙基丙基、3-甲基-1-(2,2-二甲基乙基)丁基、1-異丙基己基、3,5,5-三甲基己基、2-異丙基-5-甲基己基、1,5-二甲基-1-乙基己基、3,7-二甲基辛基、2,4,5-三甲基庚基、2,4,6-三甲基庚基、3,5-二甲基-1-(2,2-二甲基乙基)己基等。 In addition, examples of the hydrocarbon group having 6 or more carbon atoms and having 2 or more branches not containing a ring structure represented by R 15 include 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,3-dimethylbutyl, 1,2,2-trimethylpropyl, 1,1-dimethylpentyl, 1-isopropylbutyl, 1-isopropyl-2-methylpropyl, 1,1-diethylpropyl, 1-ethyl-1-isopropylpropyl, 2-ethyl-4-methylpentyl, 1- Propyl-2,2-dimethylpropyl, 1,1,2-trimethyl-pentyl, 1-isopropyl-3-methylbutyl, 1,2-dimethyl-1-ethyl Butyl, 1,3-dimethyl-1-ethylbutyl, 1-ethyl-1-isopropyl-propyl, 1,1-dimethylhexyl, 1-methyl-1-ethyl Amylpentyl, 1-methyl-1-propylbutyl, 1,4-dimethylhexyl, 1-ethyl-3-methylpentyl, 1,5-dimethylhexyl, 1-ethyl -6-methylheptyl, 1,1,3,3-tetramethylbutyl, 1,2-dimethyl-1-isopropylpropyl, 3-methyl-1-(2,2- Dimethylethyl)butyl, 1-isopropylhexyl, 3,5,5-trimethylhexyl, 2-isopropyl-5-methylhexyl, 1,5-dimethyl-1-ethyl Hexyl, 3,7-dimethyloctyl, 2,4,5-trimethylheptyl, 2,4,6-trimethylheptyl, 3,5-dimethyl-1-(2, 2-dimethylethyl)hexyl and so on.
在前述通式(1)及(8)中,R1、R16表示氫原子或碳數1~3的烷基,R2、R3、R17、R18、R19可相同亦可不同,且表示未含有環結構之具有分支的碳數6~22之醯基。X表示自三元醇脫附OH基的基。 In the aforementioned general formulas (1) and (8), R 1 and R 16 represent a hydrogen atom or a C 1-3 alkyl group, and R 2 , R 3 , R 17 , R 18 and R 19 may be the same or different , And represents a branched C 6-22 acyl group that does not contain a ring structure. X represents a group that desorbs the OH group from the triol.
在此,作為R1、R16所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R1為氫或甲基較佳。 Here, examples of the alkyl group represented by R 1 and R 16 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 1 is preferably hydrogen or methyl.
又,作為R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數6~22的醯基,可例示2-甲基戊醯基、3-甲基戊醯基、4-甲基戊醯基、2-乙基丁醯基、2-乙基丁醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、2-甲基己醯基、4-甲基己醯基、5-甲基己醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2-甲基庚醯基、2-乙基己基、2-丙基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、2-甲基辛醯基、3,3,5-三甲基己醯基、2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 In addition, examples of R 2 , R 3 , R 17 , R 18 , and R 19 that do not contain a ring structure and have branched C 6-22 acyl groups include 2-methylpentyl acyl and 3-methyl Pentylpentyl, 4-methylpentyl, 2-ethylbutyryl, 2-ethylbutyryl, 2,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2-methylhexyl , 4-methylhexyl, 5-methylhexyl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2-methylheptyl, 2-ethyl Hexyl, 2-propylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentyl, 2-methyloctyl, 3,3,5-trimethyl Hexamyl, 2-methylnonyl, 4-methylnonyl, 8-methylnonyl, 4-ethyloctyl, 2-ethyloctyl, 2-butylhexyl, 2- Tert-butylhexyl, 2,2-diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl, 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2- Butyloctyl, diethyloctyl, 2-third butyl-2,2,4-trimethylpentyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyl Yldodecyl, 11-methyldodecyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl -2-ethyloctyl, 12-methyltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-Dimethylhexyl, 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nineteen amide Base, 3,7,11,15-tetra-methylhexadecyl, 19-methyleicosyl, etc.
又,本發明之較佳的實施形態中,在通式(1)及(8)中,R2、R3、R17、R18、R19可相同亦可不同,且為未含有環結構的具有分支之碳數10~22的醯基、或未含有環結構的具有2個以上之分支的碳數6~9之醯基。 Moreover, in a preferred embodiment of the present invention, in the general formulas (1) and (8), R 2 , R 3 , R 17 , R 18 , and R 19 may be the same or different, and have no ring structure A branched carbon group with a carbon number of 10 to 22, or a ring group with no more than 2 branches and a carbon group with a carbon number of 6 to 9.
作為如此較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數10~22的醯基,可例示2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As such a preferred embodiment, R 2 , R 3 , R 17 , R 18 , and R 19 which do not contain a ring structure and have a branched C 10-22 acyl group may include 2-methylnonyl Group, 4-methylnonylyl group, 8-methylnonylyl group, 4-ethyloctylyl group, 2-ethyloctylyl group, 2-butylhexylyl group, 2-butylhexylyl group, 2-third butylhexylyl group, 2, 2-Diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl , 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2-butyloctyl, diethyloctyl, 2 -Third-butyl-2,2,4-trimethylpentylyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyldodecyl, 11-methyl Dodecanoyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl-2-ethyloctyl, 12-methyl Yltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-dimethylhexyl , 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nonadecyl, 3,7,11,15- Tetramethyl hexadecyl, 19-methyl eicosyl, etc.
又,作為較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有2個以上之分支的碳數6~9之醯基,可例示2,2-二甲基丁醯基、3,3-二甲基丁醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、3,5,5-三甲基己醯基等。 In addition, as a preferred embodiment, an acyl group having 6 to 9 carbon atoms having 2 or more branches and not containing a ring structure represented by R 2 , R 3 , R 17 , R 18 , and R 19 can be exemplified by 2 ,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentanyl, 3,5,5-trimethylhexyl, etc.
在通式(1)中,X所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可 適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (1), the group derived from triol represented by X is not particularly limited as long as it is a group from which the OH group is desorbed from the triol. A group exemplified by a trihydric alcohol selected from the group consisting of glycerin, trimethylolpropane, and trimethylolethane desorbs the OH group is suitably exemplified.
又,在通式(8)中,Y所示之自四元醇衍生的基,只要是自四元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含二丙三醇、季戊四醇、赤藻糖醇、D-蘇糖醇、L-蘇糖醇的群組之四元醇脫附OH基的基。 In addition, in the general formula (8), the group derived from a tetrahydric alcohol represented by Y is not particularly limited as long as it desorbs the OH group from the tetrahydric alcohol, and can be appropriately exemplified by The tetrahydric alcohol of the group of alcohol, pentaerythritol, erythritol, D-threitol, and L-threitol desorbs the OH group.
在本發明中,使用包含構成單元(1)的水溶性共聚物特佳。 In the present invention, it is particularly preferable to use a water-soluble copolymer containing the structural unit (1).
又,本發明之更佳的實施形態中,通式(1)所示的疏水性單體為上述通式(15)所示的疏水性單體。 In a more preferred embodiment of the present invention, the hydrophobic monomer represented by the general formula (1) is the hydrophobic monomer represented by the general formula (15).
通式(15)之R24、R25,較佳為未含有環結構之具有分支的碳數10~22之醯基。 R 24 and R 25 in the general formula (15) are preferably branched carbon groups having 10 to 22 carbon atoms without a ring structure.
通式(15)之R24、R25之醯基的碳數為12~22,更佳為14~20,特佳為16~20。 The carbon number of the acyl group of R 24 and R 25 in the general formula (15) is 12-22, more preferably 14-20, and particularly preferably 16-20.
又,通式(15)之R24、R25之醯基的主鏈之碳數,較佳為9~21,更佳為12~20,特佳為16~18。 In addition, the carbon number of the main chain of the acyl group of R 24 and R 25 in the general formula (15) is preferably 9 to 21, more preferably 12 to 20, and particularly preferably 16 to 18.
又,通式(15)之R24、R25之醯基的分支數,較佳為1~3,更佳為1或2,特佳為1。 In addition, the branch number of the acyl group of R 24 and R 25 in the general formula (15) is preferably 1 to 3, more preferably 1 or 2, and particularly preferably 1.
而且,在通式(15)之R24、R25之醯基中,分支鏈鍵結的主鏈之碳的位置編號越大越佳。具體而言,分支鏈較佳係以與自主鏈端部的第1~3個碳鍵結為較佳,更佳為第1或2個碳,特佳為第1個碳。 In addition, in the acyl group of R 24 and R 25 in the general formula (15), the larger the position number of the carbon of the main chain of the branch chain bonding, the better. Specifically, the branched chain is preferably bonded to the first to third carbons at the end of the autonomous chain, more preferably the first or second carbon, and particularly preferably the first carbon.
作為R24、R25,具體而言,可適當例示10-甲基十一醯基、10-甲基十二醯基、11-甲基十二醯基、 10-乙基十一醯基、12-甲基十三醯基、12-甲基十四醯基、14-甲基十五醯基、16-甲基十七醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As R 24 and R 25 , specifically, 10-methyl undecyl group, 10-methyl dodecyl group, 11-methyl dodecyl group, 10-ethyl undecyl group, 12-Methyltridecyl, 12-methyltetradecyl, 14-methylpentadecyl, 16-methylheptadecyl, 2,4,10,14-tetramethylpentyl , 18-methyl nineteen amide, 3,7,11,15-tetra-methyl hexadecyl, 19-methyl eicosyl, etc.
在通式(15)中,Z所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (15), the group derived from triol represented by Z is not particularly limited as long as it desorbs the OH group from the triol, and can be appropriately exemplified by a group selected from the group consisting of glycerol and triol. The trihydric alcohol of the group of methylolpropane and trimethylolethane desorbs the OH group.
作為構成成分(A)的水溶性共聚物之親水性單體,可使用聚合性羧酸、以及前述通式(2)、上述通式(9)、(10)及(11)所示的化合物。 As the hydrophilic monomer of the water-soluble copolymer constituting the component (A), a polymerizable carboxylic acid and compounds represented by the general formula (2), the general formulas (9), (10), and (11) can be used .
在本發明中,作為聚合性羧酸或其鹽,具體而言,可例示丙烯酸、甲基丙烯酸、巴豆酸、伊康酸、富馬酸及其鈉鹽、鉀鹽、銨鹽、胺鹽等。該等之中,從聚合性高之觀點,丙烯酸、甲基丙烯酸及其鹽特佳。在本發明的水溶性共聚物導入自聚合性的羧酸鹽衍生之構成單元時,可將聚合性羧酸預先製成鹽,進行聚合反應,亦可利用聚合反應,將自聚合性羧酸衍生之構成單元衍生為水溶性共聚物後,利用鹼中和而製成鹽。 In the present invention, specific examples of the polymerizable carboxylic acid or its salt include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, fumaric acid and its sodium, potassium, ammonium, and amine salts. . Among these, acrylic acid, methacrylic acid, and their salts are particularly preferred from the viewpoint of high polymerizability. When the water-soluble copolymer of the present invention is introduced into a structural unit derived from a polymerizable carboxylate, the polymerizable carboxylic acid may be prepared as a salt in advance to perform a polymerization reaction, or the polymerization reaction may be used to derive the self-polymerizable carboxylic acid After the constituent units are derived into water-soluble copolymers, they are made into salts by neutralization with alkali.
前述通式(2)中、R4表示氫原子或碳數1~3的烷基,R5表示可具有羥基之碳數2~4的伸烷基,R6表示氫原子、碳數6~10的芳香族烴基、碳數1~14的脂肪族烴基或碳數1~12的醯基。n表示6~40的整數。 In the aforementioned general formula (2), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents a hydrogen atom and a carbon atom having 6 to 6 carbon atoms The aromatic hydrocarbon group of 10, the aliphatic hydrocarbon group of 1 to 14 carbon atoms, or the acyl group of 1 to 12 carbon atoms. n represents an integer of 6~40.
作為在前述通式(2)中R4所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基。在本發明中,R4為氫原子或甲基較佳。 Examples of the alkyl group represented by R 4 in the general formula (2) include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 4 is preferably a hydrogen atom or a methyl group.
又,作為R5所示的伸烷基,可例示伸乙基、伸丙基、異伸丙基、2-羥基伸丙基、2-羥基-2-甲基伸乙基、2-羥基-1-甲基伸乙基等,該等之中,較佳為伸乙基或伸丙基,更佳為伸乙基。 In addition, as the alkylene group represented by R 5 , ethyl group, ethyl group, isopropyl group, 2-hydroxypropyl group, 2-hydroxy-2-methyl ethyl group, 2-hydroxy- 1-methylethylidene, etc. Among these, ethylidene or propylidene are preferred, and ethylidene is more preferred.
又,R6所示的基中,作為碳數6~10的芳香族基,可例示苯基、苯甲基、甲苯基、乙苯基等;作為碳數1~14的脂肪族烴基,可適當例示甲基、乙基、丁基、第三丁基、己基、環己基、辛基、2-乙基己基、月桂基等;作為碳數1~12的醯基,可適當例示甲醯基、乙醯基、丙醯基、丁醯基、異丁醯基、戊醯基、月桂醯基等。該等之中,作為R5所示的基,較佳為碳數1~14的脂肪族烴基,更佳為碳數1~12的烷基。 In addition, among the groups represented by R 6 , examples of the aromatic groups having 6 to 10 carbon atoms include phenyl, benzyl, tolyl, and ethylphenyl groups. As the aliphatic hydrocarbon groups having 1 to 14 carbon atoms, Appropriate examples include methyl, ethyl, butyl, tertiary butyl, hexyl, cyclohexyl, octyl, 2-ethylhexyl, lauryl, etc.; as a C 1-12 acyl group, a methyl acyl group can be appropriately exemplified. , Acetyl, propyl, butyl, isobutyl, pentyl, lauryl, etc. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
而且,通式(2)之n為6~40的數值範圍。 Furthermore, n in the general formula (2) is in the range of 6 to 40.
前述通式(2)所示的單體中,作為R5為伸丙基之單體,具體而言,可舉出聚丙二醇(9)單丙烯酸酯、聚丙二醇(13)單丙烯酸酯、聚丙二醇(9)單甲基丙烯酸酯、聚丙二醇(13)單甲基丙烯酸酯等。再者,括弧內的數字表示N。該等之聚合物大多可作為市售品取得。作為該等市售品,具體而言,可例示商品名「Blenmer」AP-400、AP-550、AP-800、PP-500、PP-800(均為日本油脂(股)製)等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is propylene, specifically, polypropylene glycol (9) monoacrylate, polypropylene glycol (13) monoacrylate, poly Propylene glycol (9) monomethacrylate, polypropylene glycol (13) monomethacrylate, etc. Furthermore, the number in parentheses indicates N. Most of these polymers are available as commercial products. Specific examples of these commercially available products include trade names "Blenmer" AP-400, AP-550, AP-800, PP-500, and PP-800 (all manufactured by Nippon Oil & Fats Co., Ltd.).
前述通式(2)所示的單體中,作為R5為伸乙基之單體,具體而言,可舉出聚乙二醇(10)單丙烯酸酯、聚乙二醇(8)單甲基丙烯酸酯、聚乙二醇(23)單丙烯酸酯、聚乙二醇(23)單甲基丙烯酸酯、甲氧基聚乙二醇(9)丙烯酸酯、甲氧基聚乙二醇(9)甲基丙烯酸酯、甲氧基聚乙二醇(23)甲基丙烯酸酯、油氧基聚乙二醇(18)甲基丙烯酸酯、月桂氧基聚乙二醇(18)丙烯酸酯、月桂醯氧基聚乙二醇(10)甲基丙烯酸酯、硬脂氧基聚乙二醇(30)單甲基丙烯酸酯等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is an ethylidene group, specifically, polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomer Methacrylate, polyethylene glycol (23) monoacrylate, polyethylene glycol (23) monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol ( 9) Methacrylate, methoxypolyethylene glycol (23) methacrylate, oleyloxy polyethylene glycol (18) methacrylate, lauryloxy polyethylene glycol (18) acrylate, Lauryloxy polyethylene glycol (10) methacrylate, stearyl polyethylene glycol (30) monomethacrylate, etc.
上述親水性單體,可藉由對應的聚乙二醇、聚乙二醇單醚、聚乙二醇單酯與丙烯酸或甲基丙烯酸之氯化物或酐之酯化反應而以高產率得到。又,因為已存在很多市售品,所以也可利用該市售品。作為如此市售品,具體而言,可例示商品名Blenmer、AE-400、PE-350、AME-400、PME-400、PME-1000、ALE-800、PSE-1300(均為日本油脂(股)製)等。 The above-mentioned hydrophilic monomers can be obtained in a high yield by esterification reaction of corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester with acrylic acid or methacrylic acid chloride or anhydride. In addition, since many commercial products already exist, the commercial products can also be used. As such a commercially available product, specifically, the trade names of Blenmer, AE-400, PE-350, AME-400, PME-400, PME-1000, ALE-800, and PSE-1300 (all of which are Japanese oil ) System) etc.
作為本發明的親水性單體,亦可使用上述通式(9)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the above general formula (9) can also be used.
作為前述通式(9)所示的親水性單體,具體而言,可舉出2-丙烯醯氧基乙基磷酸膽鹼(APC)、2-甲基丙烯醯氧乙基磷酸膽鹼(MPC)。該等之單體,例如,可利用Polymer Journal,Vol22,No.5記載之以下的方法合成。 Specific examples of the hydrophilic monomer represented by the general formula (9) include 2-acryloyloxyethyl phosphate choline (APC) and 2-methacryloyloxyethyl phosphate choline ( MPC). Such monomers can be synthesized by the following method described in Polymer Journal, Vol22, No. 5, for example.
使二氯化2-溴乙基磷醯與甲基丙烯酸2-羥乙酯或丙烯酸2-羥乙酯反應,得到2-甲基丙烯醯氧乙基-2‘-溴乙基磷酸或2-丙烯醯氧乙基-2‘-溴乙基磷酸後,將該等化合物與三乙胺於甲醇中進行反應。 Reacting 2-bromoethylphosphoryl dichloride with 2-hydroxyethyl methacrylate or 2-hydroxyethyl acrylate to obtain 2-methacryloxyethyl-2'-bromoethyl phosphoric acid or 2- After acryloyloxyethyl-2'-bromoethyl phosphoric acid, these compounds are reacted with triethylamine in methanol.
作為本發明的親水性單體,亦可使用上述通式(10)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the above general formula (10) can also be used.
在通式(10)所示的親水性單體中,作為G-O-所示的自還原糖之1位的羥基除去氫的基之還原糖,具體而言,可例示選自於包含葡萄糖、甘露糖、半乳糖、阿拉伯糖、木糖、核糖等之單糖、麥芽糖、乳糖、纖維雙糖等之雙糖、麥芽三糖等之三糖、麥芽寡糖等之寡糖的群組之一種或兩種以上,其中尤以選自於包含葡萄糖、半乳糖、阿拉伯糖、木糖、核糖、麥芽糖、乳糖、纖維雙糖的群組之一種或兩種以上較佳,葡萄糖特佳。又,作為通式(10)所示的單體,甲基丙烯酸葡萄糖基氧乙酯(以下省略為GEMA)或丙烯酸葡萄糖基氧乙酯(以下省略為GEA)較佳。 Among the hydrophilic monomers represented by the general formula (10), the reducing sugar that is a group that removes hydrogen from the hydroxyl group at the 1-position of the reducing sugar represented by GO- can be specifically selected from the group consisting of glucose and mannose. Groups of monosaccharides such as sugar, galactose, arabinose, xylose, ribose, disaccharides such as maltose, lactose, cellobiose, trisaccharides such as maltotriose, and oligosaccharides such as maltooligosaccharide One or two or more, among which one or two or more selected from the group consisting of glucose, galactose, arabinose, xylose, ribose, maltose, lactose, and cellobiose is preferred, and glucose is particularly preferred. Further, as the monomer represented by the general formula (10), glucosyloxyethyl methacrylate (hereinafter abbreviated as GEMA) or glucosyloxyethyl acrylate (hereinafter abbreviated as GEA) is preferred.
作為本發明的親水性單體,亦可使用上述通式(11)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the above general formula (11) can also be used.
在通式(11)的單體中,作為R23所示之胺基酸殘基的胺基酸,只要是通常已知的胺基酸,則沒有特別限定,具體而言,可例示甘胺酸、丙胺酸、麩胺酸、 離胺酸、精胺酸等。該等之中,因為得到的水溶性共聚物之皮膚屏障的恢復效果佳,所以以離胺酸殘基為特佳。 In the monomer of the general formula (11), the amino acid as the amino acid residue represented by R 23 is not particularly limited as long as it is a generally known amino acid, and specifically, glycine can be exemplified. Acid, alanine, glutamic acid, lysine, spermine, etc. Among these, since the skin barrier effect of the water-soluble copolymer obtained is good, ionic acid residues are particularly preferable.
又,R23所示的多胺殘基之多胺,意指在同一分子內具有可以烷基取代之胺基2個以上的胺,具體而言,可例示二胺、三胺、四胺或該等之胺基的氫原子被烷基取代的胺。該等之中,從含有得到的水溶性共聚物之皮膚外用劑的使用感特佳之觀點,二胺較佳,作為特佳的具體例,從合成之際的原料取得之容易度的觀點,可舉出乙二胺、1,4-二胺基-正丁烷、1,6-二胺基-正己烷等。 In addition, the polyamine of the polyamine residue represented by R 23 means an amine having two or more amine groups that can be substituted with an alkyl group in the same molecule. Specifically, a diamine, triamine, tetraamine or An amine in which the hydrogen atom of the amine group is substituted with an alkyl group. Among these, from the viewpoint of excellent use of skin external preparations containing the obtained water-soluble copolymer, diamine is preferable, and as a particularly preferable specific example, from the viewpoint of ease of obtaining raw materials at the time of synthesis, Examples include ethylenediamine, 1,4-diamino-n-butane, 1,6-diamino-n-hexane, and the like.
而且,作為R23所示之胺醇殘基的胺醇,意指在同一分子內具有可以烷基取代之胺基及醇式羥基的化合物。作為胺醇,只要是通常已知者,則沒有特別限定,作為具體例,可例示乙醇胺、三乙胺基乙醇等。 The amine alcohol as the amine alcohol residue represented by R 23 means a compound having an alkyl-substituted amine group and an alcoholic hydroxyl group in the same molecule. The amino alcohol is not particularly limited as long as it is generally known, and specific examples include ethanolamine, triethylaminoethanol, and the like.
作為通式(11)所示之單體的鹽,沒有特別限定,具體而言,可例示將酸部分以鹼中和的鈉鹽、鉀鹽、銨鹽、胺鹽等,或者,將胺基部分以酸中和的鹽酸鹽、硫酸鹽、硝酸鹽、磷酸鹽、檸檬酸鹽、草酸鹽、碳酸鹽等。在本發明的水溶性共聚物導入自通式(11)所示的單體鹽衍生之構成單元時,可將通式(11)所示的單體預先製成鹽,進行聚合反應,亦可利用聚合反應,將自通式(11)所示的單體衍生之構成單元衍生為水溶性共聚物後,中和而製成鹽。 The salt of the monomer represented by the general formula (11) is not particularly limited, and specifically, there can be exemplified sodium salts, potassium salts, ammonium salts, amine salts and the like neutralized with an acid moiety, or Partially acid neutralized hydrochloride, sulfate, nitrate, phosphate, citrate, oxalate, carbonate, etc. When the water-soluble copolymer of the present invention is introduced into the structural unit derived from the monomer salt represented by the general formula (11), the monomer represented by the general formula (11) may be prepared as a salt in advance to perform a polymerization reaction, or Using a polymerization reaction, the structural unit derived from the monomer represented by the general formula (11) is derived as a water-soluble copolymer, and then neutralized to form a salt.
通式(11)所示的單體,作為其鹽的具體例,可適當例示化合物1~11及其鹽。 As a specific example of the salt of the monomer represented by the general formula (11), compounds 1 to 11 and salts thereof can be appropriately exemplified.
通式(11)所示的親水性單體,例如,如前述反應式(1)及(2)所示,可藉由使用(甲基)丙烯酸、(甲基)丙烯醯氯的酯化反應、醯胺化反應而合成。 The hydrophilic monomer represented by the general formula (11), for example, as shown in the aforementioned reaction formulas (1) and (2), can be obtained by an esterification reaction using (meth)acrylic acid or (meth)acryloyl chloride , Amidation reaction synthesis.
如上述,在本發明中作為親水性聚合物,可使用前述通式(2)、(9)、(10)、及(11)。 As described above, in the present invention, as the hydrophilic polymer, the aforementioned general formulas (2), (9), (10), and (11) can be used.
本發明之較佳的實施形態中,水溶性共聚物係包含自前述通式(2)衍生的構成單元(2)。 In a preferred embodiment of the present invention, the water-soluble copolymer contains the structural unit (2) derived from the aforementioned general formula (2).
在本發明中,尤能適用具有構成單元(1)與構成單元(2)的水溶性共聚物。又,更佳可使用具有構成單元(15)與構成單元(2)的水溶性共聚物。 In the present invention, a water-soluble copolymer having a structural unit (1) and a structural unit (2) is particularly applicable. Furthermore, it is more preferable to use a water-soluble copolymer having a structural unit (15) and a structural unit (2).
如此水溶性共聚物中,特佳可使用(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物。 Among such water-soluble copolymers, (methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer can be particularly preferably used.
藉由含有如此水溶性共聚物,可成為低刺激且黏膩感少,乳化安定性佳的乳化組成物。 By containing such a water-soluble copolymer, it can be an emulsified composition with low irritation, less stickiness, and excellent emulsification stability.
(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物,作為構成單元(g),主要包含自前述通式(15)所示的疏水性單體中,R24、R25為16-甲基十七醯基之疏水性單體衍生的構成單元(g)。 (Methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer, as the constituent unit (g), mainly contained in the hydrophobic monomer represented by the general formula (15), R 24 and R 25 are structural units (g) derived from a hydrophobic monomer of 16-methylheptadecyl group.
又,作為構成單元(h),主要包含自前述通式(2)所示的親水性單體中,R4為甲基,R5為伸乙基,R6為甲基,n為23之親水性單體衍生的構成單元(h)。 Moreover, as a structural unit (h), it is mainly comprised from the hydrophilic monomer represented by the said general formula (2), R 4 is a methyl group, R 5 is an ethyl group, R 6 is a methyl group, and n is 23 The constituent unit (h) derived from a hydrophilic monomer.
在本發明中,水溶性共聚物之構成單元(g)在全構成單元所佔之比例,較佳為1~50質量%,更佳為5~40質量%、10~30質量%。 In the present invention, the proportion of the structural units (g) of the water-soluble copolymer in all the structural units is preferably 1 to 50% by mass, more preferably 5 to 40% by mass, and 10 to 30% by mass.
藉由使水溶性共聚物之構成單元(g)所佔之比例成為前述範圍,可提供保濕感佳,黏膩感進一步減低之防曬化妝品。 By setting the proportion of the constitutional unit (g) of the water-soluble copolymer within the aforementioned range, it is possible to provide sunscreen cosmetics having a good moisturizing feeling and further reducing the stickiness.
在本發明中,水溶性共聚物之構成單元(h)在全構成單元所佔之比例,較佳為50~99質量%,更佳為60~95質量%、70~90質量%。 In the present invention, the proportion of the constituent units (h) of the water-soluble copolymer in all constituent units is preferably 50 to 99% by mass, more preferably 60 to 95% by mass, and 70 to 90% by mass.
藉由使水溶性共聚物之構成單元(h)所佔之比例成為前述範圍,可提供保濕感佳,黏膩感進一步減低之防曬化妝品。 By making the proportion of the structural unit (h) of the water-soluble copolymer within the aforementioned range, it is possible to provide sunscreen cosmetics with good moisturizing feeling and further reducing stickiness.
在本發明中,構成水溶性共聚物之構成單元(g)與構成單元(h)的質量比,較佳為5:95~50:50,進一步較佳為10:90~45:55,更佳為20:80~40:60,特佳為25:75~35:65。 In the present invention, the mass ratio of the structural unit (g) and the structural unit (h) constituting the water-soluble copolymer is preferably 5:95 to 50:50, further preferably 10:90 to 45:55, and more The best is 20:80~40:60, and the best is 25:75~35:65.
又,構成水溶性共聚物之構成單元(g)與構成單元(h)的莫耳比,較佳為8:92~62:38,進一步較佳為15:85~57:43,更佳為29:71~52:48,特佳為35:65~46:54。 Moreover, the molar ratio of the structural unit (g) and the structural unit (h) constituting the water-soluble copolymer is preferably 8:92 to 62:38, further preferably 15:85 to 57:43, and more preferably 29:71~52:48, especially good is 35:65~46:54.
藉由使水溶性共聚物的構成單元(g)及構成單元(h)之質量比及莫耳比成為前述範圍,可進一步提升防曬化妝品的使用感。 By setting the mass ratio and the molar ratio of the constitutional unit (g) and constitutional unit (h) of the water-soluble copolymer to the aforementioned range, the sense of use of the sunscreen cosmetics can be further improved.
在本發明中,水溶性共聚物之平均分子量,較佳為20000~110000,進一步較佳為20000~80000,更佳為30000~80000,進一步更佳為40000~70000,特佳為50000~70000,進一步特佳為57000~66000。 In the present invention, the average molecular weight of the water-soluble copolymer is preferably from 20,000 to 110,000, further preferably from 20,000 to 80,000, more preferably from 30,000 to 80,000, even more preferably from 40,000 to 70,000, and particularly preferably from 50,000 to 70,000. Further particularly preferred is 57000~66000.
上述水溶性共聚物的含量,並沒有特別限定,通常為0.001~15質量%,較佳為0.01~10質量%。 The content of the water-soluble copolymer is not particularly limited, but it is usually 0.001 to 15% by mass, preferably 0.01 to 10% by mass.
本發明的防曬化妝品,其特徵為包含聚合度為10之聚丙三醇1分子與碳數16以上之脂肪酸2~5分子酯縮合而成之聚丙三醇脂肪酸酯作為成分(B)。 The sunscreen cosmetic of the present invention is characterized by comprising as a component (B) a polyglycerol fatty acid ester formed by condensing 1 molecule of polyglycerol with a polymerization degree of 10 and 2 to 5 molecules of fatty acid esters having a carbon number of 16 or more.
構成成分(B)的聚丙三醇脂肪酸酯之碳數16以上的脂肪酸,可具有分支鏈,而且,可為飽和亦可為不飽和。 The polyglycerin fatty acid ester constituting the component (B) may have a branched chain fatty acid having a carbon number of 16 or more, and may be saturated or unsaturated.
尤可例示油酸及異硬脂酸。 Especially exemplified oleic acid and isostearic acid.
又,在聚丙三醇1分子酯鍵結的脂肪酸之分子數為2~5即可,較佳為5分子。 In addition, the number of molecules of fatty acid ester-bonded to 1 molecule of polyglycerin may be 2 to 5, preferably 5 molecules.
在本發明中,尤可使用五硬脂酸聚丙三醇酯-10作為成分(B)。 In the present invention, polyglycerol pentastearate-10 can be particularly used as component (B).
成分(B)之聚丙三醇脂肪酸酯的含量,通常可設為0.1~10質量%。 The content of the polyglycerin fatty acid ester of the component (B) can be generally 0.1 to 10% by mass.
又,從乳化安定性之提升的觀點,成分(B)之含量為0.3質量%以上,更佳為0.5質量%,特佳為成為0.7質量%以上。 From the viewpoint of improving the stability of emulsification, the content of component (B) is 0.3% by mass or more, more preferably 0.5% by mass, and particularly preferably 0.7% by mass or more.
而且,從黏膩感之抑制的觀點,成分(B)之含量,較佳為7質量%以下,更佳為5質量%以下,特佳為成為3質量%以下。 Furthermore, from the viewpoint of suppression of stickiness, the content of component (B) is preferably 7 mass% or less, more preferably 5 mass% or less, and particularly preferably 3 mass% or less.
本發明的防曬化妝品,係包含離子性界面活性劑作為成分(C)。作為離子性界面活性劑,只要為使 用於化妝品者,則沒有特別限定,可使用陰離子性界面活性劑、陽離子性界面活性劑及兩性界面活性劑之任一者。 The sunscreen cosmetic of the present invention contains an ionic surfactant as component (C). As an ionic surfactant, as long as For cosmetics, it is not particularly limited, and any of anionic surfactants, cationic surfactants, and amphoteric surfactants can be used.
作為陰離子性界面活性劑,尤能例示例如,脂肪酸鈉、脂肪酸鉀、脂肪酸三乙醇胺等之脂肪酸皂、可具有聚氧乙烯基之月桂基硫酸鈉、月桂基硫酸鉀、月桂基硫酸三乙醇胺等之可具有聚氧乙烯基之烷基硫酸酯鹽、醯基乳酸鹽、可具有聚氧乙烯基之月桂基磷酸鈉、月桂基磷酸鉀、月桂基磷酸三乙醇胺等之可具有聚氧乙烯基之烷基磷酸酯鹽、磺琥珀酸烷酯鹽等。 As anionic surfactants, specific examples include fatty acid soaps such as sodium fatty acid, potassium fatty acid, and fatty acid triethanolamine, sodium lauryl sulfate, potassium lauryl sulfate, and triethanolamine lauryl sulfate, which may have polyoxyethylene groups. Alkyl sulfate which may have polyoxyethylene alkyl sulfate salt, acyl lactylate, sodium lauryl phosphate which may have polyoxyethylene, potassium lauryl phosphate, triethanolamine lauryl phosphate, etc. Phosphate salt, alkyl sulfosuccinate, etc.
作為陽離子性界面活性劑,尤可例示例如,烷基三甲基銨鹽、烷基吡啶鹽、氯化二硬脂基二甲基銨二烷基二甲基銨鹽、氯化聚(N,N’-二甲基-3,5-亞甲基哌啶)、烷基四級銨鹽、烷基二甲基苯甲基銨鹽、烷基異喹啉鹽、二烷基嗎啉鹽、POE-烷胺、烷基胺鹽、多胺脂肪酸衍生物、戊醇脂肪酸衍生物、氯化苯二甲烴銨、苄索氯銨等。 As cationic surfactants, particularly exemplified examples are alkyl trimethyl ammonium salt, alkyl pyridine salt, distearyl dimethyl ammonium chloride dialkyl dimethyl ammonium salt, chlorinated poly(N, N'-dimethyl-3,5-methylenepiperidine), alkyl quaternary ammonium salt, alkyl dimethyl benzyl ammonium salt, alkyl isoquinoline salt, dialkyl morpholine salt, POE-alkylamine, alkylamine salt, polyamine fatty acid derivative, pentanol fatty acid derivative, xylylenediamine chloride, benzethonium chloride, etc.
作為兩性界面活性劑,可舉出咪唑啉系兩性界面活性劑、甜菜鹼系界面活性劑等。 Examples of amphoteric surfactants include imidazoline-based amphoteric surfactants and betaine-based surfactants.
上述界面活性劑中,作為成分(C),使用陰離子性界面活性劑較佳,並且使用醯基乳酸鹽較佳。 Among the above-mentioned surfactants, as the component (C), it is preferable to use an anionic surfactant, and it is preferable to use an acyl lactate.
作為醯基乳酸鹽,鈉鹽較佳,具體而言,尤可例示月桂醯基乳酸鈉、異硬脂醯基乳酸鈉、硬脂醯基乳酸鈉等。 As the sodium lactate, sodium salt is preferred, and specifically, sodium lauryl lactate, isostearyl sodium lactate, sodium stearyl lactylate and the like are particularly exemplified.
離子性界面活性劑的含量,沒有特別限定,通常為0.01~2.0質量%,更佳為0.1~1質量%。 The content of the ionic surfactant is not particularly limited, but it is usually 0.01 to 2.0% by mass, more preferably 0.1 to 1% by mass.
又,從乳化安定性之提升的觀點,離子性界面活性劑的含量,較佳為0.05質量%以上,更佳為0.07質量%以上,特佳為成為0.1質量%以上。 From the viewpoint of improving the stability of emulsification, the content of the ionic surfactant is preferably 0.05% by mass or more, more preferably 0.07% by mass or more, and particularly preferably 0.1% by mass or more.
而且,從黏膩感之抑制的觀點,離子性界面活性劑的含量,較佳為1.5質量%以下,更佳為1質量%以下,特佳為成為0.5質量%以下。 Furthermore, from the viewpoint of suppression of stickiness, the content of the ionic surfactant is preferably 1.5% by mass or less, more preferably 1% by mass or less, and particularly preferably 0.5% by mass or less.
本發明的防曬化妝品,係包含紫外線散射劑及/或紫外線吸收劑作為成分(D)。 The sunscreen cosmetic of the present invention contains an ultraviolet scattering agent and/or an ultraviolet absorbent as component (D).
紫外線散射劑係指有使紫外線散射之作用的微粒金屬氧化物,且只要為可摻合於乳化型化妝品者,其種類沒有特別限定。作為金屬氧化物,可舉出二氧化鈦、氧化鋅、氧化鋯、氧化鈰等。 The ultraviolet scattering agent refers to a fine-grained metal oxide that has an effect of scattering ultraviolet rays, and as long as it can be blended into an emulsified cosmetic, its type is not particularly limited. Examples of metal oxides include titanium dioxide, zinc oxide, zirconium oxide, and cerium oxide.
紫外線散射劑的含量,沒有特別限定,通常為0.01~20質量%,更佳為0.1~15質量%,特佳為1~10質量%。 The content of the ultraviolet scattering agent is not particularly limited, but it is usually 0.01 to 20% by mass, more preferably 0.1 to 15% by mass, and particularly preferably 1 to 10% by mass.
紫外線散射劑為具有在該技術領域中稱為微粒之粒子徑者,例如,利用電子顯微鏡觀察之一級粒徑,通常為5nm以上,較佳為10nm以上,而且通常為100nm以下,較佳為80nm以下者。 The ultraviolet scattering agent has a particle diameter called fine particles in the technical field. For example, the first-order particle size observed with an electron microscope is usually 5 nm or more, preferably 10 nm or more, and usually 100 nm or less, preferably 80 nm The following.
本發明所使用的紫外線散射劑,從紫外線散射效果佳之觀點,包含選自於含有微粒二氧化鈦、及微粒氧化鋅的群組之至少1種較佳。 It is preferable that the ultraviolet scattering agent used in the present invention contains at least one selected from the group consisting of particulate titanium dioxide and particulate zinc oxide from the viewpoint of excellent ultraviolet scattering effect.
本發明所使用的紫外線散射劑,可藉由將該金屬鹽於氣相中熱分解等之常法而製備,但因為也存在很多市售品,所以也可直接使用市售品。作為如此市售品,具體而言,作為微粒二氧化鈦,可舉出「MTY-110M3S」(Tayca(股)製)、「MTY-02」(Tayca(股)製)、「MT-100TV」(Tayca(股)製)、「MT-500HSA」(Tayca(股)製)、「MT-100T」(Tayca(股)製)、「MT-01」(Tayca(股)製)、「MT-10EX」(Tayca(股)製)、「MT-05」(Tayca(股)製)、「MT-100Z」(Tayca(股)製)、「MT-150EX」(Tayca(股)製)、「MT-100AQ」(Tayca(股)製)、「MT-100WP」(Tayca(股)製)、「MT-100SA」(Tayca(股)製)、「MT-500B」(Tayca(股)製)、「MT-500SA」(Tayca(股)製)、「MT-600B」(Tayca(股)製)、「MT-500SAS」(Tayca(股)製)、「TIPAQUE CR-50」(石原產業(股)製)、「TIPAQUE TTO-M-1」(石原產業(股)製)、「TIPAQUE TTO-V4」(石原產業(股)製)、「ST-455」(Titan Kogyo(股)製)、「STT-65C-S」(Titan Kogyo(股)製)、「STT-30EHS」(Titan Kogyo(股)製)、「Bayer Titan R-KB-1」(拜耳公司製)等。 The ultraviolet scattering agent used in the present invention can be prepared by a common method such as thermal decomposition of the metal salt in the gas phase, but since there are many commercial products, commercial products can also be used directly. As such a commercially available product, specifically, as fine particle titanium dioxide, "MTY-110M3S" (made by Tayca), "MTY-02" (made by Tayca), and "MT-100TV" (Tayca) (Share system), ``MT-500HSA'' (Tayca (share) system), ``MT-100T'' (Tayca (share) system), ``MT-01'' (Tayca (share) system), ``MT-10EX'' (Tayca (share) system), ``MT-05'' (Tayca (share) system), ``MT-100Z'' (Tayca (share) system), ``MT-150EX'' (Tayca (share) system), ``MT- 100AQ'' (Tayca (share) system), ``MT-100WP'' (Tayca (share) system), ``MT-100SA'' (Tayca (share) system), ``MT-500B'' (Tayca (share) system), `` MT-500SA (Tayca (share) system), MT-600B (Tayca (share) system), MT-500SAS (Tayca (share) system), TIPAQUE CR-50 (Ishihara Industries (share) System), ``TIPAQUE TTO-M-1'' (Ishihara Industry Co., Ltd. system), ``TIPAQUE TTO-V4'' (Ishihara Industry Co., Ltd. system), ``ST-455'' (Titan Kogyo Co., Ltd. system), `` "STT-65C-S" (Titan Kogyo Co., Ltd.), "STT-30EHS" (Titan Kogyo Co., Ltd.), "Bayer Titan R-KB-1" (Bayer Co., Ltd.), etc.
又,作為微粒氧化鋅,可舉出「MZ-300」(Tayca(股)製)、「MZY-303S」(Tayca(股)製)、「MZ-306X」(Tayca(股)製)、「MZ-500」(Tayca(股)製)、「MZY-505S」(Tayca(股)製)、「MZ-506X」(Tayca(股)製)、「MZ-510HPSX」(Tayca(股)製)、「WSX-MZ-700」(Tayca(股)製)、「SAMT-UFZO-450」(三好化成(股)製)、「SAMT-UFZO-500」(三好化成(股)製)、「FZO-50」(石 原產業(股)製)、「Maxlight ZS-032」(昭和電工(股)製)、「Maxlight ZS-032」(昭和電工(股)製)等。 In addition, as fine particulate zinc oxide, "MZ-300" (made by Tayca Corporation), "MZY-303S" (made by Tayca Corporation), "MZ-306X" (made by Tayca Corporation), and " MZ-500'' (Tayca (share) system), ``MZY-505S'' (Tayca (share) system), ``MZ-506X'' (Tayca (share) system), ``MZ-510HPSX'' (Tayca (share) system) , "WSX-MZ-700" (Tayca (share) system), "SAMT-UFZO-450" (Miyoshi Chemical (share) system), "SAMT-UFZO-500" (Miyoshi Chemical (share) system), "FZO -50" (Stone The original industry (share system), "Maxlight ZS-032" (Showa Denko (share) system), "Maxlight ZS-032" (Showa Denko (share) system), etc.
在本發明中,紫外線散射劑係其表面利用二氧化矽、氧化鋁等之無機化合物、或聚丙烯酸鈉、脂肪酸金屬皂、矽酮等之有機化合物被覆較佳。 In the present invention, the ultraviolet scattering agent is preferably coated with an inorganic compound such as silica or alumina, or an organic compound such as sodium polyacrylate, fatty acid metal soap, or silicone.
紫外線散射劑為水分散性較佳。因為水分散性之紫外線散射劑均勻地分散於水相,所以如此形態的本發明之防曬化妝品,其紫外線防禦機能佳。 The ultraviolet scattering agent has better water dispersibility. Because the water-dispersible ultraviolet scattering agent is uniformly dispersed in the water phase, the sunscreen cosmetic of the present invention in such a form has a good ultraviolet defense function.
作為水分散性的紫外線散射劑,尤可例示表面藉由親水性之化合物被覆的紫外線散射劑。 As the water-dispersible ultraviolet scattering agent, an ultraviolet scattering agent whose surface is coated with a hydrophilic compound is particularly exemplified.
作為如此水分散性的紫外線散射劑,利用聚丙烯酸鈉進行表面處理的紫外線散射劑較佳。包含利用聚丙烯酸鈉進行表面處理的紫外線散射劑作為成分(D)之本發明的防曬化妝品,其分散性優異,且紫外線防禦機能佳。 As such a water-dispersible ultraviolet scattering agent, an ultraviolet scattering agent surface-treated with sodium polyacrylate is preferred. The sunscreen cosmetic of the present invention containing the ultraviolet scattering agent surface-treated with sodium polyacrylate as the component (D) has excellent dispersibility and excellent ultraviolet defense function.
作為紫外線吸收劑,只要為可摻合於通常乳化型化妝品的紫外線吸收劑,則沒有特別限定,但為了吸收寬廣的波長之紫外線,包含吸收320~400nm波長(A區域)之紫外線的UV-A吸收劑、及吸收290~320nm波長(B區域)之紫外線的UV-B吸收劑較佳。 The ultraviolet absorber is not particularly limited as long as it can be blended into general emulsified cosmetics, but in order to absorb ultraviolet light of a wide wavelength, it includes UV-A that absorbs ultraviolet light of a wavelength of 320 to 400 nm (A region) An absorber and a UV-B absorber that absorbs ultraviolet rays with a wavelength of 290 to 320 nm (B region) are preferred.
紫外線吸收劑的含量,沒有特別限定,通常為0.01質量%以上,較佳為0.1質量%以上,更佳為1質量%以上,而且,通常為20質量%以下,較佳為15質量%以下,更佳為10質量%以下。 The content of the ultraviolet absorber is not particularly limited, but it is usually 0.01% by mass or more, preferably 0.1% by mass or more, more preferably 1% by mass or more, and usually 20% by mass or less, preferably 15% by mass or less, More preferably, it is 10 mass% or less.
作為UV-A吸收劑,可例示2-羥基-4-甲氧基二苯甲酮、2-(2’-羥基-5’-甲苯基)苯并三唑、二甲氧基 苯亞甲基二側氧基咪唑啶丙酸2-乙基己酯、雙(雷瑣酸)三、亞甲基雙苯并三唑基四甲基丁酚、二乙基胺基羥基苯甲醯基苯甲酸己酯、第三丁基甲氧基二苯甲醯基甲烷等之化合物。其中,從紫外線吸收能佳之觀點,尤以二乙基胺基羥基苯甲醯基苯甲酸己酯、及第三丁基甲氧基二苯甲醯基甲烷特佳。因為該等之化合物中存在有市售品,所以可直接使用市售品。作為具體的市售品,可例示「Uvinul A Plus Granular」(二乙胺基羥基苯甲醯基苯甲酸己酯BASF公司製)、「Parsol 1789」(第三丁基甲氧基苯甲醯基甲烷DSM公司製)。 As a UV-A absorber, 2-hydroxy-4-methoxybenzophenone, 2-(2'-hydroxy-5'-tolyl)benzotriazole, dimethoxybenzylidene can be exemplified 2-ethylhexyl imidazolidinepropionate, bis (retinoic acid) , Methylene bis benzotriazolyl tetramethyl butanol, diethylamino hydroxybenzoyl benzoic acid hexyl ester, the third butyl methoxy dibenzoyl methane compound. Among them, from the viewpoint of excellent ultraviolet absorption, hexyl diethylaminohydroxybenzoyl benzoate and tert-butyl methoxydibenzoyl methane are particularly preferred. Since there are commercial products in these compounds, commercial products can be used directly. As specific commercial products, "Uvinul A Plus Granular" (diethylaminohydroxybenzoyl benzoyl hexyl ester manufactured by BASF Corporation), "Parsol 1789" (third butyl methoxy benzoyl carbamoyl methane DSM) can be exemplified Company system).
UV-A吸收劑的含量,通常為0.01質量%以上,較佳為0.1質量%以上,而且,通常為5質量%以下,較佳為3質量%以下。 The content of the UV-A absorbent is usually 0.01% by mass or more, preferably 0.1% by mass or more, and usually 5% by mass or less, preferably 3% by mass or less.
作為UV-B吸收劑,具體而言,可舉出對甲氧基肉桂酸2-乙基己酯、2-氰基-3,3-二苯基丙烯酸2-乙基己酯、二甲聚矽氧烷二乙基苯亞甲基丙二酸酯、2,4,6-三苯胺基-p-(碳-2’-乙基己基-1’-氧基)-1,3,5-三、2-羥基-4-甲氧基二苯甲酮、水楊酸高薄荷酯、水楊酸辛酯等之化合物。因為該等之化合物中存在有市售品,所以可直接使用市售品。作為具體的市售品,可例示「Uvinul MC80」(對甲氧基肉桂酸2-乙基己酯BASF公司製)、「Uvinul T150」(2,4,6-三苯胺基-p-(碳-2’-乙基己基-1’-氧基)-1,3,5-三BASF公司製)、「Uvinul M40」(2-羥基-4-甲氧基二苯甲酮BASF公司製)、「Parsol SLX」(二甲聚矽氧烷二乙基苯亞甲基丙二酸酯DSM公 司製)、「Parsol 340」(2-氰基-3,3-二苯基丙烯酸2-乙基己酯DSM公司製)、「Parsol HMS」(水楊酸高薄荷酯DSM公司製)、「Parsol HMS」(水楊酸辛酯DSM公司製)。 Specific examples of the UV-B absorber include 2-ethylhexyl p-methoxycinnamate, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, and dimethyl poly Siloxane diethylbenzylidene malonate, 2,4,6-triphenylamino-p-(carbon-2'-ethylhexyl-1'-oxy)-1,3,5- three , 2-hydroxy-4-methoxybenzophenone, high menthyl salicylate, octyl salicylate and other compounds. Since there are commercial products in these compounds, commercial products can be used directly. As specific commercially available products, "Uvinul MC80" (p-methoxycinnamic acid 2-ethylhexyl ester manufactured by BASF Corporation) and "Uvinul T150" (2,4,6-triphenylamino-p-(carbon -2'-ethylhexyl-1'-oxy)-1,3,5-tri (Made by BASF), "Uvinul M40" (2-hydroxy-4-methoxybenzophenone made by BASF), "Parsol SLX" (dimethicone diethylbenzylidene malonate DSM), "Parsol 340" (2-cyano-3,3-diphenylacrylic acid 2-ethylhexyl DSM), "Parsol HMS" (high menthyl salicylate DSM), "Parsol HMS" (manufactured by DSM Corporation).
UV-B吸收劑的含量,通常為0.1質量%以上,較佳為0.5質量%以上,而且,通常為10質量%以下,較佳為7質量%以下。 The content of the UV-B absorbent is usually 0.1% by mass or more, preferably 0.5% by mass or more, and usually 10% by mass or less, preferably 7% by mass or less.
油相與水相所含的成分沒有特別限定。 The components contained in the oil phase and the water phase are not particularly limited.
作為構成油相的油劑,可舉出例如,液體油脂、固體油脂、蠟、烴油、高級脂肪酸、高級醇、合成酯油、矽酮油等。 Examples of the oil agent constituting the oil phase include liquid fats and oils, solid fats and oils, waxes, hydrocarbon oils, higher fatty acids, higher alcohols, synthetic ester oils, and silicone oils.
作為液體油脂,可舉出例如,酪梨油、山茶油、海龜油、澳洲胡桃油、玉米油、貂油、橄欖油、油菜籽油、蛋黃油、芝麻油、杏核油、小麥胚芽油、山茶花油、蓖麻油、亞麻仁油、紅花籽油、棉籽油、紫蘇油、白芒花籽油、大豆油、花生油、苦茶油、日本榧樹籽油、米糠油、九重桐油、日本桐油、荷荷芭油、胚芽油、三丙三醇、三辛酸丙三醇、三異棕櫚酸丙三醇等。 Examples of the liquid fats and oils include avocado oil, camellia oil, turtle oil, Australian walnut oil, corn oil, mink oil, olive oil, rapeseed oil, egg butter, sesame oil, apricot kernel oil, wheat germ oil, and camellia Oil, castor oil, linseed oil, safflower seed oil, cottonseed oil, perilla oil, white awn flower seed oil, soybean oil, peanut oil, bitter tea oil, Japanese cypress seed oil, rice bran oil, bougainvillea oil, Japanese tung oil, Dutch Jojoba oil, germ oil, triglycerin, trioctanoic acid glycerin, triisopalmitic acid glycerin, etc.
作為固體油脂,可舉出可可脂、椰子油、馬脂、硬化椰子油、棕櫚油、牛脂、羊脂、硬化牛脂、棕櫚仁油、豬脂、牛骨脂、木蠟仁油、硬化油、牛腳油、木蠟、硬化蓖麻油等。 Examples of solid oils and fats include cocoa butter, coconut oil, horse fat, hardened coconut oil, palm oil, tallow, sheep fat, hardened tallow, palm kernel oil, lard, beef bone fat, wood wax kernel oil, hardened oil, Shea butter, wood wax, hardened castor oil, etc.
作為蠟類,可舉出蜂蠟、小燭樹蠟、棉蠟、巴西棕櫚蠟、楊梅蠟、蟲蠟、鯨蠟、褐煤蠟、糠蠟、羊毛脂、木棉蠟、羊毛脂乙酸酯、液狀羊毛脂、甘蔗蠟、 羊毛脂脂肪酸異丙酯、月桂酸己酯、還原羊毛脂、荷荷芭蠟、硬質羊毛脂、蟲膠蠟、POE羊毛脂醇醚、POE羊毛脂醇乙酸酯、POE膽固醇醚、羊毛脂脂肪酸聚乙二醇、POE氫化羊毛脂醇醚等。 Examples of waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, insect wax, spermaceti wax, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, and liquid Lanolin, sugar cane wax, Lanolin fatty acid isopropyl ester, hexyl laurate, reduced lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid Polyethylene glycol, POE hydrogenated lanolin alcohol ether, etc.
作為烴油,可舉出流動石蠟、地蠟、異十八烷、石蠟、礦蠟、鯊烯、凡士林、微晶蠟等。 Examples of the hydrocarbon oil include fluid paraffin, ozokerite, isooctadecane, paraffin, mineral wax, squalene, petrolatum, and microcrystalline wax.
作為高級脂肪酸,可舉出例如,月桂酸、肉荳蔻酸、棕櫚酸、硬脂酸、二十二酸(俞樹酸)、12-羥基硬脂酸、十一烯酸、妥爾油酸等。 Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid (behenic acid), 12-hydroxystearic acid, undecylenic acid, and tall oil. .
作為高級醇,可舉出例如,鯨臘醇、硬脂醇、二十二醇、鯊肝醇、肉豆蔻醇、鯨蠟硬脂醇等。 Examples of higher alcohols include cetyl alcohol, stearyl alcohol, behenyl alcohol, squalanol, myristyl alcohol, and cetearyl alcohol.
作為合成酯油,可舉出肉荳蔻酸異丙酯、辛酸鯨蠟酯、肉荳蔻酸辛基十二酯、棕櫚酸異丙酯、硬脂酸丁酯、月桂酸己酯、肉荳蔻酸肉荳蔻酯、油酸癸酯、二甲基辛酸己基癸酯、乳酸鯨蠟酯、乳酸肉荳蔻酯、羊毛脂乙酸酯、硬脂酸異鯨蠟酯、異硬脂酸異鯨蠟酯、蔗糖硬脂酸酯、蔗糖油酸酯、12-羥基硬脂酸膽固醇酯、二-2-乙基己酸乙二醇酯、二季戊四醇脂肪酸酯、單異硬脂酸N-烷二醇、二癸酸新戊二醇、蘋果酸二異硬脂酯、二-2-庚基十一酸丙三醇酯、三羥甲基丙烷三-2-乙基己酸酯、三羥甲基丙烷三異硬脂酸酯、四-2-乙基己酸季戊四醇酯、三-2-乙基己酸丙三醇酯、三羥甲基丙烷三異硬脂酸酯、己酸鯨蠟基2-乙酯、棕櫚酸2-乙基己酯、三肉荳蔻酸丙三醇酯、三-2-庚基十一酸甘油酯、蓖麻油脂肪酸甲酯、油酸油酯、鯨蠟硬脂醇、乙酸甘油酯、棕櫚酸2- 庚基十一酯、棕櫚酸鯨蠟酯、己二酸二異丁酯、N-月桂醯基-L-麩胺酸-2-辛基十二酯、己二酸二-2-庚基十一酯、月桂酸乙酯、癸二酸二-2-乙基己酯、肉荳蔻酸2-己基癸酯、棕櫚酸2-己基癸酯、己二酸2-己基癸酯、癸二酸二異丙酯、琥珀酸2-乙基己酯、乙酸乙酯、乙酸丁酯、乙酸戊酯、檸檬酸三乙酯等。 Examples of synthetic ester oils include isopropyl myristate, cetyl caprylate, octyl dodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, and myristate myristate. Ester, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, sucrose hard Fatty acid ester, sucrose oleate, cholesterol 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkanediol monoisostearate, didecane Neopentyl glycol acid, diisostearyl malate, glycerol di-2-heptyl undecanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triiso Stearate, pentaerythritol tetra-2-ethylhexanoate, glycerol tri-2-ethylhexanoate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate , 2-ethylhexyl palmitate, glycerol trimyristate, tri-2-heptyl undecyl glyceride, castor oil fatty acid methyl ester, oleic oleate, cetearyl alcohol, glycerol acetate Ester, palmitic acid 2- Heptyl undecyl ester, cetyl palmitate, diisobutyl adipate, N-lauryl-L-glutamic acid-2-octyl dodecyl ester, di-2-heptyl adipate Monoester, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, disebacate Isopropyl ester, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, etc.
作為矽酮油,可舉出二甲基聚矽氧烷、甲基苯基聚矽氧烷、甲基氫聚矽氧烷等之鏈狀聚矽氧烷、或十甲基聚矽氧烷、十二甲基聚矽氧烷、四甲基四氫聚矽氧烷等之環狀聚矽氧烷等。 Examples of the silicone oil include chain polysiloxanes such as dimethyl polysiloxane, methyl phenyl polysiloxane, methyl hydrogen polysiloxane, and decamethyl polysiloxane. Cyclic polysiloxane such as dodecyl polysiloxane, tetramethyl tetrahydropolysiloxane, etc.
油劑可使用1種或2種以上。 One oil or two or more oils can be used.
本發明的防曬化妝品中,在不損及本發明之效果的範圍,亦可摻合在通常化妝品摻合之任意添加成分。作為如此添加成分,可舉出例如,聚乙二醇、丙三醇、1,3-丁二醇、赤藻糖醇、山梨糖醇、木糖醇、麥芽糖醇等之保濕劑;乙醇等之低級醇;丁基羥基甲苯、生育酚、植酸等之抗氧化劑;苯甲酸、水楊酸、山梨酸、對羥基苯甲酸烷酯、六氯酚等之抗菌劑;醯基肌胺酸(例如,月桂醯基肌胺酸鈉)、麩胱甘肽、檸檬酸、蘋果酸、酒石酸、乳酸等之有機酸;維他命A及其衍生物、維他命B6鹽酸鹽、維他命B6三棕櫚酸酯、維他命B6二辛酸酯、維他命B2及其衍生物、維他命B12、維他命B15及其衍生物等之維他命B類、α-生育酚、β-生育酚、γ-生育酚、維他命E乙酸酯等之維他命E類、維他命D類、維他命H、泛酸、泛硫乙胺、菸鹼酸醯胺、菸鹼酸苯甲 酯等之維他命類;γ-榖維素、尿囊素、甘草酸(鹽)、甘草次酸及其衍生物、傳明酸及其衍生物〔作為傳明酸衍生物,傳明酸的二聚體(例如,鹽酸反式-4-(反式-胺甲基環己烷羰基)胺甲基環己烷羧酸等)、傳明酸與氫醌之酯(例如,反式-4-胺甲基環己烷羧酸4’-羥苯酯等)、傳明酸與龍膽酸之酯(例如,2-(反式-4-胺甲基環己基羰氧基)-5-羥基苯甲酸及其鹽等)、傳明酸的醯胺(例如,反式-4-胺甲基環己烷羧酸甲基醯胺及其鹽、反式-4-(P-甲氧基苯甲醯基)胺甲基環己烷羧酸及其鹽、反式-4-胍甲基環己烷羧酸及其鹽等)〕、檜木醇、沒藥醇、大果桉醛、百里酚、肌醇、柴胡皂素、人參皂素、絲瓜皂素、無患子皂素等之皂素類、泛酸醇基乙醚、乙炔雌二醇、傳明酸、熊果素、千金藤素、胎盤素等之各種藥劑;羊蹄、苦參、日本萍蓬草、橙、鼠尾草、蓍、錦葵、當藥、麝香草、東當歸、雲杉、樺木、問荊、絲瓜、七葉樹、虎耳草、兔菊、百合、魁蒿、芍藥、蘆薈、梔子、日本花柏等之植物的萃取物;色素;多孔質及/或吸水性的粉末(例如,由玉米或馬鈴薯等得到的澱粉類、矽酸酐、滑石、高嶺土、矽酸鋁鎂、海藻酸鈣等之粉末);中和劑;防腐劑;香料;顏料等。 The sunscreen cosmetics of the present invention may be blended with any additional ingredients usually blended in cosmetics, as long as the effects of the present invention are not impaired. As such added components, for example, moisturizing agents such as polyethylene glycol, glycerin, 1,3-butanediol, erythritol, sorbitol, xylitol, and maltitol; ethanol, etc. Lower alcohols; antioxidants such as butylhydroxytoluene, tocopherol, phytic acid, etc.; antibacterial agents such as benzoic acid, salicylic acid, sorbic acid, alkyl p-hydroxybenzoate, hexachlorophenol, etc.; acetyl sarcosinate (eg , Sodium lauryl sarcosinate), glutathione, citric acid, malic acid, tartaric acid, lactic acid and other organic acids; vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 Dicaprylate, Vitamin B2 and its derivatives, Vitamin B12, Vitamin B15 and its derivatives, Vitamin B, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, etc. Vitamin E, Vitamin D, Vitamin H, pantothenic acid, pantethine, niacinamide, nicotinic acid benzyl Vitamins such as esters; γ-glycosan, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, tranexamic acid and its derivatives [as tranexamic acid derivatives, tranexamic acid two Polymers (for example, trans-4-hydrochloric acid (trans-aminomethylcyclohexanecarbonyl) aminemethylcyclohexanecarboxylic acid, etc.), esters of tranexamic acid and hydroquinone (for example, trans-4- Aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester, etc.), esters of tranexamic acid and gentisic acid (for example, 2-(trans-4-aminomethylcyclohexylcarbonyloxy)-5-hydroxyl Benzoic acid and its salts, etc., tranexamic acid amide (for example, trans-4-amine methylcyclohexanecarboxylic acid methyl amide and its salt, trans-4-(P-methoxybenzene (Formyl) amine methylcyclohexane carboxylic acid and its salt, trans-4-guanidine methylcyclohexane carboxylic acid and its salt, etc.]), cypressol, myrrhol, cineol, thyme Saponins such as phenol, inositol, Bupleurum saponin, ginseng saponin, luffa saponin, saponin saponin, pantothenyl alcohol diethyl ether, ethinyl estradiol, tranexamic acid, arbutin, ceresin, placenta, etc. Various medicaments; Bauhinia, Sophora flavescens, Japanese wing grass, orange, sage, yarrow, mallow, Chinese medicine, thyme, angelica, spruce, birch, quince, loofah, horse chestnut, tiger ear Extracts of plants such as grass, rabbit chrysanthemum, lily, sagebrush, peony, aloe, gardenia, Japanese cypress, etc.; pigments; porous and/or water-absorbing powders (for example, starches obtained from corn or potatoes, etc.) , Silicic anhydride, talc, kaolin, aluminum magnesium silicate, calcium alginate, etc.); neutralizing agent; preservative; fragrance; pigment, etc.
本發明的防曬化妝品,例如,可利用以下的方法進行製造。 The sunscreen cosmetic of the present invention can be produced by the following method, for example.
混合油劑與成分(B),然後,混合其它的油相成分,進行加熱溶解而製備油相成分的混合物。包含紫外線散射劑(成分(D))時,在該混合物添加紫外線散射劑,並使用分散器進行分散。 The oil agent and the component (B) are mixed, and then the other oil phase components are mixed and dissolved by heating to prepare a mixture of oil phase components. When an ultraviolet scattering agent (component (D)) is included, an ultraviolet scattering agent is added to the mixture and dispersed using a disperser.
接著,混合水相成分與成分(C),在加熱時添加該油相成分的混合物,並以均質機進行乳化。乳化後,藉由添加成分(A)與視需要添加水分散性的紫外線散射劑(成分(D)),一邊攪拌混合一邊進行冷卻,可製造本發明的防曬化妝品。 Next, the water phase component and the component (C) are mixed, the mixture of the oil phase component is added during heating, and emulsified with a homogenizer. After emulsification, the sunscreen cosmetic of the present invention can be produced by adding component (A) and optionally adding a water-dispersible ultraviolet scattering agent (component (D)) and cooling while stirring and mixing.
海島結構係指相互不相溶的2種高分子引起相分離,且在包含一方的高分子之連續相散布有包含另一方的高分子之分散相的結構。然後,海島結構的連續相稱為海相,分散相稱為島相,且將分散相的粒子稱為島粒子。 The island-in-sea structure refers to a structure in which two types of polymers that are incompatible with each other cause phase separation, and a continuous phase containing one polymer is dispersed with a dispersed phase containing the other polymer. Then, the continuous phase of the sea island structure is called the sea phase, the dispersed phase is called the island phase, and the particles of the dispersed phase are called island particles.
本發明的被膜,具有包含兩親媒性共聚物的島粒子分散於包含水溶性高分子形成的水性凝膠之海相的海島結構。 The film of the present invention has an island-in-sea structure in which island particles containing an amphiphilic copolymer are dispersed in a marine phase containing an aqueous gel formed of a water-soluble polymer.
然後,島粒子所包含的兩親媒性共聚物,具有構成單元(i)與構成單元(j)作為必要的構成單元。 Then, the amphiphilic copolymer contained in the island particles has a structural unit (i) and a structural unit (j) as necessary structural units.
構成單元(i)為自疏水性單體衍生的1種或2種以上之構成單元,構成單元(j)為自親水性單體衍生的1種或2種以上之構成單元。 The structural unit (i) is one or more structural units derived from a hydrophobic monomer, and the structural unit (j) is one or more structural units derived from a hydrophilic monomer.
具有如此結構特徵之本發明的被膜,不論是否將水性成分作為主體,均具有如包含油劑之牛奶的觸感。 The film of the present invention having such a structural feature, regardless of whether or not the aqueous component is the main component, has a touch like milk containing oil.
以下對於本發明的被膜進一步詳述。 The coating of the present invention will be described in further detail below.
在本發明中,海島結構之島粒子所包含的兩親媒性共聚物,具有自前述疏水性單體衍生的構成單 元(i)與自前述親水性單體衍生的構成單元(j)作為必要的構成單元。 In the present invention, the amphiphilic copolymer contained in the island-in-the-sea island particles has a structural unit derived from the aforementioned hydrophobic monomer The element (i) and the structural unit (j) derived from the aforementioned hydrophilic monomer are necessary structural units.
作為本發明的兩親媒性共聚物,使用包含自以下[1]及[2]所說明的疏水性單體與親水性單體衍生之構成單元的水溶性共聚物較佳。 As the amphiphilic copolymer of the present invention, a water-soluble copolymer containing a structural unit derived from the hydrophobic monomer and the hydrophilic monomer described in [1] and [2] below is preferably used.
在本發明中,使用將自前述通式(1)、(7)或(8)所示之疏水性單體衍生的構成單元(以下有時也單純稱為「構成單元(7)」等)之一種或兩種以上作為必要構成單元含有的兩親媒性共聚物(也稱為丙烯酸系兩親媒性共聚物)較佳。 In the present invention, a structural unit derived from the hydrophobic monomer represented by the general formula (1), (7) or (8) (hereinafter sometimes simply referred to as "constituent unit (7)" etc.) is used One kind or two or more kinds of amphiphilic copolymers (also referred to as acrylic amphiphilic copolymers) which are necessary constituent units are preferable.
再者,在本發明中,「自單體衍生的構成單元」,係指對應的單體具有之碳-碳不飽和鍵藉由聚合反應裂解而形成的構成單元。 Furthermore, in the present invention, "constituent unit derived from a monomer" refers to a constituent unit formed by cleaving a carbon-carbon unsaturated bond possessed by the corresponding monomer by a polymerization reaction.
以下對於通式(1)、(7)或(8)所示之疏水性單體進行說明。 Hereinafter, the hydrophobic monomer represented by the general formula (1), (7) or (8) will be described.
在前述通式(7)中,R14表示氫原子或碳數1~3的烷基,R15表示碳數13~30的未含有環結構之分支狀烴基、或未含有環結構的具有2個以上之分支的碳數6~12之烴基。 In the aforementioned general formula (7), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 represents a branched hydrocarbon group having 13 to 30 carbon atoms that does not contain a ring structure, or 2 that does not contain a ring structure. More than 6 branched hydrocarbon groups with 6 to 12 carbon atoms.
在此,作為R14所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R14為氫原子或甲基較佳。 Here, examples of the alkyl group represented by R 14 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 14 is preferably a hydrogen atom or a methyl group.
又,作為R15所示之碳數13~30的未含有環結構之分支狀烴基,可例示1-甲基十二基、11-甲基十二基、3-乙基十一基、3-乙基-4,5,6-三甲基辛基、1-甲基十三基、1-己基辛基、2-丁基癸基、2-己基辛基、4-乙基-1-異丁基辛基、1-甲基十五基、2-己基癸基、2-辛基癸基、2-己基十二基、16-甲基十七基、9-甲基十七基、7-甲基-2-(3-甲基己基)癸基、3,7,11,15-四-甲基十六基、2-辛基十二基、2-癸基十四基、2-十二基十六基等。 In addition, as a branched hydrocarbon group having a ring structure of 13 to 30 carbon atoms represented by R 15 , 1-methyldodecyl, 11-methyldodecyl, 3-ethylundecyl, 3 -Ethyl-4,5,6-trimethyloctyl, 1-methyltridecyl, 1-hexyloctyl, 2-butyldecyl, 2-hexyloctyl, 4-ethyl-1- Isobutyloctyl, 1-methylpentadecyl, 2-hexyldecyl, 2-octyldecyl, 2-hexyldodecyl, 16-methylheptadecyl, 9-methylheptadecyl, 7-methyl-2-(3-methylhexyl)decyl, 3,7,11,15-tetra-methylhexadecyl, 2-octyldodecyl, 2-decyltetradecyl, 2 -Twelve bases and sixteen bases.
又,作為R15所示之未含有環結構的具有2個以上之分支的碳數6~12之烴基,可例示2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1,3-二甲基丁基、1,2,2-三甲基丙基、1,1-二甲基戊基、1-異丙基丁基、1-異丙基-2-甲基丙基、1,1-二乙基丙基、1-乙基-1-異丙基丙基、2-乙基-4-甲基戊基、1-丙基-2,2-二甲基丙基、1,1,2-三甲基-戊基、1-異丙基-3-甲基丁基、1,2-二甲基-1-乙基丁基、1,3-二甲基-1-乙基丁基、1-乙基-1-異丙基-丙基、1,1-二甲基己基、1-甲基-1-乙基戊基、1-甲基-1-丙基丁基、1,4-二甲基己基、1-乙基-3-甲基戊基、1,5-二甲基己基、1-乙基-6-甲基庚基、1,1,3,3-四甲基丁基、1,2-二甲基-1-異丙基丙基、3-甲基-1-(2,2-二甲基乙基)丁基、1-異丙基己基、3,5,5-三甲基己基、2-異丙基-5-甲基己基、1,5-二甲基-1-乙基己基、3,7-二甲基辛基、2,4,5-三甲基庚基、2,4,6-三甲基庚基、3,5-二甲基-1-(2,2-二甲基乙基)己基等。 In addition, examples of the hydrocarbon group having 6 or more carbon atoms and having 2 or more branches not containing a ring structure represented by R 15 include 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,3-dimethylbutyl, 1,2,2-trimethylpropyl, 1,1-dimethylpentyl, 1-isopropylbutyl, 1-isopropyl-2-methylpropyl, 1,1-diethylpropyl, 1-ethyl-1-isopropylpropyl, 2-ethyl-4-methylpentyl, 1- Propyl-2,2-dimethylpropyl, 1,1,2-trimethyl-pentyl, 1-isopropyl-3-methylbutyl, 1,2-dimethyl-1-ethyl Butyl, 1,3-dimethyl-1-ethylbutyl, 1-ethyl-1-isopropyl-propyl, 1,1-dimethylhexyl, 1-methyl-1-ethyl Amylpentyl, 1-methyl-1-propylbutyl, 1,4-dimethylhexyl, 1-ethyl-3-methylpentyl, 1,5-dimethylhexyl, 1-ethyl -6-methylheptyl, 1,1,3,3-tetramethylbutyl, 1,2-dimethyl-1-isopropylpropyl, 3-methyl-1-(2,2- Dimethylethyl)butyl, 1-isopropylhexyl, 3,5,5-trimethylhexyl, 2-isopropyl-5-methylhexyl, 1,5-dimethyl-1-ethyl Hexyl, 3,7-dimethyloctyl, 2,4,5-trimethylheptyl, 2,4,6-trimethylheptyl, 3,5-dimethyl-1-(2, 2-dimethylethyl)hexyl and so on.
在前述通式(1)及(8)中,R1、R16表示氫原子或碳數1~3的烷基,R2、R3、R17、R18、R19可相同亦可不同,且表示未含有環結構之具有分支的碳數6~22之醯基。X表示自三元醇脫附OH基的基。 In the aforementioned general formulas (1) and (8), R 1 and R 16 represent a hydrogen atom or a C 1-3 alkyl group, and R 2 , R 3 , R 17 , R 18 and R 19 may be the same or different , And represents a branched C 6-22 acyl group that does not contain a ring structure. X represents a group that desorbs the OH group from the triol.
在此,作為R1、R16所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基等。在本發明中,R3為氫原子或甲基較佳。 Here, examples of the alkyl group represented by R 1 and R 16 include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 3 is preferably a hydrogen atom or a methyl group.
又,作為R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數6~22的醯基,可例示2-甲基戊醯基、3-甲基戊醯基、4-甲基戊醯基、2-乙基丁醯基、2-乙基丁醯基、2,2-二甲基丁醯基、3,3-二甲基丁醯基、2-甲基己醯基、4-甲基己醯基、5-甲基己醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2-甲基庚醯基、2-乙基己基、2-丙基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、2-甲基辛醯基、3,3,5-三甲基己醯基、2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、 2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 In addition, examples of R 2 , R 3 , R 17 , R 18 , and R 19 that do not contain a ring structure and have branched C 6-22 acyl groups include 2-methylpentyl acyl and 3-methyl Pentylpentyl, 4-methylpentyl, 2-ethylbutyryl, 2-ethylbutyryl, 2,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2-methylhexyl , 4-methylhexyl, 5-methylhexyl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2-methylheptyl, 2-ethyl Hexyl, 2-propylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentyl, 2-methyloctyl, 3,3,5-trimethyl Hexamyl, 2-methylnonyl, 4-methylnonyl, 8-methylnonyl, 4-ethyloctyl, 2-ethyloctyl, 2-butylhexyl, 2- Third butylhexyl, 2,2-diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl, 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2- Butyloctyl, diethyloctyl, 2-third butyl-2,2,4-trimethylpentyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyl Yldodecyl, 11-methyldodecyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl -2-ethyloctyl, 12-methyltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-Dimethylhexyl, 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nineteen amide Base, 3,7,11,15-tetra-methylhexadecyl, 19-methyl eicosyl, etc.
又,本發明之較佳的實施形態中,在通式(1)及(8)中,R2、R3、R17、R18、R19可相同亦可不同,且為未含有環結構的具有分支之碳數10~22的醯基、或未含有環結構的具有2個以上之分支的碳數6~9之醯基。 Moreover, in a preferred embodiment of the present invention, in the general formulas (1) and (8), R 2 , R 3 , R 17 , R 18 , and R 19 may be the same or different, and have no ring structure A branched carbon group with a carbon number of 10 to 22, or a ring group with no more than 2 branches and a carbon group with a carbon number of 6 to 9.
作為如此較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有分支之碳數10~22的醯基,可例示2-甲基壬醯基、4-甲基壬醯基、8-甲基壬醯基、4-乙基辛醯基、2-乙基辛醯基、2-丁基己醯基、2-第三丁基己醯基、2,2-二乙基己醯基、2,2-二甲基辛醯基、3,7-二甲基辛醯基、新癸醯基、7-甲基癸醯基、2-甲基-2-乙基辛醯基、2-甲基十一醯基、10-甲基十一醯基、2,2-二甲基癸醯基、2-乙基癸醯基、2-丁基辛醯基、二乙基辛醯基、2-第三丁基-2,2,4-三甲基戊醯基、10-甲基十二醯基、3-甲基十二醯基、4-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、2-丁基癸醯基、2-己基辛醯基、2-丁基-2-乙基辛醯基、12-甲基十四醯基、14-甲基十五醯基、2-丁基十二醯基、2-己基癸醯基、16-甲基十七醯基、2,2-二甲基己醯基、2-丁基十六醯基、2-己基十二醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As such a preferred embodiment, R 2 , R 3 , R 17 , R 18 , and R 19 which do not contain a ring structure and have a branched C 10-22 acyl group may include 2-methylnonyl Group, 4-methylnonylyl group, 8-methylnonylyl group, 4-ethyloctylyl group, 2-ethyloctylyl group, 2-butylhexylyl group, 2-butylhexylyl group, 2-third butylhexylyl group, 2, 2-Diethylhexyl, 2,2-dimethyloctyl, 3,7-dimethyloctyl, neodecyl, 7-methyldecyl, 2-methyl-2-ethyloctyl , 2-methylundecyl, 10-methylundecyl, 2,2-dimethyldecyl, 2-ethyldecyl, 2-butyloctyl, diethyloctyl, 2 -Third-butyl-2,2,4-trimethylpentylyl, 10-methyldodecyl, 3-methyldodecyl, 4-methyldodecyl, 11-methyl Dodecanoyl, 10-ethylundecyl, 12-methyltridecyl, 2-butyldecyl, 2-hexyloctyl, 2-butyl-2-ethyloctyl, 12-methyl Yltetradecyl, 14-methylpentadecyl, 2-butyldodecyl, 2-hexyldecyl, 16-methylheptadecyl, 2,2-dimethylhexyl , 2-butylhexadecyl, 2-hexyldodecyl, 2,4,10,14-tetramethylpentyl, 18-methyl nonadecyl, 3,7,11,15- Tetramethyl hexadecyl, 19-methyl eicosyl, etc.
又,作為較佳的實施形態之R2、R3、R17、R18、R19所示之未含有環結構的具有2個以上之分支的碳數6~9之醯基,可例示2,2-二甲基丁醯基、3,3-二甲基丁醯基、2,2-二甲基戊醯基、4,4-二甲基戊醯基、2,2-二甲基己醯基、2,2,3-三甲基戊醯基、3,5,5-三甲基己醯基等。 In addition, as a preferred embodiment, an acyl group having 6 to 9 carbon atoms having 2 or more branches and not containing a ring structure represented by R 2 , R 3 , R 17 , R 18 , and R 19 can be exemplified by 2 ,2-dimethylbutyryl, 3,3-dimethylbutyryl, 2,2-dimethylpentyl, 4,4-dimethylpentyl, 2,2-dimethylhexyl, 2,2,3-trimethylpentanyl, 3,5,5-trimethylhexyl, etc.
在通式(1)中,X所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (1), the group derived from triol represented by X is not particularly limited as long as it desorbs the OH group from the triol, and can be appropriately exemplified by a group selected from the group consisting of glycerol and triol. The trihydric alcohol of the group of methylolpropane and trimethylolethane desorbs the OH group.
又,在通式(8)中,Y所示之自四元醇衍生的基,只要是自四元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含二丙三醇、季戊四醇、赤藻糖醇、D-蘇糖醇、L-蘇糖醇的群組之四元醇脫附OH基的基。 In addition, in the general formula (8), the group derived from a tetrahydric alcohol represented by Y is not particularly limited as long as it desorbs the OH group from the tetrahydric alcohol, and can be appropriately exemplified by The tetrahydric alcohol of the group of alcohol, pentaerythritol, erythritol, D-threitol, and L-threitol desorbs the OH group.
在本發明中,使用包含構成單元(1)的兩親媒性共聚物特佳。 In the present invention, it is particularly preferable to use an amphiphilic copolymer containing the structural unit (1).
又,本發明之更佳的實施形態中,通式(1)所示的疏水性單體為上述通式(15)所示的疏水性單體。 In a more preferred embodiment of the present invention, the hydrophobic monomer represented by the general formula (1) is the hydrophobic monomer represented by the general formula (15).
通式(15)之R24、R25之醯基的碳數為12~22,更佳為14~20,特佳為16~20。 The carbon number of the acyl group of R 24 and R 25 in the general formula (15) is 12-22, more preferably 14-20, and particularly preferably 16-20.
又,通式(15)之R24、R25之醯基的主鏈之碳數,較佳為9~21,更佳為12~20,特佳為16~18。 In addition, the carbon number of the main chain of the acyl group of R 24 and R 25 in the general formula (15) is preferably 9 to 21, more preferably 12 to 20, and particularly preferably 16 to 18.
又,通式(15)之R24、R25之醯基的分支數,較佳為1~3,更佳為1或2,特佳為1。 In addition, the branch number of the acyl group of R 24 and R 25 in the general formula (15) is preferably 1 to 3, more preferably 1 or 2, and particularly preferably 1.
而且,通式(15)之R24、在R25之醯基中,分支鏈鍵結的主鏈之碳的位置編號越大越佳。具體而言,分支鏈較佳係以與自主鏈端部的第1~3個碳鍵結為較佳,更佳為第1或2個碳,特佳為第1個碳。 Furthermore, in R 24 of the general formula (15) and in the acyl group of R 25, the larger the position number of the carbon of the main chain of the branch chain bonding, the better. Specifically, the branched chain is preferably bonded to the first to third carbons at the end of the autonomous chain, more preferably the first or second carbon, and particularly preferably the first carbon.
作為R24、R25,具體而言,可適當例示10-甲基十一醯基、10-甲基十二醯基、11-甲基十二醯基、10-乙基十一醯基、12-甲基十三醯基、12-甲基十四醯基、14-甲基十五醯基、16-甲基十七醯基、2,4,10,14-四甲基戊醯基、18-甲基十九醯基、3,7,11,15-四-甲基十六醯基、19-甲基二十醯基等。 As R 24 and R 25 , specifically, 10-methyl undecyl group, 10-methyl dodecyl group, 11-methyl dodecyl group, 10-ethyl undecyl group, 12-Methyltridecyl, 12-methyltetradecyl, 14-methylpentadecyl, 16-methylheptadecyl, 2,4,10,14-tetramethylpentyl , 18-methyl nineteen amide, 3,7,11,15-tetra-methyl hexadecyl, 19-methyl eicosyl, etc.
在通式(15)中,Z所示之自三元醇衍生的基,只要是自三元醇脫附OH基的基,則沒有特別限定,可適當例示自選自於包含丙三醇、三羥甲基丙烷、三羥甲基乙烷的群組之三元醇脫附OH基的基。 In the general formula (15), the group derived from triol represented by Z is not particularly limited as long as it desorbs the OH group from the triol, and can be appropriately exemplified by a group selected from the group consisting of glycerol and triol. The trihydric alcohol of the group of methylolpropane and trimethylolethane desorbs the OH group.
作為本發明的親水性單體,可使用聚合性羧酸、以及前述通式(2)、(9)、(10)及(11)所示的化合物。 As the hydrophilic monomer of the present invention, a polymerizable carboxylic acid and compounds represented by the aforementioned general formulas (2), (9), (10), and (11) can be used.
在本發明中,作為聚合性羧酸或其鹽,具體而言,可例示丙烯酸、甲基丙烯酸、巴豆酸、伊康酸、富馬酸及其鈉鹽、鉀鹽、銨鹽、胺鹽等。該等之中,從聚合性高之觀點,丙烯酸、甲基丙烯酸及其鹽特佳。在本發明的兩親媒性共聚物導入自聚合性的羧酸鹽衍生之構成單元時,可將聚合性羧酸預先製成鹽,進行聚合反應,亦可利用聚合反應,將自聚合性羧酸衍生之構成單元衍生為兩親媒性共聚物後,利用鹼中和而製成鹽。 In the present invention, specific examples of the polymerizable carboxylic acid or its salt include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, fumaric acid and its sodium, potassium, ammonium, and amine salts. . Among these, acrylic acid, methacrylic acid, and their salts are particularly preferred from the viewpoint of high polymerizability. When the amphiphilic copolymer of the present invention is introduced into a structural unit derived from a polymerizable carboxylate, the polymerizable carboxylic acid may be prepared as a salt in advance to perform a polymerization reaction, or the polymerization reaction may be used to convert the self-polymerizable carboxylate After the acid-derived constituent unit is derivatized as an amphiphilic copolymer, it is neutralized with an alkali to form a salt.
前述通式(2)中、R4表示氫原子或碳數1~3的烷基,R5表示可具有羥基之碳數2~4的伸烷基,R6表示氫原子、碳數6~10的芳香族烴基、碳數1~14的脂肪族烴基或碳數1~12的醯基。n表示6~40的整數。 In the aforementioned general formula (2), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 5 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 6 represents a hydrogen atom and a carbon atom having 6 to 6 carbon atoms The aromatic hydrocarbon group of 10, the aliphatic hydrocarbon group of 1 to 14 carbon atoms, or the acyl group of 1 to 12 carbon atoms. n represents an integer of 6~40.
作為在前述通式(2)中R4所示的烷基,可例示甲基、乙基、丙基、異丙基、環丙基。在本發明中,R6為氫原子或甲基較佳。 Examples of the alkyl group represented by R 4 in the general formula (2) include methyl, ethyl, propyl, isopropyl, and cyclopropyl. In the present invention, R 6 is preferably a hydrogen atom or a methyl group.
又,作為R5所示的伸烷基,可例示伸乙基、伸丙基、異伸丙基、2-羥基伸丙基、2-羥基-2-甲基伸乙基、2-羥基-1-甲基伸乙基等,但該等之中,較佳為伸乙基或伸丙基,更佳為伸乙基。 In addition, as the alkylene group represented by R 5 , ethyl group, ethyl group, isopropyl group, 2-hydroxypropyl group, 2-hydroxy-2-methyl ethyl group, 2-hydroxy- 1-methylethylidene, etc., but among these, ethylidene or propylidene are preferred, and ethylidene is more preferred.
又,R6所示的基中,作為碳數6~10的芳香族基,可例示苯基、苯甲基、甲苯基、乙苯基等;作為碳數1~14的脂肪族烴基,可適當例示甲基、乙基、丁基、第三丁基、己基、環己基、辛基、2-乙基己基、月桂基等;作為碳數1~12的醯基,可適當例示甲醯基、乙醯基、丙醯基、丁醯基、異丁醯基、戊醯基、月桂醯基等。該等之中,作為R5所示的基,較佳為碳數1~14的脂肪族烴基,更佳為碳數1~12的烷基。 In addition, among the groups represented by R 6 , examples of the aromatic groups having 6 to 10 carbon atoms include phenyl, benzyl, tolyl, and ethylphenyl groups. As the aliphatic hydrocarbon groups having 1 to 14 carbon atoms, Appropriate examples include methyl, ethyl, butyl, tertiary butyl, hexyl, cyclohexyl, octyl, 2-ethylhexyl, lauryl, etc.; as a C 1-12 acyl group, a methyl acyl group can be appropriately exemplified. , Acetyl, propyl, butyl, isobutyl, pentyl, lauryl, etc. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
而且,通式(2)之n為6~40的數值範圍。 Furthermore, n in the general formula (2) is in the range of 6 to 40.
前述通式(2)所示的單體中,作為R5為伸丙基之單體,具體而言,可舉出聚丙二醇(9)單丙烯酸酯、聚丙二醇(13)單丙烯酸酯、聚丙二醇(9)單甲基丙烯酸酯、聚丙二醇(13)單甲基丙烯酸酯等。再者,括弧內 的數字表示N。該等之聚合物大多可作為市售品取得。作為該等市售品,具體而言,可例示商品名「Blenmer」AP-400、AP-550、AP-800、PP-500、PP-800(均為日本油脂(股)製)等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is propylene, specifically, polypropylene glycol (9) monoacrylate, polypropylene glycol (13) monoacrylate, poly Propylene glycol (9) monomethacrylate, polypropylene glycol (13) monomethacrylate, etc. Furthermore, the number in parentheses indicates N. Most of these polymers are available as commercial products. Specific examples of these commercially available products include trade names "Blenmer" AP-400, AP-550, AP-800, PP-500, and PP-800 (all manufactured by Nippon Oil & Fats Co., Ltd.).
前述通式(2)所示的單體中,作為R5為伸乙基之單體,具體而言,可舉出聚乙二醇(10)單丙烯酸酯、聚乙二醇(8)單甲基丙烯酸酯、聚乙二醇(23)單丙烯酸酯、聚乙二醇(23)單甲基丙烯酸酯、甲氧基聚乙二醇(9)丙烯酸酯、甲氧基聚乙二醇(9)甲基丙烯酸酯、甲氧基聚乙二醇(23)甲基丙烯酸酯、油氧基聚乙二醇(18)甲基丙烯酸酯、月桂氧基聚乙二醇(18)丙烯酸酯、月桂醯氧基聚乙二醇(10)甲基丙烯酸酯、硬脂氧基聚乙二醇(30)單甲基丙烯酸酯等。 Among the monomers represented by the general formula (2), as the monomer in which R 5 is an ethylidene group, specifically, polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomer Methacrylate, polyethylene glycol (23) monoacrylate, polyethylene glycol (23) monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol ( 9) Methacrylate, methoxypolyethylene glycol (23) methacrylate, oleyloxy polyethylene glycol (18) methacrylate, lauryloxy polyethylene glycol (18) acrylate, Lauryloxy polyethylene glycol (10) methacrylate, stearyl polyethylene glycol (30) monomethacrylate, etc.
上述親水性單體,可藉由對應的聚乙二醇、聚乙二醇單醚、聚乙二醇單酯與丙烯酸或甲基丙烯酸之氯化物或酐之酯化反應而以高產率得到。又,因為已存在很多市售品,所以也可利用該市售品。作為如此市售品,具體而言,可例示商品名Blenmer、AE-400、PE-350、AME-400、PME-400、PME-1000、ALE-800、PSE-1300(均為日本油脂(股)製)等。 The above-mentioned hydrophilic monomers can be obtained in a high yield by esterification reaction of corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester with acrylic acid or methacrylic acid chloride or anhydride. In addition, since many commercial products already exist, the commercial products can also be used. As such a commercially available product, specifically, the trade names of Blenmer, AE-400, PE-350, AME-400, PME-400, PME-1000, ALE-800, and PSE-1300 (all of which are Japanese oil ) System) etc.
作為本發明的親水性單體,亦可使用上述通式(9)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the above general formula (9) can also be used.
作為前述通式(9)所示的親水性單體,具體而言,可舉出2-丙烯醯氧基乙基磷酸膽鹼(APC)、2-甲基 丙烯醯氧乙基磷酸膽鹼(MPC)。該等之單體,例如,可利用Polymer Journal,Vol22,No.5記載之以下的方法合成。 Specific examples of the hydrophilic monomer represented by the general formula (9) include 2-propenyloxyethyl phosphate choline (APC) and 2-methyl Acryloyloxyethyl phosphate choline (MPC). Such monomers can be synthesized by the following method described in Polymer Journal, Vol22, No. 5, for example.
使二氯化2-溴乙基磷醯與甲基丙烯酸2-羥乙酯或丙烯酸2-羥乙酯反應,得到2-甲基丙烯醯氧乙基-2‘-溴乙基磷酸或2-丙烯醯氧乙基-2‘-溴乙基磷酸後,將該等化合物與三乙胺於甲醇中進行反應。 Reacting 2-bromoethylphosphoryl dichloride with 2-hydroxyethyl methacrylate or 2-hydroxyethyl acrylate to obtain 2-methacryloxyethyl-2'-bromoethyl phosphoric acid or 2- After acryloyloxyethyl-2'-bromoethyl phosphoric acid, these compounds are reacted with triethylamine in methanol.
作為本發明的親水性單體,亦可使用前述通式(10)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the general formula (10) can also be used.
在通式(10)所示的親水性單體中,作為G-O-所示的自還原糖之1位的羥基除去氫的基之還原糖,具體而言,可例示選自於包含葡萄糖、甘露糖、半乳糖、阿拉伯糖、木糖、核糖等之單糖、麥芽糖、乳糖、纖維雙糖等之雙糖、麥芽三糖等之三糖、麥芽寡糖等之寡糖的群組之一種或兩種以上,其中尤以選自於包含葡萄糖、半乳糖、阿拉伯糖、木糖、核糖、麥芽糖、乳糖、纖維雙糖的群組之一種或兩種以上較佳,葡萄糖特佳。又,作為通式(10)所示的單體,甲基丙烯酸葡萄糖基氧乙酯(以下省略為GEMA)或丙烯酸葡萄糖基氧乙酯(以下省略為GEA)較佳。 Among the hydrophilic monomers represented by the general formula (10), the reducing sugar that is a group that removes hydrogen from the hydroxyl group at the 1-position of the reducing sugar represented by GO- can be specifically selected from the group consisting of glucose and mannose. Groups of monosaccharides such as sugar, galactose, arabinose, xylose, ribose, disaccharides such as maltose, lactose, cellobiose, trisaccharides such as maltotriose, and oligosaccharides such as maltooligosaccharide One or two or more, among which one or two or more selected from the group consisting of glucose, galactose, arabinose, xylose, ribose, maltose, lactose, and cellobiose is preferred, and glucose is particularly preferred. Further, as the monomer represented by the general formula (10), glucosyloxyethyl methacrylate (hereinafter abbreviated as GEMA) or glucosyloxyethyl acrylate (hereinafter abbreviated as GEA) is preferred.
作為本發明的親水性單體,亦可使用前述通式(11)所示的親水性單體。 As the hydrophilic monomer of the present invention, the hydrophilic monomer represented by the aforementioned general formula (11) can also be used.
在通式(11)的單體中,作為R23所示之胺基酸殘基的胺基酸,只要是通常已知的胺基酸,則沒有特別限定,具體而言,可例示甘胺酸、丙胺酸、麩胺酸、離胺酸、精胺酸等。該等之中,因為得到的兩親媒性共聚物之皮膚屏障的恢復效果佳,所以以離胺酸殘基為特佳。 In the monomer of the general formula (11), the amino acid as the amino acid residue represented by R 23 is not particularly limited as long as it is a generally known amino acid, and specifically, glycine can be exemplified. Acid, alanine, glutamic acid, lysine, arginine, etc. Among these, since the skin barrier recovery effect of the obtained amphiphilic copolymer is good, the amino acid residue is particularly preferable.
又,R23所示的多胺殘基之多胺,意指在同一分子內具有可以烷基取代之胺基2個以上的胺,具體而言,可例示二胺、三胺、四胺或該等之胺基的氫原子被烷基取代的胺。該等之中,從含有得到的兩親媒性共聚物之皮膚外用劑的使用感特佳之觀點,二胺較佳,作為特佳的具體例,從合成之際的原料取得之容易度的觀點,可舉出乙二胺、1,4-二胺基-正丁烷、1,6-二胺基-正己烷等。 In addition, the polyamine of the polyamine residue represented by R 23 means an amine having two or more amine groups that can be substituted with an alkyl group in the same molecule. Specifically, a diamine, triamine, tetraamine or An amine in which the hydrogen atom of the amine group is substituted with an alkyl group. Among these, from the viewpoint that the use of the skin-derived external preparation containing the obtained amphiphilic copolymer is particularly good, diamine is preferable, and as a particularly good specific example, from the viewpoint of easy availability of raw materials at the time of synthesis , Ethylenediamine, 1,4-diamino-n-butane, 1,6-diamino-n-hexane, etc. are mentioned.
而且,作為R23所示之胺醇殘基的胺醇,意指在同一分子內具有可以烷基取代之胺基及醇式羥基的化合物。作為胺醇,只要是通常已知者,則沒有特別限定,作為具體例,可例示乙醇胺、三乙胺基乙醇等。 The amine alcohol as the amine alcohol residue represented by R 23 means a compound having an alkyl-substituted amine group and an alcoholic hydroxyl group in the same molecule. The amino alcohol is not particularly limited as long as it is generally known, and specific examples include ethanolamine, triethylaminoethanol, and the like.
作為通式(11)所示之單體的鹽,沒有特別限定,具體而言,可例示將酸部分以鹼中和的鈉鹽、鉀鹽、銨鹽、胺鹽等,或者,將胺基部分以酸中和的鹽酸鹽、硫酸鹽、硝酸鹽、磷酸鹽、檸檬酸鹽、草酸鹽、碳酸鹽等。在本發明的兩親媒性共聚物導入自通式(11)所示的單體鹽衍生之構成單元時,可將通式(11)所示的單體預先製成鹽,進行聚合反應,亦可利用聚合反應,將 自通式(11)所示的單體衍生之構成單元衍生為兩親媒性共聚物後,中和而製成鹽。 The salt of the monomer represented by the general formula (11) is not particularly limited, and specifically, there can be exemplified sodium salts, potassium salts, ammonium salts, amine salts and the like neutralized with an acid moiety, or Partially acid neutralized hydrochloride, sulfate, nitrate, phosphate, citrate, oxalate, carbonate, etc. When the amphiphilic copolymer of the present invention is introduced into the structural unit derived from the monomer salt represented by the general formula (11), the monomer represented by the general formula (11) may be prepared as a salt in advance and subjected to a polymerization reaction, You can also use polymerization to The structural unit derived from the monomer represented by the general formula (11) is derived into an amphiphilic copolymer, and then neutralized to form a salt.
通式(11)所示的單體,作為其鹽的具體例,可適當例示化合物1~11及其鹽。 As a specific example of the salt of the monomer represented by the general formula (11), compounds 1 to 11 and salts thereof can be appropriately exemplified.
通式(11)所示的親水性單體,例如,如前述反應式(1)及(2)所示,可藉由使用(甲基)丙烯酸、(甲基)丙烯醯氯的酯化反應、醯胺化反應而合成。 The hydrophilic monomer represented by the general formula (11), for example, as shown in the aforementioned reaction formulas (1) and (2), can be obtained by an esterification reaction using (meth)acrylic acid or (meth)acryloyl chloride , Amidation reaction synthesis.
如上述,在本發明中作為親水性聚合物,可使用前述通式(2)、(9)、(10)、及(11)。 As described above, in the present invention, as the hydrophilic polymer, the aforementioned general formulas (2), (9), (10), and (11) can be used.
本發明之較佳的實施形態中,兩親媒性共聚物係包含自前述通式(2)衍生的構成單元(2)。 In a preferred embodiment of the present invention, the amphiphilic copolymer includes a structural unit (2) derived from the aforementioned general formula (2).
在本發明中,尤能適用具有構成單元(1)與構成單元(2)的兩親媒性共聚物。又,更佳可使用具有構成單元(15)與構成單元(2)的兩親媒性共聚物。 In the present invention, an amphiphilic copolymer having a structural unit (1) and a structural unit (2) is particularly applicable. Furthermore, it is more preferable to use an amphiphilic copolymer having a structural unit (15) and a structural unit (2).
如此丙烯酸系兩親媒性共聚物中,特佳可使用(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物。 Among such acrylic amphiphilic copolymers, (methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer can be particularly preferably used.
藉由含有如此丙烯酸系兩親媒性共聚物,可提升被膜之保濕性與柔軟性。 By containing such an acrylic amphiphilic copolymer, the moisture retention and flexibility of the coating can be improved.
(甲基丙烯酸甲氧酯PEG-23/二異硬脂酸甲基丙烯酸甘油酯)共聚物,作為構成單元(i),主要包含自前述通式(15)所示的疏水性單體中,R24、R25為16-甲基十七醯基之疏水性單體衍生的構成單元(i)。 (Methoxy methacrylate PEG-23/diisostearic acid glyceryl methacrylate) copolymer, as the structural unit (i), is mainly contained from the hydrophobic monomer represented by the aforementioned general formula (15), R 24 and R 25 are structural units (i) derived from a hydrophobic monomer of 16-methylheptadecyl group.
又,作為構成單元(j),主要包含自前述通式(2)所示的親水性單體中,R4為甲基,R5為伸乙基,R6為甲基,n為23之親水性單體衍生的構成單元(j)。 Moreover, as a structural unit (j), it is mainly comprised from the hydrophilic monomer represented by the said general formula (2), R 4 is a methyl group, R 5 is an ethyl group, R 6 is a methyl group, and n is 23 Structural unit (j) derived from a hydrophilic monomer.
作為本發明的兩親媒性共聚物,除了上述的共聚物以外,也可使用現有的共聚物。具體而言,作為兩親媒性共聚物,可使用以下舉出之現有的共聚物。 As the amphiphilic copolymer of the present invention, in addition to the above-mentioned copolymers, existing copolymers can also be used. Specifically, as the amphiphilic copolymer, conventional copolymers listed below can be used.
亦即,可使用聚季銨鹽-51(將2-甲基丙烯醯氧乙基磷酸膽鹼與甲基丙烯酸丁酯以約8:2之莫耳比包含的共聚物)、聚季銨鹽-61(將2-甲基丙烯醯氧乙基磷酸膽鹼與甲基丙烯酸硬脂酯以約3:7之莫耳比包含的共聚物)、(甲基丙烯酸甘油基醯胺乙酯/甲基丙烯酸硬脂酯)共聚物(將甘油基-N-(2-甲基丙烯醯氧乙基)胺甲酸酯與甲基丙烯酸硬脂酯以約6:4之莫耳比率包含的重量平均分子量約40000之共聚物)、PEG/PPG/聚丁二醇-8/5/3丙三醇、(水解絲蛋白/PG丙基甲基矽烷二醇)交聯聚合物(將N-〔2-羥基-3-〔3-(羥甲基矽烷基)丙氧基〕丙基〕水解絲蛋白矽烷化的共聚物)、(二十烷二酸/十四烷二酸)聚甘油酯-10(包含二十烷二酸、十四烷二酸之二鹼酸與平均聚合度為10之聚丙三醇的寡聚物酯)、(丙三醇/氧化丁烯)共聚物硬脂醚(在硬脂醇使環氧丙醇及四氫呋喃同時反應,並加成聚合之HLB為18.0的聚合物)、聚季銨鹽-7(氯化二甲基二烯丙基銨與丙烯醯胺的共聚物)、聚季銨鹽-39(丙烯酸、氯化二甲基二烯丙基銨與丙烯醯胺三聚物)、(丙烯酸Na/丙烯醯基二甲基牛磺酸)共聚物(丙烯酸鈉與丙烯醯基二甲基牛磺酸鈉之共聚物)等之現有的共聚物。 That is, polyquaternium-51 (copolymer containing 2-methacryloyloxyethyl phosphate choline and butyl methacrylate at a molar ratio of about 8:2), polyquaternium -61 (copolymer containing 2-methacryl oxyethyl phosphate choline and stearyl methacrylate at a molar ratio of about 3:7), (glyceryl methacrylate ethyl methacrylate/methyl Stearyl Acrylate) copolymer (weight average of glyceryl-N-(2-methacryloxyethyl)carbamate and stearyl methacrylate in a molar ratio of about 6:4 (Copolymer with molecular weight of about 40,000), PEG/PPG/polybutanediol-8/5/3 glycerin, (hydrolyzed silk protein/PG propylmethylsilanediol) cross-linked polymer (the N-[2 -Hydroxy-3-[3-(hydroxymethylsilyl)propoxy]propyl]silicone hydrolyzed copolymer), (Eicosanedioic acid/tetradecanedioic acid) polyglycerol ester-10 (Contains oligomeric esters of dibasic acid of eicosanedioic acid, tetradecanedioic acid and polyglycerol with an average degree of polymerization of 10), (glycerol/butylene oxide) copolymer stearic ether (in Stearyl alcohol reacts glycidol and tetrahydrofuran at the same time, and addition polymerizes the polymer with HLB of 18.0), polyquaternium-7 (copolymer of dimethyldiallylammonium chloride and propylene amide) ), polyquaternium-39 (acrylic acid, dimethyldiallyl ammonium chloride and acrylamide terpolymer), (acrylic acid Na/acryl dimethyl taurine) copolymer (sodium acrylate and Existing copolymers such as copolymers of sodium propionyl dimethyl taurine).
該等之中,特別是可適當例示聚季銨鹽-51、聚季銨鹽-61、(甲基丙烯酸甘油基醯胺乙酯/甲基丙烯酸硬脂酯)共聚物。 Among these, especially polyquaternium-51, polyquaternium-61, (glyceryl methacrylate ethyl ester/stearyl methacrylate) copolymer can be suitably exemplified.
在本發明中,兩親媒性共聚物之構成單元(i)在全構成單元所佔之比例,較佳為1~50質量%,更佳為5~40質量%、10~30質量%。 In the present invention, the proportion of the structural units (i) of the amphiphilic copolymer in the total structural units is preferably 1 to 50% by mass, more preferably 5 to 40% by mass, and 10 to 30% by mass.
藉由使兩親媒性共聚物之構成單元(i)所佔之比例成為前述範圍,可提升本發明的被膜之保濕性與柔軟性。 By making the ratio of the structural unit (i) of the amphiphilic copolymer within the aforementioned range, the moisture retention and flexibility of the coating of the present invention can be improved.
在本發明中,兩親媒性共聚物之構成單元(j)在全構成單元所佔之比例,較佳為50~99質量%,更佳為60~95質量%、70~90質量%。 In the present invention, the proportion of the structural units (j) of the amphiphilic copolymer in the total structural units is preferably 50 to 99% by mass, more preferably 60 to 95% by mass, and 70 to 90% by mass.
藉由使兩親媒性共聚物之構成單元(j)所佔之比例成為前述範圍,可提升本發明的被膜之保濕性與柔軟性。 By making the ratio of the structural unit (j) of the amphiphilic copolymer into the aforementioned range, the moisture retention and flexibility of the coating of the present invention can be improved.
在本發明中,構成兩親媒性共聚物之構成單元(i)與構成單元(j)的質量比,較佳為5:95~50:50,進一步較佳為10:90~45:55,更佳為20:80~40:60,特佳為25:75~35:65。 In the present invention, the mass ratio of the constituent unit (i) to the constituent unit (j) constituting the amphiphilic copolymer is preferably 5:95 to 50:50, further preferably 10:90 to 45:55 , Better is 20:80~40:60, especially good is 25:75~35:65.
藉由使兩親媒性共聚物的構成單元(i)及構成單元(j)之質量比成為前述範圍,可提升本發明的被膜之保濕性與柔軟性。 By setting the mass ratio of the structural unit (i) and the structural unit (j) of the amphiphilic copolymer to the aforementioned range, the moisture retention and flexibility of the coating of the present invention can be improved.
在本發明中,構成兩親媒性共聚物之構成單元(i)與構成單元(j)的莫耳比,較佳為8:92~62:38,進一步較佳為15:85~57:43,更佳為29:71~52:48,特佳為35:65~46:54。 In the present invention, the molar ratio of the constituent unit (i) and the constituent unit (j) constituting the amphiphilic copolymer is preferably 8:92 to 62:38, and more preferably 15:85 to 57: 43, better is 29:71~52:48, especially good is 35:65~46:54.
藉由使兩親媒性共聚物的構成單元(i)及構成單元(j)之莫耳比成為前述範圍,可提升本發明的被膜之保濕性與柔軟性。 By setting the molar ratio of the structural unit (i) and the structural unit (j) of the amphiphilic copolymer to the aforementioned range, the moisture retention and flexibility of the coating of the present invention can be improved.
在本發明中,兩親媒性共聚物之平均分子量,較佳為20000~110000,進一步較佳為20000~80000,更佳為30000~80000,進一步更佳為40000~70000,特佳為50000~70000,進一步特佳為57000~66000。 In the present invention, the average molecular weight of the amphiphilic copolymer is preferably 20,000 to 110,000, more preferably 20,000 to 80,000, more preferably 30,000 to 80,000, still more preferably 40,000 to 70,000, and particularly preferably 50,000 70,000, further preferably 57000~66000.
藉由使兩親媒性共聚物之分子量成為前述範圍,可提升本發明的被膜之彈力性,而且,可抑制黏膩感。 By making the molecular weight of the amphiphilic copolymer into the aforementioned range, the elasticity of the coating of the present invention can be improved, and the stickiness can be suppressed.
再者,在此,平均分子量係指利用GPC測定之聚苯乙烯換算的重量平均分子量。 Here, the average molecular weight refers to the weight average molecular weight in terms of polystyrene measured by GPC.
上述島粒子係分散於水性凝膠的海相。在本發明中,水性凝膠係利用水溶性高分子及/或其鹽與水合於該水溶性高分子的水形成。 The island particles are dispersed in the sea phase of the aqueous gel. In the present invention, the aqueous gel system is formed using water-soluble polymers and/or salts thereof and water hydrated in the water-soluble polymers.
作為形成水性凝膠的水溶性高分子及/或其鹽,只要將包含兩親媒性聚合物的相作為島粒子分散,則沒有特別限定,較佳可使用選自於包含丙烯酸系水溶性聚合物、水溶性多胜肽及水溶性多糖的群組之1種或2種以上的水溶性高分子及/或其鹽。 The water-soluble polymer and/or its salt that forms an aqueous gel is not particularly limited as long as the phase containing the amphiphilic polymer is dispersed as the island particles, and it can be preferably selected from the group consisting of acrylic water-soluble polymers. One or more than two kinds of water-soluble polymers and/or salts thereof in the group of substances, water-soluble polypeptides and water-soluble polysaccharides.
作為前述丙烯酸系水溶性聚合物,尤能例示非交聯型丙烯酸系聚合物、或者可交聯之丙烯酸系共聚物。又,作為非交聯型丙烯酸系聚合物,尤可例示聚丙烯酸鈉,作為前述可交聯之丙烯酸系共聚物,尤可例示聚丙烯酸鈉、(丙烯酸酯/丙烯酸烷酯(C10-30))交聯聚合物。 As the acrylic water-soluble polymer, a non-crosslinkable acrylic polymer or a crosslinkable acrylic copolymer can be particularly exemplified. In addition, as the non-crosslinkable acrylic polymer, sodium polyacrylate is particularly exemplified, and as the aforementioned crosslinkable acrylic copolymer, sodium polyacrylate and (acrylate/alkyl acrylate (C10-30)) are particularly exemplified. Crosslinked polymers.
作為前述水溶性多胜肽,尤可例示聚麩胺酸鈉。 As the aforementioned water-soluble polypeptide, sodium polyglutamine is particularly exemplified.
作為前述水溶性多糖,尤可例示三仙膠或銀耳多糖體。尤能適用三仙膠作為水溶性多糖。 As the aforementioned water-soluble polysaccharide, three gums or tremella polysaccharides are particularly exemplified. It is especially applicable to Sanxian gum as a water-soluble polysaccharide.
藉由使用如此水溶性高分子及/或其鹽,可提升本發明的被膜之保濕性與柔軟性。 By using such a water-soluble polymer and/or its salt, the moisture retention and flexibility of the coating of the present invention can be improved.
本發明的被膜,具有在包含水性凝膠的海相分散有包含兩親媒性共聚物的島相之海島結構。 The film of the present invention has a sea-island structure in which an island phase containing an amphiphilic copolymer is dispersed in a sea phase containing an aqueous gel.
在具有本發明之海島結構的被膜中,海相與島相之面積比,較佳為2:8~10:1,更佳為3:7~9:1,特佳為6:4~7:3。 In the coating with the island structure of the present invention, the area ratio of the sea phase to the island phase is preferably 2:8~10:1, more preferably 3:7~9:1, and particularly preferably 6:4~7 : 3.
海相與島相之面積比為前述範圍的本發明之被膜,彈力性佳,黏膩感少,且保濕性與柔軟性均佳。 The film of the present invention having an area ratio of the sea phase to the island phase within the aforementioned range has excellent elasticity, less stickiness, and excellent moisturization and flexibility.
本發明之較佳的實施形態中,島粒子之平均長軸短軸比,較佳為0.6以上,更佳為0.7以上,特佳為0.8以上,最佳為0.9以上。 In a preferred embodiment of the present invention, the average long axis to short axis ratio of the island particles is preferably 0.6 or more, more preferably 0.7 or more, particularly preferably 0.8 or more, and most preferably 0.9 or more.
藉由使島粒子之平均長軸短軸比成為前述範圍,可提升本發明的被膜之保濕性與柔軟性。 By setting the average long axis and short axis ratio of the island particles to the aforementioned range, the moisture retention and flexibility of the coating of the present invention can be improved.
再者,平均長軸短軸比,可藉由顯微鏡觀察組成物而測定。具體而言,可藉由顯微鏡觀察組成物,測定100個島粒子之長軸短軸比,並將其相加平均而求出。 In addition, the average long axis to short axis ratio can be measured by observing the composition with a microscope. Specifically, the composition can be obtained by observing the composition with a microscope, measuring the long-axis and short-axis ratios of 100 island particles, and adding them to the average.
又,本發明之較佳的實施形態中,被膜中所含之全島粒子的長軸短軸比小於0.6,更佳為小於0.7,特佳為小於0.8之島粒子的存在比率為10%以下。 Furthermore, in a preferred embodiment of the present invention, the ratio of the major axis to the minor axis of all the island particles contained in the coating is less than 0.6, more preferably less than 0.7, and particularly preferably the ratio of island particles less than 0.8 is 10% or less.
又,本發明之更佳的實施形態中,組成物中所含之全島粒子的長軸短軸比小於0.8之島粒子的存在比率為5%以下,更佳為1%以下。 Furthermore, in a more preferred embodiment of the present invention, the ratio of island particles having a long axis to short axis ratio of all island particles contained in the composition of less than 0.8 is 5% or less, more preferably 1% or less.
如此實施形態的被膜,保濕性與柔軟性更佳。 The film of this embodiment has better moisture retention and flexibility.
本發明之較佳的實施形態中,平均粒徑為0.5~10μm的島粒子,更佳為平均粒徑為1~5μm的島粒子之個數粒度分布為80%以上。 In a preferred embodiment of the present invention, the island particles having an average particle diameter of 0.5 to 10 μm, and more preferably, the number of island particles having an average particle diameter of 1 to 5 μm have a particle size distribution of 80% or more.
又,本發明之更佳的實施形態中,平均粒徑為1~5μm的島粒子之個數粒度分布為85%以上,更佳為90%以上。 Furthermore, in a more preferred embodiment of the present invention, the number of island particles having an average particle diameter of 1 to 5 μm has a particle size distribution of 85% or more, more preferably 90% or more.
藉由使如此小粒徑的島粒子之個數粒徑分布成為前述範圍,可進一步提升本發明的被膜之保濕性與柔軟性。 By making the particle size distribution of the island particles with such a small particle size into the aforementioned range, the moisture retention and flexibility of the coating of the present invention can be further improved.
再者,島粒子之平均粒徑,可藉由顯微鏡觀察組成物而測定。具體而言,可藉由顯微鏡觀察組成物,測定島粒子之長軸與短軸,並將其相加平均而求出。 Furthermore, the average particle size of island particles can be measured by observing the composition with a microscope. Specifically, the composition can be obtained by observing the composition with a microscope, measuring the long axis and short axis of the island particles, and adding them to the average.
本發明的被膜,可含有通常皮膚外用劑所使用的任意成分。作為如此成分,可舉出油‧蠟類、烴類、高級脂肪酸類、高級醇類、合成酯油類、矽酮系油劑類、界面活性劑類、多元醇類、保濕成分類、增黏劑、粉體類、無機顏料類、有機色素類、有機粉體類、紫外線吸收劑類、低級醇類、維他命類、具有生體擬似結構的聚合物等。 The coating film of the present invention may contain any components commonly used in external preparations for skin. Examples of such components include oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, synthetic ester oils, silicone oils, surfactants, polyols, moisturizing ingredients, and thickening Agents, powders, inorganic pigments, organic pigments, organic powders, ultraviolet absorbers, lower alcohols, vitamins, polymers with biosimilar structures, etc.
作為油‧蠟類,可舉出例如,澳洲胡桃油、酪梨油、玉米油、橄欖油、油菜籽油、芝麻油、蓖麻油、紅花籽油、棉籽油、荷荷芭油、椰子油、棕櫚油、液狀羊毛脂、硬化椰子油、硬化油、木蠟、硬化蓖麻油、蜂 蠟、小燭樹蠟、巴西棕櫚蠟、蟲蠟、羊毛脂、還原羊毛脂、硬質羊毛脂、荷荷芭蠟等;作為烴類,可舉出例如,流動石蠟、鯊烷、異十八烷、地蠟、石蠟、礦蠟、凡士林、微晶蠟等;作為高級脂肪酸類,可舉出例如,油酸、異硬脂酸、月桂酸、肉荳蔻酸、棕櫚酸、硬脂酸、二十二酸、十一烯酸等;作為高級醇類,可舉出例如,鯨臘醇、硬脂醇、異硬脂醇、二十二醇、辛基十二醇、肉豆蔻醇、鯨蠟硬脂醇等;作為合成酯油類,可舉出例如,異辛酸鯨蠟酯、肉荳蔻酸異丙酯、異硬脂酸十六酯、己二酸二異丙酯、癸二酸二-2-乙基己酯、乳酸鯨蠟酯、蘋果酸二異硬脂酯、二-2-乙基己酸乙二醇、二癸酸新戊二醇、二-2-庚基十一酸丙三醇酯、三-2-乙基己酸丙三醇酯、三羥甲基丙烷三-2-乙基己酸酯、三羥甲基丙烷三異硬脂酸酯、四-2-乙基己酸季戊四醇酯等;作為矽酮系油劑類,可舉出例如,二甲基聚矽氧烷、甲基苯基聚矽氧烷、二苯基聚矽氧烷等之鏈狀聚矽氧烷、八甲基環四矽氧烷、十甲基環五矽氧烷、十二甲基環己烷矽氧烷等之環狀聚矽氧烷、胺基改性聚矽氧烷、聚醚改性聚矽氧烷、烷基改性聚矽氧烷、氟改性聚矽氧烷等之改性聚矽氧烷等之矽酮油等。 Examples of oils and waxes include Australian walnut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower seed oil, cottonseed oil, jojoba oil, coconut oil, palm oil Oil, liquid lanolin, hardened coconut oil, hardened oil, wood wax, hardened castor oil, bee Wax, candelilla wax, carnauba wax, insect wax, lanolin, reduced lanolin, hard lanolin, jojoba wax, etc.; as hydrocarbons, for example, flowing paraffin, squalane, isooctadecane , Ozokerite, paraffin wax, mineral wax, petrolatum, microcrystalline wax, etc.; as the higher fatty acids, for example, oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, twenty Diacids, undecylenic acid, etc.; as higher alcohols, for example, cetyl alcohol, stearyl alcohol, isostearyl alcohol, eicosanediol, octyldodecanol, myristyl alcohol, cetearyl Fatty alcohols and the like; as synthetic ester oils, for example, cetyl isooctanoate, isopropyl myristate, cetyl isostearate, diisopropyl adipate, di-2 sebacate -Ethylhexyl ester, cetyl lactate, diisostearyl malate, ethylene glycol di-2-ethylhexanoate, neopentyl glycol didecanoate, propane tri-2-heptyl undecanoate Alcohol ester, glycerol tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra-2-ethylhexyl Pentaerythritol acid ester, etc.; Examples of silicone oils include chain polysiloxanes such as dimethyl polysiloxane, methylphenyl polysiloxane, diphenyl polysiloxane, etc. , Cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecylcyclohexanesiloxane, amine modified polysiloxane, polyether Silicone oils such as modified polysiloxanes, alkyl modified polysiloxanes, fluorine modified polysiloxanes and other modified polysiloxanes.
界面活性劑類亦可為陰離子界面活性劑類、非離子界面活性劑類之任一者。 The surfactants may be any of anionic surfactants and nonionic surfactants.
作為陰離子界面活性劑類,可舉出例如,脂肪酸皂(月桂酸鈉、棕櫚酸鈉等)、月桂基硫酸鉀、烷基硫酸三乙醇胺醚等;作為非離子界面活性劑類,可舉出例如,山梨糖醇酐脂肪酸酯類(山梨糖醇酐單硬脂酸酯、山梨糖醇酐倍半油酸酯等)、丙三醇脂肪酸類(單硬脂酸丙三醇等)、丙二醇脂肪酸酯類(單硬脂酸丙二醇等)、硬化蓖麻油衍生物、丙三醇烷醚、POE山梨糖醇酐脂肪酸酯類(POE山梨糖醇酐單油酸酯、單硬脂酸聚氧乙烯山梨糖醇酐等)、POE山梨糖醇脂肪酸酯類(POE-山梨糖醇單月桂酸酯等)、POE丙三醇脂肪酸酯類(POE-丙三醇單異硬脂酸酯等)、POE脂肪酸酯類(聚乙二醇單油酸酯、POE二硬脂酸酯等)、POE烷醚類(POE2-辛基十二醚等)、POE烷基苯醚類(POE壬基苯醚等)、普朗尼克型類、POE‧POP烷醚類(POE‧POP2-癸基十四醚等)、特窗類、POE蓖麻油‧硬化蓖麻油衍生物(POE蓖麻油、POE硬化蓖麻油等)、蔗糖脂肪酸酯、烷基葡萄糖苷等。 Examples of anionic surfactants include fatty acid soaps (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, and alkyl sulfate triethanolamine ether. Examples of nonionic surfactants include, for example. , Sorbitan fatty acid esters (sorbitan monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (glycerol monostearate, etc.), propylene glycol fatty acid esters (Propylene glycol monostearate, etc.), hardened castor oil derivatives, glycerol alkyl ether, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate Alcohol anhydride, etc.), POE sorbitol fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerol fatty acid esters (POE-glycerol monoisostearate, etc.), POE fatty acid esters (Polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyl dodecyl ether, etc.), POE alkyl phenyl ethers (POE nonyl phenyl ether, etc.), Planic type, POE‧POP alkyl ethers (POE‧POP2-decyltetradecyl ether, etc.), special windows, POE castor oil‧hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Sucrose fatty acid ester, alkyl glucoside, etc.
作為多元醇類,可舉出例如,聚乙二醇、赤藻糖醇、木糖醇、丙二醇、二丙二醇、異戊二醇、1,2-戊二醇、2,4-己二醇、1,2-己二醇、1,2-辛二醇等;作為保濕成分類,可舉出例如,吡咯啶酮羧酸鈉、乳酸、乳酸鈉等;作為增黏劑,可舉出例如,關華豆膠、榅桲種子、卡拉膠、半乳聚糖、阿拉伯膠、果膠、甘露聚糖、澱粉、卡德蘭膠、甲基纖維素、羥乙基纖維素、羧甲基纖維素、 甲基羥丙基纖維素、硫酸軟骨素、硫酸皮膚素、肝醣、硫酸乙醯肝素、玻尿酸、玻尿酸鈉、黃蓍膠、硫酸角質素、軟骨素、硫酸黏多糖、羥乙基關華豆膠、羧甲基關華豆膠、葡聚糖、硫酸角質素、刺槐豆膠、琥珀醯聚糖、栝樓酸、甲殼素、殼聚糖、羧甲基甲殼素、洋菜、聚乙烯醇、聚乙烯吡咯啶酮、聚羧乙烯、聚乙二醇、膨潤土等。 Examples of the polyhydric alcohols include polyethylene glycol, erythritol, xylitol, propylene glycol, dipropylene glycol, isopentyl glycol, 1,2-pentanediol, and 2,4-hexanediol. 1,2-hexanediol, 1,2-octanediol, etc.; as a moisturizing component, for example, sodium pyrrolidone carboxylate, lactic acid, sodium lactate, etc.; as a thickener, for example, off Huadou gum, quince seeds, carrageenan, galactosan, acacia, pectin, mannan, starch, cardlan gum, methyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, Methyl hydroxypropyl cellulose, chondroitin sulfate, dermatan sulfate, glycogen, acetoheparin sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucopolysaccharide sulfate, hydroxyethyl Guanhua bean Gum, Carboxymethyl Guanhua Gum, Glucan, Keratan Sulfate, Locust Bean Gum, Succinyl Glycan, Tonic Acid, Chitin, Chitosan, Carboxymethyl Chitosan, Watercress, Polyvinyl Alcohol , Polyvinylpyrrolidone, carbopol, polyethylene glycol, bentonite, etc.
作為粉體類,可舉出可將表面進行處理之雲母、滑石、高嶺土、合成雲母、碳酸鈣、碳酸鎂、矽酸酐(二氧化矽)、氧化鋁、硫酸鋇等;作為無機顏料類,例如,可舉出可將表面進行處理之鐵丹、黃色氧化鐵、黑色氧化鐵、氧化鈷、群青、紺青、氧化鈦、氧化鋅等;作為有機色素類,可舉出可將表面進行處理之雲母鈦、魚燐箔、氧氯化鉍等之珠光劑類、可色澱化之紅色202號、紅色228號、紅色226號、黃色4號、藍色404號、黃色5號、紅色505號、紅色230號、紅色223號、橙色201號、紅色213號、黃色204號、黃色203號、藍色1號、綠色201號、紫色201號、紅色204號等;作為有機粉體類,可舉出例如,聚乙烯粉末、聚甲基丙烯酸甲酯、耐綸粉末、有機聚矽氧烷彈性體等。 Examples of powders include mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (silica), aluminum oxide, and barium sulfate that can be treated on the surface; examples of inorganic pigments include, for example, , Can include iron dan, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, cyanine, titanium oxide, zinc oxide, etc. which can be treated on the surface; as organic pigments, mica can be treated on the surface Pearlescent agents such as titanium, fish foil, bismuth oxychloride, red 202, red 228, red 226, yellow 4, blue 404, yellow 5, red 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, etc.; as organic powders, can be mentioned For example, polyethylene powder, polymethyl methacrylate, nylon powder, organic polysiloxane elastomer, etc.
作為紫外線吸收劑類,可舉出例如,對胺基苯甲酸系紫外線吸收劑、鄰胺苯甲酸系紫外線吸收劑、水楊酸系紫外線吸收劑、肉桂酸系紫外線吸收劑、二苯甲酮系紫外線吸收劑、糖系紫外線吸收劑、2-(2’- 羥基-5’-第三丁基辛苯基)苯并三唑、4-甲氧基-4’-第三丁基二苯甲醯基甲烷等;作為低級醇類,可舉出例如,乙醇、異丙醇、苯氧基乙醇等;作為維他命類,尤可例示例如,維他命A或其衍生物、維他命B6鹽酸鹽、維他命B6三棕櫚酸酯、維他命B6二辛酸酯、維他命B2或其衍生物、維他命B12、維他命B15或其衍生物等之維他命B類、α-生育酚、β-生育酚、γ-生育酚、維他命E乙酸酯等之維他命E類、維他命D類、維他命H、泛酸、泛硫乙胺、吡咯并喹啉醌等。 Examples of the ultraviolet absorbers include p-aminobenzoic acid-based ultraviolet absorbers, o-aminobenzoic acid-based ultraviolet absorbers, salicylic acid-based ultraviolet absorbers, cinnamic acid-based ultraviolet absorbers, and benzophenone-based ultraviolet absorbers. UV absorber, sugar-based UV absorber, 2-(2'- Hydroxy-5'-tert-butyloctylphenyl)benzotriazole, 4-methoxy-4'-tert-butyldibenzoylmethane, etc.; as the lower alcohols, for example, ethanol , Isopropanol, phenoxyethanol, etc.; as vitamins, particularly exemplified examples are vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dicaprylate, vitamin B2 or Vitamin B, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, etc., vitamin E, vitamin D, vitamin D, vitamin D, vitamin B12, vitamin B12 or its derivatives H, pantothenic acid, pantethine, pyrroloquinoline quinone, etc.
作為具有生體擬似結構的聚合物,例如,尤可例示聚甲基丙烯醯基賴胺酸、聚醣苷基乙基甲基丙烯酸酯等。 As the polymer having a biosimilar structure, for example, polymethacryloyl lysine, polyglycosylethyl methacrylate, and the like are particularly exemplified.
在本發明中,油‧蠟類、烴類、高級脂肪酸類、高級醇類、合成酯油類、矽酮系油劑類等之油劑的含量,較佳為10質量%以下,進一步較佳為5質量%以下,更佳為2.5質量%以下,進一步更佳為2質量%以下,特佳為1質量%以下,進一步特佳為成為0.5質量%以下。 In the present invention, the content of oils such as oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, synthetic ester oils, and silicone oils is preferably 10% by mass or less, and more preferably It is 5% by mass or less, more preferably 2.5% by mass or less, even more preferably 2% by mass or less, particularly preferably 1% by mass or less, and even more preferably 0.5% by mass or less.
又,本發明之較佳的實施形態中,未含有油劑。 In addition, in a preferred embodiment of the present invention, no oil agent is contained.
具有本發明之海島結構的被膜,不論是否將水性成分作為主體,均可發揮如包含油劑之牛奶的使用感。 The coating film having the sea-island structure of the present invention can exert a feeling of use such as milk containing oil, regardless of whether the aqueous component is the main component.
因此,具有本發明之海島結構的被膜,可成為無油的形態。 Therefore, the film having the sea-island structure of the present invention can be in an oil-free form.
又,在本發明中,界面活性劑的含量,較佳為10質量%以下,進一步較佳為5質量%以下,更佳為2.5質量%以下,進一步更佳為2質量%以下,特佳為1質量%以下,進一步特佳為成為0.5質量%以下。 Furthermore, in the present invention, the content of the surfactant is preferably 10% by mass or less, more preferably 5% by mass or less, more preferably 2.5% by mass or less, still more preferably 2% by mass or less, and particularly preferably 1 mass% or less, further preferably 0.5 mass% or less.
又,本發明之較佳的實施形態中,未含有界面活性劑。 Furthermore, in a preferred embodiment of the present invention, no surfactant is contained.
本發明的被膜,不論是否包含界面活性劑,均可形成安定的海島結構。 The coating of the present invention can form a stable island structure regardless of whether or not it contains a surfactant.
因此,具有本發明之海島結構的被膜,可成為無界面活性劑的形態。 Therefore, the film having the sea-island structure of the present invention can be in a form free of surfactant.
本發明也關於一種組成物,藉由在肌膚塗布,可將具有上述本發明之海島結構的被膜形成於肌膚上。 The present invention also relates to a composition that can be formed on the skin by coating the skin with the sea island structure of the present invention as described above.
本發明的組成物,含有上述兩親媒性共聚物、水溶性高分子及/或其鹽、以及水。 The composition of the present invention contains the above-mentioned amphiphilic copolymer, water-soluble polymer and/or its salt, and water.
藉由塗布於肌膚,蒸發組成物中的水,可引起兩親媒性共聚物與水溶性高分子相分離。該相分離的結果,本發明的被膜形成於肌膚上。再者,在相分離後,組成物中的水及多元醇係進入水溶性高分子形成的水性凝膠。 By applying to the skin and evaporating the water in the composition, the amphiphilic copolymer and the water-soluble polymer can be separated. As a result of this phase separation, the coating of the present invention is formed on the skin. Furthermore, after phase separation, the water and polyols in the composition enter the aqueous gel formed by the water-soluble polymer.
以下對於本發明的組成物進一步詳述。再者,關於本發明之組成物,可應用與上述<1>之項目所記載的本發明之被膜相關的事項。 The composition of the present invention will be described in further detail below. In addition, regarding the composition of the present invention, the matters related to the coating film of the present invention described in the above item <1> can be applied.
在本發明之組成物中,兩親媒性共聚物的含量,較佳為0.01~10質量%,進一步較佳為0.5~7質量%,更佳為0.1~5質量%,特佳為0.5~3質量%。 In the composition of the present invention, the content of the amphiphilic copolymer is preferably 0.01 to 10% by mass, further preferably 0.5 to 7% by mass, more preferably 0.1 to 5% by mass, and particularly preferably 0.5 to 3% by mass.
根據兩親媒性共聚物的含量為前述範圍之本發明的組成物,可將彈力性佳且黏膩感少的被膜形成於肌膚上。 According to the composition of the present invention in which the content of the amphiphilic copolymer is within the aforementioned range, a film having excellent elasticity and less stickiness can be formed on the skin.
在本發明中,組成物全體所佔之前述水溶性高分子的比例,較佳為0.001~10質量%,進一步較佳為0.005~5質量%,更佳為0.01~1質量%,特佳為0.05~0.5質量%。 In the present invention, the proportion of the aforementioned water-soluble polymer in the entire composition is preferably 0.001 to 10% by mass, further preferably 0.005 to 5% by mass, more preferably 0.01 to 1% by mass, and particularly preferably 0.05~0.5% by mass.
根據水溶性高分子的含量為前述範圍之本發明的組成物,可將保濕性與柔軟性均佳的被膜形成於肌膚上。 According to the composition of the present invention in which the content of the water-soluble polymer is in the aforementioned range, a coating film having excellent moisture retention and flexibility can be formed on the skin.
本發明之較佳的實施形態中,水溶性高分子與兩親媒性共聚物的含量之質量比,較佳為1:100~1:2,進一步較佳為1:50~1:5,更佳為1:30~1:10,特佳為1:25~1:15。 In a preferred embodiment of the present invention, the mass ratio of the content of the water-soluble polymer and the amphiphilic copolymer is preferably 1:100~1:2, further preferably 1:50~1:5, More preferably, it is 1:30~1:10, and especially good is 1:25~1:15.
根據水溶性高分子與兩親媒性共聚物的含量之質量比為前述範圍之本發明的組成物,可形成均一性高的被膜。 According to the composition of the present invention in which the mass ratio of the water-soluble polymer and the amphiphilic copolymer is within the aforementioned range, a highly uniform coating can be formed.
在本發明中,包含促進‧抑制海相與島相之分離的多元醇較佳。 In the present invention, it is preferable to include a polyol that promotes and inhibits the separation of the sea phase and the island phase.
亦即,本發明之較佳的實施形態中,係包含促進水性凝膠與兩親媒性共聚物之相分離的多元醇(以下也稱為促進性多元醇)及/或抑制水性凝膠與兩親媒性共聚物之相分離的多元醇(以下也稱為抑制性多元醇)。又,包含促進性多元醇與抑制性多元醇兩者為特佳。 That is, in a preferred embodiment of the present invention, it contains a polyol (hereinafter also referred to as a promoting polyol) that promotes the phase separation of the aqueous gel and the amphiphilic copolymer and/or inhibits the aqueous gel and Phase separated polyol of amphiphilic copolymer (hereinafter also referred to as inhibitory polyol). In addition, it is particularly preferable to include both the promoting polyol and the inhibiting polyol.
根據含有如此多元醇之本發明的組成物,可將具有均一性高的海島結構之被膜形成於肌膚上。 According to the composition of the present invention containing such a polyhydric alcohol, a film having a sea-island structure with high uniformity can be formed on the skin.
作為促進性多元醇,尤可例示藉由與在親水性部分具有聚醚鏈之非離子性界面活性劑的水溶液混合,使該水溶液之濁點提升的多元醇。作為如此促進性多元醇,尤可例示1,3-丁二醇及聚乙二醇。 As the accelerating polyol, a polyol which is mixed with an aqueous solution of a nonionic surfactant having a polyether chain in the hydrophilic portion and raised to the cloud point of the aqueous solution is particularly exemplified. As such a promoting polyol, 1,3-butanediol and polyethylene glycol are particularly exemplified.
藉由使用如此多元醇,可形成均一性更高的被膜。 By using such a polyol, a more uniform coating can be formed.
在本發明中,本發明的組成物全體之促進性多元醇的含量,較佳為0.1~30質量%,進一步較佳為1~25質量%,更佳為3~20質量%,特佳為5~15質量%。 In the present invention, the content of the promoting polyol in the entire composition of the present invention is preferably 0.1 to 30% by mass, further preferably 1 to 25% by mass, more preferably 3 to 20% by mass, and particularly preferably 5~15% by mass.
藉由使本發明的組成物全體之促進性多元醇的含量成為前述範圍,可進一步提升形成的被膜之均一性。 By making the content of the promoting polyol in the entire composition of the present invention within the aforementioned range, the uniformity of the formed film can be further improved.
作為抑制性多元醇,尤可例示藉由與在親水性部分具有聚醚鏈之非離子性界面活性劑的水溶液混合,使該水溶液之濁點下降的多元醇。作為如此抑制性多元醇,尤可例示丙三醇、二丙三醇、山梨糖醇及麥芽糖醇。 As an inhibitory polyol, a polyol in which the cloud point of the aqueous solution is lowered by mixing with an aqueous solution of a nonionic surfactant having a polyether chain in the hydrophilic portion is particularly exemplified. Examples of such inhibitory polyols include glycerin, diglycerin, sorbitol, and maltitol.
藉由使用如此多元醇,可形成均一性更高的被膜。 By using such a polyol, a more uniform coating can be formed.
本發明的組成物全體之抑制性多元醇的含量,較佳為0.5~30質量%,進一步較佳為1~25質量%,更佳為5~20質量%,特佳為8~15質量%。 The content of the inhibitory polyol in the entire composition of the present invention is preferably 0.5 to 30% by mass, more preferably 1 to 25% by mass, more preferably 5 to 20% by mass, and particularly preferably 8 to 15% by mass .
藉由使促進性多元醇之含量成為前述範圍,可進一步提升形成的被膜之均一性。 By making the content of the promoting polyol into the aforementioned range, the uniformity of the formed film can be further improved.
再者,在本發明中,濁點係指在透明或半透明的液體中,根據溫度變化引起相分離,其結果成為 不透明的溫度,特別是指在將非離子系界面活性劑的水溶液加溫之際,溶質與水開始分離的溫度。 Furthermore, in the present invention, the cloud point refers to the phase separation caused by temperature change in a transparent or translucent liquid, and the result becomes The opaque temperature means, in particular, the temperature at which the solute and water begin to separate when the aqueous solution of the nonionic surfactant is heated.
使在親水性部分具有聚醚鏈之非離子性界面活性劑的水溶液之濁點上升還是下降,具體而言,可利用以下的方法進行確認。 Whether to increase or decrease the cloud point of an aqueous solution of a nonionic surfactant having a polyether chain in the hydrophilic part can be specifically confirmed by the following method.
將在親水性部分具有聚醚鏈之非離子性界面活性劑的水溶液加溫,記錄該水溶液開始混濁的溫度,亦即,記錄濁點。接著,將在該水溶液加入多元醇而混合者加溫,同樣地記錄濁點。 An aqueous solution of a nonionic surfactant having a polyether chain in the hydrophilic part is heated, and the temperature at which the aqueous solution starts to be cloudy, that is, the cloud point is recorded. Next, a polyol was added to this aqueous solution and the mixture was heated, and the cloud point was similarly recorded.
相較於加入多元醇前的水溶液,加入後的水溶液之濁點較高時,加入的多元醇係評價為「使該水溶液之濁點上升」。 When the cloud point of the aqueous solution after the addition is higher than that of the aqueous solution before the addition of the polyol, the polyol added is evaluated as "increasing the cloud point of the aqueous solution".
反之,相較於加入多元醇前的水溶液,加入後的水溶液之濁點較低時,加入的多元醇係評價為「使該水溶液之濁點下降」。 Conversely, when the cloud point of the aqueous solution after the addition is lower than that of the aqueous solution before the addition of the polyol, the polyol added is evaluated as "decrease the cloud point of the aqueous solution".
作為使用於上述濁點之計測的在親水性部分具有聚醚鏈之非離子性界面活性劑,尤可例示在親水性部分具有聚乙二醇之非離子性界面活性劑。 As the nonionic surfactant having a polyether chain in the hydrophilic part used for the measurement of the cloud point, a nonionic surfactant having polyethylene glycol in the hydrophilic part can be particularly exemplified.
作為如此非離子系界面活性劑,具體而言,可例示聚氧乙烯油醚(POE(n)OE,n=3,10,15,20,23)(NIHON EMULSION(股)製)、POE(20)山梨糖醇酐單硬脂酸酯(東邦化學(股)製)、POE(20)丙三醇單硬脂酸酯(理研VITAMIN(股)製)、POE(10)單硬脂酸酯(日光化學(股)製)、聚丙三醇(6)單月桂酸酯(阪本藥品(股)製)。 As such a nonionic surfactant, specifically, polyoxyethylene oil ether (POE(n)OE, n=3,10,15,20,23) (manufactured by NIHON EMULSION), POE( 20) Sorbitan monostearate (manufactured by Toho Chemical Co., Ltd.), POE (20) glycerin monostearate (manufactured by Riken Vitamin Co., Ltd.), POE (10) monostearate (Sunlight Chemicals Co., Ltd.), polyglycerol (6) monolaurate (Sakamoto Pharmaceutical Co., Ltd.).
在本發明中,促進性多元醇及抑制性多元醇的質量比,較佳為10:1~1:10,進一步較佳為6:1~1:5,更佳為4:1~1:3,進一步更佳為3.5:1~1:2.5,特佳為1.6:1~1:1。 In the present invention, the mass ratio of the promoting polyol to the inhibiting polyol is preferably 10:1 to 1:10, more preferably 6:1 to 1:5, and even more preferably 4:1 to 1: 3. Further better is 3.5:1~1:2.5, and particularly good is 1.6:1~1:1.
藉由使促進性多元醇及抑制性多元醇的質量比成為前述範圍,可提供一種可形成具有高安定性之海島結構的被膜之組成物。 By setting the mass ratio of the promoting polyol and the inhibiting polyol to the aforementioned range, it is possible to provide a composition capable of forming a coating film having a high-stability sea island structure.
在本發明中,促進性多元醇及抑制性多元醇的總質量與兩親媒性共聚物的含有質量之比為5:1~20:1,更佳為7:1~15:1,特佳為8:1~12:1。 In the present invention, the ratio of the total mass of the promoting polyol and the suppressing polyol to the content of the amphiphilic copolymer is 5:1 to 20:1, more preferably 7:1 to 15:1. It is preferably 8:1~12:1.
藉由使促進性多元醇及抑制性多元醇的總質量與兩親媒性共聚物的質量之比成為前述範圍,可提供一種具有高安定性之海島結構的組成物。 By making the ratio of the total mass of the promoting polyol and the suppressing polyol to the mass of the amphiphilic copolymer into the aforementioned range, it is possible to provide a composition with a sea island structure with high stability.
又,在本發明中,促進性多元醇及抑制性多元醇的總質量與兩親媒性共聚物以及水溶性高分子的總質量之比為5:1~20:1,更佳為7:1~15:1,特佳為8:1~12:1。 Furthermore, in the present invention, the ratio of the total mass of the promoting polyol and the suppressing polyol to the total mass of the amphiphilic copolymer and the water-soluble polymer is 5:1 to 20:1, more preferably 7: 1~15:1, especially good is 8:1~12:1.
藉由使促進性多元醇及抑制性多元醇的總質量與兩親媒性共聚物的質量之比成為前述範圍,可提供一種具有高安定性之海島結構的組成物。 By making the ratio of the total mass of the promoting polyol and the suppressing polyol to the mass of the amphiphilic copolymer into the aforementioned range, it is possible to provide a composition with a sea island structure with high stability.
本發明之較佳的實施形態中,促進性多元醇、抑制性多元醇及兩親媒性共聚物之3成分的總量之促進性多元醇的含量,較佳為10~80質量%,進一步較佳為20~70質量%,更佳為30~70質量%,進一步更佳為40~60質量%,特佳為40~55質量%。 In a preferred embodiment of the present invention, the content of the promoting polyol in the total amount of the three components of the promoting polyol, the inhibiting polyol and the amphiphilic copolymer is preferably 10 to 80% by mass, further It is preferably 20 to 70% by mass, more preferably 30 to 70% by mass, even more preferably 40 to 60% by mass, and particularly preferably 40 to 55% by mass.
藉由使促進性多元醇之含量成為前述範圍,可防止於組成物中產生沉澱,且可提升組成物之安定性。又,如前述形態的組成物,可形成保濕性與柔軟性均佳的被膜。 By setting the content of the promoting polyol to the aforementioned range, it is possible to prevent precipitation in the composition and to improve the stability of the composition. In addition, as in the composition of the aforementioned form, a coating having excellent moisture retention and flexibility can be formed.
又,本發明之較佳的實施形態中,促進性多元醇、抑制性多元醇及兩親媒性共聚物之3成分的總量之抑制性多元醇的含量,較佳為10~80質量%,進一步較佳為20~70質量%,更佳為30~60質量%,特佳為35~50質量%。 Furthermore, in a preferred embodiment of the present invention, the content of the inhibitory polyol in the total amount of the three components of the promoting polyol, the inhibitory polyol and the amphiphilic copolymer is preferably 10 to 80% by mass It is further preferably 20 to 70% by mass, more preferably 30 to 60% by mass, and particularly preferably 35 to 50% by mass.
藉由使抑制性多元醇之含量成為前述範圍,可防止於組成物中產生沉澱,且可提升組成物之安定性。又,如前述形態的組成物,可形成保濕性與柔軟性均佳的被膜。 By setting the content of the inhibitory polyol within the aforementioned range, precipitation of the composition can be prevented, and the stability of the composition can be improved. In addition, as in the composition of the aforementioned form, a coating having excellent moisture retention and flexibility can be formed.
又,本發明之較佳的實施形態中,促進性多元醇、抑制性多元醇及兩親媒性共聚物之3成分的總量之兩親媒性共聚物的含量,較佳為1~50質量%,進一步較佳為3~20質量%,更佳為5~15質量%,特佳為8~12質量%。 Furthermore, in a preferred embodiment of the present invention, the content of the amphiphilic copolymer in the total amount of the three components of the promoting polyol, the inhibiting polyol and the amphiphilic copolymer is preferably 1 to 50 The mass% is further preferably 3-20 mass%, more preferably 5-15 mass%, and particularly preferably 8-12 mass%.
藉由使兩親媒性共聚物之含量成為前述範圍,可提供一種具有對肌膚容易塗布之黏性的組成物。又,如前述形態的組成物,可形成保濕性與柔軟性均佳的被膜。 By making the content of the amphiphilic copolymer into the aforementioned range, it is possible to provide a composition having viscosity that is easy to apply to the skin. In addition, as in the composition of the aforementioned form, a coating having excellent moisture retention and flexibility can be formed.
本發明之較佳的形態中,在促進性多元醇、抑制性多元醇及兩親媒性共聚物之3成分的總量中,促進性多元醇之含量為20~70質量%,抑制性多元醇之含量為20~70質量%,兩親媒性共聚物之含量為5~20質量%。 In a preferred form of the present invention, in the total amount of the three components of the promoting polyol, the inhibiting polyol, and the amphiphilic copolymer, the content of the promoting polyol is 20 to 70% by mass, and the inhibiting polyol The content of alcohol is 20 to 70% by mass, and the content of amphiphilic copolymer is 5 to 20% by mass.
藉由成為如此實施形態,可提升組成物之安定性。 By becoming such an embodiment, the stability of the composition can be improved.
又,藉由將促進性多元醇、抑制性多元醇及兩親媒性共聚物之3成分的總量之促進性多元醇的含量、抑制性多元醇的含量及兩親媒性共聚物的含量調整為前述範圍,可將藉由本發明的組成物形成的被膜之島粒子的長軸短軸比及平均粒徑調整為前述<1-3>的項目所記載之較佳的範圍。 In addition, by combining the total content of the three components of the promoting polyol, the suppressing polyol and the amphiphilic copolymer, the content of the promoting polyol, the content of the inhibiting polyol and the content of the amphiphilic copolymer By adjusting to the aforementioned range, the long-axis to short-axis ratio and average particle diameter of the island particles of the film formed by the composition of the present invention can be adjusted to the preferred ranges described in the above items <1-3>.
本發明的組成物,可藉由將原料在常溫中攪拌混合而製造。 The composition of the present invention can be produced by stirring and mixing the raw materials at room temperature.
本發明的組成物之水的含量,較佳為60~99質量%,更佳為70~95質量%,特佳為80~90質量%。 The water content of the composition of the present invention is preferably 60 to 99% by mass, more preferably 70 to 95% by mass, and particularly preferably 80 to 90% by mass.
藉由將水的含量為前述範圍之本發明的組成物塗布於肌膚,可輕易地將本發明的被膜形成於肌膚上。 By applying the composition of the present invention having a water content in the aforementioned range to the skin, the coating of the present invention can be easily formed on the skin.
本發明也關於一種將上述本發明的被膜形成於肌膚上之方法。 The present invention also relates to a method of forming the above-mentioned coating of the present invention on the skin.
本發明的方法,其特徵為將本發明的組成物塗布於肌膚。藉由利用塗布蒸發組成物中的水,可引起水溶性高分子形成的水性凝膠與兩親媒性共聚物相分離。該相分離的結果,可將具有本發明的海島結構之被膜形成於肌膚上。 The method of the present invention is characterized in that the composition of the present invention is applied to the skin. By using the water in the coating evaporation composition, the aqueous gel formed by the water-soluble polymer and the amphiphilic copolymer can be separated. As a result of this phase separation, a film having the sea-island structure of the present invention can be formed on the skin.
在本發明中,使用包含促進兩親媒性共聚物與水性凝膠之相分離的多元醇及/或抑制前述水性凝膠與前述兩親媒性共聚物之相分離的多元醇之水溶液較佳。 In the present invention, an aqueous solution containing a polyol that promotes the phase separation of the amphiphilic copolymer and the aqueous gel and/or a polyol that inhibits the phase separation of the aqueous gel and the amphiphilic copolymer is preferably used .
藉由使用如此水溶液,可將均一性佳的被膜形成於肌膚上。 By using such an aqueous solution, a uniform coating can be formed on the skin.
又,在本發明之組成物中,油‧蠟類、烴類、高級脂肪酸類、高級醇類、合成酯油類、矽酮系油劑類等之油劑的含量,較佳為2質量%以下,更佳為1質量%以下,特佳為成為0.5質量%以下。 Furthermore, in the composition of the present invention, the content of oils such as oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, synthetic ester oils, silicone oils, etc. is preferably 2% by mass Below, it is more preferably 1% by mass or less, and particularly preferably 0.5% by mass or less.
又,本發明之較佳的實施形態中,未含有油劑。 In addition, in a preferred embodiment of the present invention, no oil agent is contained.
又,在本發明之組成物中,界面活性劑的含量,較佳為2質量%以下,更佳為1質量%以下,特佳為成為0.5質量%以下。 In the composition of the present invention, the content of the surfactant is preferably 2% by mass or less, more preferably 1% by mass or less, and particularly preferably 0.5% by mass or less.
又,本發明之較佳的實施形態中,未含有界面活性劑。 Furthermore, in a preferred embodiment of the present invention, no surfactant is contained.
本發明的方法之組成物與被膜的較佳之形態係如上述<1>及<2>的項目所記載。 The preferred forms of the composition and coating of the method of the present invention are as described in the above items <1> and <2>.
以下表示前述通式(1)所示的疏水性單體之製造例。 The following shows a production example of the hydrophobic monomer represented by the general formula (1).
在3L之4口燒瓶,加入R)-(+)-2,2-二甲基-1,3-二氧雜環戊烷-4-甲醇(東京化成工業(股)製)79.5g、丙烯酸甲酯258.0g、四甲氧基鈦3.7g。然後,攪拌反應液,在液中一邊導入氮氣,一邊於105~110℃進行2.5小時酯交換反應。反應結束後,藉由利用減壓蒸餾的分餾,得到縮酮丙烯酸酯1(中間體1)。 In a 3-L 4-neck flask, add 79.5 g of R)-(+)-2,2-dimethyl-1,3-dioxolane-4-methanol (manufactured by Tokyo Chemical Industry Co., Ltd.), acrylic acid 258.0g of methyl ester and 3.7g of tetramethoxy titanium. Then, the reaction liquid was stirred, and while introducing nitrogen into the liquid, the transesterification reaction was carried out at 105 to 110° C. for 2.5 hours. After the reaction was completed, ketal acrylate 1 (intermediate 1) was obtained by fractional distillation using vacuum distillation.
在3L之4口燒瓶,加入水90.2g、陽離子交換樹脂RCP160M(三菱化學製)28.4ml、94.2g的中間體1。然後,攪拌反應液,在液中一邊導入氮氣,一邊於24℃進行27小時縮酮之去酮反應。反應結束後,自反應液濾別陽離子交換樹脂,將濾別的反應液以己烷100ml清洗6次,除去未反應的原料後,在水層加入乙酸乙酯200ml而萃取生成物。然後,將該乙酸乙酯萃取液,在減壓下(800Pa)、40℃以下餾去乙酸乙酯及水,得到單丙烯酸甘油酯。
In a 3-liter 4-neck flask, 90.2 g of water, 28.4 ml of cation exchange resin RCP160M (manufactured by Mitsubishi Chemical), and 94.2 g of
步驟(1):在裝設鈣管、冷卻管及Dean-Stark分離器之茄型燒瓶,加入三羥甲基丙烷145.7g、丙酮300ml、對甲苯磺酸1水合物3g及石油醚300ml,於設定為50℃的油浴中加熱回流。12小時後,確認沒有新生成的水分後,將反應混合物冷卻直到室溫。接著,加入脂肪酸鈉3g,並攪拌30分鐘後,利用蒸發器餾去石油醚及丙酮。將得到的粗生成物利用減壓蒸餾,得到縮酮化的三羥甲基丙烷(中間體2)。 Step (1): In an eggplant-shaped flask equipped with a calcium tube, a cooling tube and a Dean-Stark separator, add 145.7 g of trimethylolpropane, 300 ml of acetone, 3 g of p-toluenesulfonic acid monohydrate and 300 ml of petroleum ether. Heat to reflux in an oil bath set at 50°C. After 12 hours, after confirming that there was no newly formed moisture, the reaction mixture was cooled to room temperature. Next, 3 g of sodium fatty acid was added and stirred for 30 minutes, and petroleum ether and acetone were distilled off with an evaporator. The obtained crude product was distilled under reduced pressure to obtain ketalized trimethylolpropane (intermediate 2).
步驟(2):在3L之4口燒瓶,加入步驟(1)所得到的中間體2 104.8g、丙烯酸甲酯258.0g、四甲氧基鈦3.7g。然後,攪拌反應液,在液中一邊導入氮氣,一邊於105~110℃進行2.5小時酯交換反應。反應結束後,藉由利用減壓蒸餾的分餾,得到縮酮化的三羥甲基丙烷之丙烯酸酯(中間體3)。
Step (2): In a 3-L 4-neck flask, 104.8 g of
步驟(3):在3L之4口燒瓶,加入水90.2g、陽離子交換樹脂RCP160M(三菱化學製)28.4ml、步驟(2)所得到的中間體3 115.3g。然後,攪拌反應液,在液中一邊導入氮氣,一邊於24℃進行27小時縮酮之去酮反應。反應結束後,自反應液濾別陽離子交換樹脂,將濾別的反應液以己烷100ml清洗6次,除去未反應的原料後,在水層加入乙酸乙酯200ml而萃取生成物。然後,將該乙酸乙酯萃取液,在減壓下(800Pa)、40℃以下餾去乙酸乙酯及水,得到三羥甲基丙烷單丙烯酸酯。 Step (3): In a 3-L 4-neck flask, 90.2 g of water, 28.4 ml of cation exchange resin RCP160M (manufactured by Mitsubishi Chemical), and 115.3 g of intermediate 3 obtained in step (2) were added. Then, the reaction liquid was stirred, and while introducing nitrogen into the liquid, the ketal deketalization reaction was performed at 24°C for 27 hours. After the reaction was completed, the cation exchange resin was filtered from the reaction solution, and the filtered reaction solution was washed 6 times with 100 ml of hexane to remove unreacted raw materials, and 200 ml of ethyl acetate was added to the aqueous layer to extract the product. Then, the ethyl acetate extract was distilled off under reduced pressure (800 Pa) at 40° C. or lower to obtain ethyl trimethylolpropane monoacrylate.
除了將製造例2的三羥甲基丙烷、丙烯酸甲酯(丙烯酸酯)、步驟(1)所得到的中間體之加入量、步驟(2)所得到的中間體之加入量,如表1所示而變更以外,係進行與製造例2同樣的操作,合成三羥甲基丙烷單甲基丙烯酸酯。關於三元醇及其加入量、步驟(1)所得到的中間體及其加入量、步驟(2)所得到的中間體及其加入量,係示於表1。 In addition to the addition amount of trimethylolpropane, methyl acrylate (acrylate) of production example 2, intermediate obtained in step (1), and addition amount of intermediate obtained in step (2), as shown in Table 1. Except for the change shown, the same operation as in Production Example 2 was carried out to synthesize trimethylolpropane monomethacrylate. Table 1 shows the triol and the amount thereof, the intermediate obtained in step (1) and the amount thereof, and the intermediate obtained in step (2) and the amount thereof.
在具備攪拌機及冷卻管的反應容器,量取16-甲基十七酸(Sigma-Aldrich公司製)28.4g及亞硫醯氯35.7g(東京化成工業(股)製)、苯200ml並攪拌混合。一邊攪拌,一邊進行回流4小時後,進行利用減壓蒸餾的精製,得到16-甲基十七醯氯。 In a reaction vessel equipped with a stirrer and a cooling tube, measure 28.4g of 16-methylheptadecanoic acid (manufactured by Sigma-Aldrich) and 35.7g of thiosulfonyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200ml of benzene, and mix . After stirring and refluxing for 4 hours, purification by vacuum distillation was performed to obtain 16-methylheptadecyl chloride.
在具備攪拌裝置的反應容器中,將單甲基丙烯酸甘油酯「Blenmer GLM」(日本油脂(股)製)16.0g、三乙胺30.0g溶解於四氫呋喃300ml。將得到的溶液冰冷卻,一邊攪拌,一邊花費2小時滴加將上述所得到的16-甲基十七醯氯60.6g溶解於四氫呋喃100ml而成的溶液。滴加結束後,過濾生成的白色沉澱,使用旋轉蒸發器自濾液除去四氫呋喃及三乙胺而得到生成物。利用NMR測定,確認得到的化合物為下述式(29)所示之衍生本發明之共聚物的必要構成單元之疏水性單體(疏水性單體1)。 In a reaction vessel equipped with a stirring device, 16.0 g of glycerin monomethacrylate "Blenmer GLM" (manufactured by Nippon Oil & Fats Co., Ltd.) and 30.0 g of triethylamine were dissolved in 300 ml of tetrahydrofuran. The resulting solution was ice-cooled, and while stirring, a solution prepared by dissolving 60.6 g of 16-methylheptadecyl chloride obtained above in 100 ml of tetrahydrofuran was added dropwise over 2 hours. After the dropwise addition was completed, the resulting white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain a product. By NMR measurement, it was confirmed that the obtained compound was a hydrophobic monomer (hydrophobic monomer 1) derived from a necessary structural unit of the copolymer of the present invention represented by the following formula (29).
在具備攪拌機及冷卻管的反應容器,量取2-十六酸(Sigma-Aldrich公司製)25.6g及亞硫醯氯35.7g(東京化成工業(股)製)、苯200ml並攪拌混合。一邊攪拌,一邊進行回流4小時後,進行利用減壓蒸餾的精製,得到2-十六醯氯。 In a reaction vessel equipped with a stirrer and a cooling tube, 25.6 g of 2-hexadecanoic acid (manufactured by Sigma-Aldrich) and 35.7 g of thiosulfonyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200 ml of benzene were weighed and mixed with stirring. After stirring and refluxing for 4 hours, purification by vacuum distillation was performed to obtain 2-hexadecyl chloride.
在具備攪拌裝置的反應容器中,將單甲基丙烯酸甘油酯「Blenmer GLM」(日本油脂(股)製)16.0g、三乙胺30.0g溶解於四氫呋喃300ml。將得到的溶液冰冷卻,一邊攪拌,一邊花費2小時滴加將上述所得到的2-十六醯氯55.0g溶解於四氫呋喃100ml而成的溶液。滴加結束後,過濾生成的白色沉澱,使用旋轉蒸發器自濾液除去四氫呋喃及三乙胺而得到生成物。利用NMR測定,確認得到的化合物為下述式(30)所示之衍生本發明之共聚物的必要構成單元之疏水性單體(疏水性單體2)。 In a reaction vessel equipped with a stirring device, 16.0 g of glycerin monomethacrylate "Blenmer GLM" (manufactured by Nippon Oil & Fats Co., Ltd.) and 30.0 g of triethylamine were dissolved in 300 ml of tetrahydrofuran. The resulting solution was ice-cooled, and while stirring, a solution prepared by dissolving 55.0 g of 2-hexadecanoyl chloride obtained above in 100 ml of tetrahydrofuran was added dropwise over 2 hours. After the dropwise addition was completed, the resulting white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain a product. By NMR measurement, it was confirmed that the obtained compound was a hydrophobic monomer (hydrophobic monomer 2) derived from a necessary structural unit of the copolymer of the present invention represented by the following formula (30).
在具備攪拌機及冷卻管的反應容器,量取9-甲基十七酸(Sigma-Aldrich公司製)28.4g及亞硫醯氯35.7g(東京化成工業(股)製)、苯200ml並攪拌混合。一邊攪拌,一邊進行回流4小時後,進行利用減壓蒸餾的精製,得到9-甲基十七醯氯。 In a reaction vessel equipped with a stirrer and a cooling tube, measure 28.4 g of 9-methylheptadecanoic acid (manufactured by Sigma-Aldrich) and 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200 ml of benzene, and mix by stirring . After stirring and refluxing for 4 hours, purification by vacuum distillation was performed to obtain 9-methylheptadecyl chloride.
在具備攪拌裝置的反應容器中,將單甲基丙烯酸甘油酯「Blenmer GLM」(日本油脂(股)製)16.0g、三乙胺30.0g溶解於四氫呋喃300ml。將得到的溶液冰冷卻,一邊攪拌,一邊花費2小時滴加將上述所得到的9-甲基十七醯氯60.6g溶解於四氫呋喃100ml而成的溶液。滴加結束後,過濾生成的白色沉澱,使用旋轉蒸發器自濾液除去四氫呋喃及三乙胺而得到生成物。利用NMR測定,確認得到的化合物為下述式(31)所示之衍生本發明之共聚物的必要構成單元之疏水性單體(疏水性單體3)。 In a reaction vessel equipped with a stirring device, 16.0 g of glycerin monomethacrylate "Blenmer GLM" (manufactured by Nippon Oil & Fats Co., Ltd.) and 30.0 g of triethylamine were dissolved in 300 ml of tetrahydrofuran. The resulting solution was ice-cooled, and a solution prepared by dissolving 60.6 g of 9-methylheptadecyl chloride obtained above in 100 ml of tetrahydrofuran was added dropwise over 2 hours while stirring. After the dropwise addition was completed, the resulting white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain a product. It was confirmed by NMR measurement that the obtained compound was a hydrophobic monomer (hydrophobic monomer 3) derived from a necessary structural unit of the copolymer of the present invention represented by the following formula (31).
在具備氮導入管、冷卻器及攪拌裝置的燒瓶,量取疏水性單體1(製造例4)24.0g、甲氧基聚乙二醇(23)甲基丙烯酸酯(日本油脂(股)製、商品名「Blenmer PME-1000」)90.0g、異丙醇300ml、磷酸鹽緩衝溶液(pH6.8)(NACALAI TESQUE(股)製)300ml並攪拌混合。 一邊攪拌,一邊進行氮氣取代1小時。對其加入將過硫酸銨2.0g溶解於20ml的溶液,並且持續攪拌,同時在65℃進行10小時反應(以同條件合成進行16小時反應的比較例1之共聚物)。反應結束後,使用氫氧化鈉水溶液,將pH調整為7.0,以旋轉蒸發器除去異丙醇,得到實施例1的共聚物之水溶液(以同條件處理,得到比較例1的共聚物之水溶液)。 In a flask equipped with a nitrogen introduction tube, a cooler and a stirring device, measure 24.0 g of hydrophobic monomer 1 (Production Example 4) and methoxypolyethylene glycol (23) methacrylate (manufactured by Nippon Oil & Fats Co., Ltd.) , Trade name "Blenmer PME-1000") 90.0g, isopropyl alcohol 300ml, phosphate buffer solution (pH 6.8) (made by NACALAI TESQUE (share)) 300ml and stirred to mix. While stirring, nitrogen substitution was performed for 1 hour. A solution in which 2.0 g of ammonium persulfate was dissolved in 20 ml was added thereto, and the reaction was continued for 10 hours at 65° C. (the copolymer of Comparative Example 1 was synthesized under the same conditions for 16 hours). After the reaction, the aqueous solution of sodium hydroxide was used to adjust the pH to 7.0, and the isopropyl alcohol was removed by a rotary evaporator to obtain an aqueous solution of the copolymer of Example 1 (treated under the same conditions to obtain an aqueous solution of the copolymer of Comparative Example 1) .
將實施例1的共聚物之重量平均分子量(聚苯乙烯換算)以GPC求出時為61000。又,利用NMR測定時,構成單元(a)與構成單元(b)的質量比約3:7。 The weight average molecular weight (in terms of polystyrene) of the copolymer of Example 1 was determined by GPC to be 61,000. In addition, when measured by NMR, the mass ratio of the constituent unit (a) to the constituent unit (b) is about 3:7.
另一方面,比較例1之共聚物的重量平均分子量為122500,構成單元(a)與構成單元(b)的質量比約3:7。 On the other hand, the weight average molecular weight of the copolymer of Comparative Example 1 was 122500, and the mass ratio of the structural unit (a) to the structural unit (b) was about 3:7.
藉由與上述(1)同樣的方法,合成具有表2所示的結構、重量平均分子量、構成單元(a)與構成單元(b)的質量比之共聚物。共聚物之重量平均分子量,係藉由變更反應時間而調整。又,構成單元(a)與構成單元(b)的質量比,可藉由調整在反應液添加之疏水性單體與親水性單體的加入量之莫耳比而調節。 By the same method as the above (1), a copolymer having a structure shown in Table 2, a weight average molecular weight, and a mass ratio of the structural unit (a) to the structural unit (b) was synthesized. The weight average molecular weight of the copolymer is adjusted by changing the reaction time. In addition, the mass ratio of the constituent unit (a) to the constituent unit (b) can be adjusted by adjusting the molar ratio of the addition amounts of the hydrophobic monomer and the hydrophilic monomer added to the reaction solution.
再者,實施例2~6為使用疏水性單體1合成的共聚物。又,實施例7為使用疏水性單體2合成的共聚物,實施例8為使用疏水性單體3合成的共聚物。
Furthermore, Examples 2 to 6 are copolymers synthesized using
製備實施例1~6及比較例1的共聚物之2質量%水溶液。將各別的共聚物水溶液塗布於3名專門感官評價者的肌膚,針對彈力感,以下述的基準進行評價。將結果示於表3。 A 2% by mass aqueous solution of the copolymers of Examples 1 to 6 and Comparative Example 1 was prepared. Each copolymer aqueous solution was applied to the skin of three specialized sensory evaluators, and the elasticity was evaluated according to the following criteria. The results are shown in Table 3.
◎...有非常強的彈力感 ◎...has a very strong sense of elasticity
○...有強的彈力感 ○...has a strong sense of elasticity
△...有彈力感 △...with elasticity
×...不太有彈力感 ×...not very elastic
如表3所示,比較構成單元(a)之構造相同的實施例1~6與比較例1的共聚物時,實施例1~6的共聚物水溶液,相較於比較例1的共聚物水溶液,具有很強的彈力感。特別是實施例1、5及6之本發明的共聚物,具有非常強的彈力感。 As shown in Table 3, when the copolymers of Examples 1 to 6 and Comparative Example 1 having the same constitutional unit (a) are compared, the copolymer aqueous solutions of Examples 1 to 6 are compared to the copolymer aqueous solutions of Comparative Example 1. , Has a strong sense of elasticity. In particular, the copolymers of the invention of Examples 1, 5 and 6 have a very strong elasticity.
以上的結果顯示包含重量平均分子量為20000~110000,特佳為57000~66000之構成單元(a)與構成單元(b)的共聚物,其彈力感佳。 The above results show that the copolymer containing the structural unit (a) and the structural unit (b) having a weight average molecular weight of 20,000 to 110,000, and particularly preferably 57,000 to 66000, has a good elasticity.
採用與試驗例1同樣的方法,針對實施例7及8的共聚物,也進行評價彈力感。其結果,可知實施例7及8的共聚物也具備彈力感。 Using the same method as in Test Example 1, the copolymers of Examples 7 and 8 were also evaluated for elasticity. As a result, it can be seen that the copolymers of Examples 7 and 8 also have an elastic feeling.
該結果顯示即使對構成單元(a)之結構進行種種變更,也可得到具有彈力感的共聚物。 This result shows that even if the structure of the constituent unit (a) is changed variously, a copolymer having elasticity can be obtained.
在實施例1的共聚物或比較例1的共聚物之2質量%水溶液添加0.5質量%的三仙膠,製備凝膠狀化妝品。將該凝膠狀化妝品塗布於與試驗例1相同之3名專門感官評價者的肌膚,針對無黏膩感、彈力感、及濕潤感進行評價。評價係將在肌膚塗布包含三異硬脂酸三羥甲基丙烷的乳液(基準化妝品)時之使用感作為基準,以下述的評價基準進行。將利用3名評價者的評價值之平均值示於表4及第1圖。 To the 2% by mass aqueous solution of the copolymer of Example 1 or the copolymer of Comparative Example 1, 0.5% by mass of Sanxian gum was added to prepare a gel-like cosmetic. This gel-like cosmetic was applied to the skin of three specialized sensory evaluators similar to Test Example 1, and evaluated for non-sticky feeling, elastic feeling, and moist feeling. The evaluation was based on the feeling of use when applying an emulsion (reference cosmetics) containing trimethyl stearic acid trimethylolpropane to the skin, and the evaluation criteria described below were used. The average value of the evaluation values by three evaluators is shown in Table 4 and Figure 1.
4點...相較於基準化妝品原料之觸感,更佳 4 points...Compared with the touch of the benchmark cosmetic raw materials, better
3點...與基準化妝品原料同程度之觸感 3 points...the same level of touch as the standard cosmetic ingredients
2點...接近基準化妝品原料之觸感,但稍差 2 points...close to the touch of the basic cosmetic ingredients, but slightly worse
1點...相較於基準化妝品原料之觸感,較差 1 point...comparable to the touch of the benchmark cosmetic raw materials, worse
0點...相較於基準化妝品原料之觸感,相當差 0 points...comparable to the touch of the benchmark cosmetic ingredients, quite poor
如表4及第1圖所示,實施例1的凝膠狀化妝品,相較於比較例1的凝膠狀化妝品,彈力性顯著強,而且,在無黏膩感與濕潤感中也佳。 As shown in Table 4 and FIG. 1, the gel-like cosmetics of Example 1 are significantly more elastic than the gel-like cosmetics of Comparative Example 1, and they are also excellent in non-sticky feeling and moist feeling.
該結果顯示包含重量平均分子量為20000~110000之構成單元(a)與構成單元(b)的共聚物,以彈力感為首,無黏膩感與濕潤感也佳。 The results show that the copolymer containing the structural unit (a) and the structural unit (b) having a weight average molecular weight of 20,000 to 110,000, with elasticity as the first priority, is not sticky and moist.
藉由將下述表5~7的成分攪拌混合,製造乳化組成物。 By stirring and mixing the components of Tables 5 to 7 below, an emulsified composition was produced.
再者,在本實施例中,作為本發明之乳化劑的水溶性共聚物,使用將疏水性單體之二異硬脂酸甘油酯甲基丙烯酸酯與親水性單體之甲基丙烯酸甲氧酯PEG-23,以約3:7的質量比共聚合之平均分子量61000的(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物。 Furthermore, in this embodiment, as the water-soluble copolymer of the emulsifier of the present invention, methacrylic acid methacrylate, which is a hydrophobic monomer diglyceryl diisostearate, and a hydrophilic monomer, are used. Ester PEG-23 is a copolymer of (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) with an average molecular weight of 61,000 copolymerized at a mass ratio of about 3:7.
又,作為水溶性共聚物,使用聚氧丙烯(聚合度60)及聚氧乙烯(平均聚合度11)與丙三醇之醚的PEG/PPG-60/11丙三醇(ADEKANOL M-3228)製造組成物(比較例2、4、6)。 As a water-soluble copolymer, PEG/PPG-60/11 glycerin (ADEKANOL M-3228) of polyoxypropylene (degree of polymerization 60) and polyoxyethylene (average degree of polymerization 11) and ether of glycerin is used The composition (Comparative Examples 2, 4, 6) was produced.
而且,使用聚氧乙烯硬化蓖麻油作為界面活性劑製造乳化組成物(比較例3、5、7)。 Furthermore, polyoxyethylene hardened castor oil was used as a surfactant to produce an emulsified composition (Comparative Examples 3, 5, and 7).
將實施例9~31之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙酸甲氧酯PEG-23)共聚物與鯊烷及水之摻合比率製圖的3成分系相圖示於第2圖。 The three-component system phase diagram plotting the blend ratio of the glyceryl diisostearate methacrylate/methoxymethyl propionate PEG-23 copolymers of Examples 9 to 31 with squalane and water Shown in Figure 2.
將實施例32~62之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙酸甲氧酯PEG-23)共聚物與三(辛酸/癸酸)甘油酯及水之摻合比率製圖的3成分系相圖示於第3圖。 Blending ratio of the copolymers of (glyceryl diisostearate methacrylate/methoxymethyl propionate PEG-23) of Examples 32 to 62 with tri(octanoic acid/capric acid) glyceride and water The three-component system phase diagram of the drawing is shown in FIG. 3.
將實施例63~89之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙酸甲氧酯PEG-23)共聚物與矽靈及水之摻合比率製圖的3成分系相圖示於第4圖。 A 3-component system phase diagram plotting the blending ratio of the copolymers of Examples 63-89 (glyceryl diisostearate methacrylate/methoxymethyl methionate PEG-23) with silin and water Shown in Figure 4.
實施例9~89之乳化組成物,即使在室溫保管3個月後也顯示安定的乳化形態。亦即,藉由(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,即使在使用非極性之烴油的鯊烷、極性之烴油的三(辛酸/癸酸)甘油酯、以及矽酮油之任一油劑的情況中,也可製造安定的乳化組成物。 The emulsified compositions of Examples 9 to 89 showed stable emulsified forms even after storage at room temperature for 3 months. That is, with the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer, even in the use of non-polar hydrocarbon oil squalane, polar hydrocarbon oil three In the case of (octanoic acid/capric acid) glyceride and silicone oil, stable emulsified compositions can also be produced.
另一方面,包含水溶性共聚物之PEG/PPG-60/11丙三醇的比較例2、4及6的組成物,即使攪拌混合也無法乳化,製造後,立刻完全地分離為油相與水相。 On the other hand, the compositions of Comparative Examples 2, 4 and 6 of PEG/PPG-60/11 glycerin containing a water-soluble copolymer cannot be emulsified even after stirring and mixing, and immediately after production, they were completely separated into an oil phase and water box.
該結果顯示根據本發明之乳化劑的水溶性共聚物,使用種種的油劑,可製造安定的乳化組成物。 This result shows that the water-soluble copolymer of the emulsifier according to the present invention can produce a stable emulsified composition using various oils.
又,如表5~7所示,(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量,即使為1~30質量%之任一配方,也可製造乳化組成物。 In addition, as shown in Tables 5 to 7, the content of (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer is any formula of 1 to 30% by mass , Can also produce emulsified compositions.
又,如表5~7所示,即使油相的含量為10~70質量%之任一情況,也可製造乳化組成物。 Furthermore, as shown in Tables 5 to 7, even if the content of the oil phase is any of 10 to 70% by mass, an emulsified composition can be produced.
將實施例9~89與比較例3、5、7適量塗布於肌膚。其結果,實施例9~89之乳化組成物,相較於比較例3、5、7的乳化組成物,沒有刺激感,而且,黏膩感少。 Appropriate amounts of Examples 9 to 89 and Comparative Examples 3, 5, and 7 were applied to the skin. As a result, the emulsified compositions of Examples 9 to 89 had no irritation and were less sticky than the emulsified compositions of Comparative Examples 3, 5, and 7.
該結果顯示藉由本發明之乳化劑的水溶性共聚物乳化的乳化組成物,相較於藉由界面活性劑而乳化之一般的乳化組成物,使用感佳。 This result shows that the emulsified composition emulsified by the water-soluble copolymer of the emulsifier of the present invention has a better usability than the general emulsified composition emulsified by the surfactant.
特別是(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量為15質量%,更佳為1質量%之實施例的乳化組成物,具有更優異的使用感。 In particular, the emulsified composition of the embodiment in which the content of the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer is 15% by mass, more preferably 1% by mass, has More excellent sense of use.
依據以下所示的配方,製造實施例90~92及比較例8、9的洗面乳。亦即,藉由將α、β的成分各別加溫至80℃,在攪拌下對α加入β並攪拌,且進行冷卻而得到洗面乳。 The facial cleansers of Examples 90 to 92 and Comparative Examples 8 and 9 were manufactured according to the recipes shown below. That is, by separately heating the components of α and β to 80° C., adding β to α while stirring and stirring, and cooling, a facial cleanser is obtained.
再者,作為水溶性共聚物,使用將疏水性單體之二異硬脂酸甘油酯甲基丙烯酸酯與親水性單體之甲基丙烯酸甲氧酯PEG-23,以約3:7的莫耳比共聚合之平均分子量61000的(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物。 In addition, as the water-soluble copolymer, glyceryl diisostearate methacrylate, which is a hydrophobic monomer, and methoxymethacrylate PEG-23, which is a hydrophilic monomer, were used in an amount of about 3:7. Copolymer of (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) with an average molecular weight of 61,000.
令熟練的評價者,使用實施例90~92及比較例8、9的洗面乳,進行洗臉,將使用時之起泡性及其泡沫品質與洗臉後的肌膚之無緊繃感及無黏滑感,根據以下的評價基準進行評價。將結果示於表8。 Let a skilled evaluator use the facial cleansers of Examples 90 to 92 and Comparative Examples 8 and 9 to wash the face. The foamability and foam quality during use and the non-tightness and stickiness of the skin after washing The feeling was evaluated according to the following evaluation criteria. The results are shown in Table 8.
◎...非常好起泡 ◎...very good lathering
○...好起泡 ○...so bubbly
△...起泡弱 △...weak foaming
×...沒有起泡 ×...no blistering
◎...非常綿密的泡沫品質 ◎...very dense foam quality
○...綿密的泡沫品質 ○...Dense foam quality
△...不太綿密 △...not too dense
△...不綿密 △...not dense
◎...沒有緊繃感 ◎...no tension
○...幾乎沒有緊繃感 ○...Almost no tightness
△...有緊繃感 △...with a sense of tension
×...有很強的緊繃感 ×... has a strong sense of tension
◎...沒有黏滑感 ◎...no stickiness
○...幾乎沒有黏滑感 ○... almost no sticky slip
△...有黏滑感 △...Slim and slippery
×...有很強的黏滑感 ×... has a strong sticky slip
如表8所示,比較例8的洗面乳,在洗臉後於肌膚有很強的緊繃感,另一方面,實施例90~92的洗面乳,在洗臉後幾乎沒有緊繃感。 As shown in Table 8, the facial cleanser of Comparative Example 8 has a strong feeling of tightness on the skin after washing the face. On the other hand, the facial cleansers of Examples 90 to 92 have almost no tightness after washing the face.
該結果顯示藉由(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,可減低起因於脂肪酸皂之肌膚的緊繃感。 This result shows that the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer can reduce the tightness of the skin due to fatty acid soap.
又,在包含水溶性高分子之羧甲基纖維素以代替(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的比較例9之洗面乳中,沒有看到脂肪酸皂的優點之良好的起泡性。另一方面,實施例90~92的洗面乳顯示良好的起泡性。 Also, in the facial cleanser of Comparative Example 9 containing carboxymethylcellulose of a water-soluble polymer instead of (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer No good foaming properties of fatty acid soap are seen. On the other hand, the facial cleansers of Examples 90 to 92 showed good foamability.
該結果顯示根據(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,不會阻礙脂肪酸皂之良好的起泡性,且可減低使用後之肌膚的緊繃感。 This result shows that according to the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer, it does not hinder the good foamability of the fatty acid soap and can reduce the skin after use Sense of tightness.
又,如表8所示,實施例91及92的洗面乳較比較例8的洗面乳顯示更優異的起泡性。 In addition, as shown in Table 8, the facial cleansing agents of Examples 91 and 92 showed more excellent foaming properties than the facial cleansing agent of Comparative Example 8.
該結果顯示藉由使(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量成為0.8質量%以上,可提升脂肪酸皂之起泡性。 This result shows that by making the content of the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer 0.8% by mass or more, the foamability of the fatty acid soap can be improved.
又,如表8所示,比較例9的洗面乳,在洗臉後於肌膚有很強的黏滑感。另一方面,實施例90~92的洗面乳,在洗臉後幾乎沒有黏滑感。 In addition, as shown in Table 8, the facial cleanser of Comparative Example 9 has a strong sticky feeling on the skin after washing the face. On the other hand, the facial cleansers of Examples 90 to 92 showed little stickiness after washing the face.
該結果顯示根據(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,不會產生黏滑感,且可減低皮膚清潔劑之使用後的肌膚之緊繃感。 The results show that according to the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer, it does not produce a sticky feeling, and can reduce the skin after the use of the skin cleanser Feeling tight.
又,如表8所示,實施例90及91的洗面乳,與實施例92的洗面乳相比,無黏滑感更佳。 In addition, as shown in Table 8, the facial cleansers of Examples 90 and 91 had better stickiness and slippery properties than the facial cleansers of Example 92.
該結果顯示藉由使(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量成為3質量%以下,不會產生黏滑感,且可減低皮膚清潔劑之使用後的肌膚之緊繃感。 This result shows that by adjusting the content of the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer to 3% by mass or less, no sticky-slip feeling is generated and the reduction can be achieved The tightness of the skin after using skin cleanser.
藉由將示於表9的成分攪拌混合,得到實施例93~96及比較例10~12的凝膠洗面乳。 By stirring and mixing the ingredients shown in Table 9, the gel facial cleansers of Examples 93 to 96 and Comparative Examples 10 to 12 were obtained.
與試驗例4相同,令熟練的評價者,使用凝膠洗面乳,進行洗臉,將清潔力、使用時之對肌膚的 延展易度、洗臉後之肌膚的無緊繃感,根據以下的評價基準進行評價(無緊繃感之評價基準與試驗例4相同)。將結果示於表9。 As in Test Example 4, the skilled evaluator was asked to use a gel facial cleanser to wash his face and apply the cleansing power to the skin The ease of extension and the non-tight feeling of the skin after washing the face were evaluated according to the following evaluation criteria (the evaluation criteria of the non-tight feeling were the same as in Test Example 4). The results are shown in Table 9.
◎...清潔力非常強 ◎...cleaning power is very strong
○...清潔力強 ○...strong cleaning power
△...清潔力弱 △...weak cleaning power
×...清潔力非常弱 ×...cleaning power is very weak
◎...非常容易延展 ◎...very easy to extend
○...容易延展 ○...easy to extend
△...不易延展 △...not easy to extend
×...非常不易延展 ×...very difficult to extend
如表9所示,比較例10及11的凝膠洗面乳,在洗臉後於肌膚有很強的緊繃感,另一方面,實施例93~96的洗面乳,在洗臉後幾乎沒有緊繃感。 As shown in Table 9, the gel facial cleansers of Comparative Examples 10 and 11 have a strong feeling of tightness on the skin after washing the face. On the other hand, the facial cleansing creams of Examples 93 to 96 showed little tightness after washing the face sense.
該結果顯示藉由(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,可減低起因於非離子性界面活性劑之肌膚的緊繃感。 This result shows that the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer can reduce the skin tightness caused by the nonionic surfactant.
又,如表9所示,實施例94及95的凝膠洗面乳,相較於實施例93的凝膠洗面乳,使用後之肌膚的緊繃感之減低效果佳。 In addition, as shown in Table 9, the gel facial cleansers of Examples 94 and 95 had a better effect of reducing the tightness of the skin after use compared to the gel facial cleansing of Example 93.
該結果顯示藉由使(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量成為0.7質量%以上,可更有效地減低使用後的肌膚之緊繃感。 This result shows that by making the content of the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer 0.7% by mass or more, the skin after use can be more effectively reduced Feeling tight.
又,如表9所示,實施例93~96的凝膠洗面乳,相較於比較例10~12的凝膠洗面乳,清潔力佳。 In addition, as shown in Table 9, the gel facial cleansers of Examples 93 to 96 have better cleaning power than the gel facial cleansers of Comparative Examples 10 to 12.
該結果顯示根據(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,可提升包含非離子性界面活性劑的皮膚清潔劑之清潔力。 This result shows that according to the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer, the cleansing power of a skin cleanser containing a nonionic surfactant can be improved.
而且,實施例95的凝膠洗面乳,相較於實施例93及94的凝膠洗面乳,清潔力佳。 Furthermore, the gel facial cleanser of Example 95 has better cleaning power than the gel facial cleanser of Examples 93 and 94.
該結果顯示藉由使(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量成為2質量%以上,可提升包含非離子性界面活性劑的皮膚清潔劑之清潔力。 This result shows that by adjusting the content of the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer to 2% by mass or more, it is possible to increase the content of nonionic surfactants. The cleansing power of skin cleansers.
又,如表9所示,實施例94的凝膠洗面乳,相較於實施例93及95的凝膠洗面乳,對肌膚之延展易度佳。 In addition, as shown in Table 9, the gel facial cleanser of Example 94 has better spreadability to the skin than the gel facial cleanser of Examples 93 and 95.
該結果顯示藉由使(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物的含量成為0.6~3質量%,可提升凝膠洗面乳之使用時的對肌膚之延展易度。 This result shows that by adjusting the content of the (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer to 0.6 to 3% by mass, the use of the gel facial cleanser can be improved The ease of extension to the skin.
又,實施例91的凝膠洗面乳與實施例93的凝膠洗面乳,非離子性界面活性劑的含量相當,但其種類不同。但是,如表9所示,該等2種凝膠洗面乳,在清潔力、對肌膚之延展易度、無緊繃感中,顯示同等的效果。 In addition, the gel facial cleanser of Example 91 and the gel facial cleanser of Example 93 have the same content of nonionic surfactant, but the types are different. However, as shown in Table 9, these two types of gel facial cleansers exhibited the same effects in terms of cleansing power, ease of extension to the skin, and no tightness.
該結果顯示在皮膚清潔劑含有(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物導致 之有利的效果,不會被皮膚清潔劑所含的界面活性劑之種類左右。 This result shows that the skin cleanser contains (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer. The advantageous effect is not influenced by the type of surfactant contained in the skin cleanser.
試驗例4及5的結果顯示根據本發明,可減低皮膚清潔劑之使用後的肌膚之緊繃感。 The results of Test Examples 4 and 5 show that according to the present invention, the feeling of tightness of the skin after use of the skin cleanser can be reduced.
又,根據本發明,顯示不會損及良質的起泡性、綿密的泡沫品質、清潔力,而且,不會損及對肌膚之延展易度等之皮膚清潔劑本來具有之有利的效果,或者可在提升前述效果的同時,減低使用後的肌膚之緊繃感。 In addition, according to the present invention, it shows that the good effects of a skin cleanser that does not impair good foamability, dense foam quality, and cleansing power, and does not impair the ease of extension to the skin, or While enhancing the aforementioned effects, it reduces the tightness of the skin after use.
根據示於表10的配方,將實施例98~103及比較例13~15之水中油型的防曬化妝品藉由以下的方法進行製造。 Based on the formulation shown in Table 10, the oil-in-water sunscreen cosmetics of Examples 98 to 103 and Comparative Examples 13 to 15 were produced by the following method.
混合、加熱溶解(I)而製備油相成分之混合物,使用分散器分散疏水化處理微粒氧化鈦。 Mix and dissolve (I) by heating to prepare a mixture of oil phase components, and use a disperser to disperse the hydrophobized titanium oxide particles.
接著,在加熱的(II)添加(I),並以均質機進行乳化。乳化後,藉由添加(III)與(IV),一邊攪拌混合一邊進行冷卻,製造防曬化妝品。 Next, (I) is added to the heated (II) and emulsified with a homogenizer. After emulsification, by adding (III) and (IV) and cooling while stirring and mixing, a sunscreen cosmetic is manufactured.
再者,在本實施例中,作為成分(A)的水溶性共聚物,使用將疏水性單體之二異硬脂酸甘油酯甲基丙烯酸酯與親水性單體之甲基丙烯酸甲氧酯PEG-23,以約3:7的莫耳比共聚合之平均分子量61000的(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物。 Furthermore, in this example, as the water-soluble copolymer of component (A), glyceryl diisostearate methacrylate, which is a hydrophobic monomer, and methoxy methacrylate, which is a hydrophilic monomer, are used. PEG-23, a copolymer of (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) with an average molecular weight of 61,000 copolymerized at a molar ratio of about 3:7.
針對製備的實施例97~102及比較例13~15之水中油型的防曬化妝品,對於乳化安定性與使用時之無黏膩感、保濕感,根據以下的基準進行評價。將結果示於表10。 The water-in-oil type sunscreen cosmetics prepared in Examples 97 to 102 and Comparative Examples 13 to 15 were evaluated according to the following criteria for emulsification stability and non-sticky feeling and moisturizing feeling during use. The results are shown in Table 10.
◎...完全無法確認油相之分離 ◎...the separation of the oil phase cannot be confirmed at all
○...幾乎無法確認油相之分離 ○...It is almost impossible to confirm the separation of the oil phase
△...在製劑的表面浮出油膜 △...An oil film floats on the surface of the preparation
×...明確地觀察到油相之分離 ×... The separation of the oil phase is clearly observed
◎...完全無黏膩感 ◎...no stickiness at all
○...幾乎無黏膩感 ○... almost no stickiness
△...有黏膩感 △...Sticky
×...相當有黏膩感 ×... quite sticky
◎...濕潤感非常強 ◎...Moisture is very strong
○...濕潤感強 ○...Strong moisture
△...濕潤感弱 △...wetting feeling
×...濕潤感非常弱 ×...wetting is very weak
如表10所示,包含成分(A)~(D)全部之實施例97~102的水中油型之防曬化妝品,具有良好的乳化安定性、無黏膩感,而且具有保濕感。 As shown in Table 10, the oil-in-water sunscreen cosmetics of Examples 97 to 102 containing all the components (A) to (D) have good emulsification stability, no stickiness, and moisturizing feeling.
另一方面,未包含成分(A)之比較例13的防曬化妝品,黏膩感相當強。又,未包含成分(B)之比較例14的 防曬化妝品與未包含成分(C)之比較例15的防曬化妝品,乳化安定性均差。 On the other hand, the sunscreen cosmetic of Comparative Example 13 which does not contain the component (A) has a very strong sticky feeling. In addition, Comparative Example 14 which does not contain the component (B) The sunscreen cosmetics and the sunscreen cosmetics of Comparative Example 15 not containing the component (C) had poor emulsification stability.
該等之結果顯示包含成分(A)~(D)之水中油型的防曬化妝品,具有優異的乳化安定性與無黏膩感,而且具有保濕性。 These results show that the oil-in-water sunscreen cosmetics containing ingredients (A) to (D) have excellent emulsification stability and non-sticky feeling, and have moisturizing properties.
又,如表10所示,包含硬脂基乳酸鈉作為成分(C)之實施例97的防曬化妝品,相較於包含椰油酸甘油酯硫酸鈉作為成分(C)之實施例100的防曬化妝品,乳化安定性較佳。 Furthermore, as shown in Table 10, the sunscreen cosmetic of Example 97 containing sodium stearyl lactate as the component (C) is compared with the sunscreen cosmetic of Example 100 containing sodium glyceryl cocoate as the component (C), Emulsion stability is better.
該結果顯示包含醯基乳酸鈉作為成分(C)之水中油型的防曬化妝品,乳化安定性佳。 The result shows that the oil-in-water sunscreen cosmetics containing sodium lactyl lactate as the component (C) have good emulsification stability.
又,如表10所示,包含五硬脂酸聚丙三醇酯-10作為成分(B)之實施例97的防曬化妝品,相較於包含三硬脂酸聚丙三醇酯-10作為成分(B)之實施例101的防曬化妝品,乳化安定性較優異。 In addition, as shown in Table 10, the sunscreen cosmetic of Example 97 containing polyglycerol pentastearate-10 as the component (B) compared with the polyglycerol tristearate-10 as the component (B ) Of the sunscreen cosmetics of Example 101 has excellent emulsification stability.
該結果顯示包含五硬脂酸聚丙三醇酯-10作為成分(B)之水中油型的防曬化妝品,乳化安定性佳。 The result shows that the oil-in-water sunscreen cosmetics containing polyglycerol pentastearate-10 as the component (B) have good emulsification stability.
又,如表10所示,包含聚丙烯酸鈉被覆微粒二氧化鈦作為成分(D)的紫外線散射劑之實施例97的防曬化妝品,相較於未含有該被覆微粒二氧化鈦之實施例102的防曬化妝品,保濕感較優異。 In addition, as shown in Table 10, the sunscreen cosmetic of Example 97 containing the ultraviolet scattering agent coated with sodium polyacrylate particulate titanium dioxide as the component (D) is more moisturizing than the sunscreen cosmetic of Example 102 not containing the coated particulate titanium dioxide. Feel better.
該結果顯示包含利用聚丙烯酸鈉進行表面處理的紫外線散射劑,亦即,包含水分散性的紫外線散射劑作為成分(D)之水中油型的防曬化妝品,具有優異的保濕感。 This result shows that the UV-scattering agent containing surface treatment with sodium polyacrylate, that is, the oil-in-water sunscreen cosmetics containing water-dispersible UV-scattering agent as component (D), has an excellent moisturizing feeling.
又,實施例102的防曬化妝品,相較於成分(B)之含量各別為0.3質量%及7質量%的實施例98及實施例99之防曬化妝品,乳化安定性、無黏膩感均較優異。 In addition, the sunscreen cosmetics of Example 102, compared with the sunscreen cosmetics of Examples 98 and 99, in which the content of component (B) was 0.3% by mass and 7% by mass, respectively, the emulsion stability and non-sticky feeling Excellent.
該結果顯示成分(B)之含量,從乳化安定性之提升的觀點,設為0.5質量%以上較佳,而且,從黏膩感的抑制之觀點,設為5質量%以下較佳。 This result shows that the content of the component (B) is preferably 0.5% by mass or more from the viewpoint of improving the stability of emulsification, and is preferably 5% by mass or less from the viewpoint of suppressing the stickiness.
又,實施例97的防曬化妝品,相較於成分(C)之含量各別為0.05質量%及1.5質量%的實施例98及實施例99之防曬化妝品,乳化安定性、無黏膩感均較優異。 In addition, the sunscreen cosmetics of Example 97, compared with the sunscreen cosmetics of Examples 98 and 99 with the contents of component (C) being 0.05% by mass and 1.5% by mass, respectively, had better emulsion stability and no stickiness. Excellent.
該結果顯示成分(C)之含量,從乳化安定性之提升的觀點,設為0.07質量%以上較佳,而且,從黏膩感的抑制之觀點,設為1質量%以下較佳。 This result shows that the content of the component (C) is preferably 0.07% by mass or more from the viewpoint of improvement in emulsification stability, and is preferably 1% by mass or less from the viewpoint of suppression of stickiness.
如表11所示,固定三仙膠與兩親媒性共聚物的含量,變更種種1,3-丁二醇(促進性多元醇)及丙三醇(抑制性多元醇)的含量,製備實施例103~123之本發明的組成物。各別的實施例之1,3-丁二醇與丙三醇的含量,以三仙膠與兩親媒性共聚物的總量之關係,如第5圖所示之以3成分系相圖表示而調整。 As shown in Table 11, the content of Sanxian gum and amphiphilic copolymer was fixed, and the contents of various 1,3-butanediols (promoting polyols) and glycerin (inhibiting polyols) were changed to prepare and implement Examples 103 to 123 of the composition of the present invention. The relationship between the content of 1,3-butanediol and glycerin in each of the various examples is based on the relationship between the total amount of tri-xanthan gum and the amphiphilic copolymer, as shown in Figure 5 with a 3-component phase diagram Adjustments.
再者,作為兩親媒性共聚物,使用將疏水性單體之二異硬脂酸甘油酯甲基丙烯酸酯與親水性單體之甲基丙烯酸甲氧酯PEG-23,以約3:7的莫耳比共聚合之平均分子量61000的(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物。 Furthermore, as the amphiphilic copolymer, glyceryl diisostearate methacrylate, which is a hydrophobic monomer, and methoxymethacrylate PEG-23, which is a hydrophilic monomer, are used at a ratio of about 3:7 (Molar ratio copolymerized with an average molecular weight of 61,000 (glyceryl diisostearate methacrylate/methoxymethacrylate PEG-23) copolymer.
又,在以下的試驗例中,為了使利用顯微鏡的海島結構之觀察變容易,使用將螢光探針「NBD-COCl」化學地導入之(甘油基二異硬脂酸酯甲基丙烯酸酯/甲基丙烯酸甲氧酯PEG-23)共聚物,製備組成物。 In the following test examples, in order to facilitate the observation of the sea-island structure using a microscope, a fluorescent probe "NBD-COCl" was chemically introduced (glyceryl diisostearate methacrylate/ Methacrylate PEG-23) copolymer to prepare a composition.
藉由將約0.5g之實施例103~123的組成物塗布於載玻片上之約1.5cm×1.5cm的範圍,在40℃放置3天,使組成物中之水分蒸發,在載玻片上形成被膜。將如此進行而形成之實施例103~123的被膜之構成藉由共軛焦雷射掃描顯微鏡進行觀察。 By applying about 0.5 g of the composition of Examples 103 to 123 on a glass slide in the range of about 1.5 cm×1.5 cm, and leaving it at 40° C. for 3 days to evaporate the water in the composition to form on the glass slide Envelope. The configuration of the coatings of Examples 103 to 123 thus formed was observed with a conjugate laser scanning microscope.
其結果,任一之組成物均形成海島結構。在第6圖表示實施例105、106、108、111、113、114、115、119、120、122、123之組成物的顯微鏡照片。 As a result, any of the components forms an island structure. FIG. 6 shows micrographs of the compositions of Examples 105, 106, 108, 111, 113, 114, 115, 119, 120, 122, and 123.
如第6圖所示,實施例115、119及120的組成物中,看到島粒子之凝聚,觀察到很多平均粒徑超過10μm的島粒子、或長軸短軸比小於0.5的島粒子。 As shown in FIG. 6, in the compositions of Examples 115, 119, and 120, agglomeration of island particles was observed, and many island particles with an average particle diameter of more than 10 μm, or island particles with a long axis to short axis ratio of less than 0.5 were observed.
另一方面,實施例106~114的組成物,均沒有看到島粒子之凝聚,平均粒徑為1~5μm之細微的島粒子之個數粒度分布為80%以上。 On the other hand, in the compositions of Examples 106 to 114, no aggregation of island particles was observed, and the number of fine island particles with an average particle diameter of 1 to 5 μm had a particle size distribution of 80% or more.
該結果顯示第5圖的3成分系相圖所示之成分的總量之水溶性高分子與兩親媒性共聚物的總量為15質量%以下之組成物,不易引起島粒子之凝聚。 This result shows that a composition in which the total amount of the components shown in the three-component phase diagram of FIG. 5 in the total amount of the water-soluble polymer and the amphiphilic copolymer is 15% by mass or less is unlikely to cause aggregation of island particles.
又,沒有看到島粒子之凝聚,且平均粒徑為1~5μm之細微的島粒子之個數粒度分布為80%以上的實施例103~114之被膜的海相與島相之面積比為6:4~7:3。 In addition, no agglomeration of island particles was observed, and the number of fine island particles with an average particle diameter of 1 to 5 μm was 80% or more. The area ratio of the sea phase to island phase of the coatings of Examples 103 to 114 was 6: 4~7: 3.
將實施例103的組成物對48人的評價者使用,針對塗布於肌膚後於肌膚上形成的被膜,對於濕潤感、彈力感、柔軟度、柔嫩感、膨潤感、黏膩感,如第7圖所示,以7點為滿分進行評價。又,使用市售的化妝水及乳液作為比較對象。結果示於第7圖。 The composition of Example 103 was used by 48 evaluators. For the coating formed on the skin after being applied to the skin, the moist feeling, elasticity, softness, tenderness, swelling, and stickiness were as described in the seventh As shown in the figure, the evaluation is based on 7 points. In addition, commercially available lotions and lotions were used as comparison objects. The results are shown in Figure 7.
再者,作為化妝品,使用主要包含水,且包含多元醇、已知的水溶性高分子、防腐劑及萃取物類之一般物。又,作為乳液,使用包含礦物油、澳洲胡桃油等作為油相成分之水中油型乳化化妝品。 In addition, as cosmetics, general substances mainly containing water and containing polyols, known water-soluble polymers, preservatives and extracts are used. In addition, as an emulsion, an oil-in-water emulsified cosmetic containing mineral oil, walnut oil, etc. as an oil phase component is used.
如第7圖所示,針對將實施例103的組成物塗布於肌膚後形成的被膜,對於濕潤感、彈力感、柔軟度、柔嫩感、膨潤感之項目,得到與包含油劑的乳液同等或其以上的高評價。 As shown in FIG. 7, for the film formed by applying the composition of Example 103 to the skin, the items of moisturization, elasticity, softness, tenderness, and swelling were obtained in the same way as the emulsion containing oil. High evaluation above it.
又,如第7圖所示,實施例103的組成物形成的被膜,黏膩感與乳液相比,顯著低,且與化妝水為同程度。 Furthermore, as shown in FIG. 7, the film formed by the composition of Example 103 had a significantly less sticky feeling than the emulsion, and the same level as the lotion.
該結果顯示本發明的組成物,不論是否將水性成分作為主體,均可將具有如包含油劑之牛奶的觸感之被膜形成於肌膚上。特別是顯示本發明的組成物,可實現將水溶性之成分作為主體的化妝品中難以達成的保濕性與柔軟性之兼具。 This result shows that the composition of the present invention can form a film having a tactile sensation like milk containing an oil agent on the skin regardless of whether the aqueous component is the main component. In particular, it is shown that the composition of the present invention can achieve both moisturizing properties and softness that are difficult to achieve in cosmetics mainly composed of water-soluble components.
又,該結果顯示本發明的組成物,因為將水性成分作為主要構成,所以在包含油劑之化妝品看到的黏膩感等之缺點少。 In addition, this result shows that the composition of the present invention has an aqueous component as the main component, and therefore has few disadvantages such as stickiness felt in cosmetics containing oils.
依據表12的配方,製備實施例124及125之本發明的組成物。 According to the formulation of Table 12, the compositions of the present invention of Examples 124 and 125 were prepared.
將實施例124及125的組成物形成之被膜,根據與試驗例8同樣的手法,藉由顯微鏡進行觀察。其結果,與實施例103~114的被膜同樣地均沒有看到島粒子之凝聚,且平均粒徑為1~5μm之細微的島粒子之個數粒度分布為80%以上。 The coatings formed by the compositions of Examples 124 and 125 were observed with a microscope in the same manner as in Test Example 8. As a result, no aggregation of island particles was observed in the same manner as the coatings of Examples 103 to 114, and the number of fine island particles with an average particle diameter of 1 to 5 μm had a particle size distribution of 80% or more.
該結果顯示即使在使用聚季銨鹽-61及(甲基丙烯酸甘油基醯胺乙酯/甲基丙烯酸硬脂酯)共聚物作為兩親媒性共聚物的情況中,也可形成具有良好的海島結構之被膜。亦即,顯示即使在變更種種具有自疏水性單體衍生的構成單元與自親水性單體衍生之構成單元的兩親媒性共聚物之情況中,藉由組合水溶性高分子與水,也可製備可形成具有海島結構之被膜的組成物。 This result shows that even in the case of using a polyquaternium-61 and (glyceryl methacrylate ethyl ester/stearyl methacrylate) copolymer as an amphiphilic copolymer, a good The membrane of the island structure. That is, even in the case of changing various amphiphilic copolymers having a structural unit derived from a hydrophobic monomer and a structural unit derived from a hydrophilic monomer, by combining a water-soluble polymer and water, A composition capable of forming a coating film having a sea-island structure can be prepared.
解決第1課題的本發明之共聚物可應用於化妝品。 The copolymer of the present invention that solves the first problem can be applied to cosmetics.
解決第2課題的本發明可應用於乳化化妝品。 The present invention that solves the second problem can be applied to emulsified cosmetics.
解決第3、第4課題的本發明可應用於洗面乳。 The present invention that solves the third and fourth problems can be applied to a facial cleanser.
解決第5課題的本發明可應用於防曬化妝品。 The present invention that solves the fifth problem can be applied to sunscreen cosmetics.
解決第6課題的本發明可應用於無油的化妝品。 The present invention that solves the sixth problem can be applied to oil-free cosmetics.
Claims (9)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015096958A JP6815719B2 (en) | 2015-05-11 | 2015-05-11 | A film having a sea-island structure and a composition forming the film |
| JP2015-096958 | 2015-05-11 | ||
| JP2015-096957 | 2015-05-11 | ||
| JP2015096957A JP6608612B2 (en) | 2015-05-11 | 2015-05-11 | Copolymer |
| JP2015-106259 | 2015-05-26 | ||
| JP2015106259A JP6584141B2 (en) | 2015-05-26 | 2015-05-26 | Sunscreen cosmetics |
| JP2015-106260 | 2015-05-26 | ||
| JP2015106260A JP6618713B2 (en) | 2015-05-26 | 2015-05-26 | Skin cleanser |
| JP2015-113897 | 2015-06-04 | ||
| JP2015113897A JP6608622B2 (en) | 2015-06-04 | 2015-06-04 | Emulsified composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201708278A TW201708278A (en) | 2017-03-01 |
| TWI690541B true TWI690541B (en) | 2020-04-11 |
Family
ID=57248829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105114662A TWI690541B (en) | 2015-05-11 | 2016-05-11 | Copolymer |
Country Status (6)
| Country | Link |
|---|---|
| CN (5) | CN107614551A (en) |
| AU (1) | AU2016261772B2 (en) |
| HK (1) | HK1243720A1 (en) |
| SG (1) | SG11201709288VA (en) |
| TW (1) | TWI690541B (en) |
| WO (1) | WO2016182006A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7126345B2 (en) * | 2017-11-20 | 2022-08-26 | ポーラ化成工業株式会社 | Emulsion composition, production method, evaluation method and design method thereof, and polymer emulsifier |
| JP7143379B2 (en) * | 2020-09-30 | 2022-09-28 | 株式会社ダイセル | laminate |
| JP2022063857A (en) * | 2020-10-12 | 2022-04-22 | ポーラ化成工業株式会社 | Emulsion composition production method |
| CN114014969B (en) * | 2021-11-15 | 2023-08-11 | 上海华峰新材料研发科技有限公司 | Water-soluble polymer and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW530038B (en) * | 1998-12-03 | 2003-05-01 | Pola Chem Ind Inc | Skin application |
| JP2014009189A (en) * | 2012-06-29 | 2014-01-20 | Pola Chem Ind Inc | Skin external preparation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6055009A (en) * | 1983-09-07 | 1985-03-29 | Toyo Soda Mfg Co Ltd | Production of spherical porous hydrophilic crosslinked polymer particle |
| JP4964570B2 (en) * | 2006-12-04 | 2012-07-04 | ポーラ化成工業株式会社 | Novel copolymer and thickener comprising the copolymer |
| JP6061520B2 (en) * | 2012-06-29 | 2017-01-18 | ポーラ化成工業株式会社 | Water-soluble copolymer |
| JP5972098B2 (en) * | 2012-06-29 | 2016-08-17 | ポーラ化成工業株式会社 | Skin preparation |
| JP6144465B2 (en) * | 2012-06-29 | 2017-06-07 | ポーラ化成工業株式会社 | Topical skin preparation |
| JP5978059B2 (en) * | 2012-08-09 | 2016-08-24 | ポーラ化成工業株式会社 | Skin preparation |
| JP2014156414A (en) * | 2013-02-15 | 2014-08-28 | Pola Chem Ind Inc | External preparation for skin |
-
2016
- 2016-05-11 CN CN201680028097.4A patent/CN107614551A/en active Pending
- 2016-05-11 CN CN202010302838.1A patent/CN111329788B/en active Active
- 2016-05-11 CN CN202010302755.2A patent/CN111358713B/en active Active
- 2016-05-11 CN CN202010301977.2A patent/CN111481469B/en active Active
- 2016-05-11 SG SG11201709288VA patent/SG11201709288VA/en unknown
- 2016-05-11 AU AU2016261772A patent/AU2016261772B2/en active Active
- 2016-05-11 CN CN202010302836.2A patent/CN111329787B/en active Active
- 2016-05-11 TW TW105114662A patent/TWI690541B/en active
- 2016-05-11 WO PCT/JP2016/064071 patent/WO2016182006A1/en not_active Ceased
- 2016-05-11 HK HK18103131.4A patent/HK1243720A1/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW530038B (en) * | 1998-12-03 | 2003-05-01 | Pola Chem Ind Inc | Skin application |
| JP2014009189A (en) * | 2012-06-29 | 2014-01-20 | Pola Chem Ind Inc | Skin external preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111329787A (en) | 2020-06-26 |
| HK1243720A1 (en) | 2018-07-20 |
| CN111481469A (en) | 2020-08-04 |
| WO2016182006A1 (en) | 2016-11-17 |
| CN111329787B (en) | 2023-03-31 |
| CN111358713A (en) | 2020-07-03 |
| AU2016261772B2 (en) | 2019-12-19 |
| SG11201709288VA (en) | 2017-12-28 |
| CN107614551A (en) | 2018-01-19 |
| AU2016261772A1 (en) | 2017-11-30 |
| CN111329788A (en) | 2020-06-26 |
| CN111358713B (en) | 2023-09-19 |
| TW201708278A (en) | 2017-03-01 |
| CN111481469B (en) | 2023-09-19 |
| CN111329788B (en) | 2023-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2134786B1 (en) | Dispersion, gel and emulsification system | |
| TWI400093B (en) | Milk-white oil-in-water type emulsification clody skin cosmetics | |
| KR100649337B1 (en) | External composition | |
| WO2011001633A1 (en) | External preparation for the skin | |
| TW200900090A (en) | Skin cosmetic | |
| TWI690541B (en) | Copolymer | |
| JP7456866B2 (en) | aerosol cosmetics | |
| JP2016216426A (en) | Sunscreen cosmetics | |
| JP7754719B2 (en) | Cosmetic composition in the form of an oil-in-water emulsion | |
| JP2016210919A (en) | Film having sea-island structure and composition forming the same | |
| HK40023209B (en) | Copolymer | |
| HK40021031B (en) | Copolymer | |
| HK40023209A (en) | Copolymer | |
| HK40020910B (en) | Copolymer | |
| HK40020911B (en) | Copolymer | |
| HK40021031A (en) | Copolymer | |
| HK40020911A (en) | Copolymer | |
| HK40020910A (en) | Copolymer | |
| WO2019107089A1 (en) | Emulsion cosmetic | |
| WO2025178096A1 (en) | Urethane polymer, method for producing urethane polymer, and cosmetic containing urethane polymer | |
| WO2020175606A1 (en) | Composition for external preparation for skin | |
| JP2015071545A (en) | Oleaginous base, and cosmetic and external preparation using the same |